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Jinjing Li  
SUPRAMOLECULAR MODIFICATION OF SELECTED  




The author’s objective was to prepare new solid phases of the antitubercular drug isoxyl 
[specifically polymorphs, solvates, cyclodextrin (CD) inclusion complexes and cocrystals] 
and to isolate and characterise a range of solvated forms of the rifamycin antibiotics 
rifampicin and rifaximin.   
 
Two polymorphic phases and a solvated phase of isoxyl were successfully isolated by the 
recrystallisation method.  β- and γ-CD inclusion complexes with isoxyl as guest were 
prepared by the kneading technique.  No cocrystal of isoxyl was isolated in reactions between 
the drug and potential co-formers; instead, serendipitous precipitation of new polymorphs of 
two widely used co-formers, namely isonicotinamide and nicotinamide, occurred. These were 
isolated and studied in depth.   Eleven novel crystalline solvated forms of the rifamycin 
antibiotic rifampicin were prepared, as were two crystalline solvated forms of rifaximin.   
 
In this study, polymorphs and solvate crystals were analysed using thermal analysis methods 
(differential scanning calorimetry, thermogravimetric analysis and hot stage microscopy) and    
X-ray diffraction methods (on monocrystals and powders). The CD complexes were analysed 
using powder X-ray diffraction.  
  
For the polymorphic systems (comprising two isoxyl polymorphs, three isonicotinamide 
polymorphs and two nicotinamide polymorphs), the differences in their molecular 
conformations, crystal packing features and thermal properties were determined.  For each 
system, schematic Energy-Temperature diagrams showing the relative thermodynamic 
stabilities of the polymorphs were subsequently derived. In addition, for the two isoxyl 
polymorphs, spectroscopic studies (FTIR, 13C SSNMR) and solubility data were recorded, 
enabling a comprehensive characterisation of this dimorphic system.    
 
Solvated forms were investigated using a combination of thermal analysis and single crystal 
X-ray structural analysis, the latter revealing new isostructural solvate series and unusual 
molecular conformations. The invariant occurrence of the zwitterionic forms of the rifampicin 
and rifaximin molecules in the solid state was also established and the role of different solvent 
molecules in the solvate crystal structures was determined.  
 
Complexation between native CDs and isoxyl was established using powder X-ray diffraction 
and data from known isostructural CD inclusion complexes. This procedure also enabled 
deduction of approximate unit cell dimensions for each complex, crystal space groups and the 
structures of the host frameworks in the crystals.  In addition, solubility enhancement 
measurements using β- and γ-CDs with isoxyl indicated that the aqueous solubility of the 
drug in β-CD and γ-CD solutions increased by factors of 2-3 relative to its concentration in 
pure water.  
 
The new supramolecular phases that were prepared and characterised are significant in the 
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In this chapter, we briefly introduce and discuss four different supramolecular 
modification methods: polymorph generation, solvate formation, cyclodextrin inclusion 
and co-crystal formation.  We also introduce the antitubercular drugs selected for study, 
namely isoxyl, rifampicin and rifaximin, and list the objectives of their investigation via 
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Supramolecular Chemistry  
In 1987, the Nobel Prize in chemistry was awarded to Cram, Lehn and Pedersen for their 
respective work in the field of supramolecular chemistry whose importance had been 
established by that time.  In 1988, the definition of ‘supramolecular chemistry as 
chemistry beyond the molecule’ was introduced by Lehn in his Nobel lecture.1  In brief, 
non-bonded interactions play a crucial role in supramolecular chemistry.  These 
interactions include hydrogen bonding, π-π, C-H···π, van der Waals and hydrophobic 
interactions.   
 
Davy2 had discovered the chlorine clathrate hydrate [Cl2 · 6H2O] in 1811; this is 
considered to have initiated the concept of guest entrapment by a host.  The discovery of 
X-rays in 1895 and X-ray crystal structure analysis introduced in 1912 enhanced the 
growth of the field of structural chemistry.  In 1936, the field of supramolecular 
chemistry started developing with the application of crystallographic techniques by 
Kratky and Giacomello3 to elucidate the crystal structure of cholanic acid.  The formation 
of a crystal is a process of self-assembly of molecules.  This is regarded as a crucial 
concept of supramolecular chemistry.  Therefore, crystallography plays a key role in this 
field for the understanding of crystal structures, crystal growth and molecular 
interactions.  
 
The principles of supramolecular chemistry have been applied in a large variety of areas, 
as described in the monograph by Steed and Atwood.4  In this thesis, the focus is on 
supramolecular modification of selected drug molecules, through their conversion into 
different polymorphic forms, new solvated forms, cyclodextrin inclusion compounds and 
co-crystals.  The general aim of such transformation is to expand the solid-state chemistry 
landscape of these drugs by providing a variety of solid forms with different properties 
and possible applications.  The crucial feature of this approach is that on generating any 
‘supramolecular derivative’ of a drug, no covalent bonds are created or destroyed, and so 
the pharmacological activity of the drug is not compromised.   
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Polymorphism    
Polymorphism occurs when a single chemical compound crystallises in different 
molecular arrangements.5  Different polymorphs can display significant differences in 
their physical properties, such as density, hardness, melting points, solubility, dissolution 
rate, stabilities and even colour.6  A well-known example is graphite and diamond.  Both 
of them consist of the element carbon only but their vastly different structural 
arrangements lead to significantly different physical properties.     
 
Applications  
Polymorphism is very common in the pharmaceutical area.7  The production of most 
active pharmaceutical ingredients requires a crystallisation stage in the manufacturing 
process.8 However, drugs can exist in a number of polymorphic forms, each having 
different properties that may affect their pharmaceutical performance.  Furthermore, the 
various forms of the drug may interconvert under various conditions.   
 
Preparative Methods  
Theoretically, a given compound may adopt several different crystalline forms.  
However, there is no certainty in our ability to predict the occurrence or the properties of 
a new polymorph.  The onus is on the individual pharmaceutical scientist to apply due 
diligence in isolating and characterising the various solid-state forms of a new chemical 
entity.9  The most common method of isolating polymorphs is crystallisation from a large 
variety of  single solvents; this has been successful in many cases.  The other methods 
normally employed to obtain different polymorphic forms are crystallisation by 
evaporation from a binary mixture of solvents, precipitation using anti-solvents, 
sublimation, vapour diffusion, thermal treatment, crystallisation from the melt, grinding 
and thermal desolvation of crystalline solvates.  In some cases, the formation of different 
polymorphic crystals is very sensitive to subtle differences in the crystallisation 
conditions.  For instance, crystallisation of the α-polymorph of mannitol is favoured by a 
slow freezing rate, whereas the δ-polymorph is favoured by a fast freezing rate.9 
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Analytical Tools   
There is no strict limit for the range of analytical tools applicable to the study of 
polymorphs.  The range should be as broad as possible.10  Commonly used methods 
include X-ray diffraction, thermal and spectroscopic techniques.  These range from 
molecular to particulate and bulk techniques.11  For instance, X-ray diffraction methods 
can provide complete structural information at the molecular level.  Thermal analysis can 
help to establish the thermodynamic relationship between polymorphs, which is a critical 
step in selecting the appropriate form for development.12  Spectroscopic studies are 
normally applied to fully characterise polymorphs by probing solid-state properties at the 
spectral energy level in conjunction with X-ray diffraction analyses.13               
 
Structural Features   
Structural features are the ultimate criteria for distinguishing different polymorphs.14  
One type of polymorphism is called ‘conformational polymorphism’. Here, the molecule 
adopts significantly different conformations in its various crystal forms.15  The other type 
of polymorphism is termed ‘packing polymorphism’ and represents instances where 
conformationally rigid molecules can be assembled into different three-dimensional 
structures through the employment of different intermolecular interactions.16  Figure 1 
illustrates these types.  However, the overlaps between the two definitions are somewhat 
blurred since different packing arrangements can induce conformational differences in 
the molecules while the conformationally different molecules will inevitably packing in 
different arrangements.16 




Figure 1 Schematic diagrams illustrating the definitions of (a) conformational polymorphism and 
(b) packing polymorphism.  
 
Thermodynamic Relationships 
The transformation process from one polymorph into another polymorph is considered as 
a phase transition.17  The two forms are related enantiotropically if an endothermic 
transition is observed at some temperature, while the two forms are related 
monotropically if an exothermic transition occurs.18  In the enantiotropic system, the 
stability order of two polymorphs is reversible before and after the transition point.  In the 
monotropic system, the stability order of two polymorphs would remain the same at all 
temperatures.  The Gibbs free-energy of a phase is defined by  
   
G = H – TS                                                                                                                        (1)   
 
In this expression, H is the enthalpy, T the absolute temperature and S the entropy of the 
phase in question.19  The thermodynamic behaviour of the polymorphs may be 
summarised by constructing their qualitative energy vs temperature diagram,19, 20 as 
(a) 
(b) 
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shown in Figure 2.  At the absolute zero of temperature, G is equal to H.  Also, at the 
given temperature, the thermodynamically stable modification has the lowest value of 
G.20   
 
Figure 2 Semi-schematic E/T diagrams for (a) an enantiotropic and (b) a monotropic dimorphic 
system (adapted from reference 19).  The subscripts ‘f’, ‘t’ and ‘liq’ refer to ‘fusion’, ‘transition’ 
and ‘supercooled liquid’, respectively, whilst the subscripts ‘1’ and ‘2’ stand for the two 
polymorphs (the higher melting polymorph is indicated by ‘2’).      
 
Noticeably, the H isobars will always have a positive slope and never intersect while the 
G isobars will always have a negative slope and intersect at most once (only in the 
enantiotropic system).10  Accordingly, Burger and Ramberger developed four useful rules 
that enable distinction between enantiotropy and monotropy and these are adapted as 
follows:18, 21 
 
Heat-of-Transition Rule: (a) If an endothermic transition is observed at some 
temperature, it may be assumed that there is a transition point below it, i.e. the two forms 
are related enantiotropically. 
                                              (b) If an exothermic transition is observed at some 
temperature, it may be assumed that there is no transition point below it, i.e. the two 
forms are either related monotropically or the transition temperature is higher.   
 
Heat-of–Fusion rule: If the higher melting form has the lower heat of fusion the two 
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Density rule: If one modification of a molecular crystal has a lower density than the 
other, it may be assumed to be less stable at absolute zero. 
 
Infrared Rule: For polymorphs with strong hydrogen bonds, the one with the larger 
frequency for the highest frequency infrared absorption band will have the larger entropy.  
 
Interestingly, the heat of transition rule and the heat of fusion rule have rare exceptions 
while the density rule has many exceptions.22  There are a few pharmaceutical examples 
where actual experimental results violate the density rule, for instance: Neotame 
andydrate,22 Ribavirin,23, 24 chloropeocaine25 and  resorcinol.26  Therefore, the density 
rule can only be employed as a rough guide, whilst the heat of transition rule and the heat 
of fusion rule are the crucially reliable principles during the examination of 
thermodynamically related polymorphs.22 
    
Dissolution Rate Measurement  
As stated previously, the different polymorphic forms of drugs give rise to variations in 
solubility.27  Due to the poor solubility of a compound as well as the lack of awareness of 
the implications, or time constraints, a solubility measurement may often not be 
performed; instead, an effective dissolution rate measurement is employed.14  The 
dissolution rate measurement has often been studied in pure solvent; however, solvent 
mixtures may be used in cases of very poor solubility of some drugs.28  Among the 
polymorphs, any metastable form should display higher dissolution rate than a more 
stable form.29, 30  
 
Solvatomorphism 
Bernstein31 defined polymorphism as follows: ‘classification of a system as polymorphic 
would be if the crystal structures are different but lead to identical liquid and vapour 
states.’  This statement implies that solvates (including hydrates as a special type) belong 
to the category of polymorphs.  Solvates, therefore, have been described using the term 
‘pseudopolymorph’ which invoked continuing debate and discussion in the recent 
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literature32-34 on its use.  The origin of the ongoing dispute is the existence of polymorphs 
of solvates.  Specifically, solvates can adopt the same chemical composition (identical 
numbers of host and guest molecules) but crystallise in different structures.  For instance, 
the monohydrates of nitrofurantoin (an antibacterial compound) crystallise in two forms 
(Form 1: monoclinic P21/n and Form 2: orthorhombic Pbca).
35  Therefore, the term 
‘pseudopolymorph’ may not be appropriate to describe solvates of this type.  They are, in 
fact, polymorphic solvates.  Also, solvates can exist in different packing arrangements 
with different elemental compositions36 (identical host but different number or species of 
solvent molecules).  An example of this is a monohydrate and a 2.5-hydrate modification 
of terbutaline sulfate. These species have been characterised by single crystal X-ray 
diffraction methods and shown to have significantly different crystal structures.37  Hence, 
a new term ‘solvatomorphism’ has been introduced.  It is stated by Brittain38 that 
‘solvatomorphism is used to denote other crystal variations where the crystal structure of 
the substance is defined by other unit cells and where these unit cells differ in their 
elemental composition through the inclusion of one or more molecules of solvent.’                  
 
Preparative Methods and General Structural Features  
Generally, solvates are obtained by recrystallising the parent substance from single 
solvents or from solvent mixtures.  In some instances, more than one type of solvent 
molecule may be incorporated in the crystal of the solvates.  Sometimes, it is possible to 
exchange one solvent within the crystal structure for another9 from the vapour phase or 
liquor which contains another kind of solvent (guest exchange).  In other words, guests 
may be free to diffuse into or out of solvated crystals since there is no covalent bond to 
bind the solvent molecules to the host assemblies.39  This can sometimes even lead to a 
structural change in the crystal during the guest exchange process [Figure 3 (a)].  An 
example of this is the dramatic structural change occurring between the solvate of cholic 
acid with 2-fluorobenzyl alcohol (space group P21) and that with water (space group 
P6522) when the single crystal of the former was soaked in aqueous solution.
40  However, 
most commonly, guest exchange leads to the production of solvates that are isomorphous 
with the parent solvate.  More specifically, organic crystalline solvates may show a 
tendency to exchange the solvation solvent with water or another solvent when exposed 
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to ambient air or if left to equilibrate in another solution, without the host structures 
converting to a different crystalline form, thus maintaining the same packing arrangement 
as the original crystal41, 42 [Figure 3 (b)].  Generally, permanent channels or tunnels are 
formed in the solvate crystal structure and the solvent molecules may move freely 
through them.43  Furthermore, the channel can expand slightly or more extensively to 
take up additional moisture when solvate crystals are exposed to high humidity.  This 
may even lead to changes in the dimensions of the unit cells16 [Figure 3 (c)].  Due to the 
small size of water molecules, they can easily fill structural voids in crystals.  A known 
case is cromolyn sodium (disodium cromoglycate) hydrate crystals which can rapidly 
absorb (or lose) water as a continuous series of interstitial solid solutions, causing the 
lattice to expand reversibly, especially in the crystallographic b-direction.44  In addition, 
the guest molecules should have similar structural features, e.g. hydrogen bond donor or 
acceptor functionalities, to allow them to form similar interactions and they also should 
possess similar sizes to allow their facile movement through the channel.  
 
Figure 3 Schematic diagrams illustrating (a) a structural change in the crystal of a solvate during 
the guest exchange process, (b) isomorphic guest change and (c) expanded channel.  Solvent 
molecules are shown in green.  Different solvent molecules are indicated by different geometrical 










As mentioned above, isostructurality or isomorphism often occurs among two or even 
more solvates where the included solvent varies but the host framework is retained in 
each case.  A case in point is the compound o-acetamidobenzamide, which forms five 
isostructural solvates with 1-propanol, 1-butanol, 2-butanol, 1, 2-dichloroethane and   
1,4-dioxane.45  Furthermore, isostructurality not only occurs in solvates, but is a common 
phenomenon in other areas, e.g. cyclodextrin inclusion and co-crystal formation.  
Caira’s46 description of isostructurality states that ‘crystal isostructurality refers to 
identical or nearly identical packing arrays of chemically distinct compounds and is 
inversely related to the phenomenon of polymorphism, which instead, refers to the ability 
of a single compound to crystallise in different packing arrays.’  Therefore, the packing 
diagrams, until cell parameters and atomic coordinates would be similar in the crystal 
structures of isostructural compounds.47  The identification of isostructural compounds is 
readily achieved by recognising similarities in their respective powder X-ray diffraction 
patterns.48  
 
Further Structural Features of Solvates 
Bingham et al.49 classified the solvates of organic compounds into two broad categories 
as ‘cocrystals’ and ‘inclusion phases’.  In the former, the solvent molecules are essential 
components of the crystal by forming intermolecular interactions, e.g. strong hydrogen 
bonds with the host molecules.50, 51  In the latter, solvent molecules function as space 
fillers in the crystal and there are few or no significant intermolecular interactions 
between solvent and host molecules.50  The solvent molecules can fill the space in 
different ways; for instance, they may be entrapped within the lattice, forming clathrates52 
or they may locate along channels in the lattice, forming layers.  Furthermore, the 
solvates of clathrate structures are found to be more stable than those of layer 
structures.50  In addition, solvates are stabilised when the incorporated solvent molecules 
strengthen the intermolecular interactions in the crystal.50  
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Sometimes, incorporation of different solvent molecules can disturb the host molecules, 
forcing them to adjust their conformations, or even adopt unfavourable   
conformations.53-55  Furthermore, the same solvent molecules can also alter the host 
conformation depending on the different crystallisation conditions.  As an example, we 
cite the case of the three solvates (hemihydrate, dihydrate and formamide solvate) of 5-
(morpholinemethyl)-3-[(4-chlorobenzylidene)amino]-2-oxazolidinone.56  The host adopts 
an extended conformation in the hemihydrate while a bent conformation occurs in the 
dihydrate and formamide solvate.  Noticeably, water is the common solvent in the 
hemihydrate and dihydrate; however, the host molecules nevertheless adopt different 
conformations in the two cases.  In addition, host molecules with different conformations 
may be present in the same solvate structure.  
 
Characterisation Methods 
The common methods for the characterisation of solvates include thermal analysis, 
spectroscopic and X-ray diffraction methods57 which are often used in combination.  For 
thermal analysis techniques, DSC (differential scanning calorimety) is the basic thermal 
technique.  TGA (thermogravimetric analysis) plays an important role in characterising 
solvates since the mass change evaluation allows quantitative determinations of 
stoichiometry.58  In the situation of solvates which contain mixed solvents, combined 
techniques such as TG-IR or TG-MS (TGA with the aid of an evolved gas analyser e.g. 
infrared spectroscopy and mass spectrometry) are particularly helpful.  These methods 
can be used to identify each component of the solvent mixture incorporated in the 
crystal,16 since the identity of the volatile component is determined in situ.59-61  In the 
case of hydrates, Karl Fischer titration is an unequivocal method for quantifying water 
contents.60, 63  For spectroscopic techniques, 13C SSNMR (13C Solid-state Nuclear 
Magnetic Resonance spectroscopy) can usually be employed to detect organic solvents in  
solvates.60  However, the solvent molecules trapped in open cavities or located in layers 
may be highly mobile or even resemble liquid phase.63  This can lead to non-
stoichiometric solvates in which solvent molecules may not be observed by SSNMR.  
Noticeably, the high solvent mobility may give rise to disorder of the solvent molecules, 
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which introduces great difficulty in modelling them from single crystal X-ray diffraction 
data.  Therefore, X-ray analysis may not be able to ascertain that the systems are 
stoichiometric with respect to solvent molecules.64   Despite these difficulties, the identity 
of included solvent molecules is normally known from the preparation of the solvate, or 
can be confirmed spectroscopically.  Furthermore, the respective amounts of mixed 
solvents may also be determined with the combined use of thermogravimetric analysis.  
 
Applications  
Solvates exhibit different physical properties such as density, stability, dissolution rate or 
bioavailability47, 65 and different mechanical behaviours during processing (e.g. tableting, 
grinding) and product performance.66   In addition, solvates containing pharmaceutically 
acceptable solvents (e.g. water, ethanol) may have advantageous properties (e.g. 
favourable crystal morphology).  Hence, the formation of solvates is not only of extreme 
importance to experimental and theoretical structural chemists, but is also of crucial 
importance in the pharmaceutical industry.67, 68  
 
Desolvation and its Applications 
Solvates may desolvate under ambient conditions or require thermal activation for this 
process to occur.69  Furthermore, the desolvation process may proceed via two 
mechanisms: one-step desolvation (simultaneous release of all the guest molecules) and  
multi-step desolvation (step-wise release of the guest molecules giving rise to 
intermediate phases).69  In addition, the desolvation process provides an opportunity to 
draw meaningful comparisons of thermal quantities for a series of isostructural 
compounds since the host molecular framework is constant in these compounds.     
 
The desolvation process can lead to several types of solid forms.  Examples include 
isomorphic desolvates which retain the same overall molecular packing as the parent 
solvate,60, 61 the same polymorph from which the solvate was prepared but one having a 
different texture, which may give rise to the improvement of certain properties (such as 
flowability and uniformity of particle size),70 amorphous material with higher free-energy 
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and solubility,71 or even an entirely new polymorph of the host.  If spontaneous 
desolvation were to go undetected, the resulting form might present undesirable 
properties.72  Eventually, these could influence the manufacturing process, dissolution 
rate, storage stability and bioavailability of pharmaceuticals.73   
 
The desolvation/desorption and resolvation/resorption processes that occur in molecular 
crystals may also allow the storage or transportation of guest molecules, for instance, 
organic compounds, gas and water.74   
 
Cyclodextrin Inclusion  
Cyclodextrins [hereinafter CDs] are macrocyclic oligosugars composed of glucopyranose 
units varying in number due to the unspecificity of the enzyme action involved in their 
production from starch.75, 76  The CDs have significance in both pure and applied research 
due to their ability to selectively form inclusion complexes with other molecules, ions or 
even radicals.77  The simplest CDs consist of 6, 7 or 8 glucosidic units and bear the 
names α-, β- and γ-CD, respectively (Figure 4).  Numerous CD derivatives have been 
synthesised in order to improve their complexing properties and to make them suitable 
for various applications, especially to increase the bioavailability of drugs which may be 
included in the CDs.77  
 
Figure 4 Schematic diagrams of (a) α-, (b) β- and (c) γ-CD 
 
 
(a) (b) (c) 
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Structural Features  
Figure 5 (a) includes a schematic diagram of the glucopyranose unit atom labelling.  The 
glucopyranose unit adopts a 4C1-chair conformation and can be considered as fairly 
rigid.78-80  The structure of the CD molecule is also reasonably rigid due to the presence 
of such chair conformations and the intramolecular ring of hydrogen bonds formed 
between the secondary hydroxyl groups of adjacent glucopyranose units.  However, there 
is conformational flexibility in the structures of CDs, reflected in the rotational freedom 
of the O6-H hydroxyl groups around the C5-C6 bond and the limited rotational 
movement around the C1-O4′-C4′ glycosidic link (the primed numbers refer to the 
adjacent glucose unit). 
 
Figure 5 Schematic diagrams of (a) glucopyranose unit labelling and (b) CD molecule showing 
the cavity, primary and secondary faces.   
 
The entire structure of the CD molecule adopts the shape of a hollow, truncated cone with 
the wide side being the secondary rim (O2-H and O3-H secondary hydroxyl groups) and 
the narrow side being the primary rim (O6-H primary hydroxyl groups), as shown in 
Figure 5 (b).  These hydroxyl groups render CDs soluble in aqueous solution while the 
internal wall of the cavity, which is lined with methine hydrogen atoms (C3-H and C5-
H), methylene (C6-H2), and the glycosidic O4 atoms, possesses a hydrophobic character.  
The important feature of CD molecules is their ability to encapsulate parts of, or entire, 
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A guest molecule with lower polarity than water has the potential to be included in the 
CD due to the hydrophobic property of the cavity, as shown in Figure 6.  However, the 
affinity of a guest towards a CD depends on various factors.  For instance, the guest 
molecule must be of the appropriate shape and size to fit into the cavity, sometimes even 
only partially.  Also, the guest will be favoured if it is able to hydrogen bond with the CD 
since no covalent bonds are formed or broken during the formation of a guest-CD 
complex.  One of the main driving forces of the complexation is the release of the higher 
enthalpy water molecules from the CD cavity.  The reason for this is that the replacement 
of enthalpy-rich water molecules by a suitable guest molecule in the cavity will result in 
lowering the energy of the system.  Several factors aimed at elucidating the driving forces 
for complexation have been considered, including van der Waals forces, hydrophobic 
interactions and hydrogen bonding.  However, the nature of the guest decides the extent 
to which each of these factors contributes to host-guest binding.78 
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Isostructurality, as mentioned earlier, refers to two or more crystalline phases having 
similar unit cell dimensions, the same space group and common moieties having almost 
identical atomic co-ordinates.81  Thus, isostructural compounds would adopt nearly 
identical packing arrangements and display nearly superimposable Powder X-ray 
diffraction (PXRD) patterns.  Because CD inclusion complexes tend to crystallise in 
various isostructural series, the use of PXRD for their definitive characterisation has 
become possible.81, 82  PXRD is therefore a crucial tool in confirming the successful 
complexation between a CD and a guest and identification of complex phases in the 
absence of single crystal X-ray data.  
 
Applications 
Over the past twenty years, CDs have been applied in a variety of areas, such as the 
pharmaceutical, food, pesticide, biomedical and analytical industries.88  However, since 
the aim of this study was supramolecular modification of different drugs, the 
pharmaceutical applications of CDs are most relevant to the present discussion.       
 
The most frequent use of CDs in the pharmaceutical area includes (i) improvement of 
certain properties of water-insoluble drugs, such as their solubility, dissolution rate, 
stability and bioavailability,84 (ii) control of the rate of drug release when the CD 
functions as drug carrier, thus increasing the duration of effectiveness,85 (iii) 
improvement in the stability of several labile drugs against hydrolysis, oxidation and 
photodecomposition,86 and (iiii) stabilisation of volatile drugs, suppression of unpleasant 
odours or tastes of certain drugs, and reduction of some adverse side effects (e.g. 
gastrointestinal ulceration).    
 
An example of a drug to which CD technology has been applied is praziquantel (PZQ), 
the drug of choice for the treatment of schistosomiasis.  Due to its low aqueous solubility, 
large doses are required to achieve adequate concentrations at the target sites.  However, 
the aqueous solubility of PZQ was significantly improved by forming inclusion 
complexes with α-, β- and γ-CDs.  Specifically, the dissolution rate of PZQ from α-, β- 
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and γ-CD complexes was 2.6-, 5- and 8-fold greater, respectively, than that of the pure 
drug.87 
 
Cocrystals   
The term ‘cocrystals’ has been widely used in the last twenty years.  However, the 
definition of a ‘cocrystal’ is still under discussion and remains a matter of topical 
debate.88  A so-called ‘cocrystal’, which might be obtained by experiment, contains at 
least two distinct species connected by intermolecular forces.89  The nature of this force is 
the major difference between the formation of cocrystals and salts.  In a salt, proton 
transfer from one molecule to the partner molecule occurs, yielding ions that are held 
together by electrostatic interactions.  Instead, in a cocrystal, the individual components 
retain their electrical neutrality and are typically associated via hydrogen bonding.88  It 
should be noted that the term ‘cocrystal’ as defined here is quite different from that used 
by Bingham et al.49 to describe a particular category of solvates, as mentioned in the 
earlier section on Solvatomorphism.  In the case of solvates, one component is a solvent 
at room temperature whereas in the case of the cocrystals described here, molecules 
involved in their formation are both solid at room temperature and atmospheric 
pressure.88  
 
Pharmaceutical Application          
Co-crystals exhibit different physicochemical properties from those of the free 
component. Properties affected include solubility, dissolution rate, chemical stability, 
meting point and hygroscopicity.  Many active pharmaceutical ingredients (APIs)90 can 
form molecular complexes (‘cocrystals’) with other more soluble and pharmaceutically 
acceptable molecules91 (co-crystal formers), of which there are over a hundred solid 
materials classified as ‘generally regarded as safe’ (GRAS).88  This presents an 
opportunity to tailor the properties of a solid-state dosage form at the molecular level.90  
Also, during the co-crystal preparation, it is a common to employ so-called ‘green’ 
methods, i.e. co-grinding of the solid API and the co-crystal former.  Therefore, the 
pharmaceutical co-crystals offer enormous potential to provide new, stable structures of 
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novel API forms.  This introduces a significant opportunity for improving the diversity 
and performance of drug compounds without breaking or making covalent bonds.88, 90  
Figure 7 illustrates the formation of a so-called ‘pharmaceutical cocrystal’.  
 
Figure 7 Schematic diagram of the formation of a cocrystal compound in the pharmaceutical area 
 
In this example, the anticonvulsant carbamazepine (CBZ) reacts with a GRAS co-former, 
namely saccharin, to form a co-crystal.  Here, the hydrogen bonding between the partner 
molecules is complementary and produces a motif called a ‘synthon’ in this case a 
‘heterosynthon’, since the H-bonding functionalities of the partners are different.  
 
Sometimes, a new polymorph of either or both of the cocrystal partners results during the 
attempted preparation of a cocrystal since one of the components may act to enhance or 
inhibit the nucleation and/or growth of a particular form of the other component rather 
than act to form a co-crystal.92   A case of this is the isolation by Rafilovich et al.93 of four 
polymorphs of benzidine (a compound to treat bladder and pancreatic cancer) during their 
attempts to prepare co-crystals of benzidine with triphenylphosphine oxide . 
 
Antitubercular Drugs Selected for Study  
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis which is a 
bacterium that can be spread through the air.  The World Health Organization (WHO) 
estimates that there are nearly 2 million deaths from tuberculosis annually.94  The disease 
ranks second as an infectious cause of human death (the first one is AIDS, caused by the 
human immunodeficiency virus),94 and occurs primarily in developing countries, 
especially Asian and African countries.  Although several drugs [e.g. isoxyl, isoniazid 
+ 
saccharin  CBZ  heterosynthon   
Chapter 1: Introduction  
 
 19 
(INH), ethionamide (ETH) and rifamycins] have been employed to successfully cure the 
disease, the problem of drug resistance and the continuing rise in disease incidence have 
promoted research on the modification of the existing drugs.95  In this study, 
supramolecular modification was carried out on the antitubercular drugs isoxyl, 
rifampicin and rifaximin.  
 
Isoxyl  
Isoxyl (Thiocarlide; N, N′-[4-(3-Methylbutoxy)phenyl]thiourea; 4, 4′-bis(isopentyloxy) 
thiocarbanilide; 4, 4′-di(isoamyloxy)thiocarbanilide; 1, 3-bis(p-isoamyloxyphenyl)-2-
thiourea; thiocarlide; DATC; Datanil (Wander); Disocarban) is a poorly water soluble 
(dissolution rate-limiting) thiourea derivative that was used in the 1960s to successfully 
treat tuberculosis.96  Figure 8 shows the chemical structure of the compound.  
 
Figure 8 Chemical structure of isoxyl 
 
Isoxyl has considerable anti-mycobacterial activity in vitro and is effective against multi-
drug resistant strains of Mycobacterium tuberculosis in the range of 1-10 µg/ml.95 
Specifically, isoxyl strongly inhibits the mycolic acid synthesis of Mycobacterium bovis 
during six hours of exposure which is similar to INH and ETH, two other prominent anti-
TB drugs.95, 96  However, unlike INH and ETH, isoxyl also partially inhibits the synthesis 
of fatty acids of free lipid, which are stimulated by INH and ETH.95  Furthermore, isoxyl 
shows no acute toxicity against primary macrophage cell cultures as demonstrated by 
diminution of redox activity.95 
 
Recently, there has been renewed interest in isoxyl.  In 2003, its activity against a range 





Chapter 1: Introduction  
 
 20 
isoxyl was finally elucidated.98  Also, new derivatives of isoxyl were synthesised in 
200699 and 2008.100  These developments motivated our revisiting isoxyl in this study.  
 
Another cogent reason for a re-investigation of the polymorphism of isoxyl is as follows. 
The crystal polymorphism of isoxyl was investigated by Csonka-Horvai et al. in 1971.101  
Two polymorphic phases α and β were isolated.  Their unit cell dimensions were 
determined from X-ray diffraction photographs and crude structural arrangements were 
postulated on the basis of these unit cell data.  However, no attempts to obtain accurate 
crystal and molecular structures for these phases followed.  These authors also 
investigated a thermal transformation between the two phases and determined the melting 
point of the stable form as ~140 oC.  This temperature is consistent with the melting point 
of isoxyl measured by Hearn et al.102 (141.5 oC) in 2006.  However, Buu-Hoi et al.103 
reported the melting point of isoxyl as 148-149oC in 1953.  These conflicting results give 
rise to the possible suspicion of the existence of another polymorphic phase of isoxyl 
which may melt in the range 148-149oC.  Such inconsistencies arising in previous studies 
of isoxyl polymorphs therefore also motivated the more detailed investigation presented 
in this thesis.  
 
Rifampicin and Rifaximin  
Rifamycins belong to the family of naphthalenic ansamycins and they display a broad 
spectrum of antibiotic activity against a large variety of organisms.104  The structural 
studies on rifamycins are of great interest to researchers and to the pharmaceutical 
industry.  A great number of chemical modifications to the structure of rifamycin have 
been made.105  These derivatives share a common structural feature comprising a 
naphthoquinonic chromophore and a 17-membered ansa chain and differ in the type of 
substituents R1 and R2 attached to the chromophore at C3/C4,105 as shown in Figure 9.  
Currently-marketed rifamycins include rifampicin, rifaximin, rifapentine and rifabutin.104   
Rifampicin and rifaximin are used to treat tuberculosis and diarrhoea caused by E. coli.  
Isolation and unequivocal characterisation of new solid forms of these drugs provides 
physicochemical data that are relevant in the context of their processing, formulation and 
performance. 




Figure 9 Chemical structure of rifamycin derivatives.  
 
Rifampicin  
Rifampicin (rifampin, rifaldazine, R/AMP, Rofact and 5,6,9,17,19,21-Hexahydroxy-23-
methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-
2,7-(epoxypentadeca[1,11,13]trienimino)-naphtho[2,1-b]furan-1,11(2H)-dione21-acetate) 
is a semisynthetic derivative of rifamycin.  Figure 10 shows the chemical structure of 
rifampicin.  
 
Figure 10 Chemical structure of rifampicin 
 
The drug was introduced in 1967 and since then it has functioned as part of the standard 
therapy and an essential component to treat TB.106  It has also shown excellent oral 
bioavailability since its therapeutic concentrations  can be achieved 2 to 4 hours after oral 
administration and it is well distributed throughout body tissue.107  However, spontaneous 
resistance against rifampicin from TB strains develops quite rapidly.108     
 
The polymorphism of rifampicin had been investigated in 1977 by Pelizza et al.109 who 
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analysis, IR spectroscopy and PXRD.  In 2000, Henwood et al.110 confirmed the 
existence of two forms which normally co-exist in the commercial sample powder.  In 
2001, Santos et al.111 reported the NMR spectrum of rifampicin in CDCl3 solution.  This 
served as the reference for peak assignments by Agrawal et al.112 when they employed 
solid-state NMR spectroscopy for the investigation of two polymorphic forms in 2004.  
Furthermore, they determined the thermal relationship of these forms as monotropy and 
identified the possible intramolecular hydrogen bonds in the two forms by interpreting 
both NMR and IR spectra.  However, due to the fact that rifampicin predominantly 
crystallises as a hydrate with different numbers of water molecules incorporated in the 
crystal,109, 110 a water-free crystalline modification of rifampicin has not been structurally 
elucidated by X-ray analysis.  
 
The solvatomorphism of rifampicin is also of great interest since the physicochemical 
properties of rifampicin when recrystallised from various solvent systems may vary quite 
significantly.  In 1975, Gadret et al.113 reported the single crystal structure of rifampicin 
pentahydrate.  In 1977, Pelizza et al.109 reported the isolation of four distinct rifampicin 
solvates which were prepared respectively by heating an absolute ethanol suspension of 
an amorphous form and by crystallisation from a mixture of ethanol and water (1:1 v/v), 
THF (tetrahydrofuran) and CCl4.  The latter two solvents yielded a 1:9 THF solvate and a 
1:1 CCl4 solvate.   In 2001, Henwood et al.
114 reported the isolation of a monohydrate and 
a dihydrate of rifampicin and a 1:1 rifampicin • acetone solvate and a 1:2 rifampicin • 2-
pyrrolidone solvate.  To date, although nine rifampicin solvates have been isolated, the 




Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazo [5,4-c]rifamycin SV, Xifaxan, 
Normix, Flonorm, Redactiv, Zaxine, Rifacol and Spiraxin) belongs to a new generation 
of semi-synthetic derivatives of rifamycin with improved pharmaceutical properties.  The 
drug was first described in 1982 and was introduced onto the Italian market five years 
later, then subsequently introduced into other European countries and licensed in some 
northern African and Asian areas as well as in Mexico.115  The use of the compound for 
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the treatment of infectious diarrhoea in the traveller was approved by the U.S. Food and 
Drug Administration in 2004.115  It is a promising new oral drug in the treatment of TB 
and it is characterised by a wide spectrum of antibacterial action with a good record of 
safety and efficacy.116  A unique property of rifaximin is its lack of systemic absorption.  
This is different from other derivatives of rifamycin which are orally administered 
antibiotics.  The poorly absorbable nature of rifaximin is due to an additional 
pyridoimidazole ring at C3 and C4, as shown in Figure 11.117  This ring also gives rise to 
the good safety profile of rifaximin and reduction of unwanted side effects.  
 
Figure 11 Chemical structure of rifaximin  
 
Five distinct hydrates of rifaximin were prepared by Visocomi et al.118 via modification 
of the drying conditions.  These five hydrates were identified on the basis of their PXRD 
patterns and they were characterised by solid-state 13C NMR and IR spectroscopy.  
Furthermore, these distinct crystalline forms of rifaximin displayed very different 
bioavailabilities which promoted the need for putting appropriate manufacturing and 
analytical procedures in place to consistently yield rifaximin of the required crystalline 
structure.118  In addition, single-crystal X-ray diffraction characterisation was carried out 
on one of the hydrates (rifaximin tetrahydrate) by Bacchi et al.119 in 2008.         
 
Objectives of the Study 
The first aim of this study was to attempt preparation of polymorphs, solvates, 
cyclodextrin complexes and cocrystals of isoxyl.  The proposed investigation of the solid-
state features of the modified phases included determination of differences in the 
structural features among different polymorphs, establishment of the thermal 
C3 
C4 
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relationships among polymorphs and confirmation of successful isolation of cyclodextrin 
complexes and cocrystals. 
 
The other important objective of the present study was to isolate and characterise a range 
of solvated forms of rifampicin and rifaximin in order to systematise their solid-state 
chemistry.  Specific objectives included identification of novel crystalline forms of 
rifampicin and rifaximin, establishment of the nature of the molecules in the solid state 
(neutral/zwitterionic character) and determination of the role of different solvent 
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Isoxyl (formula: C23H32N2O2S, Mol. Mass: 400.58 g/mol) was purchased from 
Sapphire (Redfern NSM, Australia) and rifamycin compounds rifampicin (formula: 
C43H58N4O12, Mol. Mass: 822.94 g/mol) and rifaximin (formula: C43H51N3O11, Mol. 
Mass: 785.88 g/mol) were purchased from Lanospharma Laboratories Company 
(Chongqing, China).  
 
Methanol and ethanol were supplied by Sigma-Aldrich Chemie Gmbh (Steinheim, 
Germany).  1-propanol, iso-propanol, 1-butanol, ethylene glycol and 1,4-dioxane were 
obtained from Merck (Modderfontein, South Africa).  
 
β-cyclodextrin (formula: (C6H10O5)7, Mol. Mass: 1135.00 g/mol) and γ-cyclodextrin 
(formula: (C6H10O5)8, Mol. Mass: 1297.00 g/mol) were obtained from Cyclolab 
(Budapest, Hungary) and used as received. 
 
Cocrystal formers isonicotinamide (formula: C6H6N2O, Mol. Mass: 122.12 g/mol) and 
nicotinamide (formula: C6H6N2O, Mol. Mass: 122.12 g/mol) were purchased from 
Sigma-Aldrich Chemie Gmbh (Steinheim, Germany) and used as received.   
 
Preparation Methods 
Recrystallisation of raw materials from a large range of single solvent systems and 
binary solvent systems at different temperatures was the primary method for 
polymorph and solvate preparation.  Three different methods of crystal growth were 
carried out, namely slow cooling, slow evaporation and crystal growth at variable 
temperature.   
 
The kneading method was applied in attempts to prepare CD inclusion complexes and 
co-crystals.  The co-precipitation method was also employed.  This involved addition 
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of the guest compound to a saturated solution of the CD with stirring at elevated 
temperature, filtration and crystallisation.  
 
Full details of the preparation of individual species are given in the appropriate 
chapters. 
 
Thermal Analysis  
Thermal analysis methods, which measure the change in physical properties of a 
compound as a function of temperature, play a pivotal role in the investigation of 
polymorphism, solvatomorphism and inclusion complex chemistry.  In this study, 
thermal analysis methods included differential scanning calorimetry (DSC), 
thermogravimetric analysis (TGA) and hot stage microscopy (HSM).  All three 
methods were used in combination to investigate the complex behaviour of the 
compounds. 
   
DSC 
In power-compensated DSC, both the sample and a reference material are maintained 
at the same temperature throughout the controlled program.  DSC detects the energy 
difference between the actual sample and the reference sample by showing either an 
endothermic or an exothermic deviation from the baseline.  These endothermic and 
exothermic peaks are associated with a series of thermal events, such as guest release, 
phase transformation, recrystallisation, melting and decomposition.  Thus, the onset 
temperatures and enthalpy changes (area under the peak ∝∆H) of these thermal 
events can be determined.   
 
In this study, DSC measurements were performed on a Perkin-Elmer PC7-series 
instrument at scanning rate of 10 K/min (unless otherwise stated) under N2 as purge 
gas with a flow rate of 30 cm3/min.  A sealed and empty pan was used as a reference.  
The apparatus was calibrated against the melting points and fusion enthalpy of 
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standard materials, namely Indium (∆H = 28.5 J/g, m.p. = 156.6 oC) and Zinc (∆H = 
102.1 J/g, m.p. = 419.5 oC).  Prior to the analyses, 0.3 - 3.0 mg of samples were 
placed in a crimped and vented aluminum sample pan after surface-drying on filter 
paper.  Guest release from a solvate and some phase changes (e.g. fusion) are usually 
indicated by endothermic peaks while decomposition and recrystallisation processes 
appear as exothermic peaks. 
 
TGA 
TGA measures the changes in the sample mass with temperature recorded by a 
thermobalance.  In case of solvates and inclusion compounds containing volatile 
solvents, sample mass loss usually occurs before decomposition; this is generally due 
to the guest release.  Thus, TGA can be employed to determine the ratio of guest and 
host molecules in the original sample. 
 
In this work, TGA analysis was performed on a Mettler Toledo TGA/SDTA851e 
instrument using the STARe software (version 6.10).  The sample was heated at a 
scanning rate of 10 K/min under N2 as purge gas with a flow rate of 30 cm
3/min.  
Sample masses were between 0.8 and 3 mg.  The samples were gently crushed and 
thoroughly dried on a filter paper as rapidly as possible.  The weighed samples were 
placed in open aluminium oxide crucibles.  The temperature range over which mass 
loss occurred was determined based on the first derivative of the TGA trace.  
 
HSM 
HSM is a technique used to investigate visually the thermal behaviour of chemical 
compounds.  It usually serves as a complementary tool to TGA and DSC by visually 
recording the thermal events during the heating and cooling process.  For instance, 
guest loss is usually indicated by the appearance of bubbles when the sample is 
immersed in an inert medium (e.g. silicone oil), and polymorphic transition is usually 
shown by colour or opacity changes in crystals.   
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In this study, a Linkam TP92 manual temperature controller was linked to a Linkam 
THMS600 hot stage apparatus in order to perform the heating process at a controlled 
rate, whilst images of thermal events were captured by a real-time Sony Digital Hyper 
HAD colour video camera fitted to a Nikon SMZ-10 stereo-microscope and analysed 
by the Soft Imaging System program, analySIS.1  The temperature of a given event 
obtained from HSM is often slightly different from that obtained by DSC and TGA 
analysis.  This is due to the different heating environments of the various instruments, 
but it is also affected by differences in the particle sizes in the samples (single crystals 




Infrared Spectroscopy (FTIR) 
FTIR is a very sensitive technique that finds multiple uses in solid-state chemistry.  In 
the present study, it was used to probe the N-H stretching region for polymorphs of 
the antitubercular isoxyl.  Spectra were recorded using a Perkin Elmer 983 IR 
spectrophotometer and samples were run as Nujol mulls.   
 
13C Solid-state Nuclear Magnetic Resonance Spectroscopy (SSNMR) 
Solid-state NMR spectroscopy is gaining increasing importance in the determination 
of the structure, conformation and crystallographic features of polymorphs since 
different hydrogen bond motifs and variations in packing can introduce changes in the 
spatial relations of nuclei, leading to the differences in their resonance frequencies.2  
In the present study, the 13C solid state NMR spectra were acquired on a Varian 
VNMRS 500 MHz two-channel spectrometer using 4 mm zirconia rotors and a 4 mm 
ChemagneticsTM T3 HX MAS probe.  All cross-polarization (CP) spectra were 
recorded at ambient temperature with proton decoupling, a 4 µs 90° pulse, and a 
recycle delay of 10 s.  The acquisition time was 20ms and contact time for cross-
polarization was 2.5 ms.  The free induction decay had 1667 complex points, Fourier 
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transformed with 10 Hz line broadening. Magic-angle-spinning (MAS) was 
performed at 14 kHz and Adamantane was used as an external chemical shift standard 
where the downfield peak was referenced to 38.3 ppm. 
 
X-ray Diffraction Analysis 
 
Powder X-ray Diffraction (PXRD) 
The unique ‘fingerprint’ traces of each crystalline material can be recorded by PXRD, 
which is normally employed for the identification of new species of polymorphs, 
cyclodextrin inclusion complexes and cocrystals.  Variable temperature PXRD, used 
frequently in this study, enables processes such as desolvation of solvates and     
solid-solid transformations to be detected during programmed heating of the sample.  
Such information complements data from other techniques such TGA and DSC.  
 
In this study, powder X-ray diffraction patterns of samples were measured using a 
Philips PW1120/00 X-ray generator with nickel-filtered CuKα1 radiation (λ = 1.5418 
Å).  The generator, which was fitted with a Huber long fine-focus tube PW2273/20 
and a Huber Guinier Monochromator Series 611/15, produced X-ray at 20 mA and  
40 kV.  The PXRD patterns were then recorded using a Huber Imaging Plate Guinier 
Camera 670.  In case of variable temperature PXRD, the Huber High Temperature 
controller HTC 9634 unit was used with the capillary rotation device 670.2.  Samples 
were manually ground and packed into Markröhrchen non-diffracting glass capillaries 
supplied by Hilgenberg (Germany).  In this study, samples were exposed to radiation 
for 30 – 120 min depending on the quantity and quality of the sample.  A 2θ range of 
4 to 100.0o was used with a step size of 0.005o 2θ. 
 
Single Crystal X-ray Diffraction 
Single crystals of good quality (as indicated by their ability to extinguish plane-
polarized light uniformly) and suitable size were selected for intensity data 
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collections.  Two single crystal X-ray diffractometers were employed in this study: a 
Nonius Kappa CCD (Charge Coupled Device) Single Crystal X-ray Diffractometer 
and a Bruker KAPPA APEX II DUO diffractometer.      
 
The Nonius Kappa CCD four-circle diffractometer used graphite-monochromated 
MoKα radiation (λ = 0.71069 Å) produced at 50 kV and 30 mA with a Nonius FR590 
generator.  For polymorphic crystals, unit cell determinations were carried out both at 
ambient temperature (294 ± 2 K) as well as low temperature (173 ± 2 K) in order to 
test whether there were any phase changes during the cooling process.  Solvated 
crystals were quickly removed from mother liquor and coated with paratone N oil.   
Unit cell determinations were carried out directly at low temperature without delay, so 
as to avoid solvent loss.  The low temperatures were maintained by using a constant 
stream of nitrogen vapour produced by a Cryostream cooler (Oxford Cryosystems 
UK) at a flow rate of 20 cm3 /min.  The strategies for data collections were evaluated 
by using COLLECT3 software.  Intensity data were collected by the standard φ- and 
ω-scan techniques and they were scaled and reduced using DENZO-SMN4 software.  
For the isoxyl crystals, containing sulfur atoms, the data were subjected to absorption 
correction using the multi-scan program SADABS5.  
 
The Bruker KAPPA APEX II DUO diffractometer used graphite-monochromated 
Mo-Kα radiation (λ = 0.71069 Å).  The unit cells of the solvated crystals were 
determined at low temperature (100 ± 2 K) after their removal from the mother liquor. 
The data collections were carried out in the above temperature range using 
Cryostream coolers (Oxford Cryosystems UK).  Data reduction was performed using 
the program SAINT.6 
 
For the intensity data obtained from both instruments, the space group symmetry was 
determined by examining systematic absences in the data.  The program XPREP7 was 
employed to facilitate this process.  Examination of the mean │E2-1│values (E is the 
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normalised structure factor) enabled centrosymmetric (│E2-1│= 0.968) and non-
centrosymmetric (│E2-1│ = 0.736) space groups to be distinguished. 
   
Crystal structures that contained relatively small molecules (e.g. isoxyl, 
isonicotinamide and nicotinamide) were solved by direct methods using SHELXS-978 
and those containing large molecules (e.g. rifampicin and rifaximin) were solved with 
program SHELXD9.  All structures were refined by full-matrix least-squares 
techniques using SHELXH-9710 and the graphic interface program X-Seed11.  More 
detail concerning programs SHELXD9 and SHELXH-9710 follows below. 
 
SHELXD 
SHELXD9 is a program especially designed for ab initio solution of larger structural 
problems.  The solution strategy of this program is based on the dual-space iteration 
strategy, called ‘shake and bake’,12 which has solved structures of up to 1000 
independent atoms with native data to least 1.2 Å resolution.13   
 
SHELXH-97 
Model refinement was performed with program SHELXH-9710 which employs full-
matrix least-squares minimisation of the sum of the squares of the differences 
between observed and calculated intensities ( ( )222∑ − co FFw ).  The accuracy of the 
model being refined is expressed by the residual index, R, defined by R1 and wR2.  
The residue index R1 (see expression 1) represents the agreement between the 
observed (Fo) and the calculated (Fc) structure factor amplitudes for the refinement 
against F, whereas the residual index wR2 (see expression 2) gives the agreement 
between intensities for the refinement against F2, which is the base of the goodness-
of-fit parameter, S (defined later).   
R1 = ( ) ∑∑ − oco FFF         (1)                                
















 − ∑∑ oco FwFFw      (2) 
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The default weighting scheme w employed had the form:  
w = ( ) ( )[ ]bPaPFo ++ 2221 σ   
 
where P = ( )[ ] 320 22 co FF +,max  and the terms a and b were refined to produce 






co FFw  with sinθ and ( ) 2
1
maxo FF .   
 
S (Goodness-of-Fit) was also quoted for each structure and is defined as                      










 −∑ pnFFw co , where n is the number of reflections and p is the 
total number of parameters refined.  For a well-behaved model, S should be close to 
unity while the over-determination ratio ( pn ) should be ~ 10. 
 
Structure solution and refinement details for the individual structures will be 
described in the relevant chapters.  
 
Computer Packages 
The following computer packages were employed for the analysis of crystal 
structures.  
LAYER14 displays the intensity data as simulated precession photographs, which can 
be employed to determine the space group symmetry from systematic absences.    
 
POV-RAY15 was used to create all molecular packing diagrams. 
 
LAZY PULVERIX16 was employed to generate idealised PXRD patterns which were 
usually compared with the corresponding experimental PXRD traces to confirm the 
homogeneity of bulk materials and to prove the accuracy of the crystallographic 
models.  Input to this program included atomic fractional coordinates, thermal 
parameters and space group data.     
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Program SECTION17 was used to establish the topologies of voids in the host 
molecule frameworks that contained solvent molecules.  The host molecules were 
represented with their van der Waals radii after the guest molecules were artificially 
removed from the structural models.  The program then allowed one to plot sections 
through the unit cell along a selected axis at pre-determined intervals.   
X-Seed11 was employed as a graphical interface for SHELXH-9710, LAYER14, POV-
RAY15, LAZY PULVERIX16 and SECTION17. 
 
PLATON18 was used to calculate geometrical parameters (bond distances, bond 
angles and torsion angles) and the non-covalent interaction parameters (e.g. for 
hydrogen bonding, π···π-ring and C-H···π-ring interactions) as well as their associated 
standard deviations, for each structure.   
 
WINGX19 was used as an interface for PLATON18.   
 
The Cambridge Structural Database (CSD)20 was used to access the published 
crystal data for comparison with experimental data for the polymorphs and 
solvatomorphs presented in this study.  
 
Additional Resources   
Table 1 lists the final crystallographic data files of the compounds in this thesis.  
 
Table 1 File types contained in Appendix 3. 
File extensions/formats Contents 
.HKL Reflection data 
.RES SHELX co-ordinate data 
.CIF Crystallographic information file 
.FCF Structure factor tables 
.LIS Platon output 
.XL SHELX output file 
.SUP Tabulated supplementary data 
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Supramolecular Modification of Compound Isoxyl  
 
Attempts to isolate different polymorphic and solvatomorphic phases as well as 
cyclodextrin inclusion complexes and cocrystals for the compound isoxyl were carried 
out.  Based on the results achieved, this chapter is divided into four parts: 
 
Part One:  Two polymorphic phases of isoxyl (Form 1 and Form 2). 
Part Two:  A solvatomorphic phase of isoxyl (S1). 
Part Three: β- and γ-cyclodextrin complexes of isoxyl.   
Part Four: Attempts to form cocrystals with isoxyl were not successful.  However, a new 
polymorphic phase of a cocrystal former, isonicotinamide, and that of a second cocrystal 
former, nicotinamide, were successfully isolated. 
 
We describe here the investigation of the solid-state features of these new phases using 

















The experimental methods comprised mainly recrystallisation of the raw material from a 
wide range of single solvents and binary solvent systems at different temperatures, 
sublimation of the raw material at different temperatures, and solid-state grinding.  Table 
1 lists the outcomes of recrystallisation from a range of randomly selected 
solvents/solvent mixtures, as well as the results from other methods of polymorph 
preparation.  A full listing appears in Appendix 1.  
 
Table 1 Selected results of polymorph preparation using various methods 
Method  Concentration (mg/ml) Crystallising form 
Crystallisation of raw material from 
single solvent systems* 
    
Acetonitrile 1 Form 1 
Methanol 2 Form 1 
Formamide 1 Form 1 
Sec-butyl acetate 2 Form 1 
1,3-dioxolane 1 Form 1 
Ethyl isobutyrate 2 Form1 
Propyl chloride   2 Form 1 
n-propyl acetate 1 Form 1 
Ethyl propionate 2 Form 1 
Diacetamide 2 Form 1 
m-cresol 2 Form 1 
3-methyl-1-butanol 2 Form 2 
3-pentanone 2 Form 2 
3,3-dimethyl-2-butanone 1 Form 2 
Crystallisation from binary solvent 
systems* 
    
Water:Ethanol (1:9 v/v)  1 Form 1 
Water:Ethanol (2:8 v/v) 0.5 Form 2 
Vapor diffusion     
formamidea:2-propanolb  1 Form 1 
formamidea: cyclohexanolb 1 Form 1 
formamidea: ethanol 90%b 1 Form 1 
Solid-state grinding of either Form 1 or 
Form 2 
 No effect 
Sublimation  Form 1 + Form 2 
* Each solution was prepared at 10 oC lower than the boiling point of the solvent and filtered.  The solution 
was then allowed to cool to room temperature spontaneously for recystallisation to occur.  
a solvent, b precipitant 
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As is evident from Table 1, only two distinct crystalline forms of isoxyl were isolated.  
These were initially distinguished from significant differences in their PXRD patterns 




Hot Stage Microscopy  
HSM was used to analyse the thermal behaviour of the two isoxyl polymorphs [Form1 
(needle) and Form 2 (plate)] at a constant heating rate of 10 K/min.  Single crystals of 
the two polymorphs were immersed in silicone oil, placed side by side on a glass slide 
and photographs were taken in the temperature range 30 oC to 160 oC.  These HSM 
pictures are presented in Figure 1.  The Form 1 crystal became opaque at ~93 oC, 
indicating a possible phase change.  At the same time, the Form 2 crystal remained 
unchanged during the entire heating process before melting.  Both crystals melted at the 
same temperature, indicating that Form 1 had possibly transformed into Form 2 during 
the heating process.  
 
Figure 1 HSM photographs at various temperatures of the crystals of Form 1 and Form 2  
 
Differential Scanning Calorimetry and Thermogravimetric Analysis 
TGA analysis (not shown) indicated negligible mass loss for both Form 1 and Form 2 
before the decomposition event occurs, thus confirming that they are not solvates.  The 
DSC results for the two polymorphs are shown in Figure 2.  The accurate heats of 
transition (∆Ht) and fusion (∆Hf) as well as their extrapolated onset temperatures (Tt and 
Tf respectively) for Form 1 and Form 2 are presented in Table 2.  The DSC trace for 
Form 1 exhibited two endotherms, namely A and B.  The first endotherm A corresponds 
to a phase change, since no mass loss was observed in the TGA curve.  It also coincides 
with the observation from HSM of a change in the Form 1 crystal from colourless to 
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opaque (Figure 1).  The second endotherm B results from the melting of the resulting 
modification.  The DSC trace for Form 2 exhibited one endotherm B, which represents 
the melting of Form 2.  The fact that the Tf value of the endotherm B in Form 1 is very 
close to that in Form 2 provides evidence of a complete phase transformation from Form 
1 to Form 2 on heating.  In addition, the onset melting point of Form 2 can be 
determined as 142.7 oC. 
 
Figure 2 DSC traces for Form 1 and Form 2 
 
Table 2 DSC results for Form 1 and Form 2 
Polymorph onset Tt (oC) ∆Ht (J g
-1) onset Tf (oC) ∆Hf (J g
-1) 
Form 1 Peak A 91.7 ± 0.4 (n=2) 34.7 ± 1 (n=2) ----------- ----------- 
             Peak B ----------- ----------- 142.7 ± 0.2 (n=2) 96.2 ± 2 (n=2) 
Form 2 Peak B ----------- ----------- 142.1 ± 0.3 (n=2) 95.2 ± 2 (n=2) 
 
Variable Temperature Powder X-ray Diffraction 
It was first established by PXRD at ambient temperature (25oC) that the raw material 
corresponded to Form 1.  The PXRD patterns of Form 1 and Form 2 were then 
characterised as a function of temperature as shown in Figure 3.   
 
In the case of Form 1, the PXRD pattern was first recorded at temperature intervals of  
10 oC between 30 and 90 oC.  In this range, no evidence of phase transition was observed.  
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transformation of Form 1 to a new phase, later identified as Form 2 by PXRD analysis.   
This new phase persisted as Form 2 during the rest of the heating process.  
 
Figure 3 Variable temperature PXRD patterns of (a) Form 1 and (b) Form 2.   
 
In the case of Form 2, the PXRD pattern was recorded in steps of 10 K over the 
temperature range 30-170 oC.  No phase change was evident during this heating process. 
Form 2 melted at ~150 oC.  This temperature was different from the melting point of 
Form 2 determined by DSC (142.1 oC). (The difference can be attributed to the closed 
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Attempted Measurement of the Melting Point of Form 1 
The attempt to measure the melting point of Form 1 by DSC is shown in Figure 4.  A 
sample of Form 1 was heated from 30 oC to 160 oC at 10 K/min (run 1) while a second 
sample of Form 1 was heated from 30 oC to 180 oC at 50 K/min (run 2) in order to 
remove the endothermic peak A in run 1 which indicates the phase change from Form 1 
to Form 2.  The results for run 1 and run 2 are listed in Table 3.  
 
Figure 4 DSC curves for Form 1 at different heating rates of 10 (run 1, bottom) and 50 (run 2, 
top) K/min 
 




Run 1 Peak A 91.7 ± 0.4 (n=2) ----------- 
            Peak B ----------- 142.7 ± 0.2 (n=2) 
Run 2 Peak A' 39.0 ± 6 (n=2) ----------- 
            Peak B' ----------- 150.6 ± 1 (n=2) 
 
Although the sample was heated at a relatively high scanning rate in run 2, a broad 
endothermic peak A' can be observed.  This indicates that the phase change from Form 1 
to Form 2 still occurs during the heating process at high scanning rate. 
 
A notable observation was the significant broadening of the peaks in the DSC trace 
recorded at high scanning rate.  Also, Tf of peak B shifted to a higher temperature.  A 
possible explanation is that the high heating rate, which can involve higher temperature 
gradients within the sample, increased the size of the power signals due to an alteration in 
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Consequently, it was concluded that the melting point of Form 1 cannot be measured by 
the experimental methods used in this study.  
 
Stability Relationship between Form 1 and Form 2  
The stability relationship between the polymorphs is discussed in this section as DSC 
analyses, variable temperature PXRD analysis and hot stage microscopy were the main 
tools used for this investigation.  
 
Figure 2 and Table 2 show that an endothermic phase change occurred at 91.7 oC.  
According to the Burger and Ramberger Heat of Transition Rule,3 this would establish 
the stability relationship between Form 1 and Form 2 as enantiotropy with Form 1 being 
the stable form below 91.7 oC.  
 
In Figure 5, a single crystal of Form 2 and crystals of Form 1 were immersed in solvent 
mixture (water/ethanol 2:8 v/v) saturated with isoxyl at 25 oC.  Form 1 crystals gradually 
assembled on the surface of the Form 2 crystal; the latter was entirely covered by the 
former after 3 hours.  The single crystal of Form 2 completely changed into crystals of 
Form 1 after 4 hours.  These HSM photographs provide complementary evidence that 
Form 2 is the metastable modification at 25 oC.  
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Figure 5 HSM photographs of a crystal of Form 2 and crystals of Form 1 immersed in the 
mother liquor at 25oC for 4 hours.  The single crystals of both Form 1 and Form 2 are 
highlighted in red.   
 
Since an enantiotropic relationship between the two forms was determined, the G isobars 
of the two modifications would intersect and this specific intersection point would be 
defined as the thermodynamic transition point (91.7 oC).  Based on this, the order of 
stability of the two forms should differ between absolute zero and the melting point.  In 
addition, the variable temperature PXRD patterns illustrate that Form 2 is the stable 
modification after 91.7 oC (Figure 3).  Therefore, it can be assumed that Form 1 is the 
thermodynamically stable form from the absolute zero to the transition temperature.  The 
observation from Figure 5 gives experimental evidence to support this conclusion.  
Consequently, the relative positions of the G isobars of each form at absolute zero can be 
determined. 
 
Given the result that Form 2 is the thermodynamically stable form between the 
thermodynamic transition point and its melting point, Form 2 must have a higher melting 
point than Form 1.  Therefore, it can be predicted that Form 1 will melt in the 
temperature range 91.0 oC – 142.3 oC.  Based on the course of the G isobar of the liquid, 
the melting points of the modifications are indicated by the points of intersection of the G 
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An E/T diagram for the dimorphic system comprising Form 1 and Form 2 can therefore 
be constructed, as shown in Figure 6.  According to the Heat of Fusion Rule, the enthalpy 
of fusion of Form 1 corresponds approximately to the sum of that of Form 2 and the heat 
of transition.  Based on the values in Table 2, the enthalpy of fusion of Form 1 may thus 
be estimated as ~130 J g-1.   
 
Figure 6 An E/T diagram for the two polymorphs of isoxyl  
 
In conclusion, although the melting point of Form 1 cannot be measured directly, it can 
be predicted that it is lower than that of Form 2 by interpreting the E/T diagram.  
Furthermore, Form 1 can be confirmed as the thermodynamically stable form between 
absolute zero and 91.7 oC while Form 2 is the stable form between 91.7 oC and its 
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X-Ray Crystallographic Analysis of Forms 1 and 2  
 
Single Crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
A Nonius Kappa CCD four-circle diffractometer was employed to collect the intensity 
data for Form 1 and Form 2 at low temperature (LT, 173 K).  In both cases, the 
measurement of the unit cell dimensions was first performed at room temperature (RT, 
294 K) and then compared with those at LT to establish that no phase change occurred 
during the cooling process.  In both cases, the unit cell dimensions generally decreased 
slightly as expected but no phase changes were evident.  Form 1 was found to belong to 
the triclinic crystal system and therefore, the two possible space groups are P1 and P1.  
The latter was chosen on the basis of the intensity statistics |E2-1| = 0.966 provided by 
XPREP.5  The X-ray diffraction pattern of Form 2 possesses 2/m Laue symmetry and 
therefore it was assigned to the monoclinic crystal system.  The following reflection 
conditions were observed on inspection of X-ray intensity data: hkl: none; h0l: l = 2n and 
0k0: k = 2n.  These conditions indicate the space group P21/c, which is thus uniquely 
determined.  Successful refinements of the structures subsequently confirmed the correct 
choices of the space groups.  
 
Structure Solution and Refinement 
SHELXS-976 was used for the structure solution of Form 1 and Form 2.  Direct methods 
yielded the positions of all non-hydrogen atoms in the respective asymmetric units (a 
single molecule in each case).  All the non-hydrogen atoms were then refined 
isotropically on F2 with SHELXH-97.7   
 
All hydrogen atoms were located in difference Fourier syntheses.  The hydrogen atoms of 
the N-H functions were found in trigonal planar geometry.  Subsequently, all H atoms 
were added in idealised positions in a riding model with isotropic thermal parameters in 
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the range 1.2 – 1.5 times those of the parent atoms.  The latter were all refined 
anisotropically.  The crystal and refinement data are presented in Table 4. 
 
Table 4 Crystal and refinement data for Form 1 and Form 2  
Parameter Form 1  Form 2  
Formula unit C23H32N2O2S C23H32N2O2S 
Formula Weight / g mol-1 400.58 400.58 
Crystal system triclinic monoclinic 
Space group P1 P21/c 
a / Å 5.5321(2) 19.269(5) 
b / Å 13.7052(6) 8.981(2) 
c / Å 16.7032(7) 13.360(4) 
α / o 67.987(2) 90 
β / o 87.272(2) 95.912(9) 
γ / o 78.724(2) 90 
Volume / Å3 1150.96(8) 2299.72(1) 
Z 2 4 
Densitycalc/g cm
-3 1.1557 1.1568 
µ (MoKα) /mm
-1 0.160 0.160 
F (000) 432 864 
Crystal size /mm3 0.10x0.10x0.20 0.04x0.20x0.42 
Temperature / K 173(2) 173(2) 
Range scanned θ / o 1.02 ≤ θ ≤ 25.03 1.00 ≤ θ ≤ 25.35 
h: -6, 6 h: -23, 22 
k: -16, 16 k: -10, 10 
Index ranges 
l: -19, 19 l: -15, 16 
φ scan angle / o, frames 302 / 151 352 / 1112 
ω scan angle / o, frames 160 / 80 182.7 / 574 
Dx / mm 30 40 
No. of measured reflections 17188 17028 
No. of unique reflections 3907 3954 
No. of reflections with I > 2σ(I) 2524 2186 
No. of L.S. parameters 262 257 
Rint, Rσ 0.0819, 0.0821 0.0675, 0.0880 
S 1.052 1.016 
R1 (Fo > 4σ(Fo)) 0.0553 0.0665 
No. of reflections omitted 17 34 
wR2 (all reflections) 0.1221 0.1482 
a = 0.0420 a = 0.0840 Weighting scheme 
b = 0.3974 b = 1.0553 
(∆ / σ)mean < 0.001 < 0.001 








Conformation of the Isoxyl Molecules 







Figure 7 The numbering scheme for isoxyl 
 
Figure 8 shows the structures of the isoxyl molecules in Form 1 (top) and Form 2 
(bottom) and the principal torsion angle labels.  Significant conformational differences 
are evident from Figure 8.  
 
Figure 8 The molecular structures in Form 1 (top) and Form 2 (bottom)  
    
Table 5 lists all the torsion angles of the isoxyl molecule in Form 1 and Form 2.  Twelve 
principal torsion angles are identified as defining the conformation of the molecule.  The 
major conformational difference between the two molecules is reflected in the torsion 
angle τ1.  In Form 1, the atom S15 and the aromatic ring plane A are in a trans-
configuration with respect to the linking bond C14-N13 while the aromatic ring plane B 
(b) Form 2 
τ1 τ2 τ3 τ4 
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is cis with respect to atom S15.  Instead, in Form 2, both aromatic planes A and B are in 
a cis configuration with respect to S15.  
 
Table 5 Torsion angles for Form 1 and Form 2 
Torsion angle (o) Form 1 Form 2 
S15-C14-N13-C1           (τ1)        165.1(2) ---  trans                -8.0(5) --- cis 
S15-C14-N16-C17         (τ2)               -8.1(4) --- cis                 6.7(5) --- cis 
C3-C4-O7-C8                 (τ3)        -171.1(3) --- trans        -177.8(3) --- trans 
C21-C20-O23-C24         (τ4)         176.1(2) --- trans         169.4(3) --- trans 
C4-O7-C8-C9                 (τ5)        -179.4(2) --- trans       -171.8(3) --- trans 
C20-O23-C24-C25         (τ6)        -177.2(2) --- trans       -168.5(3) --- trans 
O7-C8-C9-C10               (τ7)        -174.0(3) --- trans      -54.0(5) --- gauche 
O23-C24-C25-C26         (τ8)        57.7(4) --- gauche      -58.3(4) --- gauche 
C8-C9-C10-C11             (τ9)        70.4(3) --- gauche         176.0(4) --- trans 
C8-C9-C10-C12             (τ10)        -165.6(3) --- trans       -57.0(6) --- gauche 
C24-C25-C26-C27         (τ11)        54.1(5) --- gauche       -61.5(5) --- gauche 
C24-C25-C26-C28         (τ12)          178.9(3) --- trans         176.1(4) --- trans 
C5-C4-O7-C8                    8.6(4)                      3.8(5) 
    C19-C20-O23-C24                   -3.0(4)                   -10.0(5) 
        C14-N13-C1-C6                131.7(3)                   -22.5(5) 
      C1-N13-C14-N16                 -15.8(4)                  175.9(3) 
        C14-N13-C1-C2                 -51.1(4)                  163.4(3) 
    C14-N16-C17-C22                 -58.6(4)                 -134.4(4) 
    C17-N16-C14-N13                172.8(3)                 -177.1(3) 
    C14-N16-C17-C18                125.4(3)                    49.1(5) 
            C2-C1-C6-C5                    0.3(4)                     -2.2(5) 
          N13-C1-C6-C5                177.5(3)                 -176.1(3) 
          N13-C1-C2-C3               -179.0(3)                  175.8(3) 
            C6-C1-C2-C3                   -1.7(4)                      1.3(5) 
            C1-C2-C3-C4                    1.3(5)                      0.3(6) 
            C2-C3-C4-C5                    0.6(5)                     -1.0(6) 
            C3-C4-C5-C6                   -2.0(4)                      0.1(6) 
            O7-C4-C5-C6                 178.3(3)                  178.4(4) 
            C4-C5-C6-C1                     1.6(4)                      1.5(6) 
    N16-C17-C18-C19                 177.2(3)                  178.7(3) 
    N16-C17-C22-C21                -177.3(3)                 -177.6(3) 
    C22- C17-C18-C19                     1.2(4)                      2.2(6) 
    C18- C17-C22-C21                    -1.3(4)                     -1.0(6) 
     C17-C18-C19-C20                    -0.1(4)                     -0.8(6) 
     C18-C19-C20-C21                    -0.9(4)                     -1.9(6) 
     C19-C20-C21-C22                      0.7(4)                      3.2(6) 
     O23-C20-C21-C22                 -178.5(2)                 -176.2(3) 
C20-C21-C22-C17                      0.3(4)                     -1.8(6) 
C2-C3-C4-O7                              -179.8(3)                 -179.5(3) 
C18-C19-C20-O23                       178.3(2)                  177.4(3) 
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This significant difference is emphasised in the overlay of the isoxyl molecules present in 
the two polymorphs in Figure 9.  The Form 1 molecule adopts a ‘trans-cis’ conformation 
while that of Form 2 adopts a ‘both-cis’ conformation.  Although the absolute values of 
torsion angles τ2 are very similar, the planes of the aromatic rings B are significantly 
inclined to one another [angle of intersection = 70.1(2)o]. 
 
Figure 9 An overlay of the central moiety N2CS of the isoxyl molecules in Form 1 (red) and 
Form 2 (black).  
 
Hydrogen Bond Interactions 
Table 6 lists all the hydrogen bond interactions for both polymorphs.  An intermolecular 
hydrogen bond N13-H13···S15 and an intramolecular hydrogen bond C26-H26···O23 are 
found in the structures of both Form 1 and Form 2.  Two other intramolecular hydrogen 
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Table 6 Hydrogen bonding interactions for Form 1 and Form 2a 
Hydrogen bond N···S,  C···S or C···O Distance (Å) Angle (o) Symmetry operatorb 
Form 1 
N13-H13···S15 3.364(2) 165.0 2-x,1-y,-z 
C26-H26···O23 2.926(5) 97.3 x, y, z 
Form 2 
N13-H13···S15 3.354(3) 137.0 1-x,-1/2+y,1/2-z 
N16-H16···S15 3.311(3) 135.0 1-x,-1/2+y,1/2-z 
C6-H6···S15 3.240(4) 122.0 x, y, z 
C26-H26···O23 2.928(5) 100.0 x, y, z 
C10-H10···O7 2.878(5) 99.0 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised positions in 
a riding model. 
b Symmetry operator applies to hydrogen bonding acceptors.  
 
Figure 10 illustrates the hydrogen bond interactions in the structures of Form 1 and 
Form 2.  In the structure of Form 1, the isoxyl molecules associate as centrosymmetric, 
hydrogen bonded dimers, the unique H-bond being N13-H13···S15i (i = 2-x, 1-y, -z).  The 
cyclic H-bonded pattern contains a total of eight atoms, two of them being donors and 
two being acceptors, and is hence designated as R 2 2 (8).
8, 9  Furthermore, the weak 
hydrogen bond C26-H26···O23 generates a ring that has a graph set analysis descriptor  
R1 1(5).
 8, 9   
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Figure 10 Hydrogen bond interactions in (a) Form 1 and (b) Form 2.  Atoms with gray labels 
have been symmetry-generated from their asymmetric unit counterparts.   
 
In the structure of Form 2,  the hydrogen bonding motif is of the α-network ‘tape’ 
variety,10 occurring in N, N'-diarylureas.  In the case of isoxyl, a chain results from 
bifurcated N-H···S (rather than N-H···O) hydrogen bonds between the NH donors and the 





1 (5), involving C-H donors in weak hydrogen bonds, are shown in 
their respective hydrogen bonded rings.8, 9  These hydrogen bonds stabilise the molecular 





(b) Form 2 
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The trans-cis conformation adopted by the molecule of Form 1 is associated with 
formation of only one chemically unique N-H···S hydrogen bond (involving N13 only).  
Instead, in Form 2, the both-cis conformation allows generation of the tape motif in 
which both N13 and N16 engage in intermolecular N-H···S hydrogen bonds.  Notably, in 
the Form 1 molecule, the two N-H functions are distinctly different, one engaging in H-
bonding and the other not, whereas in the Form 2 molecule, the two N-H functions are 
chemically equivalent, forming symmetrical N-H···S hydrogen bonds. 
 
Also noteworthy is the fact that the additional intramolecular C-H···S and C-H···O 
hydrogen bonds in Form 2 render the molecule more rigid.  The effects are respectively 
to reduce the rotational flexibility of one aromatic ring and to stabilise a folded 
conformation of the isoamyloxy moiety.   
  
Crystal Packing  
The packing diagrams of Form 1 are shown in Figure 11.  The centrosymmetric dimers 
pack with interdigitation of the isoamyloxy residues [Figure 11(a)].  All the molecules in 
Figure 11 (a) define a layer, as evident in the alternative view of Figure 11 (b) (layer 
labelled B).  Furthermore, no hydrogen bond interactions are observed between the layers 
shown in Figure 11 (b). 
 
Figure 11 Crystal packing diagrams for Form 1 viewed along (a) [100] and (b) [10-1].  








(b) [10-1] (a) [100] 
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Figure 12 illustrates a partial packing diagram for Form 2.  The N-H···S hydrogen bonds 
generate a ‘tape’ motif adopting a zigzag shape along the b-axis. 
 
Figure 12 Stereoview of crystal packing diagram for Form 2 viewed along [001].  Hydrogen 
bonds are shown as red dotted lines.  Hydrogen atoms have been omitted for clarity.  
 
Other than the hydrogen bonds described above, no other significant intermolecular 
interactions, such as π-π stacking, were found in the crystals of Forms 1 and 2. 
 
Comparative PXRD 
Figure 13 presents comparisons between the experimental PXRD patterns and those 
calculated from the single crystal X-ray structures (program Lazy Pulverix11) for both 
Form 1 and Form 2 of isoxyl.  
0 b 
ap 
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Figure 13 Calculated and experimental PXRD traces for (a) Form 1 and (b) Form 2. 
 
In both cases, the match between the experimental and calculated patterns is convincing.  
Specifically, the relative intensity distributions, numbers and 2θ-values of the peaks in 
these two patterns are in general agreement.  The slight shifts of the peaks in the 
computed PXRD patterns to higher 2θ-values are due to shrinkage of the crystal unit cells 
on cooling to 173 K, the temperature of X-ray intensity data collections.  The close 
agreement of experimental and computed patterns in both cases is an indication of the 
correctness of the respective single crystal X-ray structural models.  Also, these matches 
prove that the single crystals are representative of the respective bulk polymorphs. 
 
5 10 15 20 25 30 35 40
2θo
5 10 15 20 25 30 35 40
2θo
(a) Form 1  
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Fourier-transform Infrared Spectroscopy 
Two new torsion angles τA and τB are introduced in this section.  τA describes the rotation 
of atom H13 relative to atom S15 around the C14-N13 bond while τB describes the 
rotation of atom H16 relative to atom S15 around the C14-N16 bond (Figure 14).         
 
Figure 14 The numbering scheme of the central moiety in the isoxyl molecule and torsion angles 
τA and τB. 
 
Table 7 lists torsion angles τA and τB in the structures of Form 1 and Form 2.  The two 
S/NH configurations for the isoxyl molecule in Form 1 are cis- and trans-, and the 
configuration would be named cis-trans on this basis.  Instead, in Form 2, the 
configuration is both-trans. 
 
Table 7 Torsion angles τA and τB for Form 1 and Form 2
a 
Torsion angle (o) Form 1 Form 2 
S15-C14-N13-H13     (τA) -14.9  172.0  
S15-C14-N16-H16     (τB) 157.8  -173.3  
a The average e.s.d. value is 0.4o 
 
FTIR spectra for Form 1 and Form 2 as Nujol mulls are presented in Figure 15.  The 
investigation is focused on N-H stretching bands in the spectral range 3000 - 3450 cm-1.  
Both the traces of Form 1 and Form 2 present sharp bands at around 2825 and           
2925 cm-1, which are due to the Nujol mull.  Hearn et al.12 reported that isoxyl displays an 
IR N-H stretching band at 3270 cm-1.  The presence of a strong band at 3271 cm-1 in the 
spectrum of Form 2 therefore suggests that this phase corresponds to that reported by 
Hearn et al.  This identity is further supported by the similar melting points for these 
phases (142.1oC for Form 2, 140.5oC reported by Hearn et al.).  The presence of only one 





C14 τA τB 
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associated with the both-trans conformation in the Form 2 molecule, and their 
engagement in symmetrical intermolecular N-H···S hydrogen bonds (Figure 10). 
 
Figure 15 FTIR spectra for Form 1 (top) and Form 2 (bottom) in the N-H stretching region.  
 
In the IR spectrum of Form 1, there are two N-H stretching bands, one at ~3176 cm-1 and 
one at ~3319 cm-1.  Since the lower frequency corresponds to the cis configuration,13  the 
former band can be associated with the N13-H13 bond in the Form 1 molecule (Figure 
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N16-H16 bond.  These assignments are consistent with the X-ray structural results that 
revealed strong hydrogen bonding involving N13-H13 (expected at lower frequency) and 
no hydrogen bonding in the case of N16-H16.  
 
Based on the above analysis, Form 1 and Form 2 show distinctly different numbers and 
frequencies of peaks in the spectral range 3000-3450 cm-1, that both correlate with the    
X-ray structural data and allow them to be distinguished by FTIR spectroscopy. 
 
13C Solid-state Nuclear Magnetic Resonance Spectroscopy   
The purpose of recording the 13C SSNMR spectra of the polymorphic Forms 1 and 2 of 
the drug isoxyl was to establish whether they might differ sufficiently to allow this 
technique to be used for their identification.  In addition, it was desirable to reconcile the 
spectra with the single crystal X-ray structures determined in this study.  
 
13C SSNMR assignments were based on the solution NMR peak assignments and the 
corresponding shifts for polymorphs 1 and 2 are listed in Table 8.  The atom numbering 
scheme is shown in Figure 16 and the 13C SSNMR spectra in Figure 17. 
 





Solution NMR / 
ppm 
Form 1 
SSNMR / ppm 
Form 2 
SSNMR / ppm 
C1           C17 129.58 132.57, 130.47 132.25 
C2, C6     C18, C22 127.42 126.58  126.58 
C3, C5     C19, C21 115.17 115.13  114.27 
C4           C20 158.16 157.14 156.05 
C8           C24 66.634 63.84, 66.06  66.23, 65.74 
C9           C25 37.85 39.02, 38.22 39.51, 38.21 
C10         C26 24.98 25.06 25.46 
C11,C12  C27, C28 22.49 21.12,22.79, 
23.76, 24.57 
23.68, 22.99 
C14  180.89 180.58 174.39 
 
The first two columns of Table 8 indicate the sets of chemically equivalent carbon atoms, 
from which it is evident that in the solution 13C NMR spectrum, as many as nine distinct 
peaks can be expected, as was the case (third column).  A gross count of the number of 
resonances in the 13C SSNMR spectra (last two columns) reveals a similar number for 
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each of the polymorphs, closer inspection showing, however, that in each case, the 
resonances consist of a mixture of single and double peaks for the most part.  In a 
situation where there are e.g. two crystallographically independent molecules in the 
asymmetric unit, one would expect two closely spaced peaks for all resonances.  Since 
this is clearly not the case for either Form 1 or Form 2 one concludes that there is only 
one molecule in each of the respective asymmetric units.  This conclusion is consistent 
with the single crystal X-ray results for these polymorphs, which yielded Z′ = 1 molecule 
per asymmetric unit in both cases (Form 1, space group P1, Z = 2; Form 2, space group 
P21/c, Z = 4). 
 
One further concludes that since the peak doubling does not arise from 
crystallographically distinct molecules in either polymorph, they must originate from 
conformational and environmental differences only.  One of the primary results of the X-
ray diffraction analyses was the classification of Forms 1 and 2 as conformational 
polymorphs, the molecule in Form 1 adopting the unsymmetrical trans-cis conformation 
while that of Form 2 adopts the both-cis conformation (Figure 16).  It turns out that 
practically all of the features of the resonances in Figure 17 can be reconciled with 
significant features of the accurately known solid-state molecular conformations.  
 
Figure 16 Hydrogen bond interactions and the atom numbering scheme in (a) Form 1 and (b) 
Form 2. 
 
Starting from the centre of the molecule (C14), we note from Table 8 that the magnitude 
of the difference in the shifts for this atom in the two polymorphs is the largest of all such 
differences (|∆δ|~6.19 ppm).  This is readily explained, as the gross conformational 
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difference described above affects C14 most severely.  Considering now the pair C1, C17 
appearing as two separate peaks in Form 1 and a single peak in Form 2, this again is 
consistent with the respective asymmetric trans-cis conformation and the symmetrical 
both-cis conformation.          
 
 
Figure 17 13C SSNMR spectra of Form 1 and Form 2.  (The chemical shift at 122.73 ppm is due 
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For each of the two sets of aromatic carbon atoms C2, C6, C18, C22 and C3, C5, C19, 
C21, virtually parallel behaviour of the resonances is observed in both Forms 1 and 
Form 2 as far as frequency is concerned.  Interestingly, however, both resonances are 
significantly broader in Form 1.  These features can be attributed to some degree of 
phenyl ring vibration around the C1⋅⋅⋅⋅C4 axis, which is partially hindered in the Form 2 
crystal by the intramolecular C-H⋅⋅⋅S hydrogen bond, which tethers one of the phenyl 
rings of the isoxyl molecule to the sulfur atom.   
 
Resonances associated with the isoamyl moieties are divided into four sets in Table 8. 
Considering the first entry, for the pair C8, C24, we note that their resonances are split in 
both Forms 1 and 2, but that in the former |∆δ|~2.20 ppm while in the latter          
|∆δ|~0.49 ppm only.  The smaller difference can be reconciled with the two analogously 
folded chain conformations established in the Form 2 molecule by equivalent 
intramolecular C-H⋅⋅⋅O hydrogen bonds that produce the two R1 1(5) rings.  Instead, in 
Form 1, one isoamyloxy chain is folded but the other is extended.  Features of the 
resonances for the pairs C9, C25 and C10, C26 are very similar and unremarkable in both 
polymorphs. 
 
Finally, we note that each of the four terminal C atoms in the isoxyl molecule C11, C12 
C27, C28 in the Form 1 crystal produces a separate resonance while only two peaks 
appear for the Form 2 crystal.  Again, the higher multiplicity is associated with the 
asymmetry of the conformations of the two isoamyloxy residues in Form 1, while the 
lower multiplicity is consistent with the symmetrical, folded conformation of these chains 
in Form 2.  
 
Interestingly, the signal for the central atom C14 in Form 1 appears at virtually the same 
frequency as its counterpart in chloroform solution (180.58 vs 180.89 ppm) whereas in 
Form 2, the resonance for C14 is shifted to 174.39 ppm.  This presumably indicates that 
in chloroform solutions the preferred molecular conformation is the trans-cis 
conformation.  
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In summarising the results of this section, we note that the 13C SSNMR spectra of the two 
polymorphs are significantly different and that this technique is therefore capable of 
distinguishing these two crystalline forms.  Furthermore, while local environmental 
effects also play a role in determining the 13C resonance frequencies for this dimorphic 
system, practically all of the observed spectral differences can be reconciled with the 
accurately known conformational differences revealed by the X-ray crystal structures 
determined in this study.  
 
Solubility Determination 
The aqueous solubilities of Form 1 and Form 2 were determined by accurately weighing 
5-10 mg of each crystalline solid in a 4 ml amber HPLC vial with a screw cap. Three 
milliliters of milli-Q water was subsequently added.  Three samples were prepared for 
each analysis.  The samples were rotated at 15 rpm in a VWR hybridization oven (West 
Chester, PA) which was previously equilibrated at 30 °C.  After the predetermined time, 
the liquid in each vial was extracted using a sterile 5 ml luer-lok tip syringe fitted with a 
0.45 µm syringe filter and an 18 gauge needle.  The solutions were then analysed by 
determining the UV absorbance for each sample (in triplicate) at a wavelength 272 nm 
using a Cary UV-Vis Spectrophotometer (Palo Alto, CA).  The concentration of isoxyl in 
each solution was subsequently determined from the calibration curve described by         
y = 0.0448x – 0.1666 (R2 = 0.9997).  Due to the very limited solubility of isoxyl in water, 
a solvent ethanol/water (4:1 v/v) mixture was used for setting up this calibration curve.  
The solubilities of Form 1 and Form 2 were calculated by determining the averages of 
the concentrations of the three samples, and are summarised in Table 9. 
 
Table 9 The solubility results obtained for Form 1 and Form 2. 
Polymorph Sample 1 Sample 2 Sample 3 Average solubility (µg/ml) 
Form 1 3.47 3.89 3.26 3.5(3) 
Form 2 3.06 3.86 3.20 3.4(4) 
 
The results listed in Table 9 show that the equilibrium solubilities of the two polymorphs 
are not significantly different.  PXRD analysis was carried out to identify the undissolved 
powder before and after the dissolution analysis.  A noteworthy observation is that the 
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pattern of the undissolved sample of Form 2 is identical to the pattern of Form 1 while 
the pattern of the undissolved sample of Form 1 remains the same as the pattern of  
Form 1.  This suggests that a significant portion of Form 2 transformed into Form 1 
during the solubility analysis.  This corresponds to a solvent-mediated transformation 
from the metastable form at 25oC to the stable phase at that temperature.  
 
To explore the possible polymorphic transformation during the solubility analysis, a 
series of solubility measurements were made after 6, 12, 24 and 48 h.  These results are 
shown in Figure 18.   
 
Figure 18 Solubility as a function of time for Form 1 and Form 2  
 
The solubility of Form 2 increases at a faster rate than that of Form 1 within the initial 
12 h period.  This is the expected behaviour since Form 2 is the metastable form.  At  
~12 h, the solubility of Form 2 reaches its maximum value (~ 5.8 µg/ml) which is 
approximately double that of Form 1.  At the same time, Form 1 also reaches its 
maximum solubility.  During the period from 12 h to ~25 h, the solubility of Form 2 
gradually drops and that of Form 1 remains constant.  After ~25 h, the solubility of 
Form 1 and that of Form 2 reach the same level.  This is due to the fact that a significant 
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Conclusion 
Two polymorphs, Form 1 and Form 2, of the compound isoxyl were isolated and 
characterised by thermal, X-ray diffraction and spectroscopic methods.  
 
The melting point of Form 1 cannot be determined by the experimental methods 
employed in this study.  However, DSC results indicate that Form 1, which has been 
identified as the commercial material, transforms into Form 2 at 91.7 oC in the solid 
state, the latter melting at 142.7 oC.  In addition, Form 2 was found to undergo a solvent-
mediated transformation into Form 1 at 25 oC.  Therefore, the thermodynamic 
relationship between Form 1 and Form 2 can be defined as enantiotropy.  Based on this, 
a schematic energy-temperature diagram was constructed.  From the E/T diagram, it can 
be predicted that the melting point of Form 1 will occur in the range of 91.7 oC to     
142.7 oC and its enthalpy of fusion will be ~130 J g-1.  Furthermore, Form 1 is the 
thermodynamically stable form from absolute zero to 91.7 oC while Form 2 is the stable 
form between 91.7 and 142.7 oC. 
 
Csonka-Horvai et al.14 had isolated two polymorphic phases (α and β) of isoxyl in 1971.  
They reported that phase α crystallises in P1 with a = 5.52, b = 13.80, c = 16.82 Å, α = 
66.9, β = 92.7, γ = 100.6º and Z = 2 while phase β crystallises in the space group P21/a 
with a = 13.08, b = 9.02, c = 20.31 Å, β = 94.0º and Z = 4.  The unit cell parameters, of 
relatively low precision, were obtained from precession and Weissenberg techniques.14  
In the present study, full three-dimensional X-ray intensity data were employed to 
determine the structures of Form 1 and Form 2.  Form 1 crystallises in the triclinic 
space group P1 with a = 5.5321(2), b = 13.7052(6), c = 16.7032(7) Å, α = 67.987(2), β 
= 87.272(2), γ = 78.724(2)º and 2 molecules per unit cell, whilst Form 2 crystallises in 
the space group P21/c with a = 19.076(3), b = 8.952(1), c = 13.342(1) Å, β = 96.234(4)º 
and 4 molecules per unit cell.*  We note that the unit cell parameters of Form 1 and 
Form 2 are sufficiently similar to those of the phases α and β respectively to assume that 
the same two polymorphs were investigated earlier.   
*The space group P21/a is physically identical to space group P21/c.  They differ only by interchange of 
axial labels a and c.  
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For interest, an attempt has been made to reconcile the accurate molecular structure in 
Forms 1 and 2 [Figure 19 (a) and (c), respectively] and their placement within the 
accurate unit cells with those postulated in the phases α and β [Figure 19 (b) and (d)] by 
Csonka-Horvai et al.14  The latter based their crude models on consideration of the unit 
cell dimensions and the probable existence of cis-trans rotational isomerism for isoxyl, 
gleaned from IR spectra.  The necessarily crude models of the α and β phases are 
incorrect in detail, but remarkably do bear some resemblance to the accurate structures 
determined in the present study.   
 
Figure 19 A representative molecule of isoxyl in the unit cell of (a) Form 1, (b) Phase α 









(a) Form 1  
 
 (b) Phase α  
(d) Phase β  (c) Form 2  
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The molecule of Form 1 adopts a trans-cis conformation [S-C-N-C torsion angles 
165.1(2), -8.1(4)º] and that of Form 2 adopts a both-cis conformation [S-C-N-C torsion 
angles -8.0(5), 6.7(5)º].  Different hydrogen bond patterns occur in the two crystal 
structures, designated as R2 2 (8) and R
1 
1 (5) in Form 1, but as a combination of R
1 
1(6),       
R1 2(6), R
1 
1 (5) and R
1 
1 (5) in Form 2.  Consequently, in Form 1, centrosymmetric hydrogen 
bonded dimers of molecules of isoxyl assemble in layers, with the isoamyloxy residues of 
neighbouring dimers interdigitated.  In Form 2, isoxyl molecules assemble via the         
α-network tape motif, with the tapes extending infinitely along the b-axis.  
 
In both cases, the experimental PXRD traces were found to match the calculated patterns, 
allowing the latter to serve as references for polymorphic identification as well as proving 
that the experimental batches were polymorphically pure. 
 
Both the FTIR spectra and solid-state NMR spectra highlighted differences between the 
polymorphs that allow these techniques to be used for diagnostic purposes.  The observed 
spectral similarities and differences could be correlated with the crystal structures as 
established by X-ray diffraction.    
 
Solubility measurements were carried out on Form 1 and Form 2 at 30oC in a solvent 
mixture (ethanol/water 4:1 v/v).  In both cases, the solubility increased during the initial 
12 h period.  However, the solubility of Form 2 increased at a faster rate, reaching a 
maximum value which is about twice that of Form 1.  The sample of Form 2 
transformed into Form 1 during the solubility test, evidenced by PXRD analysis of the 
undissolved sample of Form 2.  This solvent-mediated transformation proceeded from 
the metastable polymorph to the stable polymorph i.e. in the expected direction based on 
DSC data from which the thermodynamic stability order was originally determined.   
 
Evidence for a third polymorph of isoxyl, melting at 148 - 149 oC, has been published.15  
During the present study, much effort was invested into isolating this form in order to 
characterise it completely.  However, it has to date remained elusive.  
 





A crystalline solvate of isoxyl and 1,4-dioxane (designated S1) was successfully isolated.  
Suitable crystals were obtained by dissolving 0.020 g (0.050 mmol) of the isoxyl raw 
material (host) in 2 ml of 1,4-dioxane (guest) with stirring at 54 oC.  The solution was 
then filtered (0.45 µm nylon filter) and allowed to cool spontaneously.  Crystals of 
suitable quality appeared by slow evaporation at 25 oC over a period of one week. 
 
The guest numbering scheme is given in Figure 20. 
 
Figure 20 Guest numbering scheme for 1,4-dioxane molecules. Hydrogen atoms have been 
omitted for clarity.  (The molecule on the left occupies a general position in the crystal while that 
on the right is located on a centre of inversion.) 
 
Multiple TGA measurements revealed a mass loss of 14.8 ± 1.0% (n=3) for S1.  This is 
equivalent to ~0.75 1,4-dioxane molecules per solvate unit.  The stoichiometric formula 
of S1 based on X-ray analysis was calculated and found to be consistent with the formula 
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X-Ray Crystallographic Analysis of S1 
 
Single Crystal X-Ray Diffraction 
 
Data-Collection and Space Group Determination 
A crystal of S1, extracted from the mother liquor, was covered in paratone N oil without 
delay in order to prevent the loss of solvent molecules.  A Nonius Kappa CCD four-circle 
diffractometer was employed to collect reflection intensity data for S1 at 98 K.   
 
The unit cell parameters, crystal system and space group were determined from the X-ray 
diffraction data which revealed Laue 2/m symmetry for S1 indicating the monoclinic 
system.  It was found to belong to the space group P21/c, from the following reflection 
conditions: hkl: none; h0l: l = 2n and 0k0: k = 2n.   
 
Structure Solution and Refinement 
SHELXS-976 was used for the structure solution of S1.  Direct methods yielded the 
positions of all non-hydrogen atoms in the asymmetric unit, which consisted of two 
independent molecules of isoxyl (A and B), one molecule of 1,4-dioxane in a general 
position, and one half of a 1,4-dioxane molecule located near a centre of inversion.  All 
the non-hydrogen atoms were then refined isotropically on F2 with SHELXH-97.7  Atom 
C28B in the host molecule B was found to be disordered over two positions (C28B and 
C28C).  C28B, the major component, was assigned a value of x for its s.o.f. while the 
minor component C28C was allocated the value 1-x.  The s.o.f.s refined to 0.77(5) and 
0.23(4) respectively while their Uiso values refined to 0.06(Å
2) and 0.05(Å2), respectively.  
Distance restraints were employed to ensure reasonable molecular geometries of bonds 
C26B-C28B and C26B-C28C.  The C-O bond length was set at 1.52 Å with a standard 
deviation σ = 0.002 Å.   
 
Attempts to locate all the hydrogen atoms in S1 from difference Fourier maps were 
successfully carried out.  Based on the positions of the peaks found, a riding model was 
employed to place hydrogen atoms for host molecules with idealised stereochemistry.  
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All the methyl hydrogen atoms were refined with isotropic temperature factors 1.5 times 
those of their parent atoms while all the other hydrogen atoms were assigned temperature 
factors 1.2 times those of their parent atoms.  Crystal and refinement parameters for 
solvate S1 are presented in Table 10. 
 
Table 10 Crystal and refinement data for S1  
Parameter S1 
Formula unit 2(isoxyl) • 1.5(1,4-dioxane) 
Formula Weight / g mol-1 933.36 
Crystal system monoclinic   
Space group P21/c 
a / Å 23.8995(6) 
b / Å 9.1639(3) 
c / Å 24.2628(7) 
α / o 90.000 
β / o 103.062(1) 
γ / o 90.000 
Volume / Å3 5176.4(3) 
Z 4 




F (000) 2016 
Crystal size /mm3 0.06x0.12x0.44 
Temperature / K 98(2) 
Range scanned θ / o 1.00≤ θ ≤ 25.68 
h: -28, 28 
k: -11, 10 
Index ranges 
l: -29, 29 
φ scan angle / o 0.9 
ω scan angle / o 0.9 
Dx / mm 40 
No. of measured reflections 17143  
No. of unique reflections 9571 
No. of reflections with I > 2σ(I) 5257 
No. of L.S. parameters 596 
Rint, Rσ 0.0599, 0.1126 
S 0.998 
R1 (Fo > 4σ(Fo)) 0.0505 
No. of reflections omitted 32 
wR2 (all reflections) 0.1223 
a = 0.0500 Weighting scheme 
b = 0.0000 
(∆ / σ)mean < 0.001 
∆ρ excursions / еÅ-3 -0.41, 0.40 
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Conformation of the Isoxyl Molecules 
There are two crystallographically independent isoxyl host molecules (A and B) in the 
asymmetric unit of solvate S1 as shown in Figure 21.  Table 11 lists all the principal 
torsion angles of the molecules A and B.  Those of the isoxyl molecule in polymorphic 
Form 2 are also shown for comparison.  In the molecules A and B in S1 as well as the 
molecule in Form 2, the aromatic planes A and B adopt the both-cis conformation 
relative to atom S15 around the N13-C14 and N16-C14 bonds.   
 
Figure 21 The structures and the principal torsion angles of the molecules A and B in S1. 
 
Table 11 Principal torsion angles for the molecules A and B in S1 as well as the isoxyl molecule 
in Form 2a 
Torsion angle (o) A in S1 B in S1 Form 2 
S15-C14-N13-C1    (τ1) 0.3(3) ---  cis 0.3(3) --- cis -8.0(5) --- cis 
S15-C14-N16-C17    (τ2) -1.0(3) --- cis 3.4(3) --- cis 6.7(5) --- cis 
       C3-C4-O7-C8     (τ3) 9.4(3) --- cis -1.2(3) --- cis -177.8(3) --- trans 
C21-C20-O23-C24    (τ4) -7.2(3) --- cis -0.3(3) --- cis 169.4(3) --- trans 
C4-O7-C8-C9    (τ5) -173.4(2) --- trans 170.6(2) --- trans -171.8(3) --- trans 
C20-O23-C24-C25    (τ6) -174.9(2) --- trans 172.6(2) --- trans -168.5(3) --- trans 
O7-C8-C9-C10    (τ7) -56.6(3) --- gauche 174.9(2) --- trans -54.0(5) --- gauche 
O23-C24-C25-C26    (τ8) -76.1(3) --- gauche 71.7(3) --- gauche -58.3(4) --- gauche 
C8-C9-C10-C11    (τ9) 172.8(2) --- trans -171.7(2) --- trans 176.0(4) --- trans 
C8-C9-C10-C12   (τ10) -62.4(3) --- gacuhe 63.7(3) --- gauche -57.0(6) --- gauche 
C24-C25-C26-C27   (τ11) 70.4(3) --- gauche -166.7(2) --- trans -61.5(5) --- gauche 
C24-C25-C26-C28   (τ12) -166.3(2) --- trans 74.1(4) --- gauche 176.1(4) --- trans 
a See Figure 7, Part One for the isoxyl numbering scheme.  
 
The isoxyl molecules A and B in solvate S1 as well as the molecule in Form 2 are 
overlayed in Figure 22.  With the central N2CS moieties overlayed, a distribution of 
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aromatic ring orientations is evident, as is a range of conformations for the isoamyloxy 
chains.  The symmetry-independence of molecules A and B in S1 is clear.  
 
Figure 22 An overlay of the structures of the molecules A (gray) and B (pink) in S1 as well as the 
molecule in Form 2 (black).  Hydrogen atoms are omitted for clarity.  
 
Hydrogen Bond Interactions 
Table 12 lists all the hydrogen bond interactions for S1.  Two host-host intermolecular   
N-H···S hydrogen bonds can be found between the host molecule A and a symmetry-
generated molecule A.  This motif is identical to the hydrogen bond motif of Form 2.   
Two host-guest N-H···O hydrogen bonds can be found between a host molecule B and a 
1,4-dioxane guest molecule.  The average N···S distance and N-H···S angle are 3.40 Å 
and 157o, while the average N···O distance and N-H···O angle are 3.05 Å and 160o. 
 
Table 12 Hydrogen bonding interactions for S1a 
Hydrogen bond N···S or N···O Distance (Å) Angle (o) Symmetry operatorb 
N13A-H13A···S15A 3.456(2) 154.0 1-x,1/2+y,1/2-z 
N16A-H16A···S15A 3.337(2) 160.0 1-x,1/2+y,1/2-z 
N13B-H13B···O3G 3.134(2) 155.0 x, y, z, 
N16B-H16B···O3G 2.966(2) 164.0 x, y, z, 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Figure 23 illustrates the hydrogen bond interactions for the solvate S1.  Bifurcated N-
H···S hydrogen bonds link successive A molecules in the crystal.  The graph set analysis 
descriptor R1 2(6) is shown in its hydrogen bonded ring.
8, 9  Again, this is identical to the 
hydrogen bond motif of Form 2.  The host molecule B is hydrogen bonded to the guest 
molecule located on a centre of inversion, forming a hydrogen bonded ring which can be 
described as R1 2(6)
 8, 9  as shown in Figure 23.   
Chapter 3: Supramolecular Modification of Isoxyl (Part two---solvate) 
 78 
 
Figure 23 Hydrogen bonds N-H···S and N-H···O for S1.  Atoms with gray labels have been 
symmetry-generated from their asymmetric unit counterparts.  The relevant N, S and O atoms are 
shown as spheres.   
 
Several C-H···O interactions (Table 13) were found in the structure of S1.  Specifically, 
the host intramolecular interactions C10A-H10A···O7A and C27A-H27A···O23A 
stabilise the conformation of the host molecule A.  The host-host interaction            
C19B-H19B···O7A associates the host molecules A and B.  The host-guest 
intermolecular interactions C3B-H3B···O2G and C24B-H24C···O1G associate the host 
molecule B with the guest molecule located in a general position.  
 
Table 13 C-H···O interactions of solvate S1a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C10A-H10A···O7A 2.899(3) 102.0 x, y, z, 
C27A-H27A···O23A 3.101(3)      117.0 x, y, z, 
C19B-H19B···O7A 3.439(3) 154.0 1-x,1/2+y,1/2-z 
C3B-H3B···O2G 3.395(3) 164.0 x, y, z, 
C24B-H24C···O1G 3.283(3)      127.0 1-x,-y,1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
In summary, no N-H···S or N-H···O hydrogen bond interactions occur between the host 
molecules A and B.  Intermolecular hydrogen bond interactions can be found between the 
host molecules A which adopt a very similar hydrogen bond motif to that in polymorphic 
Form 2.  However, the host molecule A is not hydrogen bonded to any solvent molecule.  
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1,4-dioxane molecules through C-H···O interactions and N-H···O hydrogen bonds, 
respectively, as shown in more detail below.    
 
Crystal Packing  
The symmetry-independent host molecules A and B in the asymmetric unit of solvate S1 
are shown in Figure 24.  
 
Figure 24 Two symmetry-independent host molecules A and B in the asymmetric unit of S1. 
 
Figure 25 illustrates the packing diagram of S1.  As mentioned above, host molecules A 
are linked to each other via bifurcated N-H···S hydrogen bonds, as in polymorphic Form 
2 of isoxyl.  In an analogous way, a continuous ‘tape’ is generated along the crystal y-
direction. 
 
Figure 25 Crystal packing diagram for S1.  The atoms of the solvent molecules are shown as red 
spheres for clarity.  The molecules A and B are shown in gray and pink, respectively.  The host-
host and guest-host intermolecular hydrogen bonds are shown in gray and red dashed lines, 
respectively.    
 
The layers which consist of the host molecules B and guest molecules are interleaved by 
the layers of the host molecules A.  However, the former actually consist of two inverted, 
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Figure 26.  Furthermore, the guest molecules serve as bridges, connecting the host 
molecules B.    
 
Figure 26 Stereoview showing two interpenetrating host B-guest hydrogen bonded assemblies, 
represented in red and green.  The two assemblies are not hydrogen bonded to one another.  
 
Guest 1,4-dioxane molecules are located between the assemblies of the host molecules B 
as shown in Figure 27.  No guest-guest interactions are observed, but the three guest 
molecules shown in Figure 27 are in contact, forming an isolated solvent motif roughly 
parallel to the unit cell ac-diagonal.  The guest molecules are intimately associated with 
the host molecules B.   
 
Figure 27 Stereoview showing crystal packing for S1 viewed along [010]; atoms of the solvent 
molecules are shown as red spheres for clarity.  Molecules A and B are shown in gray and pink, 
respectively.  The host-host and guest-host intermolecular hydrogen bonds are shown in gray and 
red dashed lines, respectively.    
 
The program SECTION16 was used to view planes at y = 0 and y = 0.5 through the unit 
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Figure 28 Sections through S1 with guest molecules represented schematically by three red 
circles and host molecules represented by gray areas, viewed along [010] with the unit cell 
sectioned at (a) 0 Å and (b) 4.5 Å from 0,0,0.   
 
Comparative PXRD 
The calculated and experimental PXRD traces for solvate S1 are shown in Figure 29.  
The experimental PXRD trace is in reasonable agreement with the calculated one, based 
on the single crystal X-ray data, confirming that the prepared sample was homogeneous.  
The low temperature X-ray analysis results in calculated peaks appearing at slightly 
higher 2θ-values.  Differences in the relative intensities of peaks in the two traces are 
attributed to residual preferred orientation, the small amount of material available, and 
possible desolvation of the solvate crystals during the sample preparation. 
 




(a) 0 Å  (b) 4.5 Å  
Experimental  
Calculated  Irel 
2θo 




Hot Stage Microscopy 
The crystal of S1 was placed under silicone oil and was heated at a constant rate of        
10 K/min (Figure 30).  No bubbling associated with desolvation or other obvious optical 
change was observed during the heating process.  The crystal melted at ~148 oC.  
 
Figure 30 HSM photographs of a crystal of S1 at various temperatures 
 
Differential Scanning Calorimetry and Thermogravimetric Analysis 
The TGA and DSC traces for S1 are shown in Figure 31.  The DSC results are 
summarised in Table 14.  The DSC trace showed two thermal events which are indicated 
by peaks C and D.  The endothermic event C represents the solvent loss which 
corresponds to the mass loss indicated by A in the TGA trace.  Notably, the event C 
occurred over a wide temperature range.  The end point of this range was indicated by D 
in the figure, evidenced by the fact the DSC trace returned to the baseline at this point.  
Correspondingly, point B was placed in the TGA trace based on the position of D in the 
DSC trace, representing the complete solvent release.  Therefore, the TGA result showed 
an apparent two-step mass loss over the wide temperature range 35 – 119 oC with a value 
of 14.8 ± 1.0 % (n=3).  The calculated mass loss is 14.1% which agrees reasonably well 
with the experimental mass loss.  Event E indicates the melting of the desolvated phase.  
The fact that the melting point of the desolvated phase is very similar to that of Form 2          
[142.1 ± 0.3o (n=2)] implies that the solvate S1 possibly transformed into Form 2 after 
losing the solvent molecules.     
(b) 120 oC (c) 148 oC (a) 25 oC 
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Figure 31 TGA (red) and DSC (blue) traces for S1.  
 
Table 14 DSC results for solvate S1 
S1 Onset Temperature (oC) 
Peak C (desolvation) 61.6 ± 1.0 (n=2) 
Peak E (fusion) 141.7 ± 1.0 (n=2) 
 
Furthermore, in the TGA trace, the appearance of a two-step mass loss A instead of a 
single-step mass loss may be related to the fact that the two crystallographically distinct 
1,4-dioxane molecules are involved in different hydrogen bond environments in the 
structure of S1, as noted earlier from the X-ray structural analysis.  
 
Variable Temperature Powder X-ray Diffraction 
The PXRD patterns of the crystals of S1 were characterised as a function of temperature 
(Figure 32).  At approximately 70 oC, the crystals of solvate S1 transformed to another 
phase.  This was readily confirmed by PXRD analysis to be the isoxyl polymorphic 
Form 2.  The appearance of Form 2 was assumed to be associated with the fact that it 
becomes the thermodynamically stable form of isoxyl at elevated temperature.  
Furthermore, the melting point of the desolvated phase of S1 was earlier shown by DSC 
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Figure 32 Variable temperature PXRD patterns for S1.  The pattern of Form 2 at 25 oC is added 
for comparison.  
 
A noteworthy observation is that the crystals of S1 desolvated also when they were 
exposed to the atmosphere at 25 oC.  After equilibrating with the atmosphere for a period 
of 2 days, the desolvated phase was again identified as Form 2 by PXRD. 
 
Thus, the solvate S1 desolvates to yield the metastable polymorphic Form 2 of isoxyl, 
either during controlled heating or by spontaneous loss of included solvent at ambient 
temperature during exposure to the atmosphere.  We assume that this transformation to 
Form 2 (rather than Form 1) is facilitated by the presence of similar structural features in 
the crystals of S1 and Form 2, namely the common ‘both-cis’ conformation of all of the 
isoxyl molecules, and the existence of a common ‘tape’ motif mediated by bifurcated N-
H···S hydrogen bonds.  
 
Conclusion 
Concluding remarks interrelate various aspects of both the polymorphic species (Form 1 
and Form 2) as well those of the solvate S1. 
 
Powder X-ray Diffraction  
The experimental PXRD traces for isoxyl polymorphs (Form 1 and Form 2) and solvate 
(S1) were in reasonable agreement with their respective calculated traces based on single 
crystal X-ray data.  The calculated traces are presented here in a stacked format for 




Form 2 for comparison 
2θo 
Irel 
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comparison, Figure 33.  In general, the dissimilarity among these traces is remarkable 
enough to identify and distinguish these three different phases of isoxyl.   
 
Figure 33 Calculated PXRD traces of isoxyl polymorphs (Form 1 and Form 2) and solvate S1.  
 
Conformation of Isoxyl Molecules 
The conformational difference among the isoxyl molecules (Form 1, Form 2, host 
molecules A and B in S1) is mainly reflected in the conformations of their thiourea 
moieties.  The isoxyl molecule in Form 1 adopts a trans-cis conformation while those of 
Form 2 and S1 all adopt both-cis conformations.  Among the isoxyl molecules in Form 2 
and S1, the isoamyloxy chains adopt a range of conformations. 
 
Hydrogen Bond Interactions 
Form 1 contains a unique hydrogen bond motif comprising two isoxyl molecules related 
by a crystallographic inversion centre, associated by two identical N-H···S hydrogen 
bonds.  Form 2 and the molecule A in S1 contain identical hydrogen bonded motifs in 
which isoxyl molecules link to form infinite ‘tapes’ via bifurcated N-H···S hydrogen 
bonds N13-H13···S15 and N16-H16···S15.  In the isoxyl molecule B in solvate S1, the 
N13B and N16B atoms function as hydrogen bond donors to the same acceptor atom 
O3G of the 1,4-dioxane molecule located on a centre of inversion. 
 
Crystal Packing 
Given that isoxyl molecules in Form 2 and those of type A in the solvate S1 associate in 
a very similar motif, it is useful to compare partial packing diagrams that highlight this 
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that in the S1 unit cell [Figure 34(c)] occur as separate, inversion-related pairs, each of 
which displays the common ‘tape’ motif.  The latter is evident in the Figure 34 (b) and 
(d). 
 
Figure 34 The packing diagrams for Form 2 along (a) [010] and (b) [-101] as well as the packing 
diagrams of the molecules A in S1 along (c) [010] and (d) [-10-1].  The S atoms are shown as 
spheres and the H atoms are omitted for clarity.  In the diagrams of S1, the host molecules B and 


















(a) Form 2 [010] (b) Form 2 [-101] 




(d) Molecule A in S1 [-10-1] 
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Part Three 
The third method of attempted supramolecular modification of isoxyl is described here, 
namely its inclusion in cyclodextrin molecules.  
 
Cyclodextrin (CD) Inclusion Complex Preparation 
 
The hosts which were investigated for the isoxyl inclusion are α-CD, β-CD, γ-CD, 
heptakis(2,6-di-O-methyl)-β-CD, heptakis(2,3,6-tri-O-methyl)-β-CD, hexakis(2,3,6-tri-
O-methyl)-α-CD, heptakis(2,3,6-tri-O-acetyl)-β-CD, heptakis(2,3,6-tri-O-benzoyl)-β-CD, 
heptakis(2,3,6-tri-O-ethyl)-β-CD, and octakis(2,3,6-tri-O-acetyl)-γ-CD (all obtained from 
Cyclolab, Budapest, Hungary).  The experimental methods were kneading, 
recrystallisation of kneaded product and co-precipitation.  The first method yielded 
microcrystalline complexes of β-CD and γ-CD.  However, the latter two methods did not 
result in the expected formation of inclusion complexes in the form of single crystals.  
For all other CD s tested, crystallisation of the pure (uncomplexed) host occurred. 
 
Equimolar amounts of host and guest were used in the preparation of the inclusion 
complexes of β- and γ-CD with isoxyl.  The amount of isoxyl used was 20 mg.  Thus, the 
amounts of β- and γ-CD were 56.74 and 64.85 mg respectively.  
 
In each experiment, the CDs were placed in the mortar with a few drops of water and 
ground to a paste.  The guest (isoxyl) was slowly added with simultaneous gentle manual 
trituration.  After all the guest had been added, the paste was triturated for 45 minutes 
with dropwise additions of water to keep it moist. 
 
Confirmation of Complexation  
Powder X-ray diffraction was employed to confirm complexation.  The resultant PXRD 
traces were compared with reference traces.17, 18   The latter were originally obtained19 by 
averaging computed PXRD traces for a number of isostructural series of CD inclusion 
complexes using the single crystal XRD data available in the Cambridge Crystallographic 
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Database.  Such traces have thus been used routinely both to obtain confirmation of 
complex formation and to deduce structural information for new CD inclusion complexes 
prepared in the laboratory.  In the present study, experimental PXRD traces of putative 
CD inclusion complexes were compared with reference PXRD patterns to find matches 
that would confirm genuine complex formation (Figure 35).   
 
Figure 35 (a) The PXRD pattern for a β-CD-isoxyl complex and the reference pattern for β-CD 
complexes of a specific isostructural series crystallising in space group C2. (b) The PXRD pattern 
for the γ-CD-isoxyl complex and the reference pattern for γ-CD complexes. 
(a) β-CD  
2θo 
β-CD complex 








(b) γ-CD  
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As explained in detail in the original reference,19 this simple procedure relies primarily on 
finding reasonably good peak angular matches. (Complex isostructurality can still be 
reliably deduced even when there are significant differences in the experimental and 
reference PXRD peak intensities).  In Figure 35 (a), there is a very convincing match 
between the angular positions of the experimental PXRD peaks of the putative β-CD-
isoxyl inclusion complex and those of the reference trace for a specific isostructural 
series of known β-CD inclusion complexes crystallising in the space group C2. (There is, 
in fact, also a fair match in the relative intensities of the two PXRD traces in this case).  
Most of the peaks in the PXRD pattern of the putative γ-CD-isoxyl inclusion complex 
similarly have counterparts in the reference pattern for all known γ-CD inclusion 
complexes [Figure 35 (b)].  In both cases, we can thus deduce from these results, 
formation of genuine CD inclusion complexes.  Furthermore, through isostructurality, 
this identification yields space group information for each complex and allows deduction 
of approximate unit cell dimensions as well as the CD frameworks in the respective 
inclusion complexes.   
 
Host Frameworks in the Complexes  
In the case of the β-CD inclusion complex of isoxyl [Figure 36 (a)], its isostructurality 
with a known complex series crystallising in space group C2 informs us that dimers of 
the host molecules are stacked in a ‘head-to-head’ (and ‘tail-to-tail’) arrangement parallel 
to the c-axis, along which infinite channels are formed.  The gray column [Figure 36 (a)] 
is generated by the symmetry operator 1/2+x, 1/2+y, z (corresponding to the C-
centering).  For the γ-CD complex of isoxyl [Figure 36 (b)], the host molecules are 
stacked on top of each other along the fourfold axes parallel to the c-axis of the tetragonal 
unit cell.  Specifically, molecules A and C have the same orientation (with respect to their 
primary and secondary sides) while molecule B is of opposite orientation.  The host 
molecules are thus arranged in three possible ways: tail-to-tail (A and B), head-to-head 
(B and C) and tail-to-head (C and A′). 20   
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Figure 36 The packing motif of dimeric β-CD complexes (space group C2) viewed along [010] 
(a) and γ-CD complexes viewed along [-1-10]20 (b). 
 
Furthermore, based on the known isostructurality between the prepared complexes and 
those of the reference series, the approximate unit cell parameters for the β- and γ-CD 
complexes of isoxyl can be predicted as listed in Table 15. 
 
Table 15 Predicted space groups and approximate unit cell parameters for the β- and γ-CD 
complexes of isoxyl 
Complexes Space group a (Å) b (Å)   c (Å) (˚) (˚) (˚) Vol. (Å3) 
β- C2 19.3 24.5 15.9 90 109 90 7109 
γ- P4212 23.8 23.8 23.2 90 90 90 13158 
 
Attempts to form complexes of isoxyl with derivatised CDs were not successful. 
 
Solubility Enhancement Measurement   
Isoxyl is known to be practically insoluble in water.  The approximate aqueous solubility 
of isoxyl was determined as 1.6 µg/ml (25oC) by Nestler et al.21  In the present study, the 
aqueous solubility enhancement measurement using β- and γ-CDs was carried out.  
 
Isoxyl, in successive very accurately weighed amounts, was added to fixed, measured 
volumes of aqueous solutions of β-CD (3% w/w) and γ-CD (17% w/w) at 30 ± 2 oC over 
a period of 3 days.  Due to paucity of the raw drug, attaining saturation was not the 
objective of the experiment.  Instead, some notion of the solubility enhancement in these 
solutions of arbitrary CD-concentration22 was sought.  Based on the measured masses of 
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solubility of isoxyl in the β-CD and γ-CD solutions had increased by at least a factor of 
two in the former case, and three in the latter case, relative to its concentration in pure 
water.  To put this into perspective, a similar experiment with the anti-inflammatory drug 
ibuprofen dissolved in a 1.8% solution of β-CD at 25 oC led to a solubility enhancement 
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Part Four 
The rationale for our pursuing cocrystal formation as a supramolecular modification of 
the drug isoxyl was based on observations from our investigation of its polymorphism.   
There, it was noted that the thiourea moiety -HN-C(S)-NH- is able to adopt different 
configurations (cis-trans, both-cis, leading to different modes of supramolecular 
association via N-H···S hydrogen bonds in the solid state.  Cocrystal formation involving 
reaction between isoxyl and cocrystal formers containing amide and carboxylic acid 
functions was considered to have potential for producing novel solid phases, since these 
latter functions present possibilities for synthon formation with the thiourea moiety, at 
least in principle.   
 
In the attempts to form such cocrystals, a variety of cocrystal formers was investigated.  
These included isonicotinamide, nicotinamide, saccharin, L-(+)-tartaric acid, D-(+)-
tartaric acid, citric acid, succinic acid, maleic acid, salicylic acid and oxalic acid.  
Methods of preparation included dry co-grinding, liquid-assisted co-grinding and co-
precipitation with different molar ratios of isoxyl : cocrystal former and different 
solvents.  A list of several such experiments and their outcomes is provided in Appendix 
2.  The fact is, however, that none of the products of these reactions turned out to be a 
cocrystal.  This was the outcome gauged from examination of PXRD patterns of the 
products, which revealed primarily unreacted mixtures of the original phases.  However, 
during the screening of the products by PXRD, in a few instances, new peaks appeared 
that strongly suggested the appearance of new solid phases.  The experiments in question 
were those involving attempted cocrystallisation of isoxyl with the widely employed 
cocrystal formers isonicotinamide and nicotinamide (Figure 37).   
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Figure 37 Chemical structures of (a) isonicotinamide and (b) nicotinamide 
 
Further careful investigation revealed that the new solid phases were, in fact, polymorphs 
of the cocrystal formers that had not hitherto been structurally characterised.  Given the 
widespread current interest in pharmaceutical cocrystals and the frequent use of 
isonicotinamide and nicotinamide as cocrystal formers, the unexpected appearance of 
new polymorphs of the latter molecules in this study was recognised as providing an 
opportunity for contributing to the knowledge base of organic crystal polymorphism.  
 
In addition, though the pursuit of new polymorphs of the cocrystal formers 
isonicotinamide and nicotinamide was not an original objective of this study, it was 
nevertheless considered a sufficiently interesting and important outcome to warrant 
bringing it to the attention of others working in the field of pharmaceutical cocrystals.  
Specifically, it was decided to determine the molecular conformations and crystal 
structures of these new isonicotinamide and nicotinamide crystal modifications and to 








(b) nicotinamide (a) isonicotinamide 
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Isonicotinamide 
In an early attempt to form a cocrystal between isoxyl and the co-former isonicotinamide 
by co-precipitation from chloroform solution, different polymorphic forms of 
isonicotinamide crystallised simultaneously, among these one whose measured unit cell 
dimensions suggested a new phase.  To establish whether this outcome depended on the 
presence of isoxyl, isonicotinamide alone was dissolved in chloroform and the products 
of crystallisation were identified.  Again an apparently new phase of isonicotinamide was 
present in the mixture of crystal forms.  Details of this procedure are reported below.  In 
addition to an apparently new polymorph of isonicotinamide, this preparative procedure 
yielded also crystals of two polymorphs, referred to here as Forms 1 and 2, whose 
structures had both been reported in 2003 (CSD refcode EHOWIH02,23 CSD refcode 
EHOWIH0124).  The new polymorph was accordingly named Form 3.  
 
Polymorph Preparation 
In a typical experiment, 38 mg of isonicotinamide was dissolved in 2 ml chloroform at  
45 oC.  The solution was stirred for 10 minutes and filtered (0.45 µm nylon filter) while 
hot.  It was then placed in a Dewar flask containing water at ~45 ˚C.  The Dewar flask 
was covered with an insulating material to allow slow cooling.  The water in the Dewar 
flask returned to ambient temperature over a period of one and a half days. 
 
Visual inspection of the batch of precipitated material indicated the possible presence of 
crystals of different morphologies and thus of possibly different polymorphs (i.e. 
concomitant polymorphism).  However, morphological differences were not reliable in 
allowing definitive separation into different crystal polymorphic forms.  The very 
tedious, but reliable, procedure of determining crystal unit cells for each specimen in the 
batch using single crystal X-ray diffraction followed.  This revealed three distinct 
polymorphs of isonicotinamide, namely two monoclinic forms, Forms 1 and 2, that were 
described previously,23, 24 and a third modification of orthorhombic crystal symmetry, not 
hitherto described, and assigned as Form 3.  No crystallisation procedure yielding Form 
3 exclusively could be devised.  Only in this way, was it possible to obtain Form 3 in a 
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Differential Scanning Calorimetry and Thermogravimetric Analysis 
TGA analyses (not shown) indicated negligible mass loss for all three forms in the 
temperature range 30-180 oC, indicating that Forms 1, 2 and 3 are not solvates.  
 
Preliminary DSC runs indicated possible phase transitions on heating these crystals, 
though the enthalpies of transition appeared to be very small.  
 
Figure 38 shows the DSC results of the three forms heated at 10 K/min.  In order to 
enhance the appearance of peaks representing phase transitions, traces for both Forms 1 
and 2 were recorded using a large amount (10 mg) of each sample.  However, due to the 
difficulty in obtaining large amounts of Form 3, only 0.3 mg of this species was used in 
DSC measurement.  
 
Figure 38 DSC traces of Form 1, Form 2 and Form 3 of isonicotinamide (heating at 10 K/min) 
 
The DSC trace for Form 1 exhibited one endotherm B, which represents the melting of 
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first endotherm A corresponds to a phase change, since no mass loss was observed in the 
TGA curve.  The second endotherm B results from the melting of the resulting 
modification.  Similar results were obtained for Form 3, with however a very small, 
barely discernible, endotherm A.  The fact that the Tf value (Table 16) of the endotherm 
B in Form 1 is very close to those in Form 2 and Form 3 provides evidence of a 
complete phase transformation from Form 2/Form 3 to Form 1 on heating.  The 
observation that both the melting peaks B in the DSC traces for Forms 1 and 2 were 
broader than that in the trace for Form 3 is attributed to the very small sample of the 
latter form used in the measurement.  This possibly also accounted for the difficulty in 
identifying the peak A and determining the Tt value associated with Form 3.      
 
Table 16 Thermo-analytical data obtained from DSC for the Forms 1, 2 and 3 at 10 K/min 
Form Phase change onset temperature Tt (
oC) Melting onset temperature Tf (
oC) 
1 none 153.9 ± 2 (n=2) 
2 114.9 ± 0.4 (n=2)   155.9 ±2 (n=2) 
3 inconclusive 154.1 
 
Separate DSC experiments were performed to enhance the appearance of the phase 
transition endotherm for Form 3.  Figure 39 shows the DSC results for the three forms 
heated at 70 K/min.   
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The DSC trace for Form 1 obtained at 70 K/min exhibited a single endothermic peak B 
representing fusion, this behaviour being consistent with that of Form 1 heated at          
10 K/min.  The DSC trace for Form 2 obtained at 70 K/min exhibited an initial 
endothermic peak A, followed by a second endothermic peak B.  These possibly 
represent the phase change of Form 2 and the melting of the modified form, respectively.  
Again, the DSC trace for Form 2 obtained at 70 K/min is consistent with that obtained at 
10 K/min.  The trace for Form 3 obtained at 70 K/min showed a more convincing 
endothermic peak A compared to that obtained at 10 K/min.  This peak A indicated that 
Form 3 underwent a phase change into a modified form (peak A) which then melted 
(peak B).  Also, the DSC trace for Form 3 obtained at 70 K/min is consistent with that 
obtained at 10 K/min.  However, the onset temperature for each endothermic peak in all 
three DSC traces at     70 K/min (Table 17) is higher than those for the corresponding 
peaks at 10 K/min (Table 16).   A possible explanation is that the higher heating rate 
introduces higher temperature gradients of the endothermic peak, leading to the delay in 
the onset temperatures.1, 2  In addition, since the instrument was calibrated for a 10 K/min 
heating rate, temperatures measured at higher heating rates may not be very reliable.  
 
Table 17 Thermo-analytical data obtained from DSC for the Forms 1, 2 and 3 at 70 K/min     
Form Phase change onset temperature Tt(
oC) Melting onset temperature Tf (
oC) 
1 none 161.5 ± 1 (n=2) 
2 131.7 ± 1 (n=2)   162.6 ±2 (n=2) 
3 130.5 161.0 
 
Based on the above DSC data obtained at 10 and 70 K/min, it can be assumed that both 
Forms 2 and 3 experienced a phase change into Form 1, the latter then melting at    
153.9 oC.  The phase change of Form 2 occurs at 114.9 oC (Table 16) while an accurate 
temperature for the phase transition of Form 3 cannot be determined.  However, based on 
the onset temperatures of Forms 2 and 3 heated at 70 K/min, the phase change 
temperature of Form 3 can be determined as being slightly lower than that of Form 2 




Chapter 3: Supramolecular Modification of Isoxyl (Part four---isonicotinamide) 
 98 
Variable Temperature Powder X-ray Diffraction 
In order to confirm the conclusions drawn from the DSC analyses, variable temperature 
powder X-ray diffraction was introduced. 
 
Figure 40 firstly presents the comparison of the measured PXRD pattern of Form 1 at     
25 oC with the calculated pattern derived from the single crystal structure of Form 1 
using program LAZY PULVERIX.11  Crystals of Form 1 were then characterised by 
PXRD as a function of temperature.  The PXRD pattern was recorded at temperature 
intervals of 10 K between 30 and 180 oC.     
 
Figure 40 Variable temperature PXRD patterns of Form 1  
 
The peak positions in the calculated trace (173 K) are displaced to higher 2θ-angle 
compared to those of the experimental trace (25 oC), as expected.  However, the match 
between the two traces is convincing, proving that the bulk sample is homogeneous and 
has the same crystal structure as Form 1 described by Aakeröy et al.23 
 
No evidence of phase change was observed when Form 1 was heated to the melting 
temperature.  This is consistent with the fact that only a single endothermic peak B was 
observed in the DSC trace of Form 1 (Figure 38).   
Irel 
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Figure 41 firstly shows the comparison between the measured PXRD pattern of Form 2 
at 25 oC and the calculated pattern derived from the single crystal structure of Form 2 
using program LAZY PULVERIX.11  Crystals of Form 2 were then characterised by 
PXRD as a function of temperature.  The PXRD pattern was recorded at temperature 
intervals of 10 K between 30 and 180 oC.     
 
Figure 41 Variable temperature PXRD patterns of Form 2  
 
In Figure 41, the calculated PXRD trace (173 K) is in a good agreement with the 
experimental trace (25 oC).  This confirms that the bulk sample is homogeneous and has 
the same crystal structure as Form 2 described by Vishweshwar et al.24  
 
When crystals of Form 2 were heated, no evidence of phase change was observed until 
120 oC at which a new peak A appeared in the trace.  Form 2 produced a totally different 
trace at 130 oC from that at 25 oC.  The PXRD traces indicate the start of the phase 
transition of Form 2 at ~120 oC and its completion by ~130 oC.  This provides proof that 
the endothermic peak A, present in the DSC trace of Form 2 in Figure 38, represents a 
phase transition.  
 
Figure 42 firstly presents the comparison of the measured PXRD pattern of Form 3 at     
25 oC with the calculated pattern derived from the single crystal structure of Form 3 


















Calculated (173 K) 
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(determined in the present study and described later) using program LAZY 
PULVERIX.11  Crystals of Form 3 were then characterised by PXRD as a function of 
temperature.  The PXRD pattern was recorded at temperature intervals of 10 K between 
30 and 180 oC.     
 
Figure 42 Variable temperature PXRD patterns of Form 3  
 
The match between the calculated PXRD pattern (173 K) and the experimental pattern 
(25 oC) confirms the polymorphic purity of the experimental sample of Form 3. 
 
When the crystals of Form 3 were heated, they remained the same phase until ~110 oC.  
A distinct peak B was observed in the trace at ~110 oC.  The PXRD trace of Form 3 was 
found to be completely different at ~120 oC compared to that determined at 25 oC.  This 
indicates that Form 3 experienced a phase transition which started at ~110 oC and ended 
at ~120 oC.  Based on these results, the endothermic peak B in the DSC trace of Form 3 
in Figure 39, is confirmed as an indication of a phase change.          
 
We note that, Form 2 shows an indication of phase change at ~120 oC (Figure 41) while 
Form 3 shows the indication at ~110 oC (Figure 42).  This confirms the conclusion from 
DSC that the phase change temperature of Form 3 is lower than that of Form 2. 
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Although it was proved that both Forms 2 and 3 underwent a phase change when heated, 
these modified phases still needed to be identified unambiguously.  Therefore, the PXRD 
patterns of all three forms at 130 oC are compared in Figure 43.  The calculated trace of 
Form 1 at 173 K is shown for comparison.  The reason for choosing to display the traces 
at 130 oC is that both Forms 2 and 3 have completed the phase transition at this particular 
temperature.  
 
Figure 43 PXRD patterns of Form 1 (calculated at 173 K) and Forms 1, 2, 3 at 130 oC. 
 
The PXRD patterns of all three forms at 130 oC appear to represent the same phase.  
Although the peak positions in the experimental traces are significantly displaced to 
lower 2θ-angle owing to the different temperature conditions (a difference of 230 K), 
there is good agreement between all the experimental traces and the calculated PXRD 
pattern of Form 1 at 173 K.  This gives strong evidence that both Forms 2 and 3 
experienced phase transitions into Form 1.  In other words, both Forms 2 and 3 are 
enantiotropically related to Form 1.  
 
However, it was also necessary to establish in this study, the thermal relationship 
between Form 2 and Form 3.  Considering the fact that Form 2 underwent a phase 
change commencing at ~120 oC, it seemed useful to compare the PXRD patterns of 
Irel 
2θo 
Form 3 (130 oC) 
Form 2 (130 oC) 
Form 1 (130 oC) 
Calculated Form 1 (173 K) 
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Form 2 at 120 oC, Form 2 at 110 oC, Form 1 at 110 oC and Form 3 at 110 oC (Figure 
44).   
Figure 44 PXRD patterns used to establish direct transition of Form 2 into Form 1 upon heating. 
 
Two extra peaks A and B are observed in the PXRD pattern of Form 2 at ~120 oC 
compared to that at ~110 oC.  These two peaks are due to the phase change.  In other 
words, Form 2 at ~120 oC is a mixture of Form 2 and the modified phase.  The trace of 
Form 2 at ~120 oC was then compared with those of Forms 1 and 3 at ~110 oC.  Peaks A 
and B in the trace of Form 2 at ~120 oC are found to be consistent with peaks C and D in 
the trace of Form 1 at ~110 oC, respectively.  No peaks in the trace of Form 3 at ~110 oC 
are located in the same 2θ positions as peaks A and B in the trace of Form 2 at ~120 oC.  
Therefore, no evidence of Form 3 was found in the phase of Form 2 at ~120 oC.  In 
other words, the mixed phase of Form 2 at ~120 oC consists of the phases of Form 2 and 
Form 1.  Consequently, Form 2 did not convert into Form 3 first; instead, it experienced 
a phase change into Form 1 directly.    
 
A similar comparison was carried out to investigate Form 3 at ~110 oC at which 
temperature Form 3 starts to show indications of phase change.  The PXRD patterns of 
Form 3 at ~110 oC, Form 3 at ~100 oC, Form 1 at ~110 oC and Form 2 at ~110 oC were 
compared in Figure 45.   
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Form 3 (110 oC) 
Form 1 (110 oC) 
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Form 2 (120 oC) 
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Figure 45 PXRD patterns employed to establish direct transformation of Form 3 into Form 1 
upon heating. 
 
An extra peak A was observed in the PXRD trace of Form 3 at ~110 oC compared to that 
of Form 3 at ~100 oC.  Therefore, Form 3 started to show an indication of phase change 
at ~110 oC and this particular peak A is due to the new phase.  The trace of Form 3 at 
~110 oC was then compared with those of Forms 1 and 2 at ~110 oC.  The 2θ value of the 
peak A in the trace of Form 3 at ~110 oC and that of the peak B in the trace of Form 1 at 
~110 oC were found to be in close correspondence.  Also, the peak A was not consistent 
with any peak in the trace of Form 2 at ~110 oC.  Consequently, the phase of Form 3 at 
~110 oC is a mixed phase containing the phases of Form 3 and Form 1.  In other words, 
Form 3 did not transform into Form 2 first; instead, it experienced a phase change into 
Form 1 directly. 
 
From all of the above results, it is concluded that Forms 2 and 3 are both 
enantiotropically related to Form 1, and furthermore that Form 2 and Form 3 are 






Form 2 (110 oC) 
Form 1 (110 oC) 
Form 3 (100 oC) 
Form 3 (110 oC) 
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Hot Stage Microscopy     
In order to provide visual evidence for the above conclusions, HSM analysis was 
introduced.  Crystals of Forms 1, 2 and 3 were placed between cover slips and immersed 
in silicone oil.  Photographs were taken in the temperature range 30-170 oC at a heating 
rate of 10 K/min (Figure 46).  (It should be noted that the single crystals chosen for HSM 
were identified unambiguously from measurement of their unit cell dimensions at room 
temperature on a four-circle single crystal X-ray diffractometer). 
 
Figure 46 HSM photographs taken at various temperatures of crystals of Forms 1, 2 and 3 of 
isonicotinamide heated at 10 K/min 
 
The crystals of Forms 1, 2 and 3 were clear and transparent at 25 oC.  The crystals of 
Forms 2 and 3 appeared to become opaque at 133 oC and 131 oC, respectively.  These 
events represent the previously established phase changes of Forms 2 and 3, respectively.  
Furthermore, these observations confirm the conclusion that the phase change 
temperature of Form 3 is slightly lower than that of Form 2.  The crystal of Form 1 
remained clear during heating, indicating that no phase transition had occurred.  The 
three crystals melted simultaneously at ~166 oC and the melts all recrystallised on 
cooling to ~120 oC.  These observations are consistent with the conclusions drawn from 
DSC analysis and variable temperature PXRD.  
131 oC 133 oC 
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In order to further explore distinction of the phase change temperatures of Form 2 and 
Form 3, separate HSM experiments were performed at a much lower heating rate          
(1 K/min).  The results are shown in Figure 47.    
Figure 47 HSM photographs at various temperatures of crystals of Forms 1, 2 and 3 heated at    
1 K/min 
 
Crystals of Forms 1, 2 and 3 were heated at 1 K/min from 30 oC.  At ~121 °C, the crystal 
of Form 3 gradually became opaque, indicating the occurrence of the phase change to 
Form 1.  However, the crystal of Form 2 remained clear throughout the heating process.  
The three crystals eventually melted simultaneously at ~154 oC, strongly suggesting that 
Form 2 nevertheless experienced a phase change to Form 1. 
 
DSC and PXRD were introduced to confirm this assumption.  Crystals of Form 2 were 
placed in the open furnace of the DSC apparatus, and heated at 1 K/min.  The heating 
process was stopped at 130 oC.  The sample was then analysed by PXRD and the trace 
compared with the calculated pattern of Form 1 (Figure 48).  
121oC 123 oC 
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Figure 48 From top to bottom: PXRD patterns of Form 2 heated until 130 oC at 1 K/min; the 
calculated PXRD pattern of Form 1.  
 
The match between the two PXRD traces is very convincing, indicating that Form 2 did 
experience a phase change to Form 1 when heated at 1 K/min.  Consequently, it can be 
concluded that there is no visual phase change when Form 2 is heated at low heating 
rate; nevertheless, the phase change still occurs.  On the other hand, the phase change 
when Form 3 is heated is visible at both high and low heating rates.   
 
Construction of the Energy – Temperature Diagram 
As concluded earlier, Forms 2 and 3 are enantiotropically related to Form 1.  Also, the 
phase transition temperature of Form 2 is slightly higher than that of Form 3.  
Furthermore, Form 2 and Form 3 are monotropically related.  Based on these data, a 
schematic Energy–Temperature diagram for the three polymorphs of isonicotinamide can 
therefore be constructed, as described below and shown in Figure 49.   
 
Since Form 1 is enantiotropically related to Form 2, the G isobars of the two 
modifications should intersect and this specific intersection point (114.9 oC) would be 
defined as the thermodynamic transition point Tt2.  Similarly, the G isobars of Form 1 
and Form 3 should intersect at a specific point which is defined as Tt3.  In addition, the 
variable temperature PXRD patterns illustrate that Form 1 is the stable modification after 
Tt2 (Figure 43).  This requires the G isobar of Form 1 to be located below that of Form 2 
after the point Tt2.  Considering the fact that the G-T curve of Form 1 should intersect 
with that of Form 2, the former would be located above the latter below the temperature 
Tt2.  In addition, the variable temperature PXRD patterns indicate that Form 1 is more 
Irel 
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stable than Form 3 above Tt3.  This requires the G-isobar of Form 1 to be located below 
that of Form 3 above point Tt3.  Considering that the G-isobar of Form 1 must intersect 
that of Form 3 also, the former must be located above the latter below Tt3.  Based on the 
course of the G isobar of the liquid, the melting point of Form 1 is indicated by the point 
of intersection of its G isobar (GForm 1) with that of the liquid (Gliq).  This corresponds to 
the temperature Tf1 ~154 
oC, the melting point of Form 1. 
 
Figure 49 A schematic E/T diagram for the three polymorphs of isonicotinamide. (Note that the 
interval Tt3 → Tt2 is highly exaggerated).  
   
Since Form 2 is monotropically related to Form 3, their G isobars would not intersect.  
Therefore, the two G-T curves will be parallel to each other.  Although the exact value of 
Tt3 cannot be determined, it can be confirmed that Tt3 locates slightly ahead of Tt2 in the 
E/T diagram.  Based on this, the G-isobar of Form 3 must lie above that for Form 2.     
 
According to the density rule, the thermodynamically stable form at 0 Kelvin has the 
highest density.4  From the E/T diagram for isonicotinamide polymorphs, it can be 
predicted that the order of density at room temperature is: Form 2 > Form 3 > Form 1.  
It can also be predicted from the E/T diagram that these polymorphs would have a 
solubility order at room temperature: Form 2 < Form 3 < Form 1.  Furthermore, the 
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density order and the solubility order can be applied from 0 Kelvin to the phase transition 
temperatures.  We revisit the density order in the following section.  
    
X-Ray Crystallographic Analysis of Isonicotinamide, Form 3 
 
Single Crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
Structural information for Forms 1 and 2 was obtained from Aakeröy et al.23 and 
Vishweshwar et al.,24 respectively.  The crystal data for Forms 1 (CSD refcode 
EHOWIH0223) and 2 (CSD refcode EHOWIH0124) were obtained from the CSD25.           
 
Intensity data for Form 3 were collected on a Nonius Kappa CCD four-circle 
diffractometer.  It was confirmed that cooling the crystal of Form 3 from 294 K to 173 K, 
the temperature of the data-collection, did not result in a phase transformation.   
 
Program LAYER26 was used to determine the crystal system and space group of Form 3.  
The crystal system was found to be orthorhombic since the Laue symmetry was mmm and 
the reflection conditions were hkl: none; 0kl: k = 2n; h0l: l = 2n; hk0: h = 2n, indicating 
the space group Pbca.  This assignment was confirmed using program XPREP.5 
   
Structure Solution and Refinement 
SHELXS-976 was used for the structure solution of Form 3.  The positions of all non-
hydrogen atoms in the asymmetric unit (one molecule of isonicotinamide) were 
determined by direct methods.  The atoms were placed and refined isotropically on F2 in 
SHELXH-977.  All the non-hydrogen atoms were then refined anisotropically based on 
well-behaved isotropic temperature factors.  Attempts to locate the hydrogen atoms from 
difference Fourier maps followed and were successful.  Based on the positions of the 
peaks, a riding model was subsequently used to place all the hydrogen atoms in idealised 
positions.  These hydrogen atoms were assigned isotropic temperature factors 1.2 times 
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those of their parent atoms.  Table 18 contains relevant crystal data for Forms 1 and 2 
taken from the CSD25 as well as the crystal and refinement data for Form 3.   
 
Table 18 Crystal and refinement data for Forms 1, 2 and 3 
Parameter Form 1* Form 2** Form 3 
Formula unit C6H6N2O C6H6N2O C6H6N2O 
Formula Weight / g mol-1 122.13 122.13 122.13 
Temperature / K 173 (2) 173 (2) 173 (2) 
Crystal system monoclinic monoclinic orthorhombic  
Space group P21/c P21/c Pbca 
a / Å 15.735(3)  10.176(1)  10.1603(7) 
b / Å 7.998(1)  5.732(1)  7.3231(5)  
c / Å 9.885(3) 10.034(1)  15.8720(6)  
α / o 90.00 90.00 90.00 
β / o 105.59(1) 98.04(1) 90.00 
γ / o 90.00 90.00 90.00 
Volume / Å3 1198.21(5) 579.48(1) 1180.95(1) 
Z 8 4 8 
Densitycalc/g cm
-3 1.3538 1.3997 1.3736 
µ (MoKα) /mm
-1 ---------- ---------- 0.098 
F (000) ---------- ---------- 512 
Crystal size /mm3 ---------- ---------- 0.32x0.32x0.46 
Range scanned θ / o ---------- ---------- 1.00≤ θ ≤ 26.37 
---------- ---------- h: -12,12 
---------- ---------- k: -9,9 
Index ranges 
---------- ---------- l: -19,19 
φ scan angle / o ---------- ---------- 1.0 
ω scan angle / o ---------- ---------- 1.0 
Dx / mm ---------- ---------- 34 
No. of measured reflections ---------- ---------- 2126 
No. of unique reflections ---------- ---------- 1188 
No. of reflections with I > 2σ(I) ---------- ---------- 896 
No. of L.S. parameters ---------- ---------- 82 
Rint, Rσ ---------- ---------- 0.0286, 0.0307 
S ---------- ---------- 1.120 
R1 (Fo > 4σ(Fo)) ---------- ---------- 0.0453 
No. of reflections omitted ---------- ---------- 6 
wR2 (all reflections) ---------- ---------- 0.0960 
---------- ---------- a = 0.0367 Weighting scheme 
---------- ---------- b = 0.6587 
(∆ / σ)mean ---------- ---------- < 0.001 
∆ρ excursions / еÅ-3 ---------- ---------- -0.19, 0.22 
* Data taken from the CSD, refcode EHOWIH02.23 
** Data taken from the CSD, refcode EHOWIH01.24 
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A noteworthy observation is that the calculated densities above are in the order deduced 
earlier from the E/T diagram, namely Form 2 > Form 3 > Form 1.  
 
In the following section, detailed structural comparisons of Forms 1, 2 and 3 of 
isonicotinamide are presented at both the molecular and crystal structural levels.  
 
Molecular Structure 
The numbering scheme of the isonicotinamide molecule used in this study is presented in 
Figure 50 (left).  There are two crystallographically independent molecules (A and B) in 
the asymmetric unit of Form 1 as shown in Figure 50 (right).    
 
Figure 50 The numbering scheme of the isonicotinamide molecule (left); two 
crystallographically independent isonicotinamide molecules (A and B) in the asymmetric unit of 
Form 1. 
 
Essentially, the main conformational degree of freedom is rotation around the C3-C6 
bond (expressed in e.g. the dihedral angle O1-C6-C3-C4).  The value of this torsion angle 
is listed in Forms 1, 2, and 3 in Table 19.  It is evident that molecules A and B of Form 1 
adopt very similar conformations, but that these differ significantly (but not remarkably) 
from the nearly identical conformations observed in Forms 2 and 3.  
 
Table 19 The torsion angle O1-C6-C3-C4 of isonicotinamide molecules in Forms 1, 2 and 3* 
Torsion angle (o) Form 1 ） (A and B  Form 2 Form 3 
O1-C6-C3-C4 25.4(4), -24.0(3) 30.5(2) 30.9(3) 
*Note that since the crystals are all centrosymmetric, for any torsion angle listed, there is a 
corresponding parameter with the same magnitude but opposite sign.  
 
Figure 51 shows the overlay diagrams of the molecules in Forms 1, 2 and 3 from 











N2 O1 b 
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of its very similar conformation to that of molecule B' (where B' is the inverse of 
molecule B).   
 
Figure 51 An overlay of the molecules in Form 1 (green), Form 2 (red) and Form 3 (gray).  
Hydrogen atoms are omitted for clarity.   
 
Hydrogen Bond Interactions  
Analogous intermolecular hydrogen bonds N2-H6···O1 are found in the structures of 
Forms 1, 2 and 3.  A common hydrogen bond N2-H5···N1 is found in the structures of 
Forms 1 and 3.  A unique hydrogen bond N2-H5···O1 is found only in the structure of 
Form 2.  The geometrical details of these hydrogen bonds are listed in Table 20.   
 
Table 20 Intermolecular hydrogen bond interactions for Forms 1, 2 and 3a 
Hydrogen bond N···N or N···O Distance (Å) Angle (o) Symmetry operatorb 
Form 1 
N2A-H5A···N1A 2.982(2) 171.0 x, -1+y, z 
N2A-H6A···O1A 2.935(3) 170.0 x, 1/2-y, -1/2+z 
N2B-H5B···N1B 2.974(2) 169.0 x, -1+y, z 
N2B-H6B···O1B 2.947(3) 174.0 x, 1/2-y, -1/2+z 
Form 2 
N2-H6···O1 2.935(2) 158.0 x, 1/2-y, 1/2+z 
N2-H5···O1 2.937(2) 173.0 -x, 1-y, -z 
Form 3 
N2-H5···N1 2.982(2) 178.0 x, 1/2-y, 1/2+z 
N2-H6···O1 3.015(2) 173.0 1/2+x, 1/2-y, 2-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Figure 52 illustrates the hydrogen bond interactions for each form.  In the crystal of 
Form 1, the molecule A is hydrogen bonded to other symmetry-generated molecules A 
only.  Molecule B is likewise hydrogen bonded to symmetry-generated B molecules only. 
Since the hydrogen bond motifs are analogous, only that of the molecule A is shown as a 
representative in the figure.  A graph set analysis descriptor R
4 
3(20)
 8, 9 can be assigned to 
the hydrogen bond motif of Form 1.  In Form 2, two isonicotinamide molecules 
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associate as centrosymmetric, hydrogen bonded dimers, the unique H-bond being        
N2-H5···O1i (i = -x, 1-y, -z).  The cyclic H-bonded pattern contains a total of eight atoms, 
two of them being donors and two being acceptors, and is hence designated as R2 2(8).
8, 9  
Furthermore, a second hydrogen bond N2-H6···O1ii (ii = x, 1/2-y, 1/2+z) also associates 
two isonicotinamide molecules, and has a graph set analysis descriptor C1 1 (4).
8, 9  A 
noteworthy observation is that pyridine atom N1 in Form 2 is not hydrogen bonded to 
other atoms, which is not common in the hydrogen bond motifs of isonicotinamide 
molecules.  Form 3 adopts a similar hydrogen bonded framework as that in Form 1.    
 
Figure 52 Hydrogen bonded motifs in (a) Form 1, (b) Form 2 and (c) Form 3.  Atoms with gray 
labels have been symmetry-generated from their asymmetric unit counterparts.    
 
The hydrogen bond motifs of Forms 1 and 3 are overlayed in Figure 53.  Although the 
framework is similar in these two cases, the pyridine rings A1 and A2 of the two 
structures cannot be superimposed simultaneously.  This indicates the primary difference 
between the hydrogen bond motifs of Form 1 and Form 3.    























(b) Form 2 
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Figure 53 An overlay of hydrogen bond motifs of Form 1 (green) and Form 3 (purple).   
Hydrogen atoms are omitted for clarity. 
 
A unique weak intermolecular hydrogen bond C2-H2···O1 is found in the structure of 
Form 3 (Figure 54).  This is associated with the different pyridine ring orientations in the 
hydrogen bond motifs of Forms 1 and 3.  The geometrical details of this hydrogen bond 






8, 9 as indicated in Figure 54. 
 
Figure 54 The detailed hydrogen bond motif of Form 3.  Atoms forming hydrogen bond C2-
H2···O1 are shown as spheres for clarity.  Atom O1 with the gray label has been symmetry-
generated from its asymmetric unit counterpart.       
 
Table 21 The geometrical detail of hydrogen bond C2-H2···O1 in Form 3a 
C2···O1 Distance (Å) C2-H2···O1 Angle (o) Symmetry operator for O1 
3.205(2) 127.0 1/2+x, 1/2-y, 2-z 
a No e.s.d. is reported for the angle since the atom H2 was added in an idealised  position in a 
riding model. 
 
The hydrogen bond motifs of Form 1 and Form 3 are also investigated here on a larger 





2 (7)  
R
4 
3 (17)  
C2 
A1 A2 
Chapter 3: Supramolecular Modification of Isoxyl (Part four---isonicotinamide) 
 114
perspectives.  In Figure 55(b), all of the pyridine rings (A1, A2, A3, A4, A5 and A6) are 
parallel to each other.   
Figure 55 The hydrogen bond motif for the molecule A in Form 1 viewed along (a) [100] and (b) 
[010]. 
 
Figure 56 illustrates the hydrogen bond motif for the molecule in Form 3 from different 
orientations.  Although the motif in Figure 56 (a) shows significant similarity with that in 
Figure 55 (a), the rings A1-A6 are not all parallel to one another.  The set of parallel 
planes A1, A4 and A5 is related to the parallel set A2, A3 and A4 by the c-glide plane 
perpendicular to the b-axis at b = 1/4. 
 
Figure 56 The hydrogen bond motif for the molecule in Form 3 viewed along (a) [010] and (b) 
[001].    
 
The detailed comparisons above serve to highlight the different hydrogen bond motifs 
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Crystal Packing 
For Form 1, (CSD refcode EHOWIH0223), the asymmetric unit contains two symmetry-
independent molecules (A and B) which form two independent hydrogen bonded layers 
A and B, Figure 57 (a).  The unit cell contains eight symmetry related molecules arranged 
in four layers (A, B, A′ and B′) which extend infinitely parallel to the c-axis.  For Form 3 
(this study), there are eight symmetry related molecules in the unit cell; they arrange in 
two layers which extend infinitely parallel to the a- axis, Figure 57 (b).  Furthermore, in 
both Forms 1 and 3, there is no hydrogen bond interaction between the layers.  Layers A 
and B of Form 1 differ in the relative inclinations of the pyridine rings, whereas layers A 
and A′ in Form 3 are related to one another by a centre of inversion.  
 
Figure 57 Crystal packing diagrams for (a) Form 1 viewed along [010] and (b) Form 3 viewed 
along [001] 
 
The layers A and B in Form 1 and the layers A and A′ in Form 3 are shown in Figure 58 
from a different perspective.      
0 a 
c 
A B a 
b 0 
A′ 
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Figure 58 (a) The hydrogen bonded layers A (red) and B (green) in Form 1 viewed along [100].   
(b) The hydrogen bonded layers A (red) and A′ (green) in Form 3 viewed along [010].  
 
The unique feature of the crystal packing in Form 2 (CSD, refcode EHOWIH0124) is the 
formation of centrosymmetric hydrogen-bonded isonicotinamide dimers.  The second 
hydrogen atom of the amide group is used to link the dimers in infinite chains parallel to 
the c-axis, Figure 59. 
 







(a) Form 1 
0 c 
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Conclusion 
Two polymorphs of isonicotinamide, namely Forms 1 and 2, had been isolated in  
2003.23, 24  However, their thermal relationship had not been determined.  A new form 
(Form 3) was isolated and characterised in this study.  The thermal relationship among 
all three polymorphs was determined by thermal methods coupled with variable 
temperature PXRD data.  In order to isolate Form 3, it was not necessary for isoxyl to be 
present in the crystallising medium employed. 
     
Form 1 experienced no phase change during the heating process and it melted at       
~154 oC.  Form 2 underwent a phase change into Form 1 at ~114 oC.  Similarly, Form 3 
transformed into Form 1 upon heating.  Therefore, Form 1 is enantiotropically related to 
Form 2 and Form 3.  In addition, the fact that the changing phase of Form 2 during the 
heating process contains both Forms 1 and 2 while the changing phase of Form 3 upon 
heating contains both Forms 1 and 3 leads to the conclusion that both Forms 2 and 3 
convert to Form 1 directly.  In other words, the G isobars of Forms 2 and 3 do not 
intersect and so these polymorphs are monotropically related.  
 
Although the exact transition temperature of Form 3 could not be determined, evidence 
from variable temperature PXRD and HSM confirmed that the transition temperature of 
Form 3 is slightly lower than that of Form 2.   
 
Based on the above conclusions, a schematic Energy-Temperature diagram of the three 
forms of isonicotinamide was constructed.  Calculated crystal densities of the three 
polymorphs, based on their respective crystal data, were found to be in the order 
predicted from the Energy-Temperature diagram. 
  
Form 1 crystallises in the monoclinic space group P21/c with a = 15.735(3), b = 7.998(1), 
c = 9.885(3) Å, β = 105.59(1)º and 8 molecules per unit cell.  This requires that there are 
two symmetry-independent molecules in the asymmetric unit (namely molecules A and 
B).23  Form 2 crystallises in the space group P21/c with a = 10.176(1), b = 5.732(1), c = 
10.034(3) Å,  β = 98.04(1)º and 4 molecules per unit cell.24  Form 3, isolated and fully 
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characterised in this study, crystallises in the orthorhombic space group Pbca with a = 
10.1603(7), b = 7.3231(5), c = 15.8720(6) Å and 8 molecules per unit cell.   
 
Form 1 and Form 3 adopt very similar hydrogen bonding motifs; however, these are not 
identical.  Analogous intermolecular hydrogen bonds (N2-H5···N1 and N2-H6···O1) can 
be observed in the structures of Forms 1 and 3.  However, an additional hydrogen bond 
C2-H2···O1 is observed only in Form 3.  Form 2 contains a very different hydrogen 
bonding motif from those of Forms 1 and 3.  A noteworthy observation is that the 
pyridine nitrogen atom (N1) is not hydrogen bonded to any atoms in Form 2.  In other 
words, only one nitrogen atom (N2 of the amide function) is involved in the hydrogen 
bond motif of Form 2.  Consequently, Forms 1, 2 and 3 contain hydrogen bond motifs 
that are distinct and that may be described using graph set analysis descriptors as R
4 










8, 9 respectively.             
 
Infinite hydrogen-bonded layers are found in the structures of both Forms 1 and 3.  In 
Form 1, the molecules A assemble to form layer A while the crystallographically distinct 
molecules B assemble to form a distinct layer B.  These layers individually contain 
coplanar pyridine rings, but the layers are not superimposable because of the different 
inclinations of the rings in layers A and B.  For Form 3, the molecules assemble as two 
layers (A and A') in the unit cell and these two layers are related by a crystallographic 
inversion centre.  Molecules of isonicotinamide in Form 2 form centrosymmetric 
hydrogen bonded dimers, linked to forms chains parallel to the c-axis.  Thus, Forms 1, 2 
and 3 are different polymorphs with different hydrogen bond motifs and crystal packing 
arrangements. 
 
As is evident from the variable temperature PXRD Figures 40, 41 and 42, experimental 
PXRD traces of the three polymorphs are found to be consistent with their respective 
calculated patterns, allowing the latter to serve as reliable references for polymorphic 
identification. 
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Nicotinamide 
In an early attempt to form a cocrystal between isoxyl and nicotinamide by co-
precipitation from ethyl acetate solution, the products of crystallisation were 
identified as a mixture of a known polymorphic form of nicotinamide and a new 
phase of nicotinamide by measuring the unit cell dimensions of the respective crystals.  
To establish whether this outcome depended on the presence of isoxyl, nicotinamide 
alone was dissolved in ethyl acetate and the products of crystallisation were found to 
be a known polymorphic form of nicotinamide only.  Thus, through the preparative 
method used in this study, the appearance of the new polymorphic phase of 
nicotinamide requires the participation of the compound isoxyl.  Specifically, isoxyl 
evidently acts to enhance the nucleation and growth of this particular new phase of 
nicotinamide rather than acting to form a co-crystal.  Details of this new phase are 
reported below.  In addition to producing an apparently new polymorph of 
nicotinamide, this preparative procedure also yielded crystals of one other polymorph, 
referred to here as Form 1, whose structure was first reported in 195327 and for which 
a more accurate crystal and molecular structure was determined in 1999 (CSD refcode 
NICOAM01).28    The polymorphism of nicotinamide was subsequently first discussed 
by Hino et al.29 based on evidence obtained by DSC analysis.  However, no crystal 
structure of a second nicotinamide polymorph has hitherto been determined.  In this 
study, the new polymorph was accordingly named Form 2 and its structure was 
determined, as was its polymorphic relationship to Form 1.  As with the new 
isonicotinamide polymorph described previously, the widespread use of nicotinamide 




In a typical experiment, a physical mixture of nicotinamide (19 mg) and isoxyl (9 mg) 
was dissolved in 2 ml ethyl acetate at 54 oC.  The solution was stirred for 10 minutes 
and filtered (0.45 µm nylon filter) while hot.  It was then placed in a Dewar flask 
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containing water at ~54 oC.  Rapid cooling was prevented by using an insulating 
material to cover the flask.  It took two days for the water in the Dewar flask to cool 
to ambient temperature.  The solution was then allowed to evaporate slowly and 
crystallise under ambient conditions.  Crystallisation occurred within two weeks of 
standing.  It should be noted that using this procedure repeatedly resulted in random 
outcomes as far as the precipitation of Form 2 is concerned.  
 
Similarly to isonicotinamide, visual comparison of the batch of precipitated material 
indicated the possible presence of crystals of different morphologies and thus of 
possibly different polymorphs (i.e. concomitant polymorphism).  After that, the very 
thorough, but reliable procedure of determining crystal unit cells for each specimen in 
the batch using single crystal X-ray diffraction was employed in order to guarantee 
definite separation of each polymorphic species.  This revealed two distinct 
polymorphs of nicotinamide, namely Form 1, described previously,27, 28 and a second 
modification, not hitherto reported, and assigned as Form 2.  No crystallisation 
procedure yielding Form 2 exclusively could be devised.  Only by following the 
procedure above was it possible to obtain Form 2 in a sufficiently large sample to 




Differential Scanning Calorimetry and Thermogravimetric Analysis 
TGA analyses (not shown) indicated negligible weight loss for Forms 1 and 2 of 
nicotinamide in the temperature range 30-180 oC, indicating that they are not solvates.  
DSC analysis was performed on Form 1 and Form 2 at 10 K/min as shown in Figure 
60.  Both DSC traces exhibited a single melt endotherm, labelled A1 and A2, 
respectively.  Peak A2 displays a shoulder and a peak respectively, the shoulder 
possibly functioning as a lead into the melt.  This is probably due to the fact that an 
intact crystal (1.03 mg) of Form 2 was used for this analysis (the operation of 
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grinding was not performed to avoid the possibility of phase transformation).  
Therefore, the thickness of the specimen possibly led to non-uniform heat transport 
through the crystal.       
 
Figure 60 DSC traces of Form 1 and Form 2 of nicotinamide (heating at 10 K/min) 
 
The thermal data of Forms 1 and 2 obtained by DSC analyses are listed in Table 22.  
The onset temperature (Tf) for the melt of Form 2 is very significantly lower than that 
of Form 1.  Also, Form 2 has the lower heat of fusion.  Based on the Burger and 
Ramberger Heat of Fusion rule,3 Form 1 is monotropically related to Form 2.    
 
Table 22 Thermo-analytical data obtained from DSC for the Forms 1 and 2 at 10 K/min 
Polymorph Tf  (
oC) – onset temperature ∆Hf  (J g-1) – heat of fusion 
Form 1 121.9 ± 0.8 (n=2)  262.0 ± 5 (n=2) 
Form 2 105.8 ± 0.4 (n=2) 165.0 ± 4 (n=2) 
 
Variable Temperature Powder X-ray Diffraction   
Figure 61 firstly shows the comparison between the measured PXRD pattern of Form 
1 at 25 oC and the calculated pattern derived from the single crystal structure of Form 
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Form 1 were then characterised by PXRD as a function of temperature.  The PXRD 
pattern was recorded at temperature intervals of 10 K between 25 and 160 oC.     
 
Figure 61 Variable temperature PXRD patterns of Form 1 [From bottom to top: calculated 
(173 K), experimental at 25, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150 and 160 oC] 
 
The peak positions in the calculated trace (173 K) are displaced to higher 2θ-angles 
relative to those of the experimental trace (25 oC), as expected.  However, the match 
between the two traces is convincing, proving that the bulk sample is homogeneous 
and has the same crystal structure as Form 1(CSD refcode NICOAM0128). 
 
No evidence of phase change was observed when Form 1 was heated to the melting 
temperature.  This is consistent with the fact that only a single endothermic peak A1 
was observed in the DSC trace of Form 1 (Figure 60).   
 
Figure 62 firstly shows the comparison between the measured PXRD pattern of Form 
2 at 25 oC and the calculated pattern derived from the single crystal structure of Form 
2 (described later in this study) using program LAZY PULVERIX.11  Crystals of 
Form 2 were then characterised by PXRD as a function of temperature.  The PXRD 






Calculated Form 1 at 173 K  
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Figure 62 Variable temperature PXRD patterns of Form 2 [From bottom to top: calculated 
(173 K), experimental at 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130 and 136 oC] 
 
The match between the calculated PXRD pattern (173 K) and the experimental pattern 
(25 oC) confirms the polymorphic purity of the experimental sample of Form 2. 
 
No phase change of Form 2 was evidenced during this heating since the PXRD 
patterns remained the same.  At ~120 oC, the crystals of Form 2 started to lose their 
crystallinity.  However, the main peaks still remained, providing strong evidence that 
Form 2 melted as the original phase.  Consequently, Form 2 experienced no phase 
transition until melting.  Again, this corresponds to the observation from DSC 
analysis.  
 
A relatively large temperature difference in melting shown by DSC compared with 








Calculated Form 2 at 173 K  
Irel 
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Hot Stage Microscopy 
The single crystals of Form 1 and Form 2 were examined by HSM.  The crystals 
were placed side by side between cover slips and immersed in silicone oil.  
Photographs were recorded in the temperature range 30-140 oC at a heating rate of        
10 K/min, Figure 63.  
 
Figure 63 HSM photographs taken at various temperatures of crystals of Forms 1 and 2 
heating at 10 K/min 
  
The crystals were clear and transparent at 25 oC.  The crystal of Form 2 started to 
become opaque at ~93 oC and its shape started to round at ~96 oC.  This shape change 
indicates that it is melting slowly during heating rather than undergoing a phase 
change.  Meanwhile, the crystal of Form 1 remained clear and maintained a rigid 
shape upon heating.  Finally, the crystal of Form 2 completely melted at ~133 oC 
when the crystal of Form 1 only started to melt; the latter then completely melted at 
~134 oC.  This HSM experiment was repeated successfully, confirming the existence 
of this small temperature difference (~1 oC).   This strongly indicates that the crystals 
of Form 1 and Form 2 melt at different temperatures. 
93 oC 96 
oC 25 oC 
133 oC 134 oC 
Form 2 
Form 1 
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The fact that the crystal of Form 2 melts over a very wide temperature range         
(90–133 oC) is possibly due to its thickness.  Also, this is consistent with the fact that 
the melting peak of Form 2 in the DSC trace is composed of two parts.   
 
Construction of the Energy – Temperature Diagram 
Based on the thermal data of Form 1 and Form 2, an E/T diagram was constructed in 
Figure 64.  As concluded earlier, Form 1 is monotropically related to Form 2.  
Hence, the G-isobars of Form 1 and Form 2 do not intersect before the melting 
points.  The G isobar of the liquid intersects that of Form 1 at a specific point Tf1                      
[121.9 ± 0.8 oC(n=2)] which represents the melting of Form 1 (Table 22).  Similarly, 
the G-T curve of the liquid intersects that of Form 2 at the point Tf2 [105.8 ± 0.4 
oC 
(n=2)] which indicates the melt of Form 2.  The fact that Tf2 is lower than Tf1 allows 
the G-T curve of Form 2 to be located above that of Form 1.  
 
Figure 64 A schematic E/T diagram for the two polymorphs of nicotinamide  
 
From the E/T diagram, it can be predicted that Form 1 is the thermodynamically 
stable form between absolute zero and its melting point while Form 2 is the 
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thermodynamically metastable form between absolute zero and its melting point.  
Also, in this temperature range, the densities of the two polymorphs would be in the 
order: Form 1 > Form 2 while the solubilities of two forms would be in the order: 
Form 1 < Form 2.  The point is addressed again later.  
 
X-Ray Crystallographic Analysis of Nicotinamide, Form 2  
 
Single Crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
Structural information for Form 1 was obtained from Miwa et al.28  The crystal data 
for Form 1 (CSD refcode NICOAM0128) were obtained from the CSD.25 
 
A Nonius Kappa CCD four-circle diffractometer was employed to collect the data for 
Form 2 at 173 K.  The X-ray diffraction pattern of Form 2 displayed 2/m Laue 
symmetry, which indicated that the compound crystallises in the monoclinic crystal 
system.  The conditions limiting reflections were: hkl: none; h0l: h+l = 2n; 0k0: none. 
This indicates either the space group P2/n or Pn.  The centrosymmetric space group 
P2/n was indicated by the value of the intensity statistic |E2-1| = 1.017, and the 
structure was successfully solved and refined in this space group.  A preliminary 
calculation based on the estimated density indicated the unusually high value of Z = 
16 molecules per unit cell.    
 
Unit-cell dimension measurement for Form 2 was carried out at both ambient 
temperature and low temperature (173 K).  No significant change was observed, 
indicating that there is no phase transition of Form 2 during cooling. 
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Structure Solution and Refinement 
The structure solution of Form 2 was performed using SHELXS-97.6  Direct methods 
yielded the positions of all the non-hydrogen atoms in the asymmetric unit, which 
contains four crystallographically independent molecules.  SHELXH-977 was used to 
place the atoms which were initially refined isotropically and subsequently 
anisotropically.  Attempts to locate the hydrogen atoms from difference Fourier maps 
followed and were successful.  Based on the positions of the peaks, a riding model 
was subsequently employed to place the hydrogen atoms.  They were assigned 
isotropic temperature factors 1.2 times those of their parent atoms.  Table 23 lists 
relevant crystal data for Form 1 (CSD refcode NICOAM0128) taken from the CSD,25 
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Table 23 Crystal and refinement parameters for Form 1 and Form 2 
Parameter Form 1* Form 2 
Formula unit C6H6N2O C6H6N2O 
Formula Weight / g mol-1 122.13 122.13 
Crystal system monoclinic monoclinic 
Space group P21/c P2/n 
a / Å 3.877(4)  15.0634(5) 
b / Å 15.60(1)  10.6976(4) 
c / Å 9.375(6) 15.2067(5) 
α / o 90.00 90.00 
β / o 98.45(7) 102.188(2) 
γ / o 90.00 90.00 
Volume / Å3 560.9(8) 2395.21(14) 
Z 4 16 
Densitycalc /g cm
-3 1.4463 1.3545 
µ (MoKα) /mm
-1 0.103 0.096 
F (000) 256 1024 
Crystal size /mm3 0.7x0.7x0.6 0.28x0.4x0.52 
Temperature / K 150 173(2) 
Range scanned θ / o ------------- 1.02≤ θ ≤ 25.03 
------------- h: -18,18 
------------- k: -13,13 
Index ranges 
------------- l: -19,19 
φ scan angle / o ------------- 1.0 
ω scan angle / o ------------- 1.5 
Dx / mm ------------- 40 
No. of measured reflections ------------- 88974 
No. of unique reflections ------------- 4881 
No. of reflections with I > 2σ(I) ------------- 3492 
No. of L.S. parameters ------------- 325 
Rint, Rσ ------------- 0.1173, 0.0536 
S ------------- 1.101 
R1 (Fo > 4σ(Fo)) ------------- 0.0499 
No. of reflections omitted ------------- 13 
wR2 (all reflections) ------------- 0.1241 
------------- a = 0.0489 Weighting scheme 
------------- b = 0.7737 
(∆ / σ)mean ------------- <0.001 
∆ρ excursions / еÅ-3 ------------- -0.27, 0.19 
* Data taken from the CSD, refcode NICOAM01.28 
 
We note that the calculated density order of the polymorphs, namely Form 1 > Form 
2, agrees with the density order deduced from the E/T diagram in the temperature 
range of absolute zero to the melting point of Form 2. 
 
In the following section, detailed structural comparisons of Forms 1 and 2 of 
nicotinamide are presented at both the molecular and crystal structural levels.  
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Molecular Structure 
The numbering scheme of the nicotinamide molecule is shown in Figure 65 (left).  
There are four crystallographically independent molecules (A, B, C and D) in the 
asymmetric unit of Form 2, as shown in Figure 65 (right).    
 
Figure 65 The numbering scheme of the nicotinamide molecule (left) and four 
crystallographically independent nicotinamide molecules (A, B, C and D) in the asymmetric 
unit of Form 2 (right). 
 
The conformations of the molecules in Forms 1 and 2 are compared in Figure 66.     
 
Figure 66 The conformational comparison among the molecules in Form 1 and Form 2.  
From top to bottom: (a) the molecule in Form 1; (b) Molecule A in Form 2; (c) Molecule B 
in Form 2; (d) Molecule C in Form 2; (e) Molecule D in Form 2.  
 
 













(a) Form 1 
(b) Form 2 A 
(c) Form 2 B 
(d) Form 2 C 
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Variable conformations can be observed among these molecules.  Essentially, the 
main conformational degree of freedom is rotation around the C2-C6 bond (expressed 
e.g. in the dihedral angle O1-C6-C2-C3).  In Table 24, the value of this torsion angle 
is quoted as representative.  We note that molecule Form 2D has opposite handedness 
from the other three in the asymmetric unit.  In order to make a valid comparison of 
the various conformations, the torsion angle O1-C6-C2-C3 for the inverted image of 
Form 2D (D′) was calculated and included in Table 24.  
   
Table 24 The torsion angle τ for nicotinamide molecules in Form 1 and Form 2 
Form 2 Torsion angle (o) Form 1 
A B C D′ 
O1-C6-C2-C3 (τ) 20.8(1) 14.2(3) 7.3(3) 21.3(3) 10.6(3) 
D′ is the inverse of molecule D shown in Figure 66. 
 
From Table 24, τ spans a significant range [7.3(3)-21.3(3)o] and the significant 
differences among the four values of τ confirm that these four molecules are 
symmetry-independent.  
 
Hydrogen Bonding Interactions  
The hydrogen bond motif of Form 1 is shown in Figure 67 and the details of these 
interactions are listed in Table 25.  The atom N2 simultaneously serves as a hydrogen 
bond donor to atoms O1 and N1 through different hydrogen bonds.  In other words, 
all the N and O atoms are involved in the hydrogen bond interactions in Form 1.  The 
graph set analysis descriptors8, 9 for two rings formed by the three different hydrogen 
bonds are shown in Figure 67.  
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Figure 67 (a) The hydrogen bond motif for Form 1 (b) The stereoview illustrating the 
hydrogen bond motif for Form 1. 
        
Table 25 The hydrogen bond interactions in Form 1 
Hydrogen bond N···O, N···N or C···O Distance (Å) Angle (o) Symmetry 
operatora 
N2-H5···O1 2.964(3) 178.4(9) x, 1/2-y, -1/2+z 
N2-H6···N1 3.076(3) 169.7(9) 1+x, 1/2-y, 1/2+z 
C1-H1···O1 3.304(4) 138.9(9) -1+x, 1/2-y, -1/2+z 
a Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Molecules of nicotinamide in Form 1 form infinite ribbons by hydrogen bonding, the 
unit cell containing two such parallel ribbons that are not hydrogen bonded to one 
another, Figure 68.       
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Figure 69 shows the hydrogen bond interactions in Form 2.  In Form 2, a noteworthy 
observation is that the atom O1A in the molecule A is not involved in any hydrogen 
bonds while all the O and N atoms in molecules B, C and D are involved in hydrogen 
bonding.  Also, the molecule D is related to a symmetry-generated molecule D' by a 
crystallographic inversion center.  
 
Figure 69 The hydrogen bond interactions in Form 2.  Atom O1A is shown as a sphere for 
clarity.  Atoms with gray labels have been symmetry-generated from their asymmetric unit 
counterparts. 
 
Since there are four crystallographically independent molecules in the asymmetric 
unit of Form 2, the detailed hydrogen bond motifs of each independent molecule are 
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Figure 70 (a) The hydrogen bond motif of the molecule A in Form 2; atom O1A is shown as 
a sphere for clarity; (b) The hydrogen bond motif of the molecule B; (c) The hydrogen bond 
motif of the molecule C; (d) The hydrogen bond motif of the molecule D.  Atoms with gray 
labels have been symmetry-generated from their asymmetric unit counterparts. 
  
The geometrical details of the hydrogen bonds in Form 2 are listed in Table 26.  The 
hydrogen bonds N2-H···O1 and N2-H···N1 can be found in both Form 1 and Form 2.  
The mean distance for the N-H···N interactions in Form 2 is 3.10 Å while the mean 
angle is 168o.  The average distance for the N-H···O interactions is 2.98 Å while the 
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Table 26 The hydrogen bond interactions for Form 2a  
Hydrogen bond N···N or N···O Distance (Å) Angle (o) Symmetry operatorb 
N2A-H5A···N1B 3.089(2) 167.0 1-x, 2-y, 1-z 
N2B-H5B···N1A 3.118(2) 170.0 1/2+x, 2-y, 1/2+z 
N2C-H5C···N1D 3.067(2) 166.0 x, y, z 
N2D-H5D···N1C 3.111(2) 169.0 3/2-x, y, 1/2-z 
N2A-H6A···O1C 3.053(2) 173.0 x, y, z 
N2B-H6B···O1C 2.975(2) 163.0 x, y, z 
N2C-H6C···O1B 2.917(2) 171.0 x, y, z 
N2D-H6D···O1D 2.957(2) 171.0 2-x, -y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  
positions in a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Several C-H···N and C-H···O hydrogen bond interactions are observed in Form 2, as 
listed in Table 27.  The mean C···N distance in C-H···N interactions is 3.15 Å with a 
mean angle of 134o.  The average C···O distance in C-H···O interactions is 3.27 Å 
with a mean angle of 137o. 
 
Table 27 The C-H···N and C-H···O interactions for Form 2a 
Hydrogen bond C···N or C···O Distance (Å) Angle (o) Symmetry operatorb 
C1A-H1A···N1B 3.336(2) 149.0 1-x, 2-y, 1-z 
C1B-H1B···N2B 2.907(2) 100.0 x, y, z 
C1B-H1B···N1A 3.294(2) 167.0 1/2+x, 2-y, 1/2+z 
C1D-H1D···N2D 2.908(2) 100.0 x, y, z 
C1D-H1D···N1C 3.311(2) 154.0 3/2-x, y, 1/2-z 
C3B-H2B···O1A 3.174(2) 123.0 1-x, 1-y, 1-z 
C4B-H3B···O1A 3.184(2) 122.0 1-x, 1-y, 1-z 
C5B-H4B···O1D 3.466(2) 166.0 3/2-x, 1+y, 3/2-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  
positions in a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Crystal Packing 
Form 1 contains infinite hydrogen bonded parallel ribbons which are not hydrogen 
bonded to one another (Figure 71). 
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Figure 71 Crystal packing diagram for Form 1 viewed along [101] 
The packing arrangement for Form 2 is shown in Figure 72.   
Figure 72 Crystal packing diagram for Form 2 viewed along [010].  Molecules A, B, C and 
D are shown in green, blue, brown and pink, respectively.  Hydrogen atoms are omitted for 
clarity.    
 
The molecules A (green) and B (blue) and their respective diad-related molecules 
form a parallelogram in projection (parallelogram AB) and they are associated by 
hydrogen bonds.  Similarly, the molecules C (brown) and D (pink) and their 
respective diad-related molecules assemble as a parallelogram pattern (parallelogram 
CD) and they are associated by hydrogen bonds.  The parallelogram AB is connected 
to the parallelogram CD through the hydrogen bonds N2A-H6A···O1C and N2C-
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parallelogram AB.  However, the parallelogram CD is associated with another 
symmetry-generated parallelogram CD through the hydrogen bond N2D-H6D···O1D.   
 
Stacked networks of the type shown above along the y-direction are shown in Figure 
73.  Successive networks have alternating colours (red, green).  Within each network 
(red or green in Figure 73), molecules are hydrogen bonded to one another, but there 
are no hydrogen bonds linking a red and green network.    
 
Figure 73 A stereoview of the crystal packing for Form 2 viewed along [010].  Alternating 
networks are shown in red and green.  Hydrogen atoms and the unit cell are omitted for 
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Conclusion 
The structure of nicotinamide was determined in 1953.27  After that, no re-
examination was carried out until 1999, when Miwa et al.28 improved the accuracy of 
the first structure, namely Form 1 (CSD, refcode NICOAM01).  The indication of the 
existence of other polymorphic forms was reported by Hino et al.29 in 2001.  
However, no structural information for other forms of nicotinamide was reported.  In 
this study, a new form, namely Form 2, was isolated successfully.  It is noteworthy 
that production of Form 2 crystals required the participation of the compound isoxyl 
when the preparative procedure used in this study was employed.  The 
thermodynamic relationship between the two polymorphs was determined by thermal 
methods coupled with variable temperature PXRD data. 
 
Neither Form 1 nor Form 2 experienced a phase change during the heating process 
until melting.  This was confirmed from DSC, HSM and variable temperature PXRD 
data.  Therefore, the two forms are monotropically related.  Furthermore, the melting 
points of Form 1 and Form 2 were determined as 121.9 ± 0.8 oC (n=2) and          
105.8 ± 0.4 oC (n=2), respectively.  Based on these data, a schematic Energy-
Temperature diagram of the two polymorphic forms of nicotinamide was constructed.  
From the E/T diagram, it can be predicted that the densities of the two polymorphs 
should be in the order: Form 1 > Form 2 while the solubilities of two forms would be 
in the order: Form 1 < Form 2.  Notably, the density order deduced from the E/T 
diagram is in accord with the calculated densities of the two polymorphs based on 
their respective crystal data.    
 
Form 1 crystallises in the monoclinic space group P21/c with a = 3.877(4), b = 
15.60(1), c = 9.375(6) Å, β = 98.45(7)º and 4 molecules per unit cell.  Form 2 
crystallises in the space group P2/n with a = 15.063(4), b = 10.697(6), c = 15.206(7) 
Å, β = 102.18(8)º and 16 molecules per unit cell.  The latter requires the existence of 
four symmetry-independent molecules in the asymmetric unit, namely molecules A, 
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B, C and D.  These four molecules adopt significantly different conformations.  
Molecule C does, however, closely resemble the molecule present in Form 1 
(respective torsion angles O1-C6-C2-C3: 21.3(3)o, 20.8 (1)o]. 
   
All the N and O atoms in the molecule in Form 1 and those in the molecules B, C and 
D in Form 2 are involved in hydrogen bond motifs.  However, the atom O1A in the 
molecule A is isolated from the hydrogen bonding environment.  The hydrogen bond 
motifs of Form 1 and Form 2 are very different.  Hydrogen-bonded ribbons and 
hydrogen-bonded nets are found in Form 1 and Form 2, respectively.  Ribbons in 
Form 1 extend infinitely and are isolated from one another.  This also applies to nets 
in Form 2.  
 
As is evident from the variable temperature PXRD Figures 61 and 62, the 
experimental PXRD traces of the two polymorphs were found to be consistent with 
their respective computed patterns, allowing the latter to serve as reliable references 
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Rifampicin Solvates  
 
This chapter is divided into three parts: 
 
Part One: Isostructural Rifampicin solvates containing methanol/ethanol/water molecules. 
Part Two: Isostructural Rifampicin solvates containing 1-propanol/iso-propanol/water 
molecules. 
Part Three: Four distinct Rifampicin solvates containing iso-propanol/1-butanol/ethylene 
glycol/1,4-dioxane and water molecules. 
 
We report the isolation of these solvates and we investigate the solid-state features of 
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Part One  
Isostructural Rifampicin Solvates Containing Methanol/Ethanol and Water Molecules 
 
Crystal Preparation 
The abbreviations for the discrete rifampicin solvates in this chapter are as follows: 
Rifampicin • 1.57methanol • 3H2O:                   P1 
Rifampicin • 0.39methanol • 4.17H2O:              P2 
Rifampicin • 2ethanol • 2H2O:                           P3 
Rifampicin • 0.54ethanol • 3.92H2O:                 P4 
 
Suitable crystals of P1 and P3 were obtained by dissolving 0.020 g (0.024 mmol) of the 
host drug (rifampicin) in 2 ml of methanol-water mixture (1:1 v/v) and ethanol-water 
mixture (1:1 v/v) at 25 oC, respectively.  Crystals of suitable quality appeared by slow 
evaporation at 4 oC over a period of two weeks. 
Crystals of P1 and P3 were allowed to stand on an open bench at 25 oC.  After 
equilibrating with the atmosphere for a period of 10 h, crystals of P1 and P3 were found 
to have transformed to phases P2 and P4, respectively, with different solvent 
compositions from those of the original phases.   
 
The host and guest numbering schemes are given in Figure 1. 
 
Figure 1 Host and guest numbering schemes: (a) rifampicin, (b) methanol, (c) ethanol. Hydrogen 
atoms have been omitted for clarity. 
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TGA and XRD Characterisation 
Multiple TGA measurements were firstly employed to optimise the values of total mass 
loss for all the solvates described in this chapter.  The X-ray analyses were then used to 
reveal the nature of included solvents, either singly, or as mixtures in the solvates.  
Careful analysis of the thermal parameters and the site-occupancy factors of the solvent 
molecules eventually gave rise to reasonable crystallographic modelling of solvent 
contents consistent with the experimental TGA data.  Therefore, the derivation of 
molecular formulae for the solvates was achieved by combining the TGA data with data 
from X-ray structural refinements.  More details of this procedure are given in Chapter 6, 
dealing with the thermal analysis of these solvates.  
 
Single Crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
A crystal of P1 from mother liquor was covered in paratone N oil without delay in order 
to prevent the loss of solvent molecules.  The crystals of P2, P3 and P4 were handled in 
the same way.  A Nonius Kappa CCD four-circle diffractometer was employed to collect 
the data for P1, P2 and P3 at 173 K.  However, the data for P4 were collected on a Bruker 
Apex Duo diffractometer at 100 K.  The unit cell parameters, crystal systems and space 
groups were determined from the X-ray diffraction data which revealed Laue mmm 
symmetry for all four solvates.  Therefore, these solvates belong to the orthorhombic 
system.  The space group P212121 was deduced from the systematic absences: hkl: none; 
h00: h = 2n+1; 0k0: k = 2n+1; 00l: l = 2n +1.   
 
Structure Solution and Refinement 
For all four solvates, program SHELXD1 was used to solve the structures by ab initio 
methods, which revealed the positions of all the non-hydrogen atoms of the rifampicin 
molecule (host) in each structure.  Full-matrix least-squares refinements were performed 
with SHELXH-97.2  Difference Fourier maps exhibited the positions of primary oxygen 
and carbon atoms of the water and solvent molecules (guest).  Some of these atoms were 
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found to have full site-occupancy while the others were generally disordered over two or 
even three positions.  The host and guest molecules having full s.o.f. were then refined 
isotropically.  However, atom C41 in phase P3 is disordered over two positions (C41A 
and C41B).  C41A, the major component, was assigned a value of x for its s.o.f. while the 
minor component C41B was allocated the value 1-x.  The s.o.f.s refined to 0.54(3) and 
0.46(3) respectively while their Uiso values refined to 0.033(3) Å
2 and 0.035(4) Å2, 
respectively.  
 
For the disordered solvent molecules, a fixed Uiso (the mean of Ueq for the chemically 
equivalent ordered atoms) was assigned to each molecule and these atoms were allowed 
to refine with s.o.f.s x and 1-x, with x variable.  For some molecules, the s.o.f.s were then 
assigned as a fixed value, allowing the Uiso to refine freely.  The details of the Uiso values 
and s.o.f.s of the guest molecules in each solvate are listed in Table 1.  
 
Table 1 Isotropic thermal parameters and site-occupancy factors for the guest molecules of the 
four solvates 
Solvate Guest molecule Uiso (Å
2) s.o.f 
O1W 0.07 1.00 
O2W 0.05 1.00 
O3WA 0.05 0.57 
O3WB 0.06 0.43 
O1G-C1G 0.09-0.09 1.00 
P1 
O2G-C2G 0.04-0.07 0.57 
O1W 0.07 1.00 
O2W 0.05 1.00 
O3W 0.06 1.00 
O4W 0.07 0.70 
O5W 0.07 0.47 
P2 
O1GB-C1GB  0.09 (global Uiso) 0.39 
O1W 0.08 1.00 
O2W 0.06 1.00 
O1G-C1G-C2G 0.08-0.06-0.07 1.00 
O2GA-C3GA-C4GA  0.07 (global Uiso) 0.30 
O2GB-C3GB-C4GB  0.06 (global Uiso) 0.36 
P3 
O2GC-C3GC-C4GC  0.07 (global Uiso) 0.34 
O1WA 0.03 0.54 
O1WB 0.05 0.46 
O2W 0.03 1.00 
O3W 0.09 1.00 
O4WB 0.06 0.46 
O5WB 0.04 0.46 
P4 
O1GA-C1GA-C2GA 0.02-0.08-0.08 0.54 
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In general, attempts to locate all the hydrogen atoms in each solvate from difference 
Fourier maps were made.  Special attention was given to establishing the nature of the 
rifampicin molecules (neutral/zwitterionic) in each solvate by careful inspection of the 
difference electron density maps for the relevant hydrogen atom candidates.  Based on 
the positions of the peaks found, a riding model was employed to place hydrogen atoms 
for rifampicin and solvent molecules in idealised positions except for the water hydrogen 
atoms which were positioned based on reasonable locations of suitable electron density 
peaks and their possible hydrogen bond geometry.  All the methyl hydrogen atoms were 
refined with isotropic temperature factors 1.5 times those of their parent atoms while all 
the other hydrogen atoms were assigned temperature factors 1.2 times those of their 
parent atoms.   
   
For the methanol and ethanol molecules as well as the hydrogen atoms of water 
molecules, distance restraints were employed to ensure reasonable molecular geometries.  
The C-O bond length in the methanol molecule was set at 1.41 Å with a standard 
deviation σ = 0.001 Å.  The C-O and C-C bond lengths in the ethanol molecule were set 
at 1.43 and 1.51 Å, respectively.  The standard deviation σ for these was set between 
0.001 and 0.008 Å.  The O-H bond length of water molecules was fixed at 0.84 Å with 
the H-O-H angle setting as 104.5o.  The standard deviations σ were set between 0.001 and 
0.008 Å.     
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Table 2 Crystal and refinement data for P1 and P2  
Parameter P1 P2 
Formula unit Rifampicin · 1.57 methanol · 
3H2O 
Rifampicin · 0.39 methanol · 
4.17 H2O 
Formula Weight / g mol-1 927.29 910.39 
Crystal system orthorhombic orthorhombic 
Space group P212121 P212121 
a / Å 13.8750(3) 13.8697(3) 
b / Å 17.5152(2) 17.4494(5) 
c / Å 20.1133(4) 19.8807(5) 
α / o 90.000 90.000 
β / o 90.000 90.000 
γ / o 90.000 90.000 
Volume / Å3 4888.0(2) 4811.5(2) 
Z 4 4 
Densitycalc / g cm
-3 1.260 1.260 
µ (MoKα) /mm
-1 0.096 0.096 
F (000) 1993 1955 
Crystal size /mm3 0.12x0.14x0.14 0.23x0.40x0.42 
Temperature / K 173(2) 173(2) 
Range scanned θ / o 1.00≤ θ ≤ 25.35 1.00 ≤ θ ≤ 26.37 
h: -16, 16 h: -17, 17 
k: -21, 21 k: -21, 21 
Index ranges 
l: -24, 24 l: -24, 24 
φ scan angle / o 1.0 1.0 
ω scan angle / o 1.0 1.0 
Dx / mm 32 40 
No. of measured reflections 69973  9796 
No. of unique reflections 8888 5457 
No. of reflections with I > 
2σ(I) 
7132 4539 
No. of L.S. parameters 625 619 
Rint, Rσ 0.0632, 0.0407 0.0243, 0.0334 
S 1.051 1.027 
R1 (Fo > 4σ(Fo)) 0.0464 0.0407 
No. of reflections omitted 85 26 
wR2 (all reflections) 0.1215 0.1030 
a = 0.0575 a = 0.0557 Weighting scheme 
b = 1.8841 b = 1.1459 
(∆ / σ)mean < 0.001 < 0.001 
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Table 3 Crystal and refinement data for P3 and P4  
Parameter P3 P4 
Formula unit Rifampicin · 2ethanol · 2H2O Rifampicin · 0.54 ethanol · 
3.92 H2O 
Formula Weight / g mol-1 951.10 918.43 
Crystal system orthorhombic Orthorhombic 
Space group P212121 P212121 
a / Å 13.9546(4) 13.8297(2) 
b / Å 17.9092(6) 17.3984(2) 
c / Å 20.1400(4) 19.7789(2) 
α / o 90.000 90.000 
β / o 90.000 90.000 
γ / o 90.000 90.000 
Volume / Å3 5033.3(2) 4759.1(9) 
Z 4 4 
Densitycalc /g cm
-3 1.2550 1.2817 
µ (MoKα) /mm
-1 0.094 0.098 
F (000) 2048 1973 
Crystal size /mm3 0.08x0.11x0.22 0.20x0.26x0.27 
Temperature / K 173(2) 100(2) 
Range scanned θ / o 1.00≤ θ ≤ 25.35 2.14 ≤ θ ≤ 28.35 
h: -14, 16 h: -18, 17 
k: -21, 21 k: -23, 19 
Index ranges 
l: -24, 22 l: -26, 23 
φ scan angle / o 1.0 0.5 
ω scan angle / o ---- 0.5 
Dx / mm 33 50 
No. of measured 
reflections 
23585 38713 
No. of unique reflections  9150 6516 
No. of reflections with I > 
2σ(I) 
6165 6209 
No. of L.S. parameters 629 629 
Rint, Rσ 0.0658, 0.0922 0.0272, 0.0189 
S 1.029 1.185 
R1 (Fo > 4σ(Fo)) 0.0698 0.0542 
No. of reflections omitted 45 1 
wR2 (all reflections) 0.1616 0.1387 
a = 0.0734 a = 0.0426 Weighting scheme 
b = 2.0293 b = 5.4773 
(∆ / σ)mean < 0.001 < 0.001 









Rifampicin Molecule Conformation and Antibiotic Activity 
As described in the introductory section, rifampicin belongs to the rifamycin family 
whose antibiotic activity (via inhibition of DNA-dependent RNA polymerase) has been 
under extensive investigation.  However, not all the rifamycin derivatives show antibiotic 
properties.  Much attention has been given to the relation between the structures and 
activities of rifamycin derivatives.  In particular, conformational parameters determined 
from single crystal X-ray diffraction have been correlated with antibiotic activity.3.4  In 
this study, the rifampicin host molecules are also investigated with regard to their solid- 
state conformations. 
 
As shown in Figure 1, the rifampicin molecule can be described in terms of the ansa 
chain, involving atoms from C15 to C29, N1 and O5; the chromophore system 
comprising atoms from C1 to C12, from O1 to O4, and O12; and finally the piperazinyl 
substituent at C3, formed by carbon atoms from C38 to C43, and nitrogen atoms from N2 
to N4.4  Based on this structure, planes A, B, C are introduced to describe the average 
planes of the ansa chain backbone, the chromophore, and the piperazinyl subsitituent 
respectively.   
 
The rifampicin host molecule skeletons in the four solvates are overlaid in Figure 2.  A 
remarkable similarity is found in the conformations of these host molecules.  However, 
the dihedral angles between planes A and B as well as those between planes B and C are 
slightly different in each case.  Table 4 gives the relevant data for each solvate.  The fact 
that the dihedral angles between planes A and B are similar in the four cases while the 
angles between planes B and C are also similar represents quantitative evidence for the 
overall similarity of the host conformations in the four solvates.  Furthermore, since the A 
and B dihedral angles lie within the range 64 to 124o (established as critical for antibiotic 
activity),4, 5, 6, 7 we conclude that the crystals contain the rifampicin molecule in 
biologically relevant conformations.  
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Figure 2 An overlay of the host molecules in solvates P1 (green), P2 (pink), P3 (red) and P4 
(blue). Guest molecules and hydrogen atoms are omitted for clarity.  Left: view normal to the 
ansa chain backbone; right: view roughly perpendicular to the plane of the chromophore.  
 
Table 4 The dihedral angles between planes A and B as well as those between planes B and C of 
the host molecule in each solvate.  
solvates P1  P2  P3  P4  
Angle between  A and B (o) 83.04(2) 82.74(2) 76.63(3) 81.44(3) 
Angle between  B and C (o) 10.19(9) 10.69(8 ) 10.7(1) 12.22(9) 
 
Figure 3 shows the structure of the rifampicin molecule in solvate P1 and the torsion 
angle labelling along the ansa chain backbone.   
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Table 5 lists the torsion angles τ1-τ17 along the ansa chain backbone of the rifampicin 
host.  Among these angles, τ1 defines the junction between the chromophore and the ansa 
chain.  It is evident that the chromophore plane and the major plane of the ansa chain 
adopt a trans conformation in the rifampicin molecules of all four solvates (Table 5).  
The torsion angle τ17 indicates a gauche conformation of the etheric junction in the 
rifampicin molecule in each case.   
 
Table 5 The torsion angles along the ansa chain in the rifampicin host molecule of each solvate 
Torsion angles (o) P1 P2 P3 P4 
C2-N1-C15-C16 (τ1) 176.8(2) 177.7(3) 178.1(3) 178.3(3) 
N1-C15-C16-C17 (τ2) -27.1(4) -29.6(4) -24.5(6) -30.3(5) 
C15-C16-C17-C18 (τ3) -0.3(5) 2.1(5) 0.2(7) 3.2(6) 
C16-C17-C18-C19 (τ4) 152.2(3) 152.5(3) 159.1(4) 153.6(4) 
C17-C18-C19-C20 (τ5) -164.9(3) -164.2(3) -166.0(4) -164.4(3) 
C18-C19-C20-C21 (τ6) -17.5(4) -17.9(4) -18.0(5) -16.7(5) 
C19-C20-C21-C22 (τ7) 170.6(2) 170.0(2) 171.2(3) 168.9(3) 
C20-C21-C22-C23 (τ8) -176.9(2) -176.7(2) -179.2(3) -178.0(3) 
C21-C22-C23-C24 (τ9) 62.6(3) 62.2(3) 56.4(4) 62.0(4) 
C22-C23-C24-C25 (τ10) 163.8(2) 165.1(2) 171.0(3) 166.3(3) 
C23-C24-C25-C26 (τ11) 160.7(2) 159.3(2) 162.8(3) 159.9(3) 
C24-C25-C26-C27 (τ12) 148.3(2) 151.5(2) 156.9(3) 154.9(3) 
C25-C26-C27-C28 (τ13) -172.2(2) -170.6(2) -173.8(3) -172.7(3) 
C26-C27-C28-C29 (τ14) 121.0(3) 119.5(3) 118.5(4) 118.3(3) 
C27-C28-C29-O5 (τ15) -175.1(2) -175.1(2) -175.2(3) -174.9(3) 
C12-O5-C29-C28 (τ16) 66.1(3) 63.3(3) 61.1(5) 61.6(4) 
C29-O5-C12-O3 (τ17) -78.0(3) -77.0(3) -80.3(4) -77.4(3) 
 
Figure 4 shows the diagram of the rifampicin host molecule in P1 viewed side-on to the 
ansa chain backbone.  The methyl group C26-C34 is on the same side as O1 and O2 with 
respect to the ansa chain, pushing the acetyl group (C25-O7-C35-O8-C36) backwards 
over the chromophore.3  The bonds C21-O10 and C23-O9 are parallel to the 
chromophore plane.  Four oxygen atoms (O9, O10, O1 and O2) protrude from the cavity 
of the ansa chain and the chromophore face while their C-O vectors are perpendicular to 
the ansa chain.  Furthermore, all four oxygen atoms are disposed in the opposite direction 
from the piperazinyl subsitituent.  Based on these structural features, again the rifampicin 
host molecules in each solvate are seen to retain the characteristic arrangement of the four 
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oxygen atoms necessary for antibiotic action through the postulated drug-enzyme 
interaction.8 - 10 
 
Figure 4 Diagram of the rifampicin host molecule in P1 viewed side-on with respect to the ansa 
chain. 
 
Furthermore, it is known that the intramolecular distances between O1 and O9, O1 and 
O10, O2 and O9 as well as O2 and O10 fall in the range between ~5.41 and 9.58 Å in the 
active rifamycin derivatives.4  As listed in Table 6 which summarises the above distances 
in the rifampicin host molecules in all four solvates, all the distances fall within the 
relevant range.  Therefore, considering the geometrical location of the O9 and O10 atoms 
(see Figure 4) as well as the distances listed in Table 6, the rifampicin host molecule in 
each solvate can be characterized as having an open conformation, which once more 
gives rise to the conclusion that the host molecules adopt the antibiotically active 
conformation in the solid state.  
 
Table 6 Interatomic distances involving O1, O2, O9 and O10 atoms in the host molecules in the 
four solvatesa   
Distance (Å) P1 P2 P3 P4 
O1···O9 6.102 6.086 6.687 6.208 
O1···O10 5.339 5.349 5.688 5.405 
O2···O9 6.773 6.738 7.393 6.840 
O2···O10 6.908 6.895 7.197 6.907 
a Average e.s.d. 0.003 Å. 
 
In conclusion, the conformational parameters for the rifampicin molecules in the four 
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parameters (dihedral angles-planes A and B, planes B and C, τ1 - τ17, spatial arrangement 
of O1, O2, O9 and O10 and their interatomic distances) fall within the ranges previously 
established as prerequisites for rifamycin antibiotic activity.4 
 
Intra- and Intermolecular Interactions 
Host Intramolecular Interactions  
Four analogous intramolecular O-H···O and one N-H···N hydrogen bond (H-bond) 
interactions were found in the host molecules of P1, P2, P3 and P4 as listed in Table 7.   
 
Table 7 Intramolecular O1-H1···O2, O10-H10···O9, O12-H12···O4 and N1-H1N···N2 H-bond 
interactions in the host molecules of four solvatesa 
Hydrogen bond O···O or N···N Distance (Å) Angle (o) 
P1 
O1-H1···O2 2.500(3) 148  
O10-H10···O9 2.742(3) 144 
O12-H12···O4 2.558(3) 168 
N1-H1N···N2 2.710(3) 112 
P2 
O1-H1···O2 2.500(3) 148 
O10-H10···O9 2.720(3) 147 
O12-H12···O4 2.545(2) 167 
N1-H1N···N2 2.712(3) 113 
P3 
O1-H1···O2 2.484(4) 149 
O10-H10···O9 2.708(4) 149 
O12-H12···O4 2.558(4) 164 
N1-H1N···N2 2.707(4) 113 
P4 
O1-H1···O2 2.498(3) 148 
O10-H10···O9 2.694(3) 147 
O12-H12···O4 2.537(3) 167 
N1-H1N···N2 2.704(4) 113 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The distance between the hydrogen bond acceptor and donor, the hydrogen bond angles, 
the distance ranges and the angle ranges for the O-H···O interactions in the host 
molecules of each solvate are summarised in Table 8.  The average distance for the O-
H···O interactions is very close in all cases.  
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Table 8 The mean distances and angles as well as their ranges for the O-H···O interactions in the 
host molecules of each solvate 
O···O P1 P2 P3 P4 
Average distance (Å) 2.60 2.59 2.58 2.58 
Distance range (Å) 2.50 – 2.74 2.50-2.77 2.48 – 2.71 2.50 – 2.69 
Average angle (o) 153 154 154 154 
angle range (o) 144 – 168 147 – 167 149-164 147 – 167 
 
A noteworthy observation is that the bond length between atoms C8 and O2 is 
significantly shorter than those of the other C-O bonds which are in a similar chemical 
environment, as listed in Table 9.  Based on the data listed in International Tables for 
Crystallography11, the typical distance for the C-O bond in the above environment is 
1.333 Å.  Therefore, although bonds C4-O12, C1-O1 and C8-O2 are all represented as 
single bonds in Figure 1, the former two bonds can be confirmed as being single whilst 
C8-O2 has significant double bond character.  (In P1, the bond lengths C8-O2 and e.g. 
C1-O1 differ by 16.5 σc, where σc is the combined standard derivation.  For P2-P4, the 
corresponding values are 15.8σc, 7.1σc and 10.4σc respectively).     
 
Table 9 Bond lengths C4-O12, C1-O1 and C8-O2 in the host molecule of each solvate. 
Bond length (Å) P1 P2 P3 P4 
C4-O12 1.372(3) 1.373(3) 1.369(4) 1.371(4) 
C1-O1 1.361(3) 1.348(3) 1.340(5) 1.344(4) 
C8-O2 1.291(3) 1.281(3) 1.290(5) 1.285(4) 
 
Moreover, during the structural refinements of all four solvates, geometrically sensible 
electron density peaks, that qualified as potential H atoms, were found associated with all 
the hydroxyl oxygen atoms (O1, O9, O10, O12) except the O2 atom.  At the same time, 
an extra peak was found at ~ 1 Å from the N4 atom having an electron density value 
similar to the other peaks which had been assigned as hydrogen atoms.  Also, between 
N4 and an oxygen atom of a solvent (methanol/ethanol/water) molecule, this specific 
peak was ideally located, accounting for the formation of a N+-H···O hydrogen bond with 
very favourable geometry.  Therefore, it can be assumed that the proton transferred from 
the hydroxyl group on C8 to the nitrogen atom N4, forming a zwitterion.  This conclusion 
is in accord with an early statement that rifampicin exists as a zwitterion in the solid 
state,12 although the present study is the first to prove this zwitterionic character in the 
case of solvates P1-P4 using X-ray diffraction.  Figure 5 shows the zwitterionic structure 
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and the intramolecular O-H···O and N-H···N interactions for each rifampicin host 
molecule.  The host molecules in each solvate adopt the same motif of intramolecular O-
H···O and N-H···N hydrogen bond interactions.  
 
Figure 5 The zwitterionic structures and the intramolecular O-H···O and N-H···N interactions for 
each rifampicin host molecule.  The relevant hydrogen atoms are shown as spheres.  The other 
hydrogen atoms and the guest molecules are omitted for clarity.  The host molecule in P1 is 
shown as a stereoview.     
 
Several intramolecular C-H···O and C-H···N interactions (Table 10) were found to be 
associated with the rifampicin conformations in P1, P2, P3 and P4.  The hydrogen bonds 
C14-H···O3, C18-H18···N1, C25-H···O8, C25-H···O9, C27-H···O7 and C18-H18···N1 are 
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Table 10 Intramolecular C-H···O and C-H···N interactions in the host molecules of the four 
solvatesa 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) 
P1 
C14-H14C···O3 2.906(3) 107 
C18-H18···N1 2.892(4) 104 
C25-H25···O8 2.746(4) 106 
C25-H25···O9 2.948(3) 105 
C27-H27···O7 2.739(3) 102 
P2 
C14-H14A···O2           2.842(3)      107  
C14-H14D···O3           2.901(4)      107    
C18-H18···N1           2.885(4)      105    
C25-H25···O8           2.736(4)      106    
C25-H25···O9           2.938(3)      105  
C27-H27···O7           2.758(3)      103   
C28-H28···O3           3.073(3)      112 
P3 
C14-H14A···O3 2.897(3)      107 
C18-H18···N1 2.884(3)      105   
C25-H25···O8 2.733(4)      106    
C25-H25···O9 2.943(3)      106   
C27-H27···O7 2.759(3)      103   
C28-H28···O3 3.067(3)      113     
C30-H30A···O11 2.818(3)      107    
P4 
C14-H14A···O3 2.898(4)      106   
C18-H18···N1 2.894(4)      106    
C25-H25···O8 2.718(5)      106   
C25-H25···O9   2.911(4)      105    
C27-H27···O7 2.757(4)      102    
C28-H28···O3 3.060(4)      113    
C38-H38···O12 2.671(4)      100    
C34-H34C···O6 2.896(5)      100    
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The average distances, angles and their ranges for the intramolecular C-H···O interactions 
of each solvate are summarised in Table 11.  The average distances are very close in each 
host molecule, as are the average angles.  This is consistent with the previous 
observations that indicated a high level of conformational similarity among the four 
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Table 11 The average distances and angles as well as their ranges for the intramolecular C-H···O 
interactions in the host molecules of each solvate 
C···O P1 P2 P3 P4 
Average distance (Å) 2.83 2.87 2.87 2.85 
Distance range (Å) 2.74 – 2.95 2.74 – 3.07 2.73 – 3.07 2.72 – 3.06 
Average angle (o) 105 107 107 105 
angle range (o) 102 – 107 103 – 112 103 – 113 102 – 113 
 
Furthermore, the intramolecular hydrogen bonds O-H···O, N-H···N, C-H···O and C-H···N 
stabilise the conformation of the host molecules in P1, P2, P3 and P4.13   
 
Host-host Interactions  
A common host-host intermolecular H-bond interaction O9-H9···O12 is observed 
between the host molecules in each solvate.  Table 12 lists the distances between O9 and 
O12, and the angles of this interaction in each solvate.  The four solvates adopt similar 
distances and angles for this interaction.   
 
Table 12 Host-host intermolecular O9-H9···O12 interactions for the host molecules in each 
solvate.a  
O9···O12 Distance (Å) Angle (o) Symmetry operator for O12 
P1 2.848(3)      168 1/2-x, 1-y, 1/2+z 
P2 2.811(3)   169 1/2-x, 1-y, 1/2+z 
P3 2.910(4)      171 1/2-x, 1-y, 1/2+z 
P4 2.792(3)   169 1/2-x, 1-y, 1/2+z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Figure 6 shows the above interaction as well as the neighbouring host intramolecular 
O12-H12···O4 and O10-H10···O9 interactions occurring in the host molecules in each 
solvate.  Similar interactions occur in all four solvates.  For example, in P1, the O9 and 
O12 atoms serve both as hydrogen bond acceptor and donor while O4 and O10 atoms act 
only as acceptor and donor, respectively.  
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Figure 6 The host-host intermolecular O-H···O interactions in each solvate.  The relevant 
hydrogen atoms are shown as spheres, while the remaining H atoms and the guest molecules are 
omitted for clarity.  The host molecule in P1 is presented in stereoview.   
 
Several common host-host intermolecular C-H···O interactions are found in solvates P1, 
P2, P3 and P4 as well.  These include C29-H···O2, C32-H···O4 and C40-H···O1.  The 
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Table 13 Intermolecular C-H···O interactions between the rifampicin moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
P1 
C29-H29···O2 3.466(3) 169 1-x, 1/2+y, 3/2-z 
C31-H31B···O11 3.268(4) 142 -x, 1/2+y, 3/2-z 
C32-H32A···O4 3.449(4) 151 1/2-x, 1-y, 1/2+z 
C40-H40B···O1 3.323(4) 143 -x, 1/2+y, 3/2-z 
C43-H43C···O1 3.371(4) 138 -x, 1/2+y, 3/2-z 
P2 
C29-H29···O2 3.397(3) 168 1-x, 1/2+y, 3/2-z 
C31-H31B···O11 3.325(4) 150 -x, 1/2+y, 3/2-z 
C32-H32A···O4 3.450(4) 153 1/2-x, 1-y, 1/2+z 
C36-H36A···O11 3.492(4) 158 1/2-x, 1-y, 1/2+z 
C40-H40B···O1 3.406(4) 146 -x, 1/2+y, 3/2-z 
P3 
C29-H29···O2 3.496(4) 171 1-x, 1/2+y, 3/2-z 
C32-H32A···O4 3.371(5) 141 1/2-x, 1-y, 1/2+z 
C40-H40B···O1 3.369(5) 139 -x, 1/2+y, 3/2-z 
C43-H43A···O10 3.451(5) 152 -x, 1/2+y, 3/2-z 
C43-H43C···O1 3.247(5) 144 -x, 1/2+y, 3/2-z 
P4 
C29-H29···O2 3.335(4) 169 1-x, 1/2+y, 3/2-z 
C31-H31B···O11 3.375(4) 153 -x, 1/2+y, 3/2-z 
C32-H32C···O4 3.399(4) 149 1/2-x, 1-y, 1/2+z 
C36-H36C···O11 3.426(5) 154 1/2-x, 1-y, 1/2+z 
C40-H40B···O1 3.401(4) 146 -x, 1/2+y, 3/2-z 
C43-H43A···O1 3.402(7) 140 -x, 1/2+y, 3/2-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
The mean distances and angles, and their ranges for the host-host intermolecular C-H···O 
interactions in each solvate are summarised in Table 14.  The average C···O distances are 
very close in each solvate.   
 
Table 14 The average distances and angles as well as their ranges for the host-host intermolecular 
C-H···O interactions in the host molecules of each solvate 
C···O P1 P2 P3 P4 
Average distance (Å) 3.38 3.41 3.39 3.39 
Distance range (Å) 3.27 – 3.47 3.33 – 3.49 3.24 – 3.50 3.34 – 3.43 
Average angle (o) 149 155 150 152 
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Host-guest Interactions  
The host-guest intermolecular O-H···O and N-H···O interactions in solvates P1, P2, P3 
and P4 are shown in Figure 7.  Analogous interactions are found in each solvate.   
 
Figure 7 Stereoviews of the intermolecular O-H···O and N-H···O hydrogen bonds between the 
host and guest molecules in the solvates P1, P2, P3 and P4.  The relevant hydrogen atoms are 
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In the cases of P1, P2 and P3, O1W atoms serve as hydrogen bond donors to O10 atoms, 
thus linking the water molecule O1W to the ansa bridge of each rifampicin host molecule 
via the hydrogen bond O1W-H1W1···O10.  In the case of P4, atom O1W is disordered 
over two positions (O1WA and O1WB) while the hydrogen atom H1W1 is also 
disordered over two positions namely H1W1 and H1W3.  In addition, both H1W1 and 
H1W3 atoms form hydrogen bonds to the O10 atom in the host molecule.  Table 15 lists 
the distances between hydrogen bond donor (O1W) and acceptor (O10) as well as the 
angles in the four solvates.  The distances O1W···O10 in the four solvates span a narrow 
range.  
 
Table 15 Intermolecular O1W-H1W···O10 interactions in the four solvates 
P1 P2 P3 P4 Solvate 
O1W···O10 O1W···O10 O1W···O10 O1WA···O10 O1WB···O10 
Distance (Å) 2.796(3) 2.807(3) 2.800(5) 2.809(6) 2.789(9) 
Angle (o) 173(2) 170(2) 161(2) 160(5) 166(5) 
 
For all the solvates, the O2W atoms serve as hydrogen bond donors and function as 
bridges which stabilise the chromophore in one host molecule and that of the adjacent 
host molecule.  Considering the intramolecular and intermolecular interactions occurring 
around the O2W atoms, three adjacent rifampicin host molecules are held together by a 
long hydrogen bonded ‘chain’, namely O1···O2···H2W2-O2W-
H2W1···O4···O12···O9···O10.  In more detail, the chromophore in one rifampicin 
molecule interacts with the chromophore in a second host molecule through the host-
guest interactions; this second chromophore also interacts with the ansa chain in a third 
host molecule through a host-host interaction. 
 
Table 16 lists the distances and angles for hydrogen bonds O2W···O4 and O2W···O2 in 
the solvates.  In four cases, the distances between the hydrogen bond donor (O2W) and 
the acceptor (O4) are very close while the distances between O2W (donor) and O2 
(acceptor) are also very close, implying the presence of strong hydrogen bonding.  On 
average, the former represent stronger hydrogen bonds than the latter due to their shorter 
O···O distance. 
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Table 16 Host-guest intermolecular O2W-H2W1···O4 and O2W-H2W2···O2 interactions in four 
solvates 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatora 
P1 
O2W-H2W1···O4 2.688(3) 176(3) x, y, z 
O2W-H2W2···O2 2.800(3) 163(2) 1-x, 1/2+y, 3/2-z 
P2 
O2W-H2W1···O4 2.684(3) 171(2) x, y, z 
O2W-H2W2···O2 2.790(3) 168(4) 1-x, 1/2+y, 3/2-z 
P3 
O2W-H2W1···O4 2.742(4) 153(1) x, y, z 
O2W-H2W2···O2 2.847(4) 156(3) 1-x, 1/2+y, 3/2-z 
P4 
O2W-H2W1···O4 2.682(3) 173(4) x, y, z 
O2W-H2W2···O2 2.789(4) 176(5) 1-x, 1/2+y, 3/2-z 
a Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Two other analogous hydrogen bond interactions are also found between the host and 
guest molecules in all four solvates: the hydrogen bond chain (N4)+-
HN4···Oguest−Hguest···O6 connects the piperazinyl atom N4 in one host molecule with the 
ansa bridge (O6) in the symmetry-generated host molecule.  The solvent molecules serve 
as hydrogen bond acceptors and donors at the same time.  The hydrogen bond interaction 
Oguest−Hguest···O11 links one water or solvent alcohol molecule with one host molecule 
(O11).  However, the alcohol or water molecules which are involved in the above two 
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Table 17 Intermolecular (N4)+-HN4···Oguest-Hguest···O6 and Oguest-Hguest···O11 interactions in the 
four solvatesa 
Hydrogen bond N+···O or O···O Distance (Å) Angle (o) Symmetry operatorb 
P1 
N4-H4N···O3WA 2.690(5) 158  x, y, z 
N4-H4N···O3WB 2.760(8) 169  x, y, z 
O3WA-H3W1···O6 2.753(5) 147(2) 1/2-x, 1-y, -1/2+z 
O3WB-H3W3···O6 2.844(7) 165(3) 1/2-x, 1-y, -1/2+z 
O1G-H1G···O11 2.763(4) 163  x, y, z 
P2 
N4-H4N···O3W 2.761(4) 170  x, y, z 
O3W-H3W1···O6 2.810(3) 157(2) 1/2-x, 1-y, -1/2+z 
O1GA-H1GA···O11 2.723(11) 157  x, y, z 
O5W-H5W1···O11 2.887(7) 168(6) x, y, z 
P3 
N4-H4N···O2GA 2.604(1) 171  x, y, z 
N4-H4N···O2GB 2.869(8) 137  x, y, z 
O2GA-H2GA···O6 2.557(12) 173  1/2-x, 1-y, -1/2+z 
O1G-H1G···O11 2.768(5) 169  x, y, z 
P4 
N4-H4N···O1GA 2.851(7) 175  x, y, z 
N4-H4N···O4WB 2.594(10) 154 x, y, z 
O1GA-H1GA···O6 2.751(6) 170  1/2-x, 1-y, -1/2+z 
O3W-H3W1···O11 2.850(6) 175(3) x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
The mean distances and angles as well as ranges for the host-guest intermolecular O-
H···O interactions for all four solvates molecules are summarised in Table 18.   The mean 
distances are very close in each solvate.  
 
Table 18 The average distances and angles as well as their ranges for the host-guest 
intermolecular O-H···O interactions in all four solvates. 
O···O P1 P2 P3 P4 
Average distance (Å) 2.77 2.78 2.74 2.78 
Distance range (Å) 2.69 – 2.84 2.68-2.89 2.56 – 2.85 2.68 – 2.85 
Average angle (o) 164.5 165.1 162.4 170.0 
angle range (o) 147 – 176 157 – 171 145-175 160 – 176 
 
Several host-guest intermolecular C-H···O interactions are found in the structures of P1, 
P2, P3 and P4 as well.  The intermolecular C43-H···O2W interaction is common for all 
four solvate structures.  Geometrical details are listed in Table 19. 
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Table 19 Intermolecular C-H···O interactions between the rifampicin and guest moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
P1 
C43-H43A···O2W 3.481(4) 159 -1+x, y, z 
C43-H43B···O2G 3.282(4) 139 x, y, z 
P2 
C43-H43B···O2W 3.432(4) 157 -1+x, y, z 
C43-H43C···O4W 3.271(5) 136 x, y, z 
P3 
C13-H13B···O1G 3.459(6) 155 1/2+x,1/2-y,1-z 
C40-H40A···O2W 3.473(5) 148 -1+x, y, z 
C43-H43B···O2W 3.444(5) 147 -1+x, y, z 
P4 
C40-H40A···O2W 3.468(4) 146 -1+x, y, z 
C43-H43B···O2W 3.390(5) 154 -1+x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
The average distances and angles for the host-guest intermolecular C-H···O interactions for 
the four solvates are summarised in Table 20.  The mean distances are very close (~ 3.4 
Å) in all cases.  
 
Table 20 The average distances and angles for the host-guest intermolecular C-H···O interactions 
in solvate crystals P1-P4. 
C-H···O P1 P2 P3 P4 
Average distance (Å) 3.38 3.35 3.46 3.43 
Average angle (o) 149 147 150 150 
 
Guest-guest Interactions  
In the structures of P1, P2, P3 and P4, isolated guest clusters are formed by the alcohol 
and water molecules (but not including the molecule which is involved in the guest-host 
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Figure 8 The guest-guest intermolecular O-H···O interactions among the water and alcohol 
molecules in (a) P1, (b) P2, (c) P3 and (d) P4.  Atoms with gray labels have been symmetry- 
generated from their asymmetric unit counterparts. The disordered atoms are labelled with their 
site-occupancies. 
 
In P1, water molecule O3W is disordered over two positions O3WA and O3WB, both of 
which are hydrogen bonded to O1W.  Similarly, ethanol molecule O2G-C3G-C4G in P3 
is disordered over three positions (O2GA-C3GA-C4GA, O2GB-C3GB-C4GB and 
O2GC-C3GC-C4GC).  O2GA is hydrogen bonded to the host molecule directly while 
both O2GB and O2GC serve as hydrogen bond donors to O1W.  In P4, O1W is 
disordered over two positions, O1WA and O1WB, both of which are hydrogen bonded to 
O2W.  In particular, the hydrogen H1W2 of O1WA forms two hydrogen bonds with two 
distinct acceptors simultaneously, forming a (bifurcated) hydrogen bond with O2W and 
O1GA.  Furthermore, ethanol molecule O1GA-C1GA-C2GA and water molecules 
O4WB and O5WB are two disordered components which will not be present at the same 
time (i.e. the site-occupancy of atom O1GA is 54% while that of atoms O4WB and 
O5WB is 46%).  In addition, both the distances between O1WA···O2W and 
O1WA···O1GA fall within the hydrogen bonding distance range.  However, no peak was 
found at ~ 1 Å from the O1WA atom having an electron density value similar to the other 
peaks which had been assigned as hydrogen atoms.  Therefore, an artificial hydrogen 
atom H1W2 was generated and placed so as to maintain a reasonable molecular geometry 
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and O1GA.  This indicates the simultaneous O···O interactions between O1WA···O2W 
and O1WA···O1GA. 
 
The solvent clusters in P1 and P3 are completely isolated whilst those in P2 and P4 
extend infinitely.  All these clusters and the molecules which are involved in the guest-
host intermolecular interaction including Oguest-Hguest···O11 in each solvate are overlayed 
in Figure 9.  The included alcohol and water molecules in all four solvates are distributed 
in a similar pattern in their respective crystals.  The oxygen atom in each alcohol and 
water molecule occupies analogous positions in every solvate.  However, O2GA in P3 is 
located in a unique position.  Furthermore, O2W is involved in only one guest-guest 
hydrogen bond in P3 instead of two guest-guest hydrogen bonds as in the other solvates. 
 
Figure 9 An overlay diagram of the guest-guest intermolecular O-H···O interactions in P1 
(green), P2 (pink), P3 (red) and P4 (blue).  The molecules which are involved in the guest-host 
intermolecular interaction Oguest-Hguest···O11 are also shown and labelled. 
 
Details of guest-guest intermolecular O-H···O hydrogen bond interactions are listed in 
Table 21.  The average distances, average angles, the distance ranges and the angle 
ranges for the guest-guest intermolecular O-H···O interactions for all four solvates are 
summarised in Table 22 (bifurcated hydrogen bonds O1WA-H1W2···O2W and      
O1WA-H1W2···O1GA in P4 are not considered).  The mean distances for the 
intermolecular guest-guest O···O interactions in P1, P2, P3 and P4 are very close (~ 2.8 
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Table 21 The details of guest-guest intermolecular hydrogen bond interactions in solvates P1, P2, 
P3 and P4a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
P1 
O2G-H2G···O2W 2.909(4) 167 -1/2+x, 3/2-y, 1-z 
O1W-H1W2···O2W 2.908(3)   166(2) 1/2-x, 1-y, 1/2+z 
O3WA-H3W2···O1W 2.662(5)      162(5) -1/2-x, 1-y, -1/2+z 
O3WB-H3W4···O1W 2.785(7) 148(4) 1/2-x, 1-y, -1/2+z 
P2 
O3W-H3W2···O1W 2.690(4)      143(3) -1/2-x, 1-y, -1/2+z 
O4W-H4W1···O3W 2.867(5)      171(4) x, y, z 
O4W-H4W2···O2W 2.895(5) 154(3) -1/2+x, 3/2-y, 1-z 
O1W-H1W2···O2W 2.863(4)      157(3) 1/2-x, 1-y, 1/2+z 
P3 
O1W-H1W2···O2W 2.817(5)      168(5) 1/2-x, 1-y, 1/2+z 
O2GB-H2GB···O1W 2.827(11) 148 -1/2-x, 1-y, -1/2+z 
O2GC-H2GC···O1W 2.556(12) 170 -1/2-x, 1-y, -1/2+z 
P4 
O5WB-H5W2···O2W 2.941(8) 144(3) -1/2+x, 3/2-y, 1-z 
O5WB-H5W1···O1WB 2.831(2) 139(5) -x, 1/2+y, 3/2-z 
O1WB-H1W4···O2W 2.640(8) 129(7) 1/2-x, 1-y, -1/2+z 
O1WA-H1W2···O2W 2.926(7) 85(2) 1/2-x, 1-y, -1/2+z 
O1WA-H1W2···O1GA 2.684(8) 89(2) -1/2-x, 1-y, -1/2+z 
O4WB-H4W1···O1WB 2.664(14) 147(2) -1/2-x, 1-y, -1/2+z 
O4WB-H4W2···O5WB 2.813(11) 126.8(8) x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Table 22 The average distances and angles as well as their ranges for the guest-guest 
intermolecular O-H···O interactions in all four solvates.  
O-H···O P1 P2 P3 P4 
Average distance (Å) 2.84 2.83 2.74 2.78 
Distance range (Å) 2.75 – 2.91 2.69 – 2.90 2.57 – 2.83 2.64 – 2.94 
Average angle (o) 157 156 162 134 
angle range (o) 148 – 167 143 – 171 148 –168 129 – 147 
 
Overall Intramolecular and Intermolecular Interactions in P1, P2, P3 
and P4 
Figure 10 shows the overall hydrogen bond interactions in solvates P1, P2, P3 and P4.  A 
similar assembly of five rifampicin molecules around the solvent cluster is observed in 
each solvate structure.  
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Figure 10 Stereoviews of the overall hydrogen bond interactions in (a) P1, (b) P2, (c) P3 and (d) 
P4.  The oxygen atoms of alcohol and water molecules are shown as spheres. 
 
For the independent rifampicin molecules, the same set of oxygen and nitrogen atoms in 
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bonding with guest molecules.  In other words, although the content of the solvent cluster 
is different in each solvate, the hydrogen bonding environments provided by the 
rifampicin molecules are identical in P1, P2, P3 and P4.       
   
In solvate P4, there is only one oxygen atom within hydrogen bonding distance of water 
oxygen O3W.  This implies that the latter forms only one H-bond in the crystal, namely 
O3W-H3W1···O11 (as listed in Table 17). 
 
The schematic diagrams illustrating the overall hydrogen bond interactions for rifampicin 
solvates P1, P2, P3 and P4 are presented in Figure 11.  The solvent clusters in the fresh 
solvates P1 and P3 (which were rapidly removed from the mother liquor for X-ray 
analysis) are found to be intimately associated with the rifampicin molecules.  However, 
the clusters in the solvates P2 and P4 (which resulted from exposure of P1 and P3 
respectively to the atmosphere) form a more continuous solvent distribution, extending 
indefinitely along the channels parallel to the a-axis.  This is described in detail in the 
next section and illustrated in Figure 12. 
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Figure 11 Schematic diagrams for the overall hydrogen bond interactions in (a) P1, (b) P2, (c) P3 
and (d) P4.  The code letter for the symmetry operator of each rifampicin molecule is given as a 
suffix in the atom label. (a = x, y, z; b = x-1, y, z; c = -x-1/2, 1-y, z-1/2; d = 1/2-x, 1-y, z-1/2; e =  
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Crystal Packing 
For all four solvates, the rifampicin, solvent and water molecules shown in the packing 
diagrams are held together by hydrogen bonds whose details were discussed earlier. 
 
Figure 12 Crystal packing diagrams for (a) P1, (b) P2, (c) P3 and (d) P4 viewed along [010]; 
solvent molecules are shown as green spheres for clarity.  
 
The host rifampicin packing arrangements in solvates P1, P2, P3 and P4 are identical.  
For all the solvates, rifampicin molecules pack in a head-to-tail mode parallel to the       
c-axis and form layers parallel to the a-axis between which the guest molecules are 
located.  This arrangement gives rise to a solvent tunnel which provides the possibility of 
easy exchange of solvent molecules in the solvates and water molecules in the 
atmosphere.   
 
The solvent channels in P1, P2, P3 and P4 were examined using the program 
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axis.  Selected sections for P1 are shown in Figure 13 as representative for the 
isostructural series.  A series of views taken at regular intervals along the a-axis clearly 
illustrates the ‘endless’ channels in which the guest molecules are accommodated.  Figure 
13 shows representative sections as examples.       
 
Figure 13 Section of P1 with guest molecules omitted and host molecules represented by gray 
areas, viewed along [100] with the unit cell sectioned at (a) 4 Å (b) 7 Å (c) 9 Å from 0,0,0.  The 
channel locations are shown in green.  Host atoms are drawn with their van der Waals radii. 
 
Comparative PXRD 
The calculated and experimental PXRD traces for solvates P1, P2, P3 and P4 are shown 
in Figure 14.  For all four solvates, the experimental PXRD traces are in reasonable 
agreement with the calculated ones, confirming that each prepared sample was 
homogeneous.  Differences in the relative intensities of peaks in the traces of the four 
solvates are attributed to residual preferred orientation and differences in the respective 
solvent contents.   
 
(a) 4 Å  (c) 9 Å  (b) 7 Å  
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The solvates P1, P2, P3 and P4 display similar unit cell dimensions (a = ~14, b = ~17, c = 
~20 Å, α = β = γ = 90º), crystallise in the same space group P212121, and they have 
similar PXRD patterns (Figure 15).   Furthermore, the atomic co-ordinates of the host 
molecules in each solvate are similar, evidenced by their similar packing arrangements 
(Figure 12).  In addition, the host molecules in the four solvates are in close superposition  
(Figure 2), confirming that they adopt similar conformations.  Therefore, P1, P2, P3 and 
P4 are identified as isostructural compounds primarily with respect to the common host 
rifampicin molecular framework but also extending to some degree to include particular 
solvent atoms.  In addition, any of the calculated PXRD patterns in Figure 15 could serve 
as a reference for the identification of future crystalline forms belonging to this 
isostructural series.15 
 
Figure 15 Calculated PXRD traces of solvates P1, P2, P3 and P4. 
 
It is relevant to mention that the X-ray structure of a phase described as rifampicin 
pentahydrate was reported by Gadret et al. in 1975.16  The structures of P1, P2, P3, P4 
and the pentahydrate are superimposed in Figure 16.  As shown there, the host molecule 
in the pentahydrate adopts a similar conformation to those in the four solvates.  In 
addition, the atomic co-ordinates of the water molecules in the pentahydrate are found to 
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solvate.  Also, the pentahydrate crystallises in the same space group P212121 and has 
similar unit cell dimensions [a = 17.50(8), b = 19.94(3), c = 13.86(9) Å, α = β = γ = 90º].  
Therefore, rifampicin pentahydrate belongs to the series of isostructural solvates of mixed 
solvents discovered and described in the present study. 
 
Figure 16 An overlay diagram of the asymmetric units in P1 (green), P2 (pink), P3 (red), P4 
(blue) and the rifampicin pentahydrate (grey).  The oxygen atoms of the solvent molecules are 
drawn as spheres 
 
There are, however, shortcomings in the structural report for the pentahydrate, namely 
the omission of H atoms on the water molecules and no definitive statement as regards 
the possibility of a zwitterionic structure for the rifampicin molecules.16  In Figure 17, the 
published structure of the pentahydrate is compared with that of solvate P1.  The bond 
lengths C1-O1, C8-O2 and C4-O12 in the pentahydrate are 1.340(7), 1.273(3),        
1.374(7) Å, respectively.  The relatively short length of C8-O2 strongly suggests 
significant double bond character and thus unwarranted modeling as C-OH.  
Furthermore, the H atoms of assumed -OH groups (H1, H9, H10 and H12) in the 
pentahydrate are located in unfavourable positions, having no acceptor atoms in their 
vicinity.    
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Figure 17 The molecular structures of (a) rifampicin pentahydrate16 and (b) P1.  The hydroxyl 
hydrogen atoms in the host molecules are shown as spheres and the hydrogen atoms on carbon 
atoms are omitted for clarity.  
 
A noteworthy observation is that the crystals of both P1 and P3 were converted to a 
common phase after equilibrating with the atmosphere for a period of ~1 week.  X-ray 
structural analysis and TGA analysis revealed that this phase is rifampicin pentahydrate.  
Therefore, solvates P1 and P3 undergo guest exchange when equilibrated with the water 
in the atmosphere for a sufficiently long period, resulting in complete displacement of 
alcohol molecules by water molecules while maintaining a high level of crystallinity and 
the same host framework in the crystal structure.   
 
Conformation of the Rifampicin Host Molecules  
The similarity of the rifampicin host molecules in P1, P2, P3 and P4 has been 
demonstrated in the overlay diagram (Figure 2).  Furthermore, corresponding dihedral 
angles among the three principal planes (Table 4) are very similar in the host molecules 
in all four solvates.  This also applies to the torsion angles along the ansa chain (Table 5).  
However, the conformations of the host molecules in the four solvates are not identical; 
subtle differences can be found among these molecules.  In particular, a short 
intermolecular C38···O8 contact between host molecules (shown in Figure 18) was 
observed in each solvate when the crystal assembles.  The distances between C38 and O8 
in P1, P2, P3 and P4 are 3.11(4), 3.06(3), 3.07(4) and 2.98(4) Å, respectively.  Therefore, 
when rifampicin molecules pack, repulsive interaction occurs between the ansa chain of 
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one molecule and the piperazinyl subsitituent in another host molecule (at position 1/2-x, 
1-y, 1/2+z).  Specifically, O8 in one molecule pushes plane C (the piperazinyl ring) away 
from plane B (the chromophore) in the symmetry related host molecule.  Since the 
distance between C38 and O8 in P4 is shortest while that in P1 is the longest among those 
in the four solvates, the host molecule in P4 adopts the biggest dihedral angle between 
planes B and C in the four solvates while the host molecule in P1 adopts the smallest 
angle (as listed in Table 4).   
 
Figure 18 Representative figure showing the short contact C38···O8 between the host molecules  
 
Host-host Intramolecular and Intermolecular Hydrogen Bond Interactions  
In all of the solvates studied, the rifampicin molecule was found to exist as a zwitterion, 
resulting from proton transfer from a hydroxyl group on the chromophore to nitrogen 
atom N4 of the piperazinyl ring.  Since the packing modes of the four solvates are almost 
identical and the distributions of the alcohol and water molecules are similar, the host-
host O···O, N···N, C···O, C···N intramolecular and intermolecular hydrogen bonds involve 
analogous hydrogen bond donors and acceptors.  Furthermore, the average interatomic 
O···O distance is very similar in each solvate. The same applies to N···N, C···O and C···N 
distances.  It is noteworthy that no π-π interactions are found in the solvates.  Such 
interactions are potentially possible through stacking of the chromophore units of 
adjacent molecules.  
  
Guest-host Hydrogen Bond Interactions 
Six atoms in the rifampicin host molecule are involved in the guest-host intermolecular 
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solvate due to the almost identical packing arrangements and similar distribution mode of 
the alcohol and water molecules.  However, O2GA in P3 is located in a unique position 
and O3W in P4 has only one hydrogen bond acceptor (O11).  
 
Guest-guest Hydrogen Bond Interactions  
The water and alcohol molecules are generally described as guest molecules in all four 
solvates.  They display a variety of disordered arrangements.  Specifically, one molecule 
is disordered over two positions (O3WA and O3WB in P1 as well as O1WA and O1WB 
in P4); one molecule is disordered over three positions (O2GA-C3GA-C4GA, O2GB-
C3GB-C4GB, O2GC-C3GC-C4GC in P3) and in P4, three solvent molecules O1GA-
C1GA-C2GA , O4WB and O5WB are not present with full site-occupancy. 
 
In the structures of P1 and P3, whose data were collected immediately following their 
removal from mother liquor, the guest molecules (except the methanol molecules O1G-
C1G which are hydrogen bonded to O11 in the host molecule) assemble to form an 
isolated solvent cluster that is closely associated with five neighbouring rifampicin 
molecules.  In the structures of P2 and P4, which resulted from exposure of P1 and P3 to 
the atmosphere for a period of 10 hours, the guest molecules (except those which are 
hydrogen bonded to O11 of the host molecule) assemble into a solvent cluster which 
extends infinitely through the channel created by five rifampicin molecules.  Notably, in 
all four solvates a hydrogen bond donor can always be found adjacent to atom O11 which 
acts as a hydrogen bond acceptor.  In addition, there is no other hydrogen bond acceptor 
in the vicinity of this particular donor in each solvate.       
 
Crystal Packing 
Despite the subtle differences in the conformations of the host molecules and the 
different content of guest molecules in each solvate, solvates P1, P2, P3 and P4 
crystallise in the same space group P212121 and pack in almost identical modes.  For the 
four solvates, solvent molecules are located in the tunnel parallel to the a-axis in-between 
the layers of rifampicin molecules.  The tunnel provides access to atmospheric water 
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molecules which can enter the crystal, changing the compositions of the entrapped 
solvent mixtures.  After sufficient time, all four solvates transform into the pentahydrate.   
 
In the following part of this chapter, we report three other isostructural rifampicin 























The abbreviations for the discrete rifampicin solvates in this chapter are as follows: 
Rifampicin • 2.50(1-propanol) • 4.30H2O:   P5 
Rifampicin • 1.58(1-propanol) • 8.41H2O:   P6 
Rifampicin • 0.60(iso-propanol) • 8.09H2O:   P7 
 
Suitable crystals of P5 and P7 were obtained by dissolving 0.020 g (0.024 mmol) of the 
host drug (rifampicin) in 2 ml of 1-propanol-water mixture (9:1 v/v) and iso-propanol-
acetone-water mixture (3:14:3 v/v) at 25 oC, respectively.  Neither solution was filtered.  
Crystals of suitable quality appeared by slow solvent evaporation at 4 oC over a period of 
two weeks. 
 
Crystals of P5 were allowed to stand on an open bench at 25 oC.  After equilibrating with 
the atmosphere for a period of 10 h, crystals of P5 were found to have transformed to 
phase P6, with a different solvent composition from P5.   
 
The host and guest numbering schemes are given in Figure 19. 
 
Figure 19 Host and guest numbering schemes: (a) rifampicin, (b) 1-propanol, (c) iso-propanol. 
Hydrogen atoms have been omitted for clarity. 
 
(a) 
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Single crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
A crystal of P5 was removed from its mother liquor and was covered in paratone N oil 
without delay in order to prevent the loss of solvent molecules.  The crystals of P5 and P7 
were handled in the same way.  The X-ray intensity data for P5, P6 and P7 were collected 
on a Bruker Apex Duo diffractometer at 100 K.   
 
The unit cell parameters, crystal systems and space groups were determined from the X-
ray diffraction data which revealed Laue mmm symmetry for all three solvates.  
Therefore, these solvates belong to the orthorhombic system; the space group was 
determined as P212121 from the systematic absences: hkl: none; h00: h = 2n+1; 0k0: k = 
2n+1; 00l: l = 2n +1.   
 
Structure Solution and Refinement 
For all three crystals, program SHEXLD1 was used to solve the structures by ab initio 
methods, which revealed the positions of all the non-hydrogen atoms of the rifampicin 
molecule (host) in each structure.  In each case, the value of Z = 4 indicated that the 
asymmetric unit comprised one drug molecule and its complement of solvent molecules. 
Full-matrix least-squares refinements were performed with SHELXH-97.2  Difference 
Fourier maps revealed the positions of the oxygen and carbon atoms of the water and 
solvent molecules (guest).  Some of these atoms were found to have full site-occupancy 
while the others were generally disordered over two or even three positions.  The host 
and guest molecules having full s.o.f. were then refined isotropically.  Atom C37 in phase 
P7 is disordered over two positions (C37A and C37B).  C37A, the major component, was 
assigned a value of x for its s.o.f. while the minor component C37B was allocated the 
value 1-x.  The s.o.f.s refined to 0.71(4) and 0.29(4) respectively while their Uiso values 
refined to 0.060(3) Å2 and 0.030(6) Å2, respectively.  
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For the disordered solvent molecules, a fixed Uiso (the mean of Ueq for the chemically 
equivalent ordered atoms) was assigned to each molecule and these atoms were allowed 
to refine with site-occupancies x and 1-x, with x variable.  For some molecules, the s.o.f.s 
were then assigned as fixed values, allowing the Uiso parameters to refine freely.  For 
some of the other molecules, both the Uiso values and s.o.f.s refined freely.  The details of 
the Uiso parameters and s.o.f.s of the guest molecules in each solvate are listed in Tables 
23, 24 and 25.  
 
Table 23 Isotropic thermal parameters and site-occupancy factors for the guest molecules of the 
solvate P5 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.04 1.00 
O2WA 0.03 0.49 
O2WB 0.03 0.42 
O3WA 0.09 0.63 
O3WB 0.06 0.37 
O4W 0.03 1.00 
O5WB 0.08 0.37 
O1GA/O1GB-C1G-C2G-C3G 0.06/0.03-0.06-0.06-0.08 1.00 (O1GA-0.63;O1GB-0.37) 
O2GA-C4GA-C5GA-C6GA 0.12 (global Uiso) 0.71 
O3GA-C7GA-C8GA-C9GA 0.09 (global Uiso) 0.41 
O3GB-C7GB-C8GB-C9GB 0.09 (global Uiso) 0.38 
 
Table 24 Isotropic thermal parameters and site-occupancy factors for the guest molecules of the 
solvate P6 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.04 1.00 
O2WA 0.03 0.56 
O2WB 0.03 0.44 
O3W 0.05 1.00 
O4WA 0.05 0.56 
O4WB 0.03 0.44 
O5W 0.02 1.00 
O6W 0.04 1.00 
O7W 0.03 1.00 
O8WB 0.06 0.44 
O9WA 0.07 0.41 
O10W 0.09 0.41 
O11W 0.05 0.16 
O1GA-C1GA-C2GA-C3GA 0.03-0.03-0.03-0.05 0.84 
O2GB-C4GB-C5GB-C6GB 0.07-0.04-0.06-0.07 0.44 
O3GA-C7GA-C8GA-C9GA 0.12 (global Uiso) 0.30 
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Table 25 Isotropic thermal parameters and site-occupancy factors for the guest molecules of the 
solvate P7 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.07 0.65 
O2WA 0.04 0.70 
O2WB 0.05 0.25 
O3W 0.07 1.00 
O4W 0.03 0.56 
O5W 0.03 1.00 
O6W 0.06 1.00 
O7W 0.07 1.00 
O8W 0.06 0.56 
O9W 0.07 0.21 
O10W 0.06 0.49 
O11W 0.06 0.10 
O12W 0.05 0.14 
O13W 0.06 0.23 
O14W 0.07 0.19 
O1G-C1G-C2G-C3G 0.02-0.03-0.05-0.04 0.60 
                                
In general, location of all the hydrogen atoms in each solvate from difference Fourier 
maps was attempted.  When geometrically reasonable ∆ρ peaks indicating hydrogen atom 
presence were found, the hydrogen atoms were placed in idealised postions in a riding 
model.  For water molecules, models were generated so as to satisfy hydrogen bonding 
requirements.  All the methyl hydrogen atoms were refined with isotropic temperature 
factors 1.5 times those of their parent atoms while all the other hydrogen atoms were 
assigned temperature factors 1.2 times those of their parent atoms.   
   
For the 1-propanol and iso-propanol molecules as well as the hydrogen atoms of water 
molecules, distance restraints were employed to ensure reasonable molecular geometries.  
For the 1-propanol molecules, the bond lengths O1G-C1G, C1G-C2G and C2G-C3G 
were set at 1.43, 1.52 and 1.51 Å, respectively.  For the iso-propanol molecules, the bond 
lengths O1G-C1G, C1G-C2G and C1G-C3G were set at 1.43, 1.52 and 1.52 Å, 
respectively.  The standard deviation σ for these bonds in both molecules was set 
between 0.001 and 0.008 Å.  The O-H bond length of water molecules was fixed at 0.84 
Å with the H-O-H angle set at 104.5o.  The standard deviations σ were set between 0.001 
and 0.008 Å.     
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Crystal and refinement parameters for each solvate are presented in Table 26. 
 
Table 26 Crystal and refinement data for P5, P6 and P7.  
Parameter P5 P6 P7 









Formula Weight / g mol-1 1050.13 1069.59 1004.90 
Crystal system orthorhombic orthorhombic orthorhombic 
Space group P212121 P212121 P212121 
a / Å   13.4396(2)  13.1941(4)    13.4525(8)              
b / Å 16.869(2) 16.3019(5)  17.0141(10)  
c / Å 25.962(3)  26.5732(9)  25.9219(16)  
α / o 90.00  90.00  90.00  
β / o 90.00  90.00  90.00  
γ / o 90.00  90.00  90.00  
Volume / Å3 5886.0(13)  5715.6(3)  5933.1(6)  
Z 4 4 4 
Densitycalc / g cm
-3 1.1849 1.2428 1.1249 
µ (MoKα) /mm
-1 0.090 0.098 0.089 
F (000) 2271 2312 2166 
Crystal size /mm3 0.09x0.12x0.23 0.06x0.13x0.07 0.20x0.25x0.47 
Temperature / K 100(2) 100(2) 100(2) 
Range scanned θ / o 2.18 ≤ θ ≤ 25.03 1.98 ≤ θ ≤ 28.42 2.18 ≤ θ ≤ 27.11  
h: -14, 15 h: -17, 17 h: -17, 17 
k: -14, 20 k: -20, 21 k: -21, 21 
Index ranges 
l: -30, 17 l: -35, 35 l: -33, 12 
φ scan angle / o 0.5  0.5 0.5 
ω scan angle / o 0.5 0.5 0.5 
Dx / mm 48 40 50 
No. of measured reflections 16658 48858 43643 
No. of unique reflections 5653 7785 7128 
No. of reflections with I > 
2σ(I) 
4804 6726 6062 
No. of L.S. parameters 691 738 710 
Rint, Rσ 0.0392, 0.0464 0.0396, 0.0265 0.0294, 0.0224 
S 1.046 1.054 1.059 
R1 (Fo > 4σ(Fo)) 0.0844 0.0521 0.0729 
No. of reflections omitted 26 19 44 
wR2 (all reflections) 0.2409 0.1421 0.2289 
a = 0.1524 a = 0.0642 a = 0.1562 Weighting scheme 
b = 9.1387 b = 4.9277 b = 3.5628 
(∆ / σ)mean < 0.001 < 0.001 < 0.001 
∆ρ excursions / еÅ-3 -0.496, 0.916  -0.314, 0.672 -0.589, 0.775 
 
 




Rifampicin Molecule Conformation and Antibiotic Activity 
Similar to the rifampicin host molecules in solvates P1, P2, P3 and P4, the host molecules 
in solvates P5, P6 and P7 were also investigated with regard to their solid-state 
conformations.  The antibiotic activity of the host molecules has been correlated with the 
conformation of the ansa chain, as determined from single crystal X-ray diffraction.3  
Figure 20 shows the overlay of the rifampicin host molecule skeletons in the three 
solvates. 
 
Figure 20 An overlay of the host molecules in solvates P5 (green), P6 (pink) and P7 (gray). 
Guest molecules and hydrogen atoms are omitted for clarity.   
 
These host molecules are found to adopt a remarkably similar conformation.  However, 
the dihedral angles between planes A (ansa chain) and B (chromophore) as well as those 
between planes B and C (piperazinyl substituent) are slightly different in each case.  The 
relevant data for each solvate are listed in Table 27.  The fact that the dihedral angles 
between planes A and B are similar in the three cases while the angles between planes B 
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Table 27 The dihedral angles between planes A and B as well as those between planes B and C 
of the host molecule in each solvate.  
solvates P5  P6  P7  
Angle between A and B(o) 56.98(5) 61.34(2) 57.94(3) 
Angle between B and C(o) 73.47(9) 66.9(2) 72.2(3) 
 
It is noteworthy that the average dihedral angle between planes A and B as well as that 
between planes B and C in the host molecules of P5, P6 and P7 are very different from 
their counterparts in P1, P2, P3 and P4 (Table 26 in Part One).  This indicates the 
existence of a solvatomorphic phase of rifampicin which has not been observed 
previously.  This feature is discussed in detail in the conclusion section.  
 
Figure 21 shows the crystal structure of the rifampicin molecule in solvate P5 and the 
torsion angle labelling along the ansa chain backbone.   
 
Figure 21 The molecular structure and torsion angle scheme along the ansa chain in the 
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Table 28 lists the torsion angles τ1-τ17 along the ansa chain backbone of the rifampicin 
host in solvates P5, P6 and P7.  The chromophore plane adopts a trans conformation (τ1) 
with respect to the plane of the ansa chain.  This corresponds to the situation in the 
rifampicin host molecules in solvates P1, P2, P3 and P4.  Furthermore, it is known that 
the torsion angles τ9 and τ17 in the host molecules fall within the respective preferred 
ranges 59 ± 6o and -65 ± 13o for active rifamycins.9, 17  This also serves as evidence for 
the conclusion that the crystals (P5, P6 and P7) contain the rifampicin molecule in the 
biologically relevant conformation. 
 
Table 28 The torsion angles along the ansa chain in the rifampicin host molecule of each solvate 
Torsion angles (o) P5 P6 P7 
C2-N1-C15-C16 (τ1) 172.6(5) 170.1(3) 172.2(4) 
N1-C15-C16-C17 (τ2) -126.3(6) -123.4(3) -125.6(5) 
C15-C16-C17-C18 (τ3) 8.5(9) 8.1(4) 8.9(7) 
C16-C17-C18-C19 (τ4) -177.6(6) -175.6(3) -175.4(5) 
C17-C18-C19-C20 (τ5) -174.3(6) -175.6(3) -176.5(4) 
C18-C19-C20-C21 (τ6) -40.4(9) -44.1(4) -43.4(6) 
C19-C20-C21-C22 (τ7) 168.6(6) 170.5(3) 169.4(4) 
C20-C21-C22-C23 (τ8) -175.3(6) -173.1(3) -173.5(4) 
C21-C22-C23-C24 (τ9) 55.4(7) 59.0(4) 59.6(5) 
C22-C23-C24-C25 (τ10) 173.6(5) 169.3(3) 171.8(4) 
C23-C24-C25-C26 (τ11) 173.6(5) 173.8(2) 172.6(4) 
C24-C25-C26-C27 (τ12) 176.7(5) 170.5(3) 171.6(4) 
C25-C26-C27-C28 (τ13) -166.0(5) -167.4(3) -170.2(4) 
C26-C27-C28-C29 (τ14) 109.5(8) 108.3(3) 111.7(5) 
C27-C28-C29-O5 (τ15) -173.8(7) -174.3(3) -174.4(4) 
C12-O5-C29-C28 (τ16) 43.9(10) 46.3(4) 47.2(7) 
C29-O5-C12-O3 (τ17) -76.6(7) -72.4(3) -78.3(5) 
 
Figure 22 shows the rifampicin host molecule in P5 viewed side-on to the ansa chain 
backbone.  As explained in the former chapter, again, the four oxygen atoms (O9, O10, 
O1 and O2) protrude from the cavity of the ansa chain and the chromophore face while 
being roughly perpendicular to the average plane of the ansa chain.  Although the bonds 
C21-O10 and C23-O9 are not exactly parallel to the aromatic plane, all four of the 
oxygen atoms are disposed in the opposite direction from the piperazinyl subsitituent.  
Furthermore, the intramolecular distances among the four oxygen atoms O1, O2, O9 and 
O10 (listed in Table 29) fall in the range (~5.41 to 9.58 Å) which is favourable for active 
rifamycin derivatives.4  This also allows these host molecules to adopt an open 
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conformation, which once more gives rise to the conclusion that the host molecules adopt 
the antibiotically active conformation in the solid state.10 
 
Figure 22 Diagram of the rifampicin host molecule in P1 viewed side-on with respect to the ansa 
chain. The relevant oxygen atoms are shown as spheres. 
 
Table 29 The intramolecular distances involving O1, O2, O9 and O10 atoms in the host 
molecules in the three solvatesa 
Distance (Å) P5 P6 P7 
O1-----O9 8.237 8.017 8.138 
O1-----O10 7.567 7.511 7.562 
O2-----O9 9.032 8.709 8.910 
O2-----O10 8.995 8.887 8.993 
a Average e.s.d. 0.004 Å. 
 
In conclusion, the conformational parameters for the rifampicin molecules in the three 
solvated crystals generally span quite narrow ranges.  Furthermore, the values of these 
parameters (interplanar angles between planes A and B and between planes B and C, 
dihedral angles, τ1 - τ17, spatial arrangement of O1, O2, O9 and O10 and their interatomic 
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Intra- and Intermolecular Interactions 
 
Host Intramolecular Interactions  
As discussed in the previous part, rifampicin is known to exist as a zwitterion in the solid 
state.12  Again, a noteworthy observation is that the bond length C8-O2 is significantly 
shorter than those of the other C-O bonds which are in a similar chemical environment 
(distances listed in Table 30).  Based on the data listed in the International Tables for 
Crystallography,11 the typical distance for the C-O bond in the above chemical 
environment is 1.333 Å.  Therefore, although bonds C14-O12, C1-O1 and C8-O2 are all 
represented as single bonds in Figure 19, the former two bonds can be confirmed as being 
single whilst C8-O2 has significant double bond character.   
 
Table 30 Bond lengths C4-O12, C1-O1 and C8-O2 in the host molecule of each solvate. 
Bond length (Å) P5 P6 P7 
C4-O12 1.360(7) 1.363(4) 1.364(4) 
C1-O1 1.341(7) 1.351(4) 1.357(5) 
C8-O2 1.280(8) 1.285(4) 1.280(5) 
 
Furthermore, during the structural refinements of all four solvates, geometrically sensible 
electron density peaks, that qualified as potential H atoms, were found around all the 
hydroxyl oxygen atoms (O1, O9, O10, O12) except atom O2.  At the same time, an extra 
peak was found around the N4 atom having an electron density value similar to the other 
peaks which had been assigned as hydrogen atoms.  Also, between N4 and oxygen atoms 
of disordered water molecules, this specific peak was ideally located, accounting for the 
formation of a N+-H···O hydrogen bond with very favourable geometry.  Therefore, it can 
again be assumed that the proton transferred from the hydroxyl group on C8 to the 
nitrogen atom N4, forming a zwitterion as was found in the series of rifampicin solvates 
P1 – P4.  
 
Three analogous intramolecular O-H···O hydrogen bond (H-bond) interactions were 




Chapter 4: Rifampicin Solvates (Part two---series 2) 
 189 
Table 31 Intramolecular O1-H1···O2, O10-H10···O9 and O12-H12···O4 H-bond interactions in 
the host molecules of the three solvatesa 
Hydrogen bond O···O Distance (Å) Angle (o) 
P5 
O1-H1···O2 2.467(6) 149 
O10-H10···O9 2.649(7) 147 
O12-H12···O4 2.606(6) 168 
P6 
O1-H1···O2 2.474(3) 149 
O10-H10···O9 2.662(3) 148 
O12-H12···O4 2.617(3) 166 
P7 
O1-H1···O2 2.478(5)      148 
O10-H10···O9 2.671(5) 147 
O12-H12···O4 2.605(5)     169 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The distance between the hydrogen bond acceptor and donor, the hydrogen bond angles, 
the distance ranges and the angle ranges for the O-H···O interactions in the host 
molecules of each solvate are summarised in Table 32.  The average distances for the O-
H···O interactions are quite uniform.  
 
Table 32 The mean distances and angles as well as their ranges for the O-H···O interactions in the 
host molecules of each solvate 
O···O P5 P6 P7 
Average distance (Å) 2.57 2.58 2.59 
Distance range (Å) 2.47 – 2.65 2.47-2.66 2.48 – 2.67 
Average angle (o) 154.67 154.3 162.0 
angle range (o) 147 – 168 148 – 166 148-169 
 
Figure 23 shows the zwitterionic structure and the intramolecular O-H···O interactions for 
each rifampicin host molecule.  The host molecules in each solvate adopt the same motif 
of intramolecular O-H···O interactions.  
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Figure 23 The zwitterionic structures and the intramolecular O-H···O interactions for each 
rifampicin host molecule.  The relevant hydrogen atoms are shown as spheres.  The other 
hydrogen atoms and the guest molecules are omitted for clarity.  The host molecule in P5 is 
shown as a stereoview.  
    
Several intramolecular C-H···O interactions (Table 33) were found to be associated with 
the rifampicin conformations in P5, P6 and P7.  Identical hydrogen bond interactions are 
found to exist in the host molecule for each solvate.   
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Table 33 Intramolecular C-H···O interactions in the host molecules of the three solvatesa 
Hydrogen bond C···O Distance (Å) Angle (o) 
P5 
C14-H14A···O3 2.905(8) 107 
C18-H18···O11 2.999(8) 114 
C23-H23···O7 2.940(9) 104 
C25-H25···O8 2.726(8) 106 
C25-H25···O9 2.886(7) 104 
C27-H27···O7 2.872(8) 107 
C28-H28···O3 3.105(8) 119 
P6 
C14-H14A···O3 2.895(4) 107 
C18-H18···O11 3.051(4) 113 
C23- H23···O7 2.913(4) 106 
C25-H25···O8 2.731(4) 105 
C25-H25···O9 2.929(4) 104 
C27-H27···O7 2.844(4) 107 
C28-H28···O3 3.046(4) 118 
P7 
C14-H14A···O3 2.885(6) 107 
C18-H18···O11 3.020(6) 113 
C23-H23···O7 2.923(5) 105 
C25-H25···O8 2.734(7) 106 
C25-H25···O9 2.886(5) 105 
C27-H27···O7 2.830(6) 106 
C28-H28···O3 3.116(6) 118 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The average distances, angles and their ranges for the intramolecular C-H···O interactions 
of each solvate are summarised in Table 34.  The average distances are very similar in 
each host molecule, as are the average angles.  This is consistent with the previous 
observations that indicated a high level of conformational similarity among the three 
independent rifampicin molecules.  
 
Table 34 The average distances and angles as well as their ranges for the intramolecular C-H···O 
interactions in the host molecules of each solvate 
C···O P5 P6 P7 
Average distance (Å) 2.92 2.92 2.91 
Distance range (Å) 2.73 – 3.11 2.73-3.05 2.74 – 3.12 
Average angle (o) 109 109 109 
angle range (o) 104 – 119 104 – 118 105-118 
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In addition, these intramolecular O-H···O and C-H···O hydrogen bond interactions 
stabilise the conformations of the host molecules in P5, P6 and P7. 
 
Host-host Interactions  
No host-host intermolecular O-H···O interaction is observed in any of the structures.  
However, three common host-host intermolecular C-H···O interactions are found in P5, 
P6 and P7.  The geometrical details of these interactions in the three solvates are listed in 
Table 35.   
 
Table 35 Intermolecular C-H···O interactions between the rifampicin moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
P5 
C40-H40B···O8 3.336(10) 146 3/2-x, 2-y, 1/2+z 
C41-H41A···O11 3.366(10) 136 -1/2+x, 3/2-y, 1-z 
C43-H43A···O11 3.387(11) 138 -1/2+x, 3/2-y, 1-z 
P6 
C40-H40B···O8 3.247(5) 143 3/2-x, 2-y, 1/2+z 
C41-H41B···O11 3.429(4) 145 -1/2+x, 3/2-y, 1-z 
C43-H43B···O11 3.437(6) 146 -1/2+x, 3/2-y, 1-z 
P7 
C40-H40B···O8 3.348(7) 139 3/2-x, 2-y, 1/2+z 
C41-H41B···O11 3.415(6) 140 -1/2+x, 3/2-y, 1-z 
C43-H43C···O11 3.334(6) 149 -1/2+x, 3/2-y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator only applies to hydrogen bond acceptors.  
 
The mean distances and angles, and the ranges for the host-host intermolecular C-H···O 
interactions in each solvate are summarised in Table 36.  The average C···O distances are 
very close in each solvate.   
 
Table 36 The average distances and angles as well as their ranges for the host-host intermolecular 
C-H···O interactions in the host molecules of each solvate 
C···O P5 P6 P7 
Average distance (Å) 3.36 3.37 3.36 
Distance range (Å) 3.34 – 3.39 3.25 – 3.44 3.34 – 3.41 
Average angle (o) 140 145 143 
angle range (o) 136 – 146 143 – 146 139-150 
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These interactions stabilise two rifampicin molecules when they assemble.  Furthermore, 
the existence of the common host-host intermolecular C-H···O interactions in the crystals  
of P5, P6 and P7 not only provides proof for the remarkable similarity in the 
conformations of the host molecules, but also indicates a high similarity of the molecular 
packing in each solvate.   
  
Host-guest Interactions  
The host-guest intermolecular O-H···O and N-H···O interactions in solvates P5, P6 and P7 
are shown in Figure 24.  Analogous interactions are found in each solvate.   
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Figure 24 Stereoviews of the intermolecular O-H···O and N-H···O hydrogen bonds between the host and 
guest molecules in the solvates P5, P6 and P7.  The oxygen atoms in the guest molecules are shown as 
spheres.  The other hydrogen atoms and guest molecules are omitted for clarity.  Atoms with gray labels 
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For all the solvates, atoms N1 serve as hydrogen bond donor to a water molecule (O4W 
in P5, O5W in both P6 and P7), thus linking the water molecules to the ansa bridge of 
each rifampicin host molecule via the hydrogen bond N1-H1N···Owater.  Atoms N4
+ also 
serve as hydrogen bond donor to water molecules which are disordered over two 
positions in all three cases.  The hydrogen bonds N4+-H4N···Owater connect the water 
molecules to the piperazinyl substituent of each host molecule.  Table 37 lists the 
distances between hydrogen bond donors (N1 and N4) and acceptor (water molecules) as 
well as the angles subtended at the hydrogen atom in the three solvates.         
 
Table 37 Intermolecular N1-H1N···Owater and N4
+-H4N···Owater H-bond interactions in the three 
solvatesa 
Hydrogen bond N···O Distance (Å) Angle (o) Symmetry operatorb 
P5 
N1-H1N···O4W 2.878(6) 166 -1/2+x, 3/2-y, 1-z 
N4-H4N···O3WA 3.103(17)      139 x, y, z 
N4-H4N···O3WB 2.62(2) 157 x, y, z 
P6 
N1-H1N···O5W 2.921(3)      169 -1/2+x, 3/2-y, 1-z 
N4-H4N···O4WA 2.585(6)      163 x, y, z 
N4-H4N···O4WB 2.914(6) 158 x, y, z 
P7 
N1-H1N···O5W 2.906(4)      164   -1/2+x, 3/2-y, 1-z 
N4-H4N···O9W 2.78(2) 163 3/2-x, 2-y, 1/2+z 
N4-H4N···O4W 2.799(7) 143 3/2-x, 2-y, 1/2+z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator only applies to hydrogen bond acceptors.  
 
The average distances and angles for the host-guest intermolecular N-H···O interactions 
for the three solvate molecules are summarised in Table 38.  The mean distances are very 
close (~ 2.8 Å) in all cases.  
 
Table 38 The average distances and angles for the host-guest intermolecular N-H···O interactions 
in all solvate molecules 
N···O P5 P6 P7 
Average distance (Å) 2.87 2.81 2.83 
Average angle (o) 154 164 157 
 
For host-guest intermolecular O-H···O interactions, very similar but not identical H-bond 
interactions can be found among the three cases.  For all the solvates, the hydroxyl 
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groups O9-H serve as H-bond donors and function as bridges which stabilise the ansa 
chain in one host molecule with an alcohol molecule.  This is the only hydroxyl oxygen 
which functions as a donor in host-guest H-bond intermolecular interaction.  
Furthermore, O9 atoms also serve as H-bond acceptor to water molecules; however, this 
occurs only in P6 and P7, not in P5 (Figure 24). 
 
Atoms O1, O2, O4, O6, O10 and O11 serve as H-bond acceptors to water molecules 
(except O6 H-bonded to an alcohol molecule in P5), thus associating host with water 
molecules.  Furthermore, O6 functions as acceptor to two distinct water molecules 
simultaneously only in P6 while O10 serves as acceptor to two distinct water molecules 
in all three cases.  Notably, hydroxyl oxygen O12 is not involved in guest-host 
intermolecular interactions in any solvate. 
 
Water molecules O4W in P5 as well as O5W in P6 and P7 stabilise each independent 
host molecule by serving as H-bond donors to O11 and O10 on the ansa chain 
simultaneously.  Atoms O1W and O2WB in P5, P6 and P7 as well as atoms             
O2WA in P5 and P7 form a long hydrogen bonded chain 
O9···O10···O1W···O1···O2···O2WB(O2WA)···O4···O12, which connects the ansa bridge 
(O9 and O10) in one host molecule with the chromophore plane (O1 and O2) in a second 
host molecule through O1W; the latter is then associated with the chromophore plane (O4 
and O12) of a third host molecule through O2WB (O2WA), as shown in Figure 25. 
 
Figure 25 Representative stereoview of the long hydrogen bonded chain 
O9···O10···O1W···O1···O2···O2WB (O2WA)···O4···O12 in P5.  The relevant oxygen atoms are 
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The geometrical details of the above hydrogen bonds are listed in Table 39.  Due to the 
low site-occupancy of some water molecules, their hydrogen atoms could not be located.  
In P5, the distance between the hydrogen bond donor (O2WA) and the acceptor (O2) is 
very short, implying strong hydrogen bonding.   
 
Table 39 Host-guest intermolecular O-H···O interactions in three solvatesa 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
P5 
O9-H9···O1GA 2.696(11) 175 x, y, z 
O9-H9···O1GB 2.847(13) 155 x, y, z 
O1W-H1W1···O1 2.782(6) 159(1) x, y, z 
O2WA-H2W1···O2 2.594(12) 169(5) x, y, z 
O2WB-H2W3···O2 2.898(13) 168(6) x, y, z 
O2WA-H2W2···O4 2.688(12) 159(15) 1-x, 1/2+y, 1/2-z 
O2WB-H2W4···O4 2.786(13) 167(13) 1-x, 1/2+y, 1/2-z 
O3GB-H3GB···O6 3.135(17) 150 x, y, z 
O1W-H1W2···O10 2.802(7) 174(6) 1/2+x, 3/2-y, 1-z 
O4W-H4W2···O10 2.840(7) 173(5) x, y, z 
O4W-H4W1···O11 2.743(6) 163(5) x, y, z 
P6 
O9-H9···O1GA 2.744(4) 172 x, y, z 
O6W-H6W2···O9 3.016(3) 168(2) x, y, z 
O1W-H1W1···O1 2.815(3) 174(2) x, y, z 
O2WA-H2W1···O2 2.805(5) 157(2) x, y, z 
O2WA-H2W2···O4 2.674(5) 146(2) 1-x, 1/2+y, 1/2-z 
O2WB-H2W3···O4 2.865(6) 167(5) 1-x, 1/2+y, 1/2-z 
O3W-H3W2···O6 2.918(6) 168(3) x, y, z 
O11W···O6 2.88(2) -------- x, y, z 
O1W-H1W2···O10 2.819(4) 163(2) 1/2+x, 3/2-y, 1-z 
O5W···O10 2.776(3) -------- x, y, z 
O5W···O11 2.685(3) -------- x, y, z 
P7 
O9-H9···O1G 2.715(5)      168 x, y, z 
O6W-H6W2···O9 3.042(6)      172(4) x, y, z 
O1W···O1 2.791(8) -------- x, y, z 
O2WA-H2W2···O2 2.654(6)      170(3) x, y, z 
O2WB-H2W3···O2 2.955(12) 166(5) x, y, z 
O2WA-H2W1···O4 2.720(6)      169(4) 1-x, 1/2+y, 1/2-z 
O2WB-H2W4···O4 2.843(13) 164(7) 1-x, 1/2+y, 1/2-z 
O3W-H3W2···O6 2.828(7)      151(3) x, y, z 
O5W-H5W1···O10 2.774(5)      161(2) x, y, z 
O1W···O10 2.742(8) -------- 1/2+x, 3/2-y, 1-z 
O5W-H5W2···O11 2.719(4)      178(8) x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator only applies to hydrogen bond acceptors.  
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The mean distances and angles as well as ranges for the host-guest intermolecular O-
H···O interactions in each solvate are summarised in Table 40.   The mean distances are 
very close in each solvate.  
 
Table 40 The average distances and angles as well as their ranges for the host-guest 
intermolecular O-H···O interactions in the three solvates. 
O···O P5 P6 P7 
Average distance (Å) 2.80 2.82 2.80 
Distance range (Å) 2.594 – 3.135 2.67 – 3.02 2.65 – 3.04 
Average angle (o) 164.7 164.4 166.6 
angle range (o) 150 – 175 146 – 172 151 – 178 
 
Several host-guest intermolecular C-H···O interactions are found in the structures of P5, 
P6 and P7.  Geometrical details are listed in Table 41. 
 
Table 41 Intermolecular C-H···O interactions between the rifampicin and guest moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
P5 
C40-H40···O4W 3.421(10)      159 -1/2+x, 3/2-y, 1-z 
C42-H42B···O3WA 3.310(17)      130 x, y, z 
P6 
C14-H14C··· O2WA 3.397(6)      139 x, y, z 
C40-H40A···O5W  3.416(4)     164   -1/2+x, 3/2-y, 1-z 
C41-H41A···O1W 3.275(5)      130 -1/2+x, 3/2-y, 1-z 
P7 
C37A-H37D···O3W 3.103(13)      113 x, y, z 
C40-H40A···O5W 3.409(6)      160 -1/2+x, 3/2-y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator only applies to hydrogen bond acceptors.  
 
The average distances and angles for the host-guest intermolecular C-H···O interactions for 
each solvate are summarised in Table 42.  The mean distances are close (~ 3.3 Å) in all 
cases.  
 
Table 42 The average distances and angles for the host-guest intermolecular C-H···O interactions 
in the three solvates. 
C···O P5 P6 P7 
Average distance (Å) 3.37 3.36 3.26 
Average angle (o) 144.5 144.3 136.5 
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Guest-guest Interactions  
For the three solvates, guest molecules (water and 1-propanol/iso-propanol molecules) 
display a variety of disordered arrangements.  Furthermore, the 1-propanol molecule can 
be disordered in many different ways.  Figure 26 illustrates the different disordered 
motifs of 1-propanol molecules in P5 and P6.  
 
Figure 26 Disordered 1-propanol molecules (a) O1GA/O1GB-C1GA-C2GA-C3GA in P5, (b) 
O3GA-C7GA-C8GA-C9GA and O3GB-C7GB-C8GB-C9GB in P5, (c) O2GB-C4GB-C5GB-
C6GB and O3GA-C7GA-C8GA-C9GA in P6. 
 
In the structures of P5, P6 and P7, guest clusters are formed by the alcohol and water 
molecules, as shown in Figure 27.  
(a) (b) (c) 
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Figure 27 The guest-guest intermolecular O-H···O interactions among the water and alcohol molecules in 
(a) P5, (b) P6 and (c) P7.  Atoms with gray labels have been symmetry-generated from their asymmetric 
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In P5, the guest cluster is completely isolated.  Water molecule O4W and the 1-propanol 
molecule O3GB-C7GB-C8GB-C9GB are two isolated guest molecules.  The former 
occupies the cavity of the ansa chain while the latter is linked to atom O6 in the host 
molecule (shown in Figure 24).  In the guest cluster, water molecule O5W is located very 
close to the hydrogen bond O3WA-H3W1···O2GA.  Furthermore, three solvent sites 
(O5W, O2GA-C4GA-C5GA-C6GA and O3WA) are not fully-occupied.  In addition, 
O5W is hydrogen bonded to O3WB which is then hydrogen bonded to disordered water 
molecules O2WA and O2WB.  Also, O3WA is situated very close to the hydrogen bond 
O5W···O3WB.  A noteworthy observation is that the hydrogen H3W1 in O3WA is 
involved in a bifurcated hydrogen bond with O2GA and O2WA. 
 
In P6, an infinitely extended guest cluster and an isolated water molecule O11W can be 
observed.  Atom O4WB is located very close to the hydrogen bond O10W-H101···O4WA 
and both O4WA and O4WB function as H-bond donors to O3W.  O11W is only 
hydrogen bonded to O6 in the host molecule (Figure 24).  In addition, O11W occupies a 
unique position compared with the situation in the other two solvates.   
 
In P7, all the guest molecules assemble in a cluster which extends infinitely.  A variety of 
disordered arrangements involving water molecules occurs.  
 
The geometrical details of the guest-guest intermolecular O-H···O hydrogen bond 
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Table 43 Guest-guest intermolecular H-bond interactions in solvate P5a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O2GA-H2GA···O1W 2.66(2)      163.0   x, y, z 
O5WB···O1W 2.96(2) ------ x, y, z 
O5WB···O3WB 2.81(3) ------ 1/2+x, 3/2-y, 1-z 
O3WB···O2WA 2.648 ------ x-1/2, 3/2-y, 1-z 
O3WB···O2WB 2.754 ------ x-1/2, 3/2-y, 1-z 
O3WA-H3W1···O2GA 2.716 98.5 x-1/2, 3/2-y, 1-z 
O3WA-H3W1···O2WA 2.756 105.7 x-1/2, 3/2-y, 1-z 
O3WA-H3W2···O3GA 3.160 153.9 3/2-x, 2-y, 1/2+z 
O3GA-H3GA···O2WA 2.656 168.2 2-x,1/2+y, 1/2-z 
O1GA-H1GA···O3GA 2.697 154.3 x, y, z 
O1GB-H1GB···O2WB 2.873 174.7 2-x, 1/2+y, 1/2-z 
a Average e.s.d.s 0.009 Å for distance and 0.3o for angle 
b Symmetry operator only applies to hydrogen bond acceptors.  
 
Table 44 Guest-guest intermolecular H-bond interactions in solvate P6a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O2GB-H2GB···O1W 2.805(7) 157.0 x, y, z 
O3GA-H3GA···O10W 2.793 171.7 x, y-1, z 
O10W-H102···O9WA 2.85(2) 160.4 x-1/2, 3/2-y, 1-z 
O10W-H101···O4WA 2.76(1) 174.0 x, y, z 
O4WA-H4W1···O2WA 2.714(7)      139.0 -1/2+x, 3/2-y,1-z 
O4WA-H4W2···O3W 2.653(6) 123.4 3/2-x, 2-y, 1/2+z 
O4WB-H4W3···O8WB 2.75(1) 150.7 x, y, z 
O8WB···O2WA 2.877 ------ x-1/2, 3/2-y, 1-z 
O4WB-H4W4···O3W 2.771 168.5 3/2-x, 2-y, 1/2+z 
O3W-H3W1···O7W 2.753 168.5 x, y, z 
O7W-H7W1···O6W 2.739 156.7 x, y, z 
O6W-H6W1···O5W 2.813 173.0 x, y, z 
O2WB-H2W4···O3W 2.974 173.7 2-x, y-1/2, 1/2-z 
O1GA-H1GA···O2WA 2.931 160.9 2-x, 1/2+y, 1/2-z 
O1GA-H1GA···O2WB 2.531 154.4 2-x, 1/2+y, 1/2-z 
O7W-H7W2···O1GA 2.837 174.5 2-x, y-1/2, 1/2-z 
O9WA-H9W2···O3GA 2.736 178.2 x, y, z 
O9WA-H9W1···O1W 2.739 172.9 x, y, z 
a Average e.s.d.s 0.005 Å for distance and 0.8o for angle 
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Table 45 Guest-guest intermolecular H-bond interactions in solvate P7a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O8W···O3W 2.823 ------ 2-x, y-1/2, 1/2-z 
O13W···O11W 3.090 ------ 1-x, 1/2+y, 1/2-z 
O11W···O14W 3.045 ------ 1-x, y-1/2, 1/2-z 
O13W···O12W 2.879 ------ 1-x, 1/2+y, 1/2-z 
O12W···O1W 2.59(3) ------ x, y, z 
O10W-H102···O12W 2.699 165.2 x, y, z 
O10W-H101···O2WA 2.749 139.6 x, y, z 
O8W-H8W2···O10W 2.768 173.0 x, y, z 
O8W-H8W1···O3W 2.824(9) 151.7 2-x, y-1/2, 1/2-z 
O3W···O9W 2.90(2) ------ x, y, z 
O9W···O2WA 2.59(3) ------ 2-x, 1/2+y, 1/2-z 
O9W···O2WB 2.724 ------ 2-x, 1/2+y, 1/2-z 
O2WA···O4W 2.642 ------ 2-x, y-1/2, 1/2-z 
O4W···O3W 2.725(7) ------ x, y, z 
O3W-H3W1···O7W 2.842(7) 138.4 x, y, z 
O7W-H7W1···O6W 2.806(7) 136.2 x, y, z 
O6W-H6W1···O5W 2.802(6) 158.4 x, y, z 
O1G-H1G···O4W 2.745 169.1 x, y, z 
O7W-H7W2···O1G 2.887(6) 121.6 2-x, y-1/2, 1/2-z 
O8W···O13W 2.712 ------ 3/2-x, 1-y, 1/2+z 
a Average e.s.d.s 0.004 Å for distance and 0.7o for angle 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
The average distances, average angles, the distance ranges and the angle ranges for the 
guest-guest intermolecular O-H···O interactions for the three solvates are summarised in 
Table 46 (bifurcated hydrogen bonds O3WA-H3W1···O2GA and O3WA-H3W1···O2WA 
in P5 are not considered).  The mean distances for the intermolecular guest-guest O···O 
interactions in P5, P6 and P7 are very close (~ 2.8 Å). 
 
Table 46 The average distances and angles as well as their ranges for the guest-guest 
intermolecular O-H···O interactions in all three solvates. 
O···O P5 P6 P7 
Average distance (Å) 2.79 2.78 2.79 
Distance range (Å) 2.66 – 3.66 2.53 – 2.97 2.59 – 3.09 
Average angle (o) 163 162 150 
angle range (o) 153.9 – 168.2 123.0 – 178.2 121.3 – 173.0 
 
No significant intermolecular guest-guest C-H···O interactions occur in the structures of 
P5 – P7.  
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Overall Intramolecular and Intermolecular Interactions in P5, P6 and 
P7  
Figure 28 shows the overall hydrogen bond interactions in solvates P5, P6 and P7.  A 
common assembly of five rifampicin molecules around the solvent cluster is observed in 
each solvate structure.  The same set of oxygen and nitrogen atoms in the five symmetry-
related rifampicin molecules of solvates P5 – P7 is involved in hydrogen bonding with 
guest molecules.  In other words, although the content of the solvent cluster is different in 
each solvate, the hydrogen bonding environments provided by the rifampicin molecules 
are identical in P5, P6 and P7.   
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Figure 28 Stereoviews of the overall hydrogen bond interactions in (a) P5, (b) P6 and (c) P7.  
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Crystal Packing 
The packing arrangements for solvates P5, P6 and P7 [Figures 29 (a), (b) and (c)] are 
identical.  This arrangement gives rise to solvent tunnels [Figure 29 (d)] along the a-axis, 
which provide the possibility of facile replacement of solvent molecules in the crystals 
with water molecules in the atmosphere.  
 
Figure 29 Crystal packing diagrams for (a) P5, (b) P6 and (c) P7 viewed along [100]; solvent 
molecules are shown as green spheres for clarity.  (d) Solvents channels viewed along [100].  













(a) P5 (b) P6 
(c) P7 (d) P5-space filling 
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The solvent channels for P5, P6 and P7 were examined using the program SECTION14, 
which was used to view planes through the unit cells along the a-axis.  The sections for 
P6 are shown in Figure 30 as representatives of those for P5, P6 and P7.  A series of 
views taken at regular intervals along the a-axis clearly illustrates the continuous 
channels in which the guest molecules are accommodated.   
 
Figure 30 Sections of P6 with guest molecules omitted and host molecules represented by gray 
areas, viewed along [100] with the unit cell sectioned at (a) 0 Å (b) 6.5 Å from the origin 0,0,0.  




The calculated and experimental PXRD traces for solvates P5, P6 and P7 are shown in 
Figure 31.  For all three solvates, the experimental PXRD traces are in reasonable 
agreement with the calculated ones, confirming that each prepared sample was 
homogeneous.  Corresponding PXRD peaks for the solvates P5 – P7 generally have 
different intensities.  This is expected since their solvent contents differ.  Preferred 





(a) 0 Å (b) 6.5 Å 

























The solvates P5, P6 and P7 display similar unit cell dimensions (a = ~13, b = ~17, c = 
~26 Å, α = β = γ = 90º), and crystallise in the same space group P212121.  Their calculated 
PXRD traces are stacked here for comparison as presented in Figure 32.  A remarkable 
similarity can be found among the three traces.  In addition, the three – dimensional 
packing arrangements of the drug molecules in each solvate are the same (Figure 29).  
Furthermore, the host molecules in the three solvates adopt similar conformations 
evidenced by the fact they are superimposable (Figure 20). Consequently, P5, P6 and P7 
are identified as isostructural compounds with regard to the uniform host rifampicin 
molecular assemblies.  Also, any of the calculated PXRD patterns in Figure 32 could 
serve as a reference for the identification of future crystalline forms belonging to this 
isostructural series. 15 
 
Figure 32 Calculated PXRD traces for solvates P5, P6 and P7. 
 
Guest Exchange 
Crystals of P5 were converted to a solvate with a different solvent composition after 
equilibrating with the atmosphere for a certain period.  This can be explained as 
spontaneous guest exchange from alcohol molecules to atmospheric water molecules.  
For the crystals which had experienced a one-week exposure to the atmosphere, single 
crystal X-ray structure determination was attempted to examine the structural change, if 
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any.  However, the attempt failed since the crystals cracked during the guest exchange 
process.  TGA and PXRD analyses were then carried out to characterise the nature of 
these crystals.  The PXRD pattern revealed that a phase change had occurred during the 
equilibration.  The TGA result showed a mass loss during the heating process.  However, 
the exact composition of the solvent content in the phase could not be determined from 
the above data.  
 
Conformation of the Rifampicin Host Molecules  
The similarity of the hosts of P5, P6 and P7 was demonstrated in the overlay diagram 
(Figure 20) and reflected in the parameters that described the similar dihedral angles 
among the three principal planes (Table 27) and similar torsion angles along the ansa 
chain (Table 28).  A considerable difference can be observed between the conformations 
of the rifampicin molecule in the two isostructural series 1 (P1 – P4) and 2 (P5 – P7), as 
shown in Figure 33.  In the former series, the piperazinyl moiety is linked to the rest of 
the molecule through an equatorial N3-N2 bond, whereas in the latter, this bond is axial. 
Furthermore, the O11 atom in the former points away from the ansa chain while that in 
the latter points towards the ansa chain.  In other words, atoms O11 point in different 
directions in the host molecules in series 1 and 2.  Therefore, the structures of host 
molecules in series 1 and those in series 2 can be identified as two significantly different 
conformations of the rifampicin molecules.  
 
Figure 33 An overlay diagram of the rifampicin molecules in P1 (green) and P5 (red).  Guest 
molecules and hydrogen atoms are omitted for clarity.  (a) View side-on with respect to the ansa 
chain, (b) view normal to the ansa chain backbone. 
(a)  (b)  
O11  
O11  
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A common feature in all of the rifampicin molecules in solvates P1 – P7 is their 
zwitterionic nature, resulting from proton transfer from a hydroxyl group on the 
chromophore to nitrogen atom N4 of the piperazinyl ring.   
 
However, in both series 1 and 2, these host molecules all adopt an open conformation, 
which leads to the conclusion that the two conformationally different rifampicin 
molecules both adopt antibiotically active conformations in the solid state, i.e. their 
conformational parameters fall within the ranges associated with biological activity.4 
 
Host-host Intramolecular and Intermolecular Hydrogen Bond Interactions  
Since the packing modes of the three solvates P5 – P7 are almost identical, the host-host 
O-H···O and C-H···O intramolecular hydrogen bonds have identical hydrogen bond 
donors and acceptors.  Furthermore, the average interatomic O···O distance is very 
similar in each solvate. This also applies to C···O distances.  It is noteworthy that no host-
host O···O intermolecular hydrogen bonds or π-π interactions are found in the solvates.   
 
In addition, the hydrogen bond donors and acceptors of host-host O···O intramolecular 
interactions in series 2 are identical with those in series 1 except that hydrogen bond N1-
H1N···N2 occurs in the latter.  This is associated with the equatorial configuration of the 
piperazinyl substituent in series 1. 
 
Guest-host Hydrogen Bond Interactions 
Atoms O1, O2, O4, O6, O10, O11, N1 and N4+ in the rifampicin host molecule are 
involved in the guest-host intermolecular hydrogen bond motif.  This applies to each 
solvate due to the almost identical common crystal packing arrangement.  However, O6 
functions as acceptor to two distinct water molecules simultaneously only in P6 while O9 
serves as H-bond acceptor to water molecules only in P6 and P7.  Furthermore, both N1 
and N4+ atoms function as hydrogen bond donors to water molecules in all three cases.   
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The fact that the piperazinyl substituent adopts an axial configuration in isostructural 
series 2 gives rise to the interaction N1···Owater which cannot be observed in the structures 
of series 1. 
 
Guest-guest Hydrogen Bond Interactions  
The water and alcohol molecules are generally described as guest molecules in all three 
solvates.  They display a variety of disordered arrangements.  For example, most of the 
water molecule sites are partially occupied.  Therefore, the hydrogen bond networks are 
very complicated in all three cases.  In the structure of the crystal of P5, whose data were 
collected immediately following its removal from the mother liquor, the guest molecules 
(except the water molecule O4W and 1-propanol molecule O3GB-C7GB-C8GB-C9GB) 
assemble to form an isolated solvent cluster that is closely associated with five 
neighbouring rifampicin molecules.  In the structure of P6, which resulted from exposure 
of P5 to the atmosphere for a period of 10 hours, an infinitely extended guest cluster and 
an isolated water molecule O11W can be observed.  However, although the data for the 
crystals of  P7 were collected immediately following their removal from mother liquor, 
all the guest molecules in the structure of P7 assemble into a guest cluster which extends 
infinitely.  The average O···O distance of guest-guest O-H···O interactions in series 2 is 
very close to that in series 1 (~2.8 Å). 
  
Crystal Packing 
Despite the subtle differences in the conformations of the host molecules and the 
different content of guest molecules in each crystal, solvates P5, P6 and P7 pack in 
almost identical modes.  Solvent molecules are located in the continuous channel parallel 
to the a-axis.  This channel provides access to atmospheric water molecules which can 
enter the crystal, changing the compositions of the entrapped solvent mixtures.  Infinite 
solvent channels which allow easy guest exchange can be found in both solvate series 1 
and 2.  The difference between the packing arrangements of series 1 and 2 will be 
discussed further in Part Three, where we also report a series of four distinct rifampicin 
solvates with different unit cell dimensions and packing arrangements. 
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Part Three 
Here we report the isolation and characterisation of four distinct rifampicin solvates that 
contain water and one of each of the solvents iso-propanol, 1-butanol, ethylene glycol 
and 1,4-dioxane.  The host conformation and PXRD patterns of each solvate will be 
discussed together; however, the intra- and intermolecular interactions as well as packing 
arrangements in each solvate will be discussed separately. 
 
Crystal Preparation 
The abbreviations for the discrete rifampicin solvates in this chapter are as follows: 
2rifampicin • 4.30iso-propanol • 14.7H2O:   P8 
2rifampicin • 5.53(1-butanol) • 1.40H2O:   P9 
2rifampicin • 5.75ethylene glycol • 5.59H2O:  P10 
2rifampicin • 6(1, 4-dioxane) • 3H2O:   P11 
 
Suitable crystals of P8 were obtained by dissolving 0.020 g (0.024 mmol) of the host 
drug (rifampicin) in 2 ml of (iso-propanol)-acetone-water mixture (3:14:3 v /v /v) at      
25 oC.  The solution was then filtered.  Crystals of suitable quality appeared by slow 
evaporation at 4 oC over a period of two weeks.  It is noteworthy that the only difference 
between the crystal preparation methods of P7 (also containing isopropanol and water) 
and P8 is that the solution was not filtered in the former but was filtered in the latter.  
 
Suitable crystals of P9 and P10 were obtained by dissolving 0.020 g (0.024 mmol) of the 
host drug (rifampicin) in 2 ml of 1-butanol-water mixture (9:1 v/v) and ethylene glycol-
ethanol-water mixture (3:15:2 v/v/v) at 25 oC, respectively.  The solutions were then 
filtered.   Crystals of suitable quality appeared by slow evaporation at 4 oC over a period 
of two weeks.   
 
Suitable crystals of P11 were obtained by dissolving 0.020 g (0.024 mmol) of the host 
drug (rifampicin) in 2 ml of 1, 4-dioxane-water mixture (19:1 v/v) at 25 oC.  The solution 
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was not filtered.   Crystals of suitable quality appeared by slow evaporation at 25 oC over 
a period of three weeks.   
 
The host and guest numbering schemes are given in Figure 34. 
 
Figure 34 Host and guest numbering schemes: (a) rifampicin, (b) iso-propanol, (c) 1-butanol, (d) 
ethylene glycol and (e) 1, 4-dioxane. Hydrogen atoms have been omitted for clarity. 
 
 
Single crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
A crystal of P8 was moved from its mother liquor and was covered in paratone N oil 
without delay in order to prevent the loss of solvent molecules.  The crystals of P9, P10 
and P11 were handled in the same way.  A Nonius Kappa CCD four-circle diffractometer 
was employed to collect the data for all four solvates at 100 K.   
 
The unit cell parameters, crystal systems and space groups were determined from the X-
ray diffraction data which revealed Laue 2/m symmetry for all four solvates.  Therefore, 












































































(d) ethylene glycol (e) 1, 4-dioxane 
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none; h0l: none; 0k0: k = 2n.  The two space group choices were P21 and P21/m.  The 
former was chosen due to the chirality of the rifampicin host molecules.    
 
Structure Solution and Refinement 
From unit cell data and density considerations, each of the solvates was found to contain 
a total of four rifampicin molecules (plus complementary solvent molecules) per unit cell.  
Since the number of equivalent positions in the space group P21 is two, it follows that the 
asymmetric unit comprises two independent rifampicin molecules (plus solvent 
complement) in each case.  
 
For all four solvates, program SHEXLD1 was used to solve the structures by ab initio 
methods, which revealed the positions of all the non-hydrogen atoms of the two 
independent rifampicin molecules (host) in each structure.  Full-matrix least-squares 
refinements were performed with SHELXH-97.2  Difference Fourier maps yielded the 
positions of the oxygen and carbon atoms of the water and organic solvent molecules 
(guest).  Some of these atoms were found to have full site-occupancy while the others 
were disordered over two or even three positions.  The host and guest molecules having 
full s.o.f. were then refined isotropically.  
 
A few atoms in the host molecules were found to be disordered over two positions in all 
four solvates except P10.  In P8, atoms C41 and C42 in the host molecule A are 
disordered over two positions (C41A and C41C as well as C42A and C42 C).  C41C and 
C42C, the major components, were assigned a value of x for their s.o.f.s while the minor 
components C41A and C42A were allocated the value 1-x.  The s.o.f.s refined to 0.63(2) 
and 0.37(2) respectively while the Uiso values of C41C, C41A, C42C and C42A refined 
to 0.051(3), 0.014(3), 0.041(3) and 0.021(3) Å2, respectively.  In P9, atom C36 in the host 
molecule A is disordered over two positions (C36A and C36C).  Their s.o.f.s refined to 
0.67(3) and 0.33(3) respectively while their Uiso values refined to 0.072(3) and 0.022(4) 
Å2, respectively.  In P11, atoms C18 and O11 in the host molecule B are disordered over 
two positions (C18B and C18E as well as O11B and O11E).  The s.o.f.s of C18B and 
C18E refined to 0.80(2) and 0.20(2) respectively while their Uiso values refined to 
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0.039(3) and 0.034(7) Å2, respectively.  The s.o.f.s of O11B and O11E refined to 0.78(1) 
and 0.22(1) respectively while their Uiso values refined to 0.029(2) and 0.045(6) Å
2, 
respectively     
 
For the disordered solvent molecules, a fixed Uiso (the mean of Ueq for the chemically 
equivalent ordered atoms) was assigned to each molecule and these atoms were allowed 
to refine with site-occupancies x and 1-x, with x variable.  For some molecules, the s.o.f.s 
were then assigned as fixed values, allowing the Uiso parameters to refine freely.  For 
some of the other molecules, both the Uiso values and s.o.f.s refined freely.  The details of 
the Uiso parameters and s.o.f.s of the guest molecules in each solvate are listed in Tables 
47, 48, 49 and 50.  
 
Table 47 Isotropic thermal parameters and site-occupancy factors for the guest molecules of P8 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.04 1.00 
O2W 0.04 1.00 
O3W 0.03 1.00 
O4W 0.05 0.70 
O5W 0.03 1.00 
O6W 0.05 1.00 
O7W 0.04 1.00 
O8W 0.05 1.00 
O9W 0.04 1.00 
O10W 0.06 1.00 
O11W 0.05 0.50 
O12W 0.06 0.85 
O13W 0.05 0.28 
O14W 0.06 0.30 
O15W 0.04 0.50 
O16W 0.05 0.50 
O17W 0.05 0.38 
O18W 0.06 0.70 
O19W 0.06 0.60 
O20W 0.06 0.20 
O21W 0.07 0.21 
O1G-C1G-C2G-C3G 0.07-0.06-0.09-0.07 1.00 
O2G-C4G-C5G-C6G 0.08-0.05-0.04-0.05 0.50 
O3G-C7G-C8G-C9G 0.04-0.03-0.07-0.05 0.70 
O4G-C10G-C11G-C12G 0.07-0.05-0.06-0.07 1.00 
O5GA-C13G-C14G-C15G 0.02 (global Uiso) 0.34 
O6GA-C16G-C17G-C18G 0.02 (global Uiso) 0.34 
O6GB-C19G-C21G-C20G 0.06 (global Uiso) 0.42 
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Table 48 Isotropic thermal parameters and site-occupancy factors for the guest molecules of P9 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.07 1.00 







O2G-C5G-C6G-C7G-C8G 0.03-0.03-0.03-0.04-0.04 1.00 
O3G-C9G-C10G-C11G-C12G 0.06-0.08-0.08-0.07-0.10 0.94 











Table 49 Isotropic thermal parameters and site-occupancy factors for the guest molecules of P10 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.07 1.00 
O2W 0.08 1.00 
O3W 0.06 0.15 
O4W 0.08 1.00 
O5W 0.07 0.61 
O6W 0.07 0.50 
O7W 0.06 0.20 
O8W 0.06 0.32 
O9W 0.07 0.46 
O10W 0.06 0.15 
O11W 0.07 0.20 
O1G-C1G-C2G-O2G 0.09 (global Uiso) 0.73 
O3G-C3G-C4G-O4G 0.08 (global Uiso) 0.63 
O5G-C5G-C6G-O6G 0.07 (global Uiso) 0.67 
O7G-C7G-C8G-O8G 0.08 (global Uiso) 0.70 
O9G-C9G-C10G-O10G 0.09 (global Uiso) 0.61 
O11G-C11G-C12G-O12G 0.09-0.09-0.09-0.10 1.00 
O13G-C13G-C14G-O14G 0.09 (global Uiso) 0.73 
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Table 50 Isotropic thermal parameters and site-occupancy factors for the guest molecules of P11 
Guest molecule Uiso (Å
2) s.o.f. 
O1W 0.04 1.00 
O2W 0.04 1.00 
O3W 0.06 1.00 
O1C-C1C-C2C-O2C-C3C-C4C 0.05-0.06-0.08-0.06-0.05-0.05 0.65 
O1D-C1D-C2D-O2D-C3D-C4D 0.06-0.06-0.03-0.09-0.07-0.06 0.35 
O3C-C5C-C6C-O4C-C7C-C8C 0.03-0.03-0.03-0.04-0.04-0.04 0.66 
O3D-C5D-C6D-O4D-C7D-C8D 0.05 (global Uiso) 0.44 
O5G-C9G-C10G-O6G-C11G-C12G 0.03-0.03-0.03-0.04-0.03-0.03 1.00 
O7G-C13G-C14G-O8G-C15G-C16G 0.04-0.05-0.07-0.09-0.05-0.03 1.00 
O9G-C17G-C18G-O10G-C19G-C20G 0.06-0.05-0.05-0.06-0.05-0.06 1.00 
O11C-C21C-C22C-O12C-C23C-C24C 0.06-0.02-0.04-0.07-0.04-0.06 0.62 
O11D-C21D-C22D-O12D-C23D-C24D 0.09 (global Uiso) 0.38 
 
Hydrogen atoms were identified in successive difference electron-density maps.  Based 
on the positions of the peaks found, a riding model was employed to place hydrogen 
atoms for the rifampicin and solvent molecules in idealised positions except for the water 
hydrogen atoms which were positioned based on reasonable locations of suitable 
electron-density peaks and appropriate hydrogen bond geometry.  All the methyl 
hydrogen atoms were refined with isotropic temperature factors equal to 1.5 times those 
of their parent atoms while all the other hydrogen atoms were assigned temperature 
factors 1.2 times those of their parent atoms.   
   
For the iso-propanol, 1-butanol, ethylene glycol and 1, 4-dioxane molecules as well as the 
hydrogen atoms of water molecules, distance restraints were employed to ensure 
reasonable molecular geometries.  For the iso-propanol molecules, the bond lengths 
O1G-C1G, C1G-C2G and C1G-C3G were set at 1.43, 1.52 and 1.52 Å, respectively.  The 
standard deviation σ for these bonds was set between 0.001 and 0.01 Å.  For the             
1-butanol molecules, the bond lengths O1G-C1G, C1G-C2G, C2G-C3G and C3G-C4G 
were set at 1.53, 1.52, 1.52 and 1.51 Å, respectively.  The standard deviation σ for these 
bonds was set between 0.001 and 0.004 Å.  For the ethylene glycol molecule, the bond 
lengths O1G-C1G, C1G-C2G and C2G-O2G were set at 1.40, 1.52 and 1.53 Å, 
respectively.  The standard deviation σ for these bonds was set at 0.01 Å.  For the         
1,4-dioxane molecules, the bond lengths O1G-C1G, C1G-C2G, C2G-O2G, O2G-C3G, 
C3G-C4G and C4G-O1G were set at 1.52, 1.42, 1.52, 1.52, 1.42 and 1.52 Å, respectively.  
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The standard deviation σ for these bonds was set between 0.004 and 0.008 Å.  The O-H 
bond length of water molecules was fixed at 0.84 Å with the H-O-H angle set at 104.5o.  
The standard deviations σ were set between 0.001 and 0.008 Å.     
 
Crystal and refinement parameters for each solvate are presented in Tables 51 and 52.  A 
variety of disordered arrangements is observed in each case.  Large fractions of solvent 
disorders (30, 40, 49 and 32 %) are observed in the structures of solvates P8, P9, P10 and 
P11, respectively.  This gives rise to the difficulty in achieving low final residual factors 
(R1, wR2). 
 
This was especially the case for solvate P10, whose crystals diffracted poorly.  It should 
be noted here that for each solvate, at least two, and in some cases, three full intensity 
data-collections and subsequent refinements were performed in an effort to obtain the 
highest quality data.  Despite all data-collections being carried out at low temperature 
(typically 100 K), solvent disorder persisted and presented formidable challenges in 
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Table 51 Crystal and refinement data for P8 and P9 
Parameter P8 P9 
Formula unit 2rifampicin ·  
4.30iso-propanol ·  
14.7H2O 
2rifampicin ·  
5.53(1-butanol) ·  
1.40H2O 
Formula Weight / g mol-1 2169.58 2081.14 
Crystal system Monoclinic Monoclinic 
Space group P21 P21 
a / Å 13.9354(7) 14.0774(13) 
b / Å 17.6109(8) 23.401(2) 
c / Å 25.4284(12) 17.4839(16) 
α / o 90.00 90.00 
β / o 94.2140(10) 90.689(2) 
γ / o 90.00 90.00 
Volume / Å3 6223.6(5) 5759.3(9) 
Z 2 2 
Densitycalc / g cm
-3 1.158 1.200 
µ (MoKα) /mm
-1 0.090 0.087 
F (000) 2347 2253 
Crystal size /mm3 0.25x0.22x0.06 0.18x0.34x0.41 
Temperature / K 100(2) 100(2) 
Range scanned θ / o 1.99 ≤ θ ≤ 27.88 1.85 ≤ θ ≤ 28.44 
h: -18, 18 h: -18, 18 
k: -23, 23 k: -31, 31 
Index ranges 
l: -33, 33 l: -23, 23 
φ scan angle / o 0.5 0.5 
ω scan angle / o 0.5 0.5 
Dx / mm 42 40 
No. of measured reflections 85745 60374 
No. of unique reflections 15309 14710 
No. of reflections with I > 
2σ(I) 
11589 12138 
No. of L.S. parameters 1414 1375 
Rint, Rσ 0.0336, 0.0276 0.0426, 0.0406 
S 1.025 1.027 
R1 (Fo > 4σ(Fo)) 0.0881 0.0598 
No. of reflections omitted 31 37 
wR2 (all reflections) 0.2709 0.1738 
0.1701 0.1142 Weighting scheme 
6.6353 1.9393 
(∆ / σ)mean < 0.001 < 0.001 
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Table 52 Crystal and refinement data for P10 and P11 
Parameter P10 P11 
Formula unit 2rifampicin ·  
5.75ethylene glycol ·  
5.59H2O 
2rifampicin ·  
6(1,4-dioxane) ·  
3H2O 
Formula Weight / g mol-1 2103.36 2228.56 
Crystal system Monoclinic Monoclinic 
Space group P21 P21 
a / Å 13.802(4) 12.1131(14) 
b / Å 17.517(5) 20.515(2) 
c / Å 24.848(8) 23.438(3) 
α / o 90.00 90.00 
β / o 105.803(6) 98.020(2) 
γ / o 90.00 90.00 
Volume / Å3 5781(3) 5767.4(11) 
Z 2 2 
Densitycalc /g cm
-3 1.208 1.283 
µ (MoKα) /mm
-1 0.094 0.097 
F (000) 2263 2396 
Crystal size /mm3 0.02x0.17x0.28 0.20x0.31x0.42 
Temperature / K 100(2) 100(2) 
Range scanned θ / o 2.28 ≤ θ ≤ 24.98 2.17 ≤ θ ≤ 27.54 
h: -16, 13 h: -15, 15 
k: -20, 20 k: -26, 26 
Index ranges 
l: -29, 28 l: -30, 30 
φ scan angle / o 0.5 0.5 
ω scan angle / o 0.5 0.5 
Dx / mm 65 50 
No. of measured 
reflections 
32578 48483 
No. of unique reflections 10456 13629 
No. of reflections with I > 
2σ(I) 
6192 12331 
No. of L.S. parameters 1151 1436 
Rint, Rσ 0.1040, 0.1318 0.0300, 0.0294 
S 1.310 1.057 
R1 (Fo > 4σ(Fo)) 0.1367 0.0625 
No. of reflections omitted 8 12 
wR2 (all reflections) 0.3769 0.1745 
0.2000 0.1046 Weighting scheme 
0.0000 4.5133 
(∆ / σ)mean < 0.001 < 0.001 








Rifampicin Molecule Conformation and Antibiotic Activity 
Similar to the rifampicin host molecules in series 1 (solvates P1 - P4) and 2 (P5 - P7), the 
host molecules in solvates P8, P9, P10 and P11 were also investigated with regard to their 
solid-state conformations.  The antibiotic activity of the host molecules has been 
correlated with the conformation of the ansa chain, as determined from single crystal X-
ray diffraction.3   
 
In each case, the value of Z = 4 indicated that the asymmetric unit comprised two 
crystallographically independent drug molecules (A and B) and their complements of 
solvent molecules.  The two independent host molecules A and B in each solvate are 
overlayed in Figure 35.   For P8, a remarkable similarity is found in the conformations of 
the molecules A and B.  However, small but significant differences between the 
conformations of the host molecules can be observed, which confirms the presence of 
two symmetry-independent host molecules in the asymmetric unit.  This also applies to 
solvates P9 and P10.  In the molecule B of solvate P11, atom C18 is disordered over two 
positions where C18B has the major site-occupancy [0.80(1)].  It is important to note 
that C18B in molecule B points towards the ansa chain while C18A in molecule A points 
away from the ansa chain.  This strongly indicates that host molecules A and B are two 
symmetry-independent molecules in the asymmetric unit of P11.        
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Figure 35 Overlay diagrams of the crystallographically independent host molecules A (green) 
and B (pink) in solvates (a) P8, (b) P9, (c) P10 and (d) P11.  Guest molecules and hydrogen atoms 
are omitted for clarity.   
 
A noteworthy observation is that atom O11 points away from the ansa chain in the host 
molecules of solvates P8 and P10 while it points towards the ansa chain in solvates P9 
and P11, as shown in Figure 36.  This indicates the existence of two distinct 
conformations of the rifampicin molecules.  
 
 
(a) P8 (b) P9 
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Figure 36 An overlay of the host molecules A in solvates P8 (red), P9 (gray), P10 (yellow) and 
P11 (green).  Hydrogen atoms are omitted for clarity.   
 
Table 53 lists the dihedral angles between planes A (ansa chain) and B (chromophore) as 
well as those between planes B and C (piperazinyl substituent) in the two independent 
host molecules (A and B) in each solvate.  For each solvate, the difference between the 
chemically equivalent dihedral angles in molecules A and B provides firm evidence for 
the existence of two independent host molecules in the asymmetric unit.  Furthermore, 
since dihedral angles between planes A and B lie within the range 64 to 124o (established 
as critical for antibiotic activity),4, 5, 6, 7 we conclude that the crystals in the four solvates 
contain the rifampicin molecule in biologically relevant conformations.  Also, for the 
molecules A and B in P11, the difference between the dihedral angles of planes B and C 
is much more significant than those of others.  
 
Table 53 The dihedral angles (o) between planes A and B as well as those between planes B and 
C of the host molecules (A and B) in each solvate.  
P8  P9  P10  P11 Angles 
between 
planes 
A B A B A B A B 
A and B(o) 72.58(4) 71.24(4) 62.02(3) 58.52(3) 73.0(1) 70.3(2) 56.02(4) 49.66(4) 
B and C(o) 12.9(2) 7.7(1) 15.8(1) 15.82(9) 8.9(3) 7.9(3) 3.81(8) 16.96(7) 
 
Tables 54 and 55 list the torsion angles τ1-τ17 along the ansa chain backbone of the 
rifampicin host molecules (the scheme was shown in earlier parts of this chapter).  
Among these angles, τ1 defines the junction between the chromophore and the ansa 
chain, indicating a trans conformation in the rifampicin molecules of all four solvates.  
O11A in P9  
O11A in P11 
O11A in P8 
O11A in P10 
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The torsion angle τ17 indicates a gauche conformation of the etheric junction in the 
rifampicin molecule in each case.  These are similar to the conformations of the host 
molecules in series 1 and 2.  Furthermore, it is known that the torsion angles τ9 and τ17 in 
the host molecules fall within the preferred range 59 ± 6o and -65 ± 13o respectively for 
active rifamycins.9, 17 This also serves as evidence for the conclusion that the crystals of 
P8, P9, P10 and P11 contain the rifampicin molecule in biologically relevant 
conformations. 
   
Table 54 The torsion angles along the ansa chain in the rifampicin host molecules A and B in 
solvates P8 and P9, respectively.  
P8 P9 Torsion angles (o) 
A B A B 
C2-N1-C15-C16 (τ1) 179.7(4) -179.6(4) 169.6(3) 169.2(3) 
N1-C15-C16-C17 (τ2) -24.4(7) -23.5(7) -105.3(4) -96.8(4) 
C15-C16-C17-C18 (τ3) -1.4(9) -0.7(9) 0.5(6) -1.3(6) 
C16-C17-C18-C19 (τ4) 158.1(6) 157.0(6) 174.3(4) 172.6(4) 
C17-C18-C19-C20 (τ5) -169.8(5) -167.9(5) -173.7(4) -174.6(4) 
C18-C19-C20-C21 (τ6) -5.6(7) -5.9(7) -8.0(6) -16.8(6) 
C19-C20-C21-C22 (τ7) 169.6(4) 169.2(4) 171.9(3) 171.3(3) 
C20-C21-C22-C23 (τ8) 179.0(4) 179.3(4) -178.6(3) -171.9(3) 
C21-C22-C23-C24 (τ9) 55.2(6) 56.6(6) 54.5(4) 61.4(4) 
C22-C23-C24-C25 (τ10) 173.8(4) 173.6(4) 170.8(3) 164.6(3) 
C23-C24-C25-C26 (τ11) 160.7(4) 160.1(4) 159.4(3) 163.2(3) 
C24-C25-C26-C27 (τ12) 161.2(4) 161.5(4) 174.3(3) 169.0(3) 
C25-C26-C27-C28 (τ13) -175.2(4) -176.9(4) -169.5(3) -171.0(3) 
C26-C27-C28-C29 (τ14) 112.8(5) 112.9(5) 106.4(4) 104.8(4) 
C27-C28-C29-O5 (τ15) -173.6(4) -173.4(4) -171.3(3) -172.5(3) 
C12-O5-C29-C28 (τ16) 58.4(6) 58.0(6) 52.6(4) 57.7(4) 
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Table 55 The torsion angles along the ansa chain in the rifampicin host molecules A and B in 
solvates P10 and P11, respectively.  
P10 P11 Torsion angles (o) 
A B A B 
C2-N1-C15-C16 (τ1) 180(1) 176(1) -168.7(4) 172.5(4) 
N1-C15-C16-C17 (τ2) -34(2) -25(2) -127.5(4) -86.6(5) 
C15-C16-C17-C18 (τ3) 6(3) 2(2) 6.8(7) 1.8(8) 
C16-C17-C18-C19 (τ4) 158(2) 153(2) 43.2(7) 177.2(6) 
C17-C18-C19-C20 (τ5) -164(2) -167(1) -170.6(4) 178.9(5) 
C18-C19-C20-C21 (τ6) -18(2) -8(2) 109.2(5) -9.1(8) 
C19-C20-C21-C22 (τ7) 172(1) 173(1) 175.2(3) -179.4(4) 
C20-C21-C22-C23 (τ8) -178(1) -180(1) 173.1(3) 179.2(3) 
C21-C22-C23-C24 (τ9) 59(2) 52(2) 51.4(4) 54.9(4) 
C22-C23-C24-C25 (τ10) 168(1) 174(1) 178.8(3) 176.6(3) 
C23-C24-C25-C26 (τ11) 160(1) 163(1) 156.9(3) 159.8(3) 
C24-C25-C26-C27 (τ12) 161(1) 159(1) 167.2(3) 166.7(3) 
C25-C26-C27-C28 (τ13) -173(1) -179(1) -179.3(3) -174.1(3) 
C26-C27-C28-C29 (τ14) 113(2) 116(2) 104.5(4) 107.2(4) 
C27-C28-C29-O5 (τ15) -177(1) -175(1) -168.7(3) -168.1(4) 
C12-O5-C29-C28 (τ16) 60(2) 63(2) 57.1(5) 51.9(6) 
C29-O5-C12-O3 (τ17) -77(1) -82(1) -80.6(4) -82.5(5) 
 
Interestingly, τ4 in the molecule A in solvate P11 indicates a gauche conformation while 
that in all the other solvates indicates a trans conformation.  This indicates the existence 
of yet another conformation of the rifampicin molecule.  In addition, τ4 in the molecule B 
in solvate P11 indicates a trans conformation, showing clearly that the two 
crystallographically independent rifampicin molecules in P11 adopt different 
conformations.      
 
Figure 37 shows the rifampicin host molecules A viewed side-on to the ansa chain 
backbone in P8, P9, P10 and P11, respectively.  Similarly to the rifampicin molecules in 
series 1 and 2, the four oxygen atoms (O9, O10, O1 and O2) are approximately 
perpendicular to the average plane of the ansa chain and roughly parallel to the aromatic 
plane.  Furthermore, all four oxygen atoms protrude from the cavity of the ansa chain and 
the chromophore face, their C-O vectors pointing away from the piperazinyl subsitituent.  
In addition, the intramolecular distances among the four oxygen atoms O1, O2, O9 and 
O10 (listed in Table 56) fall in the range (~5.41 to 9.58 Å) which is favourable for active 
rifamycin derivatives.4  This also allows these host molecules to adopt an open 
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conformation, which again leads to the conclusion that the host molecules adopt 
antibiotically active conformations in the solid state.10 
 
Figure 37 Diagrams of the rifampicin host molecule A viewed side-on with respect to the ansa 
chain in solvates (a) P8, (b) P9, (c) P10 and (d) P11.  
 
Table 56 Interatomic distances involving O1, O2, O9 and O10 atoms in the host molecules in the 
four solvatesa   
P8 P9 P10 P11 Distance (Å) 
A B A B A B A B 
O1···O9 6.592 6.618 7.163 7.351 6.627 6.813 7.320 7.610 
O1···O10 5.357 5.432 6.291 6.793 5.459 5.563 5.661 6.412 
O2···O9 7.287 7.312 7.912 8.121 7.398 7.544 7.965 8.216 
O2···O10 6.871 6.940 7.795 8.290 7.015 7.073 7.045 7.759 
a Average e.s.d. 0.008 Å. 
 
In conclusion, indications of different conformations for the rifampicin molecule are 
observed.  However, all the rifampicin host molecules in the solvates P8 – P11 were 
(a) P8 (b) P9 
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confirmed to adopt conformations whose parameters fall within the range identified with 
antibiotic activity.4, 5, 6, 7, 10  
 
As discussed in the previous parts of this chapter, rifampicin is known to exist as a 
zwitterion in the solid state.12  For all the host molecules in solvates P8 - P11, the bond 
length C8-O2 is significantly shorter than those of the other C-O bonds which are in a 
similar chemical space environment except in the case of molecule A in P10 (listed in 
Table 57).  Based on the lists of standard bond distances in International Tables for 
Crystallography,11 the typical distance for the C-O bond in the above chemical 
environment is 1.333 Å.  Therefore, although bonds C14-O12, C1-O1 and C8-O2 are all 
represented as single bonds in Figure 34, the former two bonds can be confirmed as being 
single whilst C8-O2 has significant double bond character.  However, in the molecule A 
in P10, the bond C8-O2 cannot be confirmed as having a double bond character as its 
length is not significantly different from that of C1-O1. 
 
Table 57 Bond lengths of C4-O12, C1-O1 and C8-O2 in the host molecule of each solvate. 
P8 P9 P10 P11 Bond length 
(Å) A B A B A B A B 
C4-O12 1.366(7) 1.370(6) 1.354(4) 1.354(4) 1.35(2) 1.36(2) 1.368(4) 1.352(5) 
C1-O1 1.363(6) 1.357(5) 1.356(4) 1.358(4) 1.34(2) 1.36(1) 1.363(4) 1.359(5) 
C8-O2 1.289(6) 1.285(6) 1.286(4) 1.274(4) 1.32(2) 1.25(2) 1.268(5) 1.254(5) 
 
Furthermore, during the structural refinements of all four solvates, geometrically sensible 
electron density peaks, that qualified as potential H atoms, were found at ~ 1 Å from the 
hydroxyl oxygen atoms (O1, O9, O10 and O12) but not near the atom O2.  At the same 
time, a peak was found around the N4 atom having an electron density value similar to 
the other peaks which had been assigned as hydrogen atoms.  Also, between N4 and 
oxygen atoms of other molecules, this specific peak was ideally located, accounting for 
the formation of a N+-H···O hydrogen bond with very favourable geometry.  
Consequently, it can be assumed that the proton transferred from the hydroxyl group on 
C8 to the nitrogen atom N4, forming a zwitterion. This phenomenon occurs in both host 
molecules A and B in solvates P8, P9 and P11 as well as in the host molecule B in P10; 
however, for the host molecule A in P10, the situation is not definitive (i.e. zwitterionic 
character could not be confirmed).  
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Intra- and Intermolecular Interactions 
 
Solvate P8 – 2rifampicin • 4.30iso-propanol • 14.7H2O 
 
Host Intramolecular Interactions  
Three analogous intramolecular O-H···O hydrogen bonds and one N-H···N hydrogen 
bond are found in the host molecules A and B of P8 as presented in Figure 38.   
 
Figure 38 The zwitterionic structures and the stereoviews of intramolecular O-H···O and N-H···N 
interactions for host molecules A and B in P8.  The relevant hydrogen atoms are shown as 
spheres.  The other hydrogen atoms and the guest molecules are omitted for clarity.   
 
The geometrical details of these O-H···O and N-H···N hydrogen bond interactions are 
listed in Table 58.  For P8, the O···O distances range from 2.49 to 2.70 Å with a mean 
value of 2.59 Å while the O-H···O angles range from 142 to 176o with a mean value of 









(a) Molecule A 
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Table 58 Intramolecular O-H···O and N-H···N interactions in the host molecules A and B of 
solvate P8a 
Hydrogen bond O···O or N···N Distance (Å) Angle (o) 
O1A-H1A···O2A 2.489(5) 149 
O9A-H9A···O10A 2.704(4) 142 
O12A-H12A···O4A 2.575(6) 176 
O1B-H1B···O2B 2.495(5) 147 
O9B-H9B···O10B 2.689(5) 145 
O12B-H12B···O4B 2.573(5) 174 
N1A-H1NA···N2A 2.704(6) 113 
N1B-H1NB···N2B 2.696(5) 113 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Several intramolecular C-H···O and C-H···N interactions (Table 59) are found to be 
associated with the host rifampicin conformations in P8.  The hydrogen bonds C14-
H···O2, C18-H···N1, C25-H···O8, C25-H···O9, C27-H···O7 and C28-H···O3 are found to 
exist in the both host molecules A and B.  The C···O distances range from 2.66 to 3.11 Å 
with a mean value of 2.87 Å.  The C-H···O angles range from 100 to 116o with a mean 
value of 107o.   
 
Table 59 Intramolecular C-H···O and C-H···N interactions in the host molecules A and B of P8a 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) 
C14A-H14B···O2A 2.816(7) 100 
C14B-H14D···O2B 2.836(6) 107 
C18A-H18A···N1A 2.893(6) 107 
C18B-H18B···O10B 3.110(5) 116 
C18B-H18B···N1B 2.905(6) 107 
C25A-H25A···O8A 2.747(6) 106 
C25A-H25A···O9A 2.871(5) 109 
C25B-H25B···O8B 2.761(6) 106 
C25B-H25B···O9B 2.869(6) 109 
C27A-H27A···O7A 2.780(6) 102 
C27B-H27B···O7B 2.769(6) 101 
C28A-H28A···O3A 3.085(6) 114 
C28B-H28B···O3B 3.088(6) 114 
C38B-H38B···O12B 2.658(7) 101 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The intramolecular hydrogen bonds O-H···O, N-H···N, C-H···O and C-H···N stabilise the 
conformations of the host molecules A and B in P8. 
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Host-host Interactions  
No host-host intermolecular O-H···O interaction are observed in solvate P8.  However, 
three host-host intermolecular C-H···O interactions occur.  The geometrical details of 
these C-H···O interactions are listed in Table 60.  The C···O distances range from 3.33 to 
3.43 Å with a mean value of 3.38 Å.  The C-H···O angles range from 147 to 168o with a 
mean value of 161o.   
   
Table 60 Intermolecular C-H···O interactions between the rifampicin molecules A and B in P8a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C29A-H29A···O2A 3.396(6) 167  1-x, -1/2+y, -z 
C29B-H29B···O2B 3.331(6) 168 3-x, -1/2+y, 1-z 
C40A-H40B···O1A 3.427(6) 147 2-x, -1/2+y, -z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms. 
 
Host-guest Interactions  
The host-guest intermolecular O-H···O and N-H···O interactions in P8 are shown in 
Figure 39.   
 
Figure 39 Stereoviews of the intermolecular O-H···O and N-H···O hydrogen bonds between the 
host and guest molecules in P8.  The relevant oxygen atoms in the guest molecules are shown as 
spheres.  The other hydrogen atoms and guest molecules are omitted for clarity.  Atoms with gray 
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The same atoms (O2, O4, O6, O8, O10, O11 and N4) are involved in the host-guest 
intermolecular interactions in the molecules A and B.  Specifically, atoms O2, O4, O6 
and O8 serve as H-bond donors to the water molecules.  O11 atoms function as H-bond 
donors to the iso-propanol molecules in both molecules A and B.  O10 and (N4)+ atoms 
serve as H-bond acceptors for water molecules.    
  
Water molecule O6W serves as hydrogen bond donor to O8B and O9B simultaneously 
(Figure 39).  This also applies to water molecule O8W which functions as H-bond donor 
linking O2A and O4A of different A molecules (Figure 40).  Water molecules O8W 
function as bridges to associate one host molecule A with a symmetry-generated host 
molecule A while O9W connects two host molecules B, as shown in Figure 40.  The 
identical hydrogen bond chains (O12-H12···O4···O8W/O9W···O2···H1-O1) can be found 
between two molecules A and between two molecules B. 
 
Figure 40 Water molecules O8W associating two host molecules A while O9W associates two 
host molecules B.  The relevant oxygen atoms are shown as spheres.  Atoms with gray labels 
have been symmetry-generated from their asymmetric unit counterparts.    
 
Table 61 lists the distances and angles for host-guest intermolecular O-H···O and N-H···O 
interactions.  The O···O distances range from 2.72 to 3.06 Å with a mean value of 2.84 Å.  
The O-H···O angles range from 137 to 174o with a mean value of 163o.   
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Table 61 Host-guest intermolecular O-H···O and N-H···O interactions for P8.a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) Symmetry operatorb 
O1G-H1G···O11A 2.843(6) 172 x, y, z 
N4A-H4NA···O15W 2.814(9) 137 x, y, z 
O4G-H4G···O11B 2.846(6) 174 x, y, z 
N4B-H4NB···O18W 2.762(9) 167 x, y, z 
O10A-H10A···O1W 2.756(5) 163 x, y, z 
O10B-H10B···O5W 2.719(5) 164 x, y, z 
O4A···O8W 2.804(6) ------- x, y, z 
O2A···O8W 2.858(6) ------- 1-x, 1/2+y, -z 
O6A···O3W 2.888(5) ------- x, y, z 
O9A···O2W 2.752(5) ------- x, y, z 
O8B···O6W 3.059(7) ------- x, y, z 
O6B···O7W 2.837(5) ------- x, y, z 
O4B···O9W 2.789(6) ------- x, y, z 
O2B···O9W 2.893(6) ------- 3-x, 1/2+y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Two host-guest intermolecular C-H···O interactions are found in the structure of P8 
(Table 62).  The mean value of the O···O distances is 3.418 Å with a mean angle of 150o.   
 
Table 62 Intermolecular C-H···O interactions between the rifampicin and guest moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C40A-H40A···O8W 3.457(8) 146 1+x, y, z 
C43A-H43B···O8W 3.379(8) 154  1+x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Guest-guest Interactions  
For P8, the water molecules display a variety of disordered arrangements.  All the guest 
molecules assemble into a guest cluster which extends infinitely (Figure 41).   
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Figure 41 The guest-guest intermolecular O-H···O interactions among the water and iso-propanol 
molecules in P8. (a) Numbering scheme of these interactions; (b) Stereoview of these 
interactions.  Atoms with gray labels have been symmetry-generated from their asymmetric unit 
counterparts.  
 
The geometrical details of the guest-guest intermolecular O-H···O interactions in P8 are 
listed in Table 63.  Due to low site-occupancy of the water molecules, the hydrogen 
atoms of these water molecules cannot be located.  The O···O distances range from 2.52 
to 3.02 Å with a mean value of 2.75 Å.  The O-H···O angles range from 152.8 to 174.0o 
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Table 63 Guest-guest intermolecular H-bonds interactions in solvates P8a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O2W···O5W 2.660(7) --------- x, y, z 
O6W···O1W 2.691(7) --------- x, y, z 
O1W···O4W 2.775(7) --------- x, y, z 
O4W···O5W 2.766(7) --------- x, y, z 
O2W···O3W 2.870(6) --------- x, y, z 
O3W···O7W 2.785(6) --------- x-1, y, z 
O6W···O7W 2.855(6) --------- x, y, z 
O4W···O18W 2.597(11) --------- 2-x, 1/2+y, 1-z 
O7GB-H7GB···O1W 2.81(2) 162.0 x, y, z 
O6GA-H6GA···O1W 2.719(17) 167.0 x, y, z 
O18W···O21W 3.00(3) --------- x, y, 1+z 
O18W···O14W 2.906 --------- 2-x, y-1/2, 1-z 
O18W···O19W 3.021 --------- 2-x, y-1/2, 1-z 
O19W···O14W 2.64(2) --------- x, y, z 
O14W···O20W 2.899 --------- x, y, z 
O19W···O15W 2.707 --------- 2-x, 1/2+y, -z 
O15W···O12W 2.645 --------- 1+x, y, z 
O12W···O8W 2.741(9) --------- x, y, z 
O12W···O11W 2.850 --------- x-1, y, z-1 
O5GA···O17W 2.748 --------- x, y, z 
O11W···O16W 2.931 --------- 3-x, y-1/2,1-z 
O16W···O10W 2.621 --------- 3-x, 1/2+y, 1-z 
O16W···O7GB 2.662 --------- x, y, z 
O16W···O6GA 2.706 --------- x, y, z 
O16W···O13W 2.703 --------- 2-x, 1/2+y, -z 
O13W···O2G 2.71(2) --------- x, y, z 
O2G-H2G···O1G 2.634(14) 173.0 x, y, z 
O5GA-H5GA···O11W 2.793(13) 174.0 x, y, z 
O4W···O14W 2.158 --------- x, y, z 
O3G-H3G···O19W 2.747 152.8 x, y, z 
O19W···O17W 2.673(16) --------- 2-x, 1/2+y, 1-z 
O17W···O14G 2.730 --------- x, y, z 
O7W···O10W 2.846(8) --------- 3-x, 1/2+y, 1-z 
O10W···O9W 2.750(7) --------- x, y, z 
a Average e.s.d.s 0.004 Å for distance and 0.7o for angle 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Overall Intramolecular and Intermolecular Interactions in P8  
Figure 42 shows the overall hydrogen bond interactions in solvate P8.  Six rifampicin 
molecules form two layers which consist of the molecules A (the top layer) and the 
molecules B (the bottom layer), respectively.   The guest cluster is located in-between the 
two layers.   
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Figure 42 Stereoviews of the overall hydrogen bond interactions in P8.  The oxygen atoms in the 
guest molecules are shown as spheres.  The code letter for the symmetry operator of each 
rifampicin molecule is labelled. (a = x, y, z; b = 2-x, 1/2+y, -z; c = 1-x, 1/2+y, -z; d = 2-x, 1/2+y, 




The packing arrangement for P8 is shown in Figure 43.  Host molecules A and B are 
related by a pseudo 2-fold rotation axis parallel to the b-axis, leading to the formation of 
alternating layers (A, B) along the c-axis, interleaved by layers of guest molecules.  In 
each layer parallel to the b-axis, the host molecules pack in a head-to-tail mode, 
associating through mediation of water molecules.   
 
 
Figure 43 Crystal packing diagrams for P8 viewed along (a) [100] and (b) [010].  Solvent 
molecules are shown as green spheres for clarity.  Host molecules A and B are shown in gray and 
red, respectively. 
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The program SECTION14 was employed to examine the solvent channels for P8.  The 
section views are taken at regular intervals through the unit cell along the a-axis.  Figure 
44 shows two representative views, illustrating the ‘endless’ channels in which the guest 
molecules are accommodated.      
Figure 44 Sections of P8 with guest molecules omitted and host molecules represented by gray 
areas, viewed along [100] with the unit cell sectioned at (a) 0 Å (b) 7 Å from the origin 0,0,0.  A 















(a) 0 Å (b) 7 Å 
Chapter 4: Rifampicin Solvates (Part three---P9) 
 238
Solvate P9 – 2rifampicin • 5.53(1-butanol) • 1.40H2O 
 
Host Intramolecular Interactions  
In the structure of P9, three analogous intramolecular O-H···O H-bonds and one N-H···N 
H-bond are found in the host molecules A and B as presented in Figure 45.   
 
Figure 45 Stereoview of the zwitterionic structures and the intramolecular O-H···O and N-H···N 
interactions for host molecules A and B in P9.  The relevant hydrogen atoms are shown as 
spheres.  The other hydrogen atoms and the guest molecules are omitted for clarity.   
 
The geometrical details of these O-H···O and N-H···N interactions are listed in Table 64.  
For P9, the O···O distances range from 2.429 to 2.706 Å with a mean value of 2.57 Å.  
The O-H···O angles range from 146 to 178o with a mean value of 158o.   
 
Table 64 Intramolecular O-H···O and N-H···N interactions in the host molecules A and B of P9a 
Hydrogen bond O···O or N···N Distance (Å) Angle (o) 
N1B-H1NB···N2B 2.681(4) 111 
O1A-H1A···O2A 2.429(3) 151 
O1B-H1B···O2B 2.453(3) 150 
N1A-H1NA···N2A 2.683(4) 108 
O10A-H10A···O9A 2.706(4) 148 
O10B-H10B···O9B 2.646(4) 146 
O12A-H12A···O4A 2.575(3) 176 
O12B-H12B···O4B 2.587(3) 178 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
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Several intramolecular C-H···O interactions (Table 65) were found to be associated with 
the rifampicin conformations in both molecules A and B of P9.  The hydrogen bonds 
C25-H···O8, C25-H···O9, C27-H···O7, C28-H···O3 and C38-H38···O12 are found to exist 
in both molecules A and B.  The C···O distances range from 2.67 to 3.35 Å with a mean 
value of 2.93 Å.  The C-H···O angles range from 102 to 135o with a mean value of 110o.   
 
Table 65 Intramolecular C-H···O interactions in the host molecules A and B of P9a 
Hydrogen bond C···O Distance (Å) Angle (o) 
C14B-H14F···O3B 2.923(4) 104 
C18A-H18A···O10A 3.023(5) 113 
C18A-H18A···O11A 3.141(5) 119 
C23B-H23B···O8B 3.346(4) 135 
C25A-H25A···O8A 2.743(5) 103 
C25A-H25A···O9A          2.870(5) 107 
C25B-H25B···O8B           2.788(5) 103 
C25B-H25B···O9B           2.983(4) 104 
C27A-H27A···O7A          2.833(4) 106 
C27B-H27B···O7B           2.835(4) 105 
C28A-H28A···O3A          3.097(4) 116 
C28B-H28B···O3B           3.105(5) 114 
C38A-H38A···O12A 2.668(4) 102 
C38B-H38B···O12B 2.672(4) 102 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
The intramolecular hydrogen bonds O-H···O, N-H···N and C-H···O stabilise the 
conformations of the host molecules in P9. 
 
Host-host Interactions  
Two host molecules A and two host molecules B are associated by the intermolecular O-
H···O and N-H···O interactions which include three bifurcated hydrogen bonds (Figure 
46).  Specifically, the hydrogen H4NA in host molecule A forms two hydrogen bonds 
with two distinct acceptors simultaneously, namely O1B and O11B.  Similarly, the 
hydrogen H4NB in the host molecule B forms a bifurcated hydrogen bond with O1A and 
O11A, associating host B with a symmetry-generated host A.  Between the host 
molecules A and B of the original asymmetric unit, H10A forms an intramolecular 
hydrogen bond with O9A and an intermolecular hydrogen bond with O8B 
simultaneously.  
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Figure 46 Stereoview of host-host intermolecular O-H···O and N-H···O interactions in P9.  The 
relevant hydrogen atoms are shown as spheres while the other H atoms and the guest molecules 
are omitted for clarity.   
 
The geometrical details of the O-H···O and N-H···O hydrogen bond interactions are listed 
in Table 66.  For P9, the O···O distances range from 2.66 to 3.08 Å with a mean value of 
2.85 Å.  The O-H···O angles range from 124 to 154o with a mean value of 143o.  For 
N···O distances, the range is 2.67 to 2.91 (mean 2.8 Å).  
 
Table 66 Intermolecular O-H···O and N-H···O interactions between the rifampicin molecules A 
and B in P9a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) Symmetry operatorb 
N4B-H4NB···O1A 2.912(4) 142  1-x, 1/2+y, 1-z 
N4B-H4NB···O11A 2.663(4) 131  1-x, 1/2+y, 1-z 
N4A-H4NA···O1B 2.902(4) 145 1-x, -1/2+y, -z 
N4A-H4NA···O11B 2.723(4) 129 1-x, -1/2+y, -z 
O9A-H9A···O6B 2.816(4) 152 x, y, z 
O9B-H9B···O10A 2.656(4) 154 x, y, z 
O10A-H10A···O8B 3.079(4) 124  x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms. 
 
Furthermore, two analogous close contacts (C41A···O11B and C41B···O11A) are found 
between host molecules A and B when they assemble (Figure 47).  The distances 
C41A···O11B and C41B···O11A are 2.905(5) and 2.878(5) Å, respectively.  Considering 
the interactions described in Figures 46 and 47, the N-H···O, O-H···O and C-H···O 
H4NA 




H9A H10A H9B 
H10B 
H4NB 
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interactions stabilise the four host molecules (two A and two B molecules) when they 
assemble.  
 
Figure 47 The close contacts C41A···O11B and C41B···O11A between host molecules A and B 
 
Several host-host intermolecular C-H···O interactions are found in P9.  The geometrical 
details are listed in Table 67.  The C···O distances range from 2.91 to 3.54 Å with a mean 
value of 3.23 Å.  The C-H···O angles range from 102 to 172o with a mean value of 140 o.   
 
Table 67 Intermolecular C-H···O interactions between the rifampicin molecules in P9a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C14A-H14A···O7B 3.544(4) 172 2-x, -1/2+y, 1-z 
C29A-H29A···O2B 3.341(4) 153 2-x, -1/2+y, -z 
C29B-H29B···O2A 3.222(4) 154  2-x, 1/2+y, 1-z 
C31B-H31D···O1A 3.187(5) 140  1-x, 1/2+y, 1-z 
C40A-H40B···O2B 3.407(4) 149  1-x, -1/2+y, -z 
C41A-H41A···O11B 2.905(5) 105 1-x, -1/2+y, -z 
C41B-H41C···O11A 2.878(5) 102  1-x, 1/2+y, 1-z 
C37B-H37E···O8A 3.319(7) 145 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms. 
 
Host-guest Interactions  
The host-guest O-H···O interactions in solvate P9 are shown in Figure 48.  The host 
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Figure 48 Stereoview of the O-H···O hydrogen bonds between the host and guest molecules in 
P9.  The relevant oxygen atoms are shown as spheres.  The other hydrogen atoms and guest 
molecules are omitted for clarity.   
 
The geometrical details of these O-H···O hydrogen bond interactions are listed in Table 
68.  For P9, the O···O distances range from 2.77 to 2.84 Å with a mean value of 2.80 Å.  
The O-H···O angles range from 139.4 to 173o with a mean value of 159o.   
   
Table 68 O-H···O interactions between the host and guest molecules in P9a 
Hydrogen bond O···O Distance (Å) Angle (o) 
O1G-H1G···O8A 2.835(9) 165(3) 
O2G-H2G···O4B 2.768(4) 173(2) 
O1W-H1W1···O8B 2.802(5) 139(2) 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Two host-guest C-H···O interactions are found in P9.  The geometrical details are listed in 
Table 69.  The mean C-H···O distance is 3.46 Å with a mean angle of 155o.   
 
Table 69 Intermolecular C-H···O interactions between the rifampicin molecules in P9a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C40A-H40A···O5GB 3.461(8) 154 -1+x,y,z 
C41A-H41A···O1W 3.453(5) 155  1-x,-1/2+y,-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
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Guest-guest Interactions  
For P9, two isolated clusters are formed by the guest molecules (Figure 49).   One guest 
cluster consists of the 1-butanol molecules, indicated by their oxygen atoms O1G, O6G 
and O5GB.  Water molecules O1W and O2W, whose hydrogen atoms cannot be located 
due to their low site-occupancy, are also involved in this guest cluster.   The other guest 
cluster is composed of 1-propanol molecules, indicated by their oxygen atoms O4G, O3G 
and O2G.  In more detail, a 1-butanol molecule is disordered over two positions O5GB-
C17D-C18D-C19D-C20D and O5GA-C17C-C18C-C19C-C20C.  The former is 
hydrogen bonded to O2W while the latter functions as H-bond donor to O4G.  
Furthermore, O2W and the molecule O4G-C13G-C14G-C15G-C16G are two disordered 
components.  
 
Figure 49 The guest-guest intermolecular O-H···O interactions among the water and 1-butanol 
molecules in P9.  The disordered atoms are labelled with their site-occupancies. 
 
In addition, 1-butanol molecules display a variety of disordered arrangements.  As shown 
in Figure 49, both the second and fourth carbon atoms are disordered over two positions 
in molecule O1G-C1G-C2GA/C2GB-C3G-C4GA/C4GA while only the second carbon 
atom is disordered over two positions in the molecule O6G-C21G-C22C/C22D-C23G-
C24G.  Also, the entire 1-butanol molecule can be disordered over two positions as 
illustrated by the molecules O5GA-C17C-C18C-C19C-C20C and O5GB-C17D-C18D-
C19D-C20D.   
 
Details of guest-guest intermolecular O-H···O hydrogen bond interactions are listed in 
Table 70.  The O···O distances range from 2.42 to 2.73 Å with a mean value of 2.66 Å.  
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Table 70 The details of guest-guest intermolecular hydrogen bond interactions in solvate P9a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O1W-H1W2···O1G 2.575(10) 146(5) x-1, y, z 
O6G-H6G···O1W 2.725(7) 173.0 1+x, y, z 
O2W···O6G 2.639(9) ------- 3-x, 1/2+y, -z 
O5GB-H5GB···O2W 2.760(10) 173.0 x, y, z 
O5GA-H5GA···O4G 2.751 175.0 x, y, z 
O4G-H4G···O3G 2.424 167.3 x, y, z 
O3G-H3G···O2G 2.731(5) 173.0 x, y, z 
a Where no e.s.d. is reported, the average values are 0.01 Å for distances and 0.4o for angles.  
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
One guest-guest C···O interaction (C15G-H15G···O4G) occurs in the structure of P9.  The 
hydrogen bond angle and distance C···O are 104o and 2.90(1) Å, respectively. 
 
Overall Intramolecular and Intermolecular Interactions in P9  
Figure 50 shows the overall hydrogen bond interactions in solvate P9.  Three host 
molecules A and three host molecules B are associated by the overall intermolecular 
interactions.  The two disordered guest clusters are both intimately associated with the 
rifampicin molecules.  A noteworthy observation is that there are only two oxygen atoms 
(O6G and O5GB) located within hydrogen bonding distance of the water molecule O2W.  
In addition, O5GB is determined as functioning as hydrogen bond donor to the atom 
O2W.  This implies that O2W serves as hydrogen bond donor to only one oxygen atom in 
the structure, in the bond O2W-H···O6G (Table 70). 
 
Figure 50 Stereoview of the overall hydrogen bond interactions in P9.  The oxygen atoms in the guest 
molecules are shown as spheres.  The code letter for the symmetry operator of each rifampicin molecule is 
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Crystal Packing 
The packing diagram for P9 is shown in Figure 51.  Host molecules A and B are related 
by a pseudo 2-fold screw axis parallel to the a-axis and are associated by host-host 
interactions parallel to the b-axis, forming layers parallel to c.  Each layer consists not 
only of host molecules A but also of B molecules which are linked by other host-host 
intermolecular and C···O close contact interactions parallel to the c-axis.  Solvent 
molecules are intimately associated with the rifampicin molecules, and are located in 
channels parallel to the a-axis.  The layers of host molecules parallel to the c-axis are 
connected both directly by hydrogen bonding and indirectly by hydrogen bonding via 
mediation of solvent molecules. 
 
Figure 51 Crystal packing diagram for P9 viewed along [100]; solvent molecules are shown as 
green spheres for clarity.  Host molecules A and B are shown in gray and red, respectively.    
 
The solvent channels for P9 were examined using the program SECTION,14 as shown in 
Figure 52.  A series of views were taken at regular intervals through the unit cell along 
the a-axis, illustrating the ‘endless’ channels in which the guest molecules are located.   
0 b 
cp 
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Figure 52 Sections of P9 with guest molecules omitted and host molecules represented by gray 
areas, viewed along [100] with the unit cell sectioned at (a) 0 Å (b) 7 Å from the origin 0,0,0.  A 






















(a) 0 Å (b) 7 Å 
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Solvate P10 – 2rifampicin • 5.75ethylene glycol • 5.59H2O 
 
Host Intramolecular Interactions  
Figure 53 shows the intramolecular interactions for the host molecules A and B and the 
zwitterionic structure of the molecule B in P10.  The appearance of hydrogen atoms H2A 
in the molecule A and H4NB in the molecule B is attributed to the probable absence of a 
zwitterion in the fomer and its presence in the latter.  Although the geometrical location 
of H2A is not chemically reasonable, it is positioned based on the location of a peak 
which appeared at ~1 Å from atom O2A in difference Fourier maps.  However, it is more 
likely that H1A and H2A are disordered and the model (Figure 53) shows a pair with 
partial site-occupancies (e.g. 0.5 each).  
 
Furthermore, three analogous hydrogen bond interactions occur in host molecules A and 
B.  In addition, the atom O9A serves as H-bond donor and O10A functions as acceptor in 
the molecule A while the atom O10B serves as H-bond donor and O9B functions as 
acceptor in the molecule B.  
 
Figure 53 Stereoview of the zwitterionic structure (molecule B) and the intramolecular O-H···O 
and N-H···N interactions for P10.  The relevant hydrogen atoms are shown as spheres.  The other 
hydrogen atoms and the guest molecules are omitted for clarity.   
 
Details of guest-guest intermolecular O-H···O and N-H···O hydrogen bonds are listed in 
Table 71.  The O···O distances range from 2.47 to 2.70 Å with a mean value of 2.60 Å.  
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Table 71 Intramolecular O-H···O and N-H···O hydrogen bond interactions in the host molecules 
in P10a 
Hydrogen bond O···O or N···N Distance (Å) Angle (o) 
N1B-H1NB···N2B 2.656(15) 118 
O1B-H1B···O2B 2.466(13) 148 
N1A-H1NA···N2A 2.653(15) 119 
O9A-H9A···O10A 2.686(14) 142 
O10B-H10B···O9B 2.699(14) 152 
O12A-H12A···O4A 2.584(15) 172 
O12B-H12B···O4B 2.588(15) 169 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Several intramolecular C-H···O and C-H···N interactions (Table 72) are found to be 
associated with the rifampicin conformations in P10.  The hydrogen bonds C18-
H18···N1, C25-H···O8, C25-H···O9, C27-H···O7, C28-H···O3 and C38-H18···O12 are 
found to exist in both molecules A and B.  The C···O distances range from 2.62 to 3.08 Å 
with a mean value of 2.86 Å.  The C-H···O angles range from 100 to 115o with a mean 
value of 107o.   
 
Table 72 Intramolecular C-H···O and C-H···N interactions in the host molecules of P10a 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) 
C14A-H14A···O3A 2.943(16) 108 
C14B-H14F···O2B 2.849(19) 106 
C18A-H18A···N1A 2.917(19) 109 
C18B-H18B···O10B 3.082(18) 113 
C18B-H18B···N1B 2.903(19) 105 
C25A-H25A···O8A          2.758(18) 106 
C25A-H25A···O9A          2.938(17) 108 
C25B-H25B···O8B           2.70(2) 107 
C25B-H25B···O9B           2.846(17) 107 
C27A-H27A···O7A          2.789(15) 103 
C28A-H28A···O3A          3.042(17) 116 
C28B-H28B···O3B           3.039(19) 115 
C30A-H30A···O11A 2.768(19) 107 
C38A-H38A···O12A 2.659(18) 101 
C38B-H38B···O12B 2.615(16) 100 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
 
Host-host Interactions  
A host-host hydrogen bond O9B-H9B···O8A is found to associate the host molecule B 
with a symmetry generated host molecule A, as shown in Figure 54.  The distance 
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between the hydrogen bond donor and acceptor (O9B···O8A) is 2.784(15) Å while the 
angle of this hydrogen bond is 167o.   
 
Figure 54 Stereoview of the host-host intermolecular O-H···O interactions in P10.  The relevant 
oxygen atoms are shown as spheres while the remaining H atoms and the guest molecules are 
omitted for clarity.  
 
Several intermolecular C-H···O and C-H···N interactions (Table 73) are found to be 
associated with the rifampicin conformations in P10.  The C···O distances range from 
3.12 to 3.47 Å with a mean value of 3.32 Å.  The C-H···O angles range from 120 to 158o 
with a mean value of 146o.   
 
Table 73 Intermolecular C-H···O interactions in the host molecules of P10a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C14B-H14D···O7B 3.12(3) 120 x, y, z 
C29A-H29A···O2A 3.29(2) 158 -x, -1/2+y, 2-z 
C29B-H29B···O2B 3.41(2) 156 -x, 1/2+y, 1-z 
C37A-H37A···O8B 3.23(2) 137  x, y, 1+z 
C40A-H40B···O1A 3.47(2) 148 1-x, -1/2+y, 2-z 
C43A-H43C···O1A 3.40(2) 154 1-x, -1/2+y, 2-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Host-guest Interactions  
The host-guest O-H···O and N-H···O interactions in P10 are shown in Figure 55.  Atoms 
O4, O6, O10, O11 and N4 are involved in the interactions in both molecules A and B.  In 
more detail, the atom O10A serves as H-bond donor in the molecule A while O10B 
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and O11B function as hydrogen bond acceptor; however, O11A is associated with one 
ethylene glycol molecule while O11B connects with one ethylene glycol molecule and 
one water molecule simultaneously.  Due to the zwitterionic structure of the molecule B, 
(N4B)+ functions as hydrogen bond donor to a water molecule and an ethylene glycol 
molecule while N4A serves as H-bond acceptor for an ethylene glycol molecule. 
 
Figure 55 The stereoview of the intermolecular O-H···O and N-H···O hydrogen bonds between 
the host and guest molecules in P10.  The relevant oxygen atoms are shown as spheres.  The other 
hydrogen atoms and guest molecules are omitted for clarity.  Atoms with gray labels have been 
symmetry-generated from their asymmetric unit counterparts.    
 
Molecules O1G-C1G-C2G-O2G, O1W and O5G-C5G-C6G-O6G all serve as bridges 
linking host molecules.  In Figure 56, molecule A is thus linked to two molecules B 
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Figure 56 Guest molecules O1G-C1G-C2G-O2G, O1W and O5G-C5G-C6G-O6G serving as 
bridges to associate host molecules A and B.  The relevant oxygen atoms are shown as spheres.  
The other hydrogen atoms and guest molecules are omitted for clarity.  Atoms with gray labels 
have been symmetry-generated from their asymmetric unit counterparts.      
 
Details of host-guest intermolecular O-H···O and N-H···O hydrogen bond interactions are 
listed in Table 74.  The O···O distances range from 2.64 to 3.14 Å with a mean value of 
2.84 Å.  The O-H···O angles range from 137 to 160o with a mean value of 152o.   
 
Table 74 Intermolecular (N4)+-H4NB···O and O-H···O interactions in P10a 
Hydrogen bond N+···O or O···O Distance (Å) Angle (o) Symmetry operatorb 
O4G-H4G···N4A 2.83(3) 142 x, y, z 
O3G-H3G···N4A 3.08(2) 118 x, y, z 
O2W···O6A 2.86(2) -------- x, y, z 
O1W···O9A 2.77(2) -------- x, y, z 
O10A-H10A···O1G 2.71(2) 160 x, y, z 
O13G-H13G···O4A 2.67(2) 147 x, y, z 
O6G-H6G···O11A 2.64(2) 159 -x, 1/2+y, 1-z 
O2G-H2G···O11B 2.78(2) 162 1-x, y-1/2, 2-z 
O1W···O11B 2.96(2) -------- 1-x, y-1/2, 2-z 
(N4B)+-H4B···O5W 2.83(2) 135 x, y, z 
(N4B)+-H4B···O7G 2.94(2) 126 x, y, z 
O4W···O4B 2.69(2) -------- x, y, z 
O8W···O6B 3.14(4) -------- x, y, z 
O5G-H5G···O8B 2.87(2) 149 x, y, z 
O11W···O10B 3.06(7) -------- x, y, z 
O15G-H15G···O10B 2.73(2) 137 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised positions in 
a riding model. 
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Several host-guest C-H···O interactions are found in the structure of P10.  Geometrical 
details are listed in Table 75.  The C···O distances range from 3.02 to 3.34 Å with a mean 
value of 3.19 Å.  The C-H···O angles range from 111 to 146o with a mean value of 128o.   
 
Table 75 Intermolecular C-H···O interactions between the host and guest molecules in P10a 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C5G-H5G1···O8B 3.12(3) 120 x, y, z 
C30A-H30A···O16G 3.18(3) 120 1-x, 1/2+y, 1-z 
C36A-H36B···O5G 3.34(2) 146 x, y, 1+z 
C36A-H36C···O16G 3.26(2) 141 x, y, 1+z 
C40B-H40D···O7G 3.02(2) 111 x, y, z 
C42B-H42D···O12G 3.20(2) 129 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator only applies to hydrogen bonding donors.  
 
Guest-guest Interactions  
The guest molecules assemble into one extended cluster, as shown in Figure 57.  A 
variety of disordered arrangements occurs in the cluster.  For instance, the atom O8G 
functions as hydrogen bond donor to two disordered molecules (O8W and O5G-C5G-
C6G-O6G) simultaneously.   
    
Figure 57 The extended guest cluster in P10.  Atoms with gray labels have been symmetry- 
generated from their asymmetric unit counterparts. The disordered atoms are labelled with their 
site-occupancies.  
 
Details of guest-guest intermolecular O-H···O and N-H···O hydrogen bond interactions 
are listed in Table 76.  The O···O distances range from 2.59 to 3.08 Å with a mean value 
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Table 76 The details of guest-guest intermolecular hydrogen bond interactions in P10a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O8G-H8G···O5G 2.818 177.8 1-x, 1/2+y, 1-z 
O8G-H8G···O8W 2.970 143.3 1-x, 1/2+y, 1-z 
O7G-H7G···O4W 2.72(2) 160.0 1+x, y , z 
O4W···O10W 2.79(7) --------- x-1, y, z 
O4W···O11G 2.73(2) --------- x, y, z 
O11G-H11G···O10G 2.62(3) 152.0 x, y, z 
O10G-H10G···O6G 2.668 176.7 -x, 1/2+y, 1-z 
O12G-H12G···O15G 2.60(3) 174.0 1-x, 1/2+y, 1-z 
O16G-H16G···O5W 3.023 152.8 1-x, y-1/2, 1-z 
O5W···O11W 3.07(6) --------- 1-x, 1/2+y, 1-z 
O5W···O8G 2.717 --------- x, y, z 
O5W···O9W 2.829 --------- x, y, z 
O9W···O9G 2.674 --------- x, y, z 
O9G-H9G···O12G 2.64(3) 165.0 x, y, z 
O9G···O7W 3.08(6) --------- x, y, z 
O9W···O3G 2.936 --------- x, y, z 
O3G-H3G···O13G 2.576 117.5 1+x, y, z 
O1W···O3W 2.70(7) --------- 1-x, 1/2+y, 2-z 
O1W···O2W 2.73(2) --------- x, y, z 
O2W···O14G 2.67(2) --------- -x, 1/2+y, 2-z 
O14G-H14G···O6W 2.693 170.6 x, y, z 
O1G-H1G···O6W 2.590 176.0 1-x, 1/2+y, 2-z 
a Where no e.s.d. is reported, the average values are 0.01 Å for distances and 0.6o for angles. 
 b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
 
Overall Intramolecular and Intermolecular Interactions in P10  
Figure 58 shows the overall hydrogen bond interactions for the solvate P10.  Seven 
rifampicin molecules are found to assemble around the solvent cluster which forms an 
extended solvent distribution.  The hydrogen H3G in the molecule O3G-C3G-C4G-O4G 
forms two hydrogen bonds with two distinct acceptors simultaneously, i.e. bifurcated 
host-guest and guest-guest hydrogen bonds with N4A and O13G, respectively.  
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Figure 58 Stereoviews of the overall hydrogen bond interactions in P10.  The oxygen atoms in 
the guest molecules are shown as spheres.  The code letter for the symmetry operator of each 
rifampicin molecule is labelled (a = x, y, z; b = 1-x, 1/2+y, 1-z; c = -x, 1/2+y, 1-z; d = 1+x, y, z;  
e = 1-x, y-1/2, 2-z ).   
 
Crystal Packing 
The packing diagram for P10 is shown in Figure 59.  Host molecules A and B are related 
by a pseudo 2-fold screw-axis parallel to the a-axis, forming separate layers normal to the 
c-axis which only consist of the molecules A or B.  In each layer along the b-axis, the 
molecules pack in a head-to-tail mode.  The molecules A and B pack in alternating tail-
to-tail and head-to-head modes parallel to the c-axis.  The solvent molecules are located 
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Figure 59 Crystal packing diagrams for P10 viewed along (a) [100] and (b) [010].  Solvent 
molecules are shown as green spheres for clarity.  Host molecules A and B are shown in gray and 
red, respectively. 
 
In a more detailed description, the host-host hydrogen bond interactions associate the tail 
of the molecule A with that of the molecule B along the c-axis while the guest-host 
hydrogen bond interactions connect the molecule A with two adjacent molecules B, as 
shown in Figure 60.  When the molecules A and B assemble in head-to-head mode along 
the c-axis, no interaction is observed to associate the two host molecules.  This introduces 
the voids where the solvent molecules can be accommodated.    
 
Figure 60 Host-host and guest-host hydrogen bond interactions associating host molecule layers 
along the b-axis.  The solvent, A and B molecules are shown in green, gray and red, respectively.  
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The program SECTION14 was used to examine the voids occupied by guest molecules.  
A series of representative views take at regular intervals along the a-axis is shown in 
Figure 61.  This clearly illustrates the ‘endless’ channels in which the guest molecules are 
accommodated.      
 
Figure 61 Sections through P10 with guest molecules omitted and host molecules represented by 
gray areas, viewed along [100] with the unit cell sectioned at (a) 0 Å, (b) 4 Å and (c) 8 Å from the 

















(a) 0 Å (b) 4 Å (c) 8 Å 
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Solvate P11 – 2rifampicin • 6(1, 4-dioxane) • 3H2O 
 
Host Intramolecular Interactions  
In the structure of P11, three analogous intramolecular O-H···O hydrogen bond 
interactions (O1-H1···O2, O9-H9···O10, O12-H12···O4) are found in the host molecules 
A and B, as presented in Figure 62.  An additional hydrogen bond N1B-H1NB···N2B is 
found in the molecule B.  This specific hydrogen bond can often be observed in the host 
molecules of other solvates; however, it does not occur in the host molecule A in P11.  
This corresponds to the fact that the molecule A adopts a much smaller dihedral angle 
between the planes of the chromophore (B) and the piperazinyl residue (C) [3.81(8)o] 
than that in the molecule B [16.96(7)o].  Furthermore, this introduces a unique host 
intramolecular interaction O10A-H10A···O11A which is not found in the host molecules 
in all the other solvates. 
 
Figure 62 The zwitterionic structures and the intramolecular O-H···O and N-H···N interactions 
for rifampicin host molecules A and B in P11.  The relevant hydrogen atoms are shown as 
spheres.  The other hydrogen atoms and the guest molecules are omitted for clarity.   
 
Details of host intramolecular O-H···O and N-H···N interactions are listed in Table 77.  
The O···O distances range from 2.48 to 2.83 Å with a mean value of 2.61 Å.  The O-H···O 
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Table 77 Intramolecular hydrogen bond interactions in the host molecules A and B in P11a 
Hydrogen bond O···O or N···N Distance (Å) Angle (o) 
O1A-H1A···O2A 2.481(4) 148.0  
O1B-H1B···O2B 2.469(5) 148.0 
O9A-H9A···O10A 2.688(4) 138.0 
O9B-H9B···O10B 2.648(4) 143.0 
O12A-H12A···O4A 2.593(4) 174.0 
O12B-H12B···O4B 2.584(4) 179.0 
N1B-H1NB···N2B 2.701(5) 109.0 
O10A-H10A···O11A 2.829(4) 175.0 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised positions in 
a riding model. 
 
Several intramolecular C-H···O interactions (Table 78) were found to be associated with 
the rifampicin conformations in P11.  The hydrogen bonds C14-H···O3, C25-H···O8, 
C25-H···O9, C27-H···O7 and C38-H···O12 are found to exist in both molecules A and B.  
The C···O distances range from 2.65 to 3.11 Å with a mean value of 2.83 Å.  The C-H···O 
angles range from 102 to 115o with a mean value of 107o.      
 
Table 78 Intramolecular C-H···O interactions in the host molecules of P11a 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) 
C14A-H14A···O3A 2.944(5) 106.0 
C14B-H14D···O3B 2.922(6) 105.0 
C18B-H18B···O10B 2.957(6) 112.0 
C25A-H25A···O8A 2.739(5) 105.0 
C25A-H25A···O9A 2.828(4) 110.0 
C25B-H25B···O8B           2.723(5)      106.0 
C25B-H25B···O9B           2.865(5)      110.0  
C27A-H27A···O7A          2.757(4)      100.0  
C27B-H27B···O7B           2.787(4)      103.0  
C28B-H28B···O3B           3.107(5)      115.0 
C38A-H38A···O12A          2.671(4)      103.0 
C38B-H38B···O12B          2.648(5)      102.0 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Host-host Interactions  
Host-host hydrogen bond interactions (N4A)+-H···O8A and (N4A)+-H···O9A and two 
close contacts O9A···C41A [2.978(5) Å] and O8A···C40A [3.130(5) Å] are observed 
between the host molecule A and a symmetry transformed molecule A, as shown in 
Figure 63.  Analogous interactions are associated with the B molecules.  
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Figure 63 Stereoview of host-host intermolecular N-H···O interactions in P11.  The relevant 
oxygen and nitrogen atoms are shown as spheres, while the other H atoms and the guest 
molecules are omitted for clarity.  Atoms with gray labels have been symmetry-generated from 
their asymmetric unit counterparts.    
 
A detailed description of these interactions is as follows: H4NA in the host molecule A 
forms bifurcated hydrogen bonds with O9A and O8A of a symmetry-transformed host 
molecule A.  Analogous interactions occur for the pair of B molecules.  In addition, close 
contacts O9B···C41B [3.143(5) Å] and O8B···C40B [3.053(5) Å] are found between two 
B molecules.   
 
Details of host intermolecular N-H···O hydrogen bond interactions are listed in Table 79.  
The bifurcated N···O distances range from 2.84 to 3.17 Å with a mean value of 2.98 Å.  
The N-H···O angles range from 121 to 148o with a mean value of 133o.   
 
Table 79 Intermolecular H-bond interactions in the host molecules A and B in P11a 
Hydrogen bond N···O Distance (Å) Angle (o) Symmetry operatorb 
N4A-H4NA···O8A 3.026(5) 134.0 -x,-1/2+y, -z 
N4A-H4NA···O9A 2.862(4) 130.0 -x,-1/2+y, -z 
N4B-H4NB···O8B 3.165(5) 121.0 1-x, y-1/2, 1-z 
N4B-H4NB···O9B 2.842(5) 148.0 1-x, y-1/2, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
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Several host-host intermolecular C-H···O interactions are found in P11.  The details of all 
C-H···O interactions are listed in Table 80.  The C···O distances range from 2.97 to 3.25Å 
with a mean value of 3.18 Å.  The C-H···O angles range from 104 to 163o with a mean 
value of 130o.   
 
Table 80 Intermolecular C-H···O interactions between the rifampicin moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C39A-H39B···O8A 3.249(5) 129.0 -x, -1/2+y, -z 
C41A-H41B···O9A 2.978(5) 104.0 -x, -1/2+y, -z 
C41B-H41C···O2B 3.251(5) 163.0  1+x, y, z 
C42A-H42A···O9A 3.233(5) 122.0 -x, -1/2+y, -z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Host-guest Interactions  
The host-guest O-H···O and N-H···O interactions in P11 are shown in Figure 64.  Two 
bifurcated hydrogen bonds are found among the host-guest interactions.  H1NA in the 
host molecule A forms hydrogen bonds with two acceptors O3D and O3C which belong 
to two disordered 1,4-dioxane molecules.  H10B in the molecule B forms bifurcated 
hydrogen bonds with O1D and O1C which belong to the disordered 1,4-dioxane 
molecule.  The water molecule O1W serves as a bridge linking two host molecules A and 
B in the asymmetric unit.  
Chapter 4: Rifampicin Solvates (Part three---P11) 
 261 
 
Figure 64 Stereoviews of the intermolecular O-H···O and N-H···O hydrogen bonds between the 
host and guest molecules in the P11.  The relevant oxygen atoms are shown as spheres.  The other 
hydrogen atoms and guest molecules are omitted for clarity.   
 
Details of host intermolecular O-H···O and N-H···O hydrogen bonds are listed in Table 
81.  The O···O distances range from 2.82 to 3.13 Å with a mean value of 2.95 Å.  The O-
H···O angles range from 140 to 169o with a mean value of 154o.   
 
Table 81 Host-guest O-H···O or N-H···O interactions and O···O short contacts in the structure of 
P11a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) 
O3W-H3W1···O1B 2.895(6)     153(4) 
O11B···O11D 3.060 ------------- 
O11B···O11C 3.043 ------------- 
O11E···O11C 2.967 ------------- 
O10B-H10B···O2D 2.96(2) 145.0 
O10B-H10B···O1C           2.739(7)      147.0 
O1W-H1W2···O4B           2.928(4)     168(2) 
O1W-H1W1···O1A          3.126(4)      154(2) 
N1A-H1NA···O3D           3.08(2) 153.0 
N1A-H1NA···O3C           3.036(5)      140.0 
O2W-H2W1···O4A          2.815(4)      169(6) 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
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Several host-guest C-H···O interactions are found in the structure of P11.  Geometrical 
details are listed in Table 82.  The C···O distances range from 3.31 to 3.46 Å (mean    
3.40 Å) while the C-H···O angles range from 146 to 165o (mean 156o).   
 
Table 82 C-H···O interactions between the rifampicin and guest moleculesa 
Hydrogen bond C···O Distance (Å) Angle (o) Symmetry operatorb 
C9G-H9D···O12A 3.424(5)      146.0 x, y, z 
C11G-H11D···O10A 3.361(5)      156.0 -x, -1/2+y, -z 
C29A-H29A···O3W 3.462(6) 165.0 -1+x, y, -1+z 
C37B-H3C···O8G 3.425(8) 151.0 x, y, z 
C43A-H43C···O7G 3.306(5) 163.0 -x, -1/2+y, -z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Guest-guest Interactions  
A variety of disordered arrangements occur in the 1,4-dioxane molecules, as shown in 
Figure 65.  Three 1,4-dioxane molecules are disordered over two positions.  However, the 
geometrical distributions of the two disordered components are different in each case.  
The solvent molecules retain a chair-conformation throughout.  
 
Figure 65 Three 1,4-dioxane molecules disordered over two positions.  (a) O1C-C1C-C2C-O2C-
C3C-C4C and O1D-C1D-C2D-O2D-C3D-C4D; (b) O3C-C5C-C6C-O4C-C7C-C8C and O3D-
C5D-C6D-O4D-C7D-C8D; (c) O11C-C21C-C22C-O12C-23C-24D and O11D-C21D-C22D-
O12D-C23D-C24D.  
   
Two water molecules O3W and O2W as well as a 1,4-dioxane molecule O5G-C9G-
C10G-O6G-C11G-C12G are connected by a hydrogen bond chain: O3W-H3W2···O2W-
H2W2···O5G (shown in Figure 66).  
 
(a) (b) (c) 
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Figure 66 The guest-guest intermolecular O-H···O interactions among the water and 1, 4-dioxane 
molecules.   
 
Details of host intermolecular O-H···O interactions are listed in Table 83.  The O···O 
distances range from 2.76 to 2.91 Å (mean value 2.84 Å).  The average value of O-H···O 
angles is 161o.   
 
Table 83 Guest-guest intermolecular O-H···O interactions and O···O short contacts among guest 
molecules 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O2W-H2W2···O5G 2.865(4)      177(4) x, y, z 
O3W-H3W2···O2W 2.906(7) 145(2) 1+x, y, 1+z 
O3D···O2C 2.76(2) -------- 1-x, y-1/2, 1-z 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Overall Intramolcular and Intermolecular Interactions in P11  
The overall hydrogen bond interactions of P11 are shown in Figure 67.  Five rifampicin 
host molecules (including three host molecules A and two host molecules B) assemble 
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Figure 67 Stereoview of the overall hydrogen bond interactions in P11.  The oxygen atoms in 
solvent molecules are shown as spheres.  The code letter for the symmetry operator of each 
rifampicin molecule is labelled. (a = x, y, z; b = 1-x, y-1/2, 1-z; c = 1-x, y-1/2, 1-z; d = 1+x, y, 
1+z).   
 
A noteworthy observation is that the oxygen atoms in the 1,4-dioxane molecules O7G-
C13G-C14G-O8G-C16G-C17G and O9G-C18G-C19G-O10G-C20G-C21G are not 
hydrogen bonded to other oxygen atoms.  However, C16G in the former molecule is 
within C-H···O H-bonding distance of atom O11A [3.064(4) Å].  Initially it was thought 
that the atoms C16G may have been misassigned as carbon and should instead have been 
treated as oxygen.  However, the original atom assigned as oxygen had a significantly 
higher electron-density than those atoms assigned as carbons in the 1,4-dioxane 
molecules.  The rather short C16G···O11A distance was finally accepted as a real feature.  
Thus, the molecule of 1,4-dioxane labelled O7G-C13G-C14G-O8G-C16G-C17G is in 
close contact with host molecule A while the 1,4-dioxane molecule O9G-C18G-C19G-
O10G-C20G-C21G is isolated.  
   
Crystal Packing 
The packing diagrams of P11 are shown in Figure 68.  Host molecules A and B are 
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the b-axis, as do the B molecules.  Layers, assembled from interlocking lattices of A and 
B molecules, lie perpendicular to the b-axis.  Analogous host-host interactions and C···O 
close contacts are found to associate host molecules A to A and B to B parallel to the b-
axis while the host-guest intermolecular interactions are found to associate the host 
molecules A and B along the c-axis.  This arrangement results in the formation of isolated 
solvent cluster.    
 
Figure 68 Crystal packing diagram for P11 viewed along (a) [100] and (b) [001].  Solvent 
molecules are shown in green and spheres for clarity.  Host molecules A and B are shown in gray 
and red, respectively.  
 
The program SECTION14 was used to view planes at x = 0 and x = 7.7 through the unit 
cell along the a-axis (Figure 69).  The isolated sets of 1,4-dioxane molecules are evident.  
 
Figure 69 Sections through P11 with guest molecules and host molecules represented by green 
and gray areas, respectively; viewed along [100] with the unit cell sectioned at (a) 0 Å and  (b) 







(a) 0 Å  (b) 7.7 Å  
Chapter 4: Rifampicin Solvates (Part three) 
 266
Comparative PXRD 
The PXRD traces for solvates P8 - P11 generated from their single crystal X-ray 
structures are shown in Figure 70.  These traces are all significantly different, excluding 
the possibility of isostructurality in this solvate series.  
 




Concluding remarks, based on the data discussed above for all the rifampicin solvates 
(isostructural series 1 and 2, P8, P9, P10 and P11) are presented here. 
 
Crystal Preparation 
For the preparation of the crystals of all the solvates, certain amounts of water were 
required in the mother liquors to dissolve the raw material at 25 oC.  Furthermore, all the 
crystals grew at 4 oC except those of P11 which grew at 25 oC.  In addition, the only 
difference between the preparative methods for P7 and P8 is that the recrystallisation 
solution of the former was not filtered while that of the latter was filtered.  The above is 
merely a summary of crystallisation procedures employed.  No particular correlation 
between e.g. temperature of crystallisation and drug conformation in the resulting crystal 
structure was observed. 
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Powder X-ray Diffraction  
The experimental PXRD traces for isostructural series 1 and 2 were in reasonable 
agreement with their respective calculated traces which were based on single crystal X-
ray data.  The latter are included in Figure 71.  In general, the dissimilarity among these 
traces is sufficiently marked to identify and distinguish the six distinct solvatomorphic 
phases of rifampicin identified and characterised in this study.  
 
Figure 71 Calculated PXRD traces of isostructural series 1 (P1 as representative) and 2 (P5 as 
representative), P8, P9, P10 and P11. 
   
Conformation of the Rifampicin Host Molecules  
Rifampicin molecules in the isostructural series 1 adopt a similar conformation to those 
in P8 and P10 of series 2, as presented in Figure 72.  The host molecule in P1 is chosen as 
a representative for the host molecules in series 1 while the host molecules A in P8 and 
P9 are selected for comparison.  Although subtle differences exist among these 
molecules, the overall conformations are very similar.  
5 10 15 20 25 30 35 40
2θ(o)
Irel 
Series 1(P1)  
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Figure 72 An overlay of host molecules in P1 (green), A in P8 (red) and A in P10 (yellow). 
 
As discussed previously, two distinct conformations of rifampicin molecules are found to 
co-exist in the structure of P11.  The rifampicin molecule A in P9 is overlayed with the 
molecule B in P11 (Figure 73).  In the latter, the atom C18 is disordered over two 
positions where C18B is the major component [s.o.f. 0.78(1)].  The major conformational 
difference is in the orientation of the piperazinyl moiety in the two molecules.  
 
Figure 73 An overlay of the host molecule A in P9 (gray) and B in P11 (green).  
 
Indications of four distinct conformations of the rifampicin molecules were found during 
the investigation of the rifampicin solvates.  The host molecule in P1 is employed as a 
representative for those in series 1, P8 and P10 while that in P5 is selected as a 
representative for those in series 2.  The conformational differences among these 
rifampicin molecules are reflected in the values of all the torsion angles along the ansa 




C18B in P11 
C38A in P9  
C38B in P11  
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Table 84 The conformations reflected by the torsion angles along the ansa chain in the host 
molecules of series 1, series 2, A in P9 and A in P11, respectively.  
Torsion angles (o) Series 1 Series 2 P9 (A) P11 (A) 
C2-N1-C15-C16 (τ1) trans trans trans trans 
N1-C15-C16-C17 (τ2) cis anticlinal anticlinal anticlinal 
C15-C16-C17-C18 (τ3) cis cis cis cis 
C16-C17-C18-C19 (τ4) trans trans trans gauche 
C17-C18-C19-C20 (τ5) trans trans trans trans 
C18-C19-C20-C21 (τ6) cis gauche cis anticlinal 
C19-C20-C21-C22 (τ7) trans trans trans trans 
C20-C21-C22-C23 (τ8) trans trans trans trans 
C21-C22-C23-C24 (τ9) gauche gauche gauche gauche 
C22-C23-C24-C25 (τ10) trans trans trans trans 
C23-C24-C25-C26 (τ11) trans trans trans trans 
C24-C25-C26-C27 (τ12) trans trans trans trans 
C25-C26-C27-C28 (τ13) trans trans trans trans 
C26-C27-C28-C29 (τ14) anticlinal anticlinal anticlinal anticlinal 
C27-C28-C29-O5 (τ15) trans trans trans trans 
C12-O5-C29-C28 (τ16) gauche gauche gauche gauche 
C29-O5-C12-O3 (τ17) gauche gauche gauche gauche 
   
The torsion angle τ2 in the host molecules of series 1 [Figure 74 (a)] is distinctly different 
from the τ2 values for the other molecules in Figure 74.  This corresponds to the fact that 
the C15=O11 bond in series 1 points away from the ansa chain while it points towards 
the chain in the others.  The torsion angle τ4 in the host molecule A of P11 [Figure 74 (d)] 
is distinct.  Accompanying this, τ6 in this molecule is distinctive.  Finally, we note that 
for P5, the piperazinyl substituent (‘plane’ C) is unique in linking to the imine group via 
an axial N-N bond [Figure 74 (b)] whereas in the other molecules shown, the N-N bond 
is equatorial.  For the latter cases, plane C is located above, parallel to, and below the 
chromophore (plane B) in series 1, P9 and P11, respectively.  This is one of the several 
novel features established for rifampicin in this study.    
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Figure 74 Conformational differences among rifampicin host molecules in (a) P1, (b) P5, (c) 
molecules A in P9 and (d) molecule A in P11.  O11 atoms in each molecule are shown as spheres 
for clarity. 
 
 Figure 75 illustrates the overlay diagram of these four molecules for comparison.  The 
unique configuration of the piperazinyl moiety (in blue) is quite evident.  
 
Figure 75 An overlay of the host molecules in solvates P1 (pink), P5 (blue), A in P9 (gray) and A 
in P11 (green). Guest molecules and hydrogen atoms are omitted for clarity.  (a): view roughly 
side-on with respect to the ansa chain; (b): view normal to the ansa chain backbone. 
 
(a) P1 (b) P5 



















(a)  (b)  
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In addition, the dihedral angles between the plane of the ansa chain (plane A) and the 
chromophore (plane B) differ significantly among the host conformations of the four 
solvatomorphic phases.  This also applies to the dihedral angles between the planes B and 
C (piperazinyl residue), as listed in Table 85.  In more detail, the angles for the series 1 
and series 2 are the average values of those in P1, P2, P3, P4, P8 and P10 as well as P5, 
P6 and P7, respectively.  The angles listed for P9 are the average values of those in the 
molecules A and B in P9 and in the molecule B in P11, while the angle for P11 is the 
angle for the molecule A in P11.  
 
Table 85 The dihedral angles between planes A and B as well as those between planes B and C 
of the rifampicin molecule in the series 1, series 2, P9 and P11. 
solvates Series 1  Series 2  P9  P11  
Angle between  A and B(o) 76.37(2) 58.76(3) 56.73(3) 56.02(4) 
Angle between  B and C(o) 10.15(8) 70.86(6) 16.2(5) 3.81(8) 
 
Thus, the existence of four distinct conformations of the rifampicin molecule can be 
confirmed.  Three main indicators can be applied to determine the different 
conformations, as shown in Table 86 and evident from Figure 74. 
 
Table 86 Directional indicators for different conformations of the rifampicin molecule* 
Indicators Series 1 Series 2 P9 (A) P11 (A) 
C15=O11 bond and ansa chain away towards towards towards 
C18 and ansa chain towards towards towards away 
piperazinyl substituent equatorial axial equatorial equatorial 
* ‘away’ meaning pointing away from each other, ‘towards’ meaning the opposite.   
 
Furthermore, as previously discussed, all the rifampicin molecules in the solvate             
P1 – P11 adopt antibiotically active conformations in the solid state.  In other words, the 
parameters defining the four distinct conformations lie within the ranges associated with 
biological relevance.  
 
In addition, zwitterionic nature is a common feature in all of the rifampicin molecules in 
solvates P1 – P11, with the possible exception of the molecule A in P10.  Moreover, a 
consequence of the zwitterionic nature that is common to all the rifampicin molecules is 
the formation of one or more N+-H···O hydrogen bonds to neighbouring donor atoms.   
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It is relevant to mention that the X-ray structure of a phase described as rifampicin 
pentahydrate was reported by Gadret et al. in 1975.16 (This is the only crystal structure of 
rifampicin hitherto published).18  The host molecule in the pentahydrate adopts a similar 
conformation to those in series 1 reported here.  Furthermore, the pentahydrate has 
similar unit cell dimensions and calculated PXRD patterns to those of series 1.  In 
addition, the atomic co-ordinates of the water molecules in the hydrate are found to 
correspond closely to the co-ordinates of the oxygen atoms in the guest molecules in each 
solvate of series 1.  It can thus be confirmed that rifampicin pentahydrate belongs to the 
isostructural series 1.  However, there are shortcomings in the structural report for the 
pentahydrate, namely omission of H atoms on the water molecules in the crystallographic 
modelling and no definitive statement as regards the possibility of a zwitterionic structure 
for the rifampicin molecules.16  In this study, a significantly more detailed and systematic 
investigation of the solvatomorphism of rifampicin has been undertaken.  
 
Host Intramolecular Hydrogen Bond Interactions  
 
A common intramolecular hydrogen bond O12-H12···O4 is found in the host molecules 
in all the solvates.  Hydrogen bond O1-H1···O2 can be found in all of the host molecules 
expect the molecule A in P10 due to its apparent non-zwitterionic nature.  The hydrogen 
bond N1-H1N···O2N can be found in the host molecules of series 1, P8, P9, P10 and B in 
P11 but not in series 2 and the molecule A in P11.  These can be attributed to the axial 
configuration of the host molecules of series 2 and the very small dihedral angles 
between planes B and C [3.81(8)o] in the host molecule A of P11.  The hydrogen bond 
O10-H10···O9 is observed in the host molecules of series 1, series 2 and P9 while O9-
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H9···O10 is found in those of P8, P10 and P11.  This indicates that the existence of a 
hydrogen bond interaction between O10 and O9 is indispensable for the host molecules 
in all the solvates.  However, the geometrical orientation of this hydrogen bond depends 
on other conditions, for instance, the positions of the oxygen atoms in the neighbouring 
guest or host molecules.  Furthermore, the unique hydrogen bond O10A-H10A···O11A is 
only found in the host molecule A of P11.  The formation of this H-bond is facilitated by 
the distinct combination of torsion angles τ4 and τ6 [Figure 74 (d)] which enable the 
donor and acceptor atoms to approach one another sufficiently closely.  In all of the 
solvates, the O···O distances of host O-H···O intramolecular hydrogen bonds are short 
(~2.6 Å) and span a narrow range.  
 
Host-host Hydrogen Bond Interactions  
No common host-host intermolecular interactions and C···O close contacts are found in 
the structures of series 1, series 2 and solvates P8 - P11 since each solvatomorphic form 
adopts a unique packing motif.  Furthermore, no O-H···O and C-H···O interactions exist 
between the host molecules in series 2 and P8.  Figure 76 illustrates the host-host 
interactions for the structures of series 1, P9, P10 and P11.  
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Figure 76 The host-host interaction and C···O close contacts viewed down the a-axis in (a) P1, 
(b) P9, (c) P10 and (d) P11.  Atoms with gray labels have been symmetry- generated from their 
asymmetric unit counterparts 
 
In the structure of P9, similar atoms function as acceptors and donors in the molecules A 
and B.  For example, both of the hydrogen bonds N4A-H4NA···O1B/O11B have 
counterparts N4B-H4NB···O1A/O11A.  In the structure of P11, the host A···A and B···B 
molecular interactions are common.  For example, the N4A-H4NA···O8A/O9A hydrogen 
bonds have counterparts N4B-H4NB···O8B/O9B 
 
Furthermore, the average O···O distances for the host-host O-H···O interactions (~2.9 Å) 
are very similar in all the solvates.  This also applies to those of C···O close contacts 
(~3.0 Å). 
 
Host-guest Hydrogen Bond Interactions  
In the host molecules of each solvatomorphic form, not all oxygen and nitrogen atoms 
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specific N and O atoms which are involved in the interactions are different in each 
solvatomorphic form. 
 
For the rifampicin molecules in series 1, the oxygen and nitrogen atoms which are 
involved in the hydrogen bond interactions with the guest molecules are identical in P1, 
P2, P3 and P4.  In other words, although the content of the solvent cluster is different in 
each solvate, the hydrogen bonding environments provided by the rifampicin molecules 
are identical.  This also applies to the rifampicin molecules in series 2. 
 
Table 87 indicates which, if any, of the host N and O atoms is involved in hydrogen 
bonding with guest molecules.  Notably, the atom N1 is only involved in the host-guest 
interactions in the structures of series 2 and the molecules A in P11; this may attributed to 
the fact that atom N1 in all the other solvates participates in the common N1-H1N···O2N 
intramolecular hydrogen bond, thereby precluding intermolecular H-bonding.  Again, the 
average O···O distances for host-guest interactions (~2.9 Å) are very similar in all the 
solvatomorphic forms.   
 
Table 87 Involvement of the nitrogen and oxygen atoms in the host-guest H-bond interactions in 
each solvatomorphic form of rifampicin.  
P8 P9 P10 P11 Atom Series 
1 
Series 
2 A B A B A B A B 
N1 ------- yes ------- ------- ------- ------- ------- ------- yes ------ 
N4+ yes yes yes yes ------- ------- yes yes ------- ------ 
O1 ------- yes ------- ------- ------- ------- ------- ------- yes yes 
O2 yes yes yes yes ------- ------- ------- ------- ------- ------ 
O4 yes yes yes yes ------- yes yes yes yes yes 
O6 yes yes yes yes ------- ------- yes yes ------- ------ 
O8 ------- ------- ------- yes yes yes ------- yes ------- ------- 
O9 ------- ------- yes ------- ------- ------- yes ------- ------- ------- 
O10 yes yes yes yes ------- ------- yes yes ------- yes 
O11 yes yes yes yes ------- ------- yes yes ------- yes 
 
Finally, a guest-host C···O close contact C16G···O11A is found only in the structure of 
the solvate P11. 
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Guest-guest Hydrogen Bond Interactions  
For all the solvates, the guest molecules display a variety of disordered arrangements.  
For instance, one molecule may be completely or partially disordered over two positions 
in different ways [Figure 77 (a) and (b)].  Furthermore, one ethanol molecule can be 
disordered over three different positions as in P3 [Figure 77 (c)].  Also, two solvent sites 
(for a water molecule and a methanol molecule) are not fully-occupied [Figure 77 (d)].  
Furthermore, a large number of water molecules which are partially occupied can be 
located very close to one another.  
 
Figure 77 A variety of disordered arrangements displayed by guest molecules. 
 
In each solvate, guest molecules form clusters.  For solvates P7 and P8, all the guest 
molecules assemble into a complete cluster.  For the other solvates, some guest molecules 
are found to be involved only in the host-guest interactions.   
  
Some of the guest clusters are intimately associated with the rifampicin molecules (P1, 
P3, P5, P9 and P11) while others form a more continuous solvent distribution, extending 
indefinitely through the crystal (P2, P4, P6, P7, P8 and P10).  Interestingly, the higher the 
water content in the structure of the solvate, the more chance there is that the guest 
cluster will extend indefinitely.  This may be associated with the fact that the crystals of 
rifampicin solvates easily tend to absorb atmospheric water molecules, changing the 
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have a saturated solvent molecule condition where the guest clusters are intimately 
associated with the rifampicin molecules.  After equilibrating with the atmosphere for a 
certain period, atmospheric water molecules enter the crystals while solvent molecules 
diffuse out of the crystals, resulting in the formation of water-rich guest clusters which 
extend indefinitely through the solvent channel.   
 
Crystal Packing 
Both isostructural series 1 and 2 crystallise in the same space group P212121 while 
solvates P8, P9, P10 and P11 all crystallise in the space group P21.  In the structures of 
series 1, P8, P9, P10 and P11, host molecules form layers, interleaved by layers of guest 
molecules parallel to the a- or the c-axis.  However, extensive hydrogen bonding links the 
respective layers in each case.  In the structures of series 2, no host or guest molecule 
layers are formed.  Nevertheless, using program SECTION14 to examine crystal voids, 
infinite guest channels can be found in all the solvates except P11.  The shapes and 
positions of the solvent channels were clearly visualised.  
   
The packing diagrams in the structures of series 1, P8, P10 and P11 are comparable, as 
shown in Figure 78.  There is one symmetry-independent host molecule in the structures 
of series 1 (P1 is shown as representative) while two (A and B) occur in the structures of 
P8, P10 and P11.  In all four cases, the molecules repeat themselves in the same way, 
being generated by a 2-fold screw-axis running parallel to [010].  Series 1 forms layers A 
and A′ parallel to the b-axis.  P8, P10 and P11 also form layers A and B parallel to the    
b-axis.  However, layers A contain only molecules A while layers B contain only B.  
Furthermore, in the structure of P8, molecules A and B are related by a pseudo 2-fold 
symmetry parallel to the b-axis.  In the structure of P10, molecules A and B are related by 
a pseudo 2-fold screw axis parallel to the a-axis.  In the structure of P11, molecules A 
and B are related by a pseudo B-centering translation.  
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Figure 78 The similarities and differences among the packing diagrams of (a) P1, (b) P8, (c) P10 
and (d) P11.  The guest molecules and hydrogen atoms are omitted for clarity.  The symmetry-
independent molecules A and B are shown in gray and red, respectively.   
 
Molecular packing in the crystals of series 2 and P9 are significantly different from each 
other and from those in series 1, P8, P10 and P11, as shown in Figure 79.  There is one 
symmetry-independent host molecule in the structures of series 2 (P5 is shown as 
representative) while there are two (A and B) in the structure of P8.  For P5, host 
molecules formed layers parallel to the unit cell bc-diagonal.  For P9, host molecules 
form layers which consist of both molecules A and B parallel to the b- or the c-axis.  
 
Figure 79 The packing diagrams of (a) P5 and (b) P9.  The guest molecules and hydrogen atoms 
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We report here the isolation of two rifaximin solvates (a rifaximin hydrate and a 
rifaximin solvate containing ethylene glycol and water molecules) and we investigate the 
solid-state features of these two modifications using single crystal and powder X-ray 




















The abbreviations for the discrete rifaximin hydrate and rifaximin solvate in this chapter 
are as follows: 
2Rifaximin • 7.4H2O:      F1 
4Rifaximin • 7.72ethylene glycol • 6.83H2O:   F2 
 
Suitable crystals of F1 were obtained by dissolving 20 mg (0.025 mmol) of the host drug 
(rifaximin) in 2 ml of acetone-water mixture (2:3 v/v) at 25 oC.  The solution was stirred 
for 20 min and filtered (0.45 µm nylon filter) while hot.  The clear solution was then left 
on the bench at 25 oC.  Crystals of suitable quality were obtained over a period of one 
week.  Suitable crystals of F2 were obtained by dissolving 20 mg (0.025 mmol) of the 
host drug (rifaximin) in 2 ml of ethylene glycol–water mixture (95:5 v/v) at 54 oC.  The 
solution was stirred until clear and not filtered.  The clear solution was then left on the 
hotplate at 54 oC in a sealed vial.  Crystals of suitable quality grew over a period of three 
weeks.  
 
The host and guest numbering schemes are given in Figure 1. 
 
Figure 1 Host and guest numbering schemes: (a) rifaximin, (b) ethylene glycol.  Hydrogen atoms 
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Single crystal X-Ray Diffraction 
 
Data-collection and Space Group Determination 
A crystal of F1 removed from the mother liquor was rapidly covered in paratone N oil in 
order to reduce solvent loss to a minimum.  The crystals of F2 were handled in the same 
way.  A Nonius Kappa CCD four-circle diffractometer was employed to collect X-ray 
intensity data for F1 and F2 at 173 K.   
 
The unit cell parameters, crystal systems and space groups were determined from the X-
ray diffraction data which revealed Laue 2/m symmetry for both F1 and F2.  Therefore, 
they belong to the monoclinic system.  Reflection conditions were hkl: none; h0l: none; 
0k0: k = 2n, indicating the space groups P21 or P21/m.  Given that the rifaximin molecule 
is chiral, the former space group was selected for the analysis.  The program XPREP1 
was used to confirm the choice of the space group in both cases.  
 
Structure Solution and Refinement 
For both F1 and F2, program SHEXLD2 was used to solve the structures by ab initio 
methods, which revealed the positions of all the non-hydrogen atoms of the rifaximin 
molecule (host) in each structure.  In F1, the value of Z = 4 indicated that there are two 
crystallographically independent rifaximin molecules (A and B) with their complement of 
water molecules in the asymmetric unit.  In F2, there are four symmetry-independent 
rifaximin molecules (A, B, C, D) in the asymmetric unit.  Full-matrix least-squares 
refinements were performed with SHELXH-97.3  Difference Fourier maps revealed the 
positions of oxygen and carbon atoms of the water and ethylene glycol molecules (guest).  
Some of these atoms were found to have full site-occupancy while the others were 
generally disordered over two positions.   
 
For F1, the host and guest molecules having full s.o.f. were then refined isotropically.  
For the disordered water molecules, a fixed Uiso (the mean of Ueq for the chemically 
equivalent ordered atoms) was assigned to each molecule and these atoms were allowed 
Chapter 5: Rifaximin Solvates  
 
 284
to refine with s.o.f.s x and 1-x, with x variable.  The details of the Uiso values and s.o.f.s 
of the water molecules in F1 are listed in Table 1.  
 
Table 1 Isotropic thermal parameters and site-occupancy factors for the water molecules of F1 
Water molecules Uiso (Å
2) s.o.f 
O1W 0.08 0.36 
O2W 0.07 0.70 
O3W 0.07 0.60 
O4W 0.06 1.00 
O5W 0.07 1.00 
O6W 0.08 1.00 
O7W 0.07 0.74 
O8W 0.07 1.00 
O9W 0.08 1.00 
 
For F2, the host molecules were refined isotropically, with the exception of atoms C5A, 
C9A, C34A, O6C, C4C, C37C, O8D, C2D, C7D, C13D, C14D, C20D, C28D and C29D, 
which were refined anisotropically. (This was necessitated by the very large number of 
atoms in the crystal asymmetric unit.  Even with these limitations to the model, the 
number of least-squares variables exceeded 2000).   Distance restraints were employed to 
ensure reasonable molecular geometries.  The single and double C-C bond lengths were 
set at ~ 1.5 Å with a standard deviation σ = 0.004 Å and ~ 1.3 Å with σ = 0.004 Å, 
respectively.  For ethylene glycol molecules, distance restraints were similarly employed 
to ensure reasonable molecular geometries.  The C-O and C-C bond lengths in the 
ethylene glycol molecule were set at 1.40 Å with a standard deviation σ = 0.004 Å and 
1.53 Å with σ = 0.001 Å, respectively.  For all the guest molecules (water and ethylene 
glycol), only those with full site-occupancy were refined anisotropically.  The details of 
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Table 2 Isotropic thermal parameters and site-occupancy factors for the guest molecules of F2 
Water and ethylene glycol molecules Uiso (Å
2) s.o.f 
O1W 0.08 0.45 
O2WA 0.08 0.36 
O2WB 0.08 0.26 
O3W 0.09 1.00 
O4WA 0.08 0.32 
O4WB 0.08 0.28 
O5W 0.06 1.00 
O6W 0.08 0.22 
O7W 0.11 1.00 
O8WA 0.08 0.19 
O8WB 0.08 0.20 
O9WA 0.08 0.28 
O9WB 0.08 0.23 
O9WC 0.09 0.16 
O10W 0.08 0.29 
O11W 0.08 0.35 
O12W 0.08 0.24 
O1G-C1G-C2G-O2G 0.12-0.12-0.08-0.08 1.00 
O3G-C3G-C4G-O4G 0.07-0.08-0.08-0.09 1.00 
O5G-C5G-C6G-O6G 0.09 0.39 
O7G-C7G-C8G-O8G 0.09 0.40 
O9G-C9G-C10G-O10G 0.07 0.43 
O11G-C11G-C12G-O12G 0.09 0.59 
O13G-C13G-C14G-O14G 0.09 0.39 
O15G-C15G-C16G-O16G 0.10 0.41 
O17G-C17G-C18G-O18G 0.09 0.32 
O19G-C19G-C20G-O20G 0.11-0.12-0.10-0.10 1.00 
O21G-C21G-C22G-O22G 0.10 0.71 
O23G-C23G-C24G-O24G 0.09 0.40 
O25G-C25G-C26G-O26G 0.09 0.31 
O27G-C27G-C28G-O28G 0.09 0.37 
 
Following refinement of the non-H atoms, efforts were made to identify all H atoms in 
difference Fourier syntheses.  Based on the positions of the peaks found, a riding model 
was employed to place hydrogen atoms for rifaximin and ethylene glycol molecules in 
idealised positions.  The hydrogen atoms of the water molecules in F1 were positioned 
based on reasonable locations of suitable electron density peaks and their reasonable 
hydrogen bonding geometry.  Furthermore, distance restraints were employed to ensure 
reasonable water molecular geometries.  The O-H bond length was fixed at 0.84 Å with 
the H-O-H angle restrained to 104.5o.  The standard deviations (σ) for distance restraints 
were set between 0.004 and 0.01 Å.  Hydrogen atoms of the water molecules in F2 could 
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not be located due to the very low site-occupancies of the water molecules.  All the 
methyl hydrogen atoms in F1 and F2 were refined with isotropic temperature factors 1.5 
times those of their parent atoms while all the other hydrogen atoms were assigned 
temperature factors 1.2 times those of their parent atoms.  Crystal and refinement 
parameters for F1 and F2 are presented in Table 3. 
 
Table 3 Crystal and refinement data for F1 and F2 
Parameter F1 F2 
Formula unit 2rifaximin · 7.4H2O 4rifaximin· 7.72ethylene 
glycol · 6.83H2O 
Formula Weight / g mol-1 1697.84 3794.56 
Crystal system Monoclinic Monoclinic   
Space group P21 P21 
a / Å 13.7912(3) 14.4931(2) 
b / Å 19.8434(3) 36.2486(4) 
c / Å 16.4341(4) 21.2664(3) 
α / o 90.000 90.000 
β / o 92.351(1) 90.183(1) 
γ / o 90.000 90.000 
Volume / Å3 4493.6(2) 11172.3(3) 
Z 2 2 
Densitycalc / g cm
-3 1.255 1.128 
µ (MoKα) /mm
-1 0.094 0.086 
F (000) 1812 4059 
Crystal size /mm3 0.09x0.15x0.18 0.09x0.12x0.19 
Temperature / K 173(2) 173(2) 
Range scanned θ / o 1.00≤ θ ≤ 25.35 1.79 ≤ θ ≤ 24.71 
h: -16, 16 h: -17, 17 
k: -23, 23 k: -42, 42 
Index ranges 
l: -19, 19 l: -25, 25 
φ scan angle / o 1.0 0.5  
ω scan angle / o 1.0  0.5 
Dx / mm 32 45 
No. of measured reflections 16385 37600 
No. of unique reflections 16385 19315 
No. of reflections with I > 2σ(I) 12355 9358 
No. of L.S. parameters 1144 2299 
Rint, Rσ 0.0000, 0.0516 0.1133, 0.1573 
S 1.049 1.070 
R1 (Fo > 4σ(Fo)) 0.0661 0.1149 
No. of reflections omitted 36 55 
wR2 (all reflections) 0.1903 0.3386 
a = 0.1136 a = 0.2000 Weighting scheme 
b = 1.7790 b = 0.0000 
(∆ / σ)mean < 0.001 < 0.001 
∆ρ excursions / еÅ-3 -0.28, 0.85 -0.49,0.79 





Rifaximin Molecule Conformation and Antibiotic Activity (F1 and F2) 
As explained in the introductory section, rifaximin belongs to the rifamycin derivatives. 
Similarly to rifampicin in Chapter 4, rifaximin was also investigated with regard to its 
solid-state conformations which can be correlated with antibiotic activity in this study. 
 
Again, similarly to the rifampicin molecule, the rifaximin molecule (Figure 1) can be 
described in terms of the ansa chain, comprising atoms from C15 to C29, N1 and O5; the 
chromophore system, comprising atoms from C1 to C12, from O1 to O4, and O11; and 
finally the benzimidazole ring system at C3, formed by carbon atoms from C38 to C43, 
and nitrogen atoms from N2 and N3.4  Based on this structure, planes A, B, C are 
introduced to describe the average planes of the ansa chain backbone, the 
naphthoquinonic chromophore and the fused benzimidazole system, respectively. 
 
The rationale for this division is as follows.  In the rifamycin series, biologically relevant 
parameters included the dihedral angle between the ansa chain and the chromophore (A 
and B respectively) and the dihedral angle between plane B and a substituent bonded to 
the chromophore (e.g. piperazinyl in the case of rifampicin).  In rifaximin, the 
benzimidazole residue is fused to the chromophore, rendering the entire 4-ring fused 
system planar, in theory.  However, since we observed some degree of non-planarity 
between the chromophore moiety and the benzimidazole system, it was decided to treat 
as separate ‘planes’ B and C, and to calculate all relevant dihedral angles involving 
planes A, B and C.     
 
The rifaximin host molecule skeletons in F1 and F2 are overlaid in Figure 2.  A 
remarkable similarity is found in the conformations of the host molecule A in F1 and the 
host molecules A, B, C and D in F2.  However, a significantly different structural 
conformation can be observed in the host molecule B in F1, reflected in the orientation of 
the C15B=O11B bond.  Specifically, the bond C15B=O11B points towards the ansa 
chain in the host molecule B of F1 while it points away from the ansa chain in the others.  
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For the host molecule A in F1 as well as the host molecules A, B, C and D in F2, the 
dihedral angles between planes A and B as well as those between planes B and C are 
slightly different in each molecule (Table 4).  The fact that the dihedral angles between 
planes A and B are similar while the angles between planes B and C are also similar 
represents quantitative evidence for the overall similarity of the host conformations in F2.  
This also applies to the host molecule A in F1 when compared with the host molecules in 
F2.   However, the host molecule B in F1 adopts a very different dihedral angle between 
planes A and B as well as that between planes B and C.  This is associated with the 
unusual orientation of the C15B=O11B bond in F1, as shown in Figure 2.   
 
Figure 2 An overlay of the host molecules A (red), B (green) in F1 and A (orange), B (pink), C 
(blue) and D (gray) in F2.  Guest molecules and hydrogen atoms are omitted for clarity.  
 
Table 4 The dihedral angles between planes A and B as well as those between planes B and C of 
the host molecules A and B in F1 and molecules A, B, C and D in F2. 
F1 F2 Angles 
between A B A B C D 
A and B(o) 67.9(4) 49.8(4) 64.7(2) 67.4(2) 67.4(1) 72.4(2) 
B and C(o) 6.6(1) 9.6(1) 7.2(3) 7.5(3) 6.3(3) 6.0(4) 
 
The structure of the rifaximin molecule and the torsion angle labelling along the ansa 
chain backbone are shown in Figure 3.   
O11B in F1 




Figure 3 The molecular structure and torsion angle scheme along the ansa chain.  
 
Table 5 lists the torsion angles τ1-τ17 along the ansa chain backbone of the rifaximin host 
molecule.  The torsion angle τ1 defines the junction between the chromophore and the 
ansa chain.  A trans conformation at this junction is indicated for all the host molecules 
in F1 and F2.  However, the torsion angle τ2 in the host molecule A in F1 and A, B, C and 
D in F2 indicates a gauche conformation while an anticlinal conformation is found in the 
host molecule B in F1.  This again can be associated with the unique orientation of the 
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Table 5 The torsion angles along the ansa chain in each rifaximin host molecule of F1 and F2 
F1 F2 Torsion angles (o) 
A B A B C D 
C2-N1-C15-C16 (τ1) 162.4(4) 165.6(3) 165(1) 177(1) 167(1) 166(1) 
N1-C15-C16-C17 (τ2) 57.3(6) -128.3(4) 65(2) 53(2) 55(2) 50(2) 
C15-C16-C17-C18 (τ3) 1.6(7) 4.6(6) -2(2) -3(2) 3(2) 12(2) 
C16-C17-C18-C19 (τ4) -166.9(4) 178.9(4) -167(2) 177(2) -168(2) -170(2) 
C17-C18-C19-C20 (τ5) 175.6(4) -172.2(4) -178(1) -172(1) 177(1) 176(2) 
C18-C19-C20-C21 (τ6) -73.8(6) -37.3(6) -62(2) -42(2) -65(2) -64(2) 
C19-C20-C21-C22 (τ7) 170.1(4) 171.8(3) 176(1) 175(1) -178(1) -171(1) 
C20-C21-C22-C23 (τ8) -168.9(4) -171.5(3) 178(1) 178(1) -175(1) -180(1) 
C21-C22-C23-C24 (τ9) 55.6(5) 59.3(4) 51(2) 51(2) 55(2) 55(2) 
C22-C23-C24-C25 (τ10) 170.5(3) -177.3(3) -179(1) 178(1) 170(1) 171(1) 
C23-C24-C25-C26 (τ11) 171.6(3) 172.3(3) 167(1) 164(1) 160(1) 163(1) 
C24-C25-C26-C27 (τ12) 175.8(3) 174.4(3) 170(1) 172(1) 173(1) 169(1) 
C25-C26-C27-C28 (τ13) -173.9(4) -167.8(3) -175(1) -169(1) -175(1) -157(1) 
C26-C27-C28-C29 (τ14) 110.5(5) 110.0(5) 102(2) 97(2) 113(2) -99(2) 
C27-C28-C29-O5 (τ15) -175.5(4) -172.5(4) -177(1) -178(1) -173(2) 176(2) 
C12-O5-C29-C28 (τ16) 55.4(7) 31.8(7) 70(2) 69(2) 57(2) -102(2) 
C29-O5-C12-O3 (τ17) -79.3(5) -75.5(5) -82(1) -80(1) -84(1) -58(2) 
 
Figure 4 shows the rifaximin host molecules A and B in F1 and host molecule A (as 
representative for the host molecules B, C and D) in F2 viewed side-on to the ansa chain 
backbone.   
 
 
Figure 4 Diagram of the rifampicin host molecule in F1 viewed side-on with respect to the ansa 
chain. (a) The molecule A in F1, (b) The molecule B in F1, (c) The molecule A in F2. 
 
Four oxygen atoms (O9, O10, O1 and O2) protrude from the cavity of the ansa chain and 
the chromophore face while being nearly perpendicular to the ansa chain.  Furthermore, 
all four oxygen atoms are disposed in the opposite direction from the cyclic ring 
subsitituent.  In addition, the intramolecular distances among the four oxygen atoms O1, 
O2, O9 and O10 (listed in Table 6) fall in the range (~5.41 to 9.58 Å) which is favourable 
(a) (b) (c) 
O9A 
O10A 
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for active rifamycin derivatives.4  Based on these structural features, these rifaximin host 
molecules are seen to retain an open conformation which is the characteristic 
arrangement of the four oxygen atoms necessary for antibiotic action through the 
postulated drug-enzyme interaction.5 – 7      
 
Table 6 Interatomic distances involving atoms O1, O2, O9 and O10 in each host molecule in F1 
and F2a   
F1 F2 Distance (Å) 
A B A B C D 
O1···O9 7.365 8.628 7.438 7.297 6.968 6.722 
O1···O10 6.641 7.906 6.065 6.037 5.923 5.555 
O2···O9 8.307 9.424 8.372 8.171 7.942 7.662 
O2···O10 8.330 9.335 7.645 7.621 7.609 7.241 
a Average e.s.d. 0.009 Å. 
 
From the above data, the four symmetry-independent host molecules in F2 adopt a 
similar conformation to that of the host molecule A in F1, the other symmetry-
independent host molecule B in F1 presenting a distinctly different conformation of  the 
rifaximin molecule.  Furthermore, all these molecules can be confirmed as being in 
biologically relevant conformations.  
 
Similar to the structure of rifampicin molecules, a noteworthy observation is that the 
bond length C8-O2 is significantly shorter than C1-O1, which is in a similar chemical 
environment (Table 7).  Based on the values for interatomic distances listed in 
International Tables for Crystallography8, the typical distance for the C-O bond in the 
above environment is 1.333 Å.  Therefore, although bonds C1-O1 and C8-O2 are all 
represented as single bonds in Figure 1, the former bond can be confirmed as being single 
whilst C8-O2 tends to display some double bond character.  A significance test shows 
that the C1-O1 and C8-O2 bonds are significantly different except in entries C and D in 
Table 7, where C8-O2 is only nominally shorter than C1-O1. 
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Table 7 Bond lengths C1-O1 and C8-O2 in each host molecule of F1 and F2. 
F1 F2 Bond length 
(Å) A B A B C D 
C1-O1 1.360(5) 1.342(5) 1.38(1) 1.37(2) 1.33(1) 1.32(2) 
C8-O2 1.294(5) 1.301(5) 1.33(1) 1.30(2) 1.32(2) 1.31(2) 
 
This trend is consistent with the known zwitterionic nature of rifaximin in the solid-
state.9, 10  Furthermore, during the structural refinements of both F1 and F2, geometrically 
reasonable electron density peaks, that qualified as potential H atoms, were found at        
~1 Å from all the hydroxyl oxygen atoms (O1, O9 and O10) but not in the vicinity of O2.  
At the same time, an extra peak, with electron density value similar to that of the 
previously located H atoms, was found at ~1 Å from the imidazole nitrogen atom N2.  
Also, between N2 and an oxygen atom of another molecule, this specific peak was ideally 
located, accounting for the formation of a N+-H···O hydrogen bond with very favourable 
geometry.  Therefore, it can be assumed that a zwitterion is formed in each host 
molecule, as a result of proton transfer from the hydroxyl group at C8 to the atom N2. 
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Intra- and Intermolecular Interactions 
 
F1 – 2Rifaximin • 7.4H2O 
 
Host-host Intra- and Intermolecular Hydrogen Bond Interactions  
Figure 5 illustrates the zwitterionic structure, the host intramolecular interactions and a 
host-host intermolecular hydrogen bond N1B-H1NB···O11A for F1.  The hydrogen bonds 
O1-H1···O2 and N2+-H2N···O4 are common intramolecular interactions in the host 
molecules A and B.  As regards the O9···O10 interaction on the ansa chain, in the 
molecule A, the atom O10A serves as a hydrogen bond donor while O9A serves as an 
acceptor.  On the other hand, in the molecule B, O9B serves as hydrogen bond donor 
while O10 B acts as acceptor.  Finally, the intermolecular hydrogen bond N1B-
H1NB···O11A links the two symmetry-independent molecules A and B in the asymmetric 
unit.   
 
Figure 5 The zwitterionic structures, the host intramolecular O-H···O interactions and one host-
host intermolecular hydrogen bond N1B-H1NB···O11A for F1.  The relevant hydrogen atoms are 
shown as spheres.  The other hydrogen atoms and the guest molecules are omitted for clarity.   
 
Figure 6 illustrates additional host-host hydrogen bond interactions for F1.  Three 
intermolecular interactions are thus found between molecule A and a symmetry-


















Figure 6 Additional host-host intermolecular O-H···O interactions in F1.  The relevant oxygen 
atoms are shown as spheres, while the remaining H atoms are omitted for clarity.   
  
Geometrical details of these hydrogen bonds are listed in Table 8.  For the intramolecular 
interactions, the average O···O distance for the O-H···O interactions is 2.68 Å while the 
mean angle is 146o.  Furthermore, the average N···O distance for the N-H···O interactions 
is 2.78 Å with the average angle is 141o.  For the intermolecular O-H···O interactions, the 
mean distance is 2.77 Å while the mean angle is 149o.        
 
Table 8 The details of host intramolecular interactions and host-host interactions in hydrate F1.a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) Symmetry operatorb 
Intramolecular  
O1A-H1A···O2A 2.474(4) 150.0 x, y, z 
O1B-H1B···O2B 2.428(4) 150.0 x, y, z 
N2A+-H2NA···O4A 2.759(4) 141.0 x, y, z 
N2B+-H2NB···O4B 2.811(4) 140.0 x, y, z 
O10A-H10A···O9A 3.065(5) 138.0 x, y, z 
O9B-H9B···O10B 2.730(4) 144.0 x, y, z 
Intermolecular 
N1B-H1NB···O11A 2.830(4) 131.0 x, y, z 
O9A-H9A···O11B 2.861(4) 166.0 2-x, -1/2+y, 1-z 
O10A-H10A···O11B 2.722(5) 111.0 2-x, -1/2+y, 1-z 
O10B-H10B···O9A 2.727(4) 169.0 2-x, 1/2+y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 












Chapter 5: Rifaximin Solvates (F1)  
 
 295 
Several intramolecular and intermolecular C-H···O and C-H···N interactions are found in 
the structure of F1.  Figure 7 shows the intramolecular C-H···O interactions and one 
intermolecular C-H···O interaction for F1.  Similar intramolecular hydrogen bond 
interactions can be found in the molecules A and B.  The difference between the torsion 
angles τ2A and τ2B gives rise to the distinct interactions C38A-H38A···O11A, C38B-
H38B···O11A, C38B-H38B···N1B and C18B-H18B···O11B.  The appearance of the 
interaction C38A-H38A···O11A is due to the fact that the atom O11A points away from 
the ansa chain in the molecule A.  Furthermore, the appearance of the interaction C18B-
H18B···O11B is associated with the bond C11B=O11B that points towards the ansa chain 
in the molecule B.  In addition, the intermolecular interaction C38B-H38B···O11A links 
the two symmetry-independent rifaximin molecules A and B in the asymmetric unit.    
 
Table 9 lists the geometrical details of all the intramolecular and intermolecular C-H···O 
and C-H···N hydrogen bonds.  For the intramolecular C···O interactions, the mean 
distance is 2.91 Å while the mean angle is 108o.  For the intermolecular C···O 
interactions, the mean distance is 3.15 Å while the mean angle is 129o.      
 
Figure 7 Stereoview of the intramolecular and intermolecular C-H···O and C-H···N interactions 
in F1.  The relevant O, N and C atoms are shown as spheres, while the H atoms and the guest 
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Table 9 Intramolecular and intermolecular C-H···O and C-H···N interactions in the rifaximin 
moleculesa 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) Symmetry operatorb 
Intramolecular 
C14A-H14B···O2A 2.824(6) 107.0 x, y, z 
C14B-H14F···O3B 2.935(5) 103.0 x, y, z 
C18B-H18B···O11B 2.982(5) 118.0 x, y, z 
C23A-H23A···O7A 2.950(5) 106.0 x, y, z  
C25A-H25A···O8A 2.726(6) 105.0 x, y, z 
C25A-H25A···O9A 2.903(5) 105.0 x, y, z 
C25B-H25B···O8B 2.743(5) 105.0 x, y, z 
C25B-H25B···O9B 2.855(5) 104.0 x, y, z 
C27A-H27A···O7A 2.886(5) 104.0 x, y, z 
C27B-H27B···O7B 2.897(5) 105.0 x, y, z 
C28B-H28B···O3B 3.118(6) 120.0 x, y, z 
C33A-H33C···O7A 2.867(5) 100.0 x, y, z 
C38A-H38A···O11A 3.172(6) 125.0 x, y, z 
C38B-H38B···N1B 3.094(5) 120.0 x, y, z 
Intermolecular 
C38B-H38B···O11A 2.970(6) 107.0 x, y, z 
C34B-H34E···O10A 3.107(7) 117.7 2-x, 1/2+y, 1-z 
C43A-H43A···O9B 3.373(6) 163.0 x, y, -1+z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Three π-π interactions are found between the rifaximin molecules (Figure 8).  
 
Figure 8 Aromatic rings involved in π-π interactions between the rifaximin molecules A and B in 
the asymmetric unit. (Cg2 represents the centroid of the imidazole ring N2A-C4A-C3A-N3A-
C42A; Cg4 is C centroid of the phenyl ring C1A-C2A-C3A-C4A-C10A-C9A; Cg7 is the centroid 
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A summary of the π-π and C-H···π interactions are given in Table 10.  The average 
distance for the π-π interactions is 3.74 Å.  The mean distance for the C-H···π interactions 
is 3.31 Å with a mean angle of 128o. 
   
Table 10 All possible π-π interactions with cg···cg < 4 Å and C-H···π interactions between the 
rifaximin moleculesa 




cg2···cg9 3.824(2) -------- 
cg4···cg7 3.880(2) -------- 
cg4···cg9 3.518(2) -------- 
C-H···π interactions 
C28A-H28A···cg1(O3A-C6B-C5A-C11A-C12A) 3.000(6) 99.0 
C28B-H28B···cg6(O3B-C6B-C5B-C11B-C12B) 2.947(5) 112 .0  
C33A-H33B···cg2(N2A-C4A-C3A-N3A-C42A) 3.758(5) 149.0 
C34A-H34C···cg5(C5A-C6A-C7A-C8A-C9A-C10A) 3.526(5) 151.0 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Host-guest Interactions  
Figure 9 shows the host-guest hydrogen bond interactions among the host and the water 
molecules.  The O8A and O8B atoms in the molecules A and B are hydrogen bonded to 
the water molecules O9W and O6W, respectively.  The water molecules O5W and O9W 
both serve as bridges in associating the rifaximin molecules A with a symmetry-
generated host molecule B.  Similar to the host-host intermolecular interaction 
N1B···O11A, the water molecule O8W also assists in stabilising the two symmetry-
independent rifaximin molecules A and B in the asymmetric unit of F1. 
 




Figure 9 Stereoview of the intermolecular O-H···O and N-H···O hydrogen bonds among the host 
and guest molecules in F1.  The relevant hydrogen atoms are shown as spheres.  The other 
hydrogen atoms and guest molecules are omitted for clarity.   
 
The distances O4A···O4W and O2B···O4W are 2.945(6) and 2.799(6) Å, respectively.  
Therefore, both O4A and O2B are located within hydrogen bonding distance of O4W.  
During the structure refinement, a geometrically sensible electron density peak located in 
the difference Fourier maps, was assigned as the hydrogen atom H4W2 (Figure 10).  The 
angles of the H-bond interactions O4W-H4W2···O4A and O4W-H4W2···O2B are 
118.4(6)o and 116.6(9)o, respectively (Figure 10).  In other words, the hydrogen H4W2 is 

























Figure 10 The hydrogen bond environment of the water molecule O4W.  The relevant oxygen 
atoms are shown as spheres.  The hydrogen atoms in the rifaximin molecules are omitted for 
clarity. 
 
The geometrical details for the host-guest intermolecular N-H···O and O-H···O 
interactions are listed in Table 11.  The mean N···O distance is 2.93 Å while the mean 
angle is 134o.  The average O···O distance is 2.86 Å while the average angle is 160o. 
 
Table 11 Host-guest intermolecular N-H···O and O-H···O interactions in F1a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) Symmetry operatorb 
N1A-H1NA···O5W 2.845(5) 140.0 x, y, z 
N2A-H2NA···O4W 3.049(6) 135.0 x, y, z 
N2B-H2NB···O8W 2.907(5) 128.0 x, y, z 
O2W-H2W1···O4A 2.843(6) 169(4) x, y, z 
O5W-H5W1···O1B 2.775(5) 163(2) 2-x, -1/2+y, 1-z 
O9W-H9W1···O10B 2.864(6)      167.0(4) 2-x, -1/2+y, 2-z 
O5W-H5W2···O1A 2.938(6)      161.0(5) x, y, z 
O6W-H6W1···O8B 2.861(5) 169(5) 1-x, 1/2+y, 2-z 
O7W-H7W2···O4B 2.873(6)      170.0(6) x, y, z 
O9W-H9W2···O8A 2.757(6)      155.0(4)  x, y, 1+z 
O3W-H3W1···O2A 2.908(7)      138.0(3) 1-x, 1/2+y, 1-z 
O8W-H8W1···O2A 2.926(6)      146.0(5) x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
There are three intermolecular C-H···O interactions between the rifaximin and water 
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Table 12 Host-guest intermolecular C-H···O and N-H···O interactions in F1a  
Hydrogen bond C···O or N···O Distance (Å) Angle (o) Symmetry operatorb 
C39A-H39A···O3W 3.365(7) 162.0 1+x, y, z 
C41A-H41A···O4W 3.189(8) 131.0 x, y, z 
N41B-H41B···O8W 3.035(6) 128.0 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Water-water Interactions  
Figure 11 illustrates the water-water interactions in F1.  Water molecules form a cluster, 
except for O5W which is isolated by forming hydrogen bond interactions with two 
distinct rifaximin molecules.  The hydrogen atoms of O1W could not be located due to its 
very low site-occupancy (0.36). 
 
Figure 11 The water-water intermolecular O-H···O interactions among the water molecules in F1. 
 
The details of the water-water intermolecular hydrogen bond interactions are listed in 
Table 13.  The mean O···O distances for these interactions is 2.85 Å while the mean      
O-H···O angle is 160o. 
 
Table 13 The details of water-water hydrogen bond interactions in hydrate F1a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O4W-H4W1···O6W 2.765(6)      146.0  1-x, 1/2+y, 1-z 
O7W-H7W1···O9W 2.859(7)      163.0 x, y, z 
O2W-H2W2···O6W 2.975(7)      154.0 1-x, 1/2+y, 1-z 
O6W-H6W2···O7W 2.759(7)      167.0 x, y, z 
O8W-H8W2···O9W 2.889(7)      169.0 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
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Overall Intramolecular and Intermolecular Interactions in F1 
The overall hydrogen bond interactions of F1 are shown in Figure 12.  The water cluster 
is found to be intimately associated with seven rifaximin molecules.  The water molecule 
O2W functions as hydrogen bond donor to two molecules and serves as a hydrogen bond 
acceptor to two other molecules simultaneously.  This also applies to water molecules 
O6W and O9W.  The water molecule O7W functions as a hydrogen bond donor to two 
different molecules while simultaneously serves as a hydrogen bond acceptor to another 
molecule.  This also applies to the water molecule O8W.  Due to the bifurcated hydrogen 
bonds formed by H4W2 of O4W, O4W servers as a hydrogen bond donor to three 
different molecules while it functions as a hydrogen bond acceptor to another molecule.  
The water molecule O3W functions as hydrogen bond donor to two different molecules 
but is not an acceptor of hydrogen bonds. 
 
Figure 12 Stereoview of the overall hydrogen bond interactions in F1.  The oxygen atoms in 
water molecules are shown as spheres. 
 
A noteworthy observation is that the water molecule O5W is isolated from the water 
cluster described above.  O5W associates one host molecule A with a symmetry-
generated host molecule B by serving as hydrogen bond donor to O1A and O1B while 
functioning as hydrogen bond acceptor to N1A (Figure 13).   




Figure 13 The hydrogen bond environment of the water molecule O5W, whose oxygen atom is 
shown as a sphere.  Molecule B is located at the position 2-x, -1/2+y, 1-z.   
 
The schematic diagram illustrating the overall hydrogen bond interactions for F1 are 
presented in Figure 14.  Notably, not only the hydrogen atom H4W2 of O4W forms 
bifurcated hydrogen bonds; this also applies to H10A (with O9A and O11B), H2NA 
(with O4W and O4A) as well as H2NB (with O8W and O4B). 
 
Figure 14 The schematic diagram for the overall hydrogen bond interactions in hydrate F1.  The 
code letter for the symmetry operator of each rifaximin molecule is given as a suffix in the atom 
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Crystal Packing  
F1 packs in a layer arrangement, as shown in Figure 15.  Host molecules A and B are 
related by a pseudo 2-fold rotation parallel to the a-axis, forming layers which consist of 
both molecules A and B parallel to the c-axis.  In each layer, the host molecules are 
associated by π-π interactions when they pack in head-to-head mode and associated by 
water molecules when they pack in tail-to-tail mode.  Furthermore, the host molecules are 
connected by intermolecular interactions, some mediated by water molecules, when they 
pack along the b-axis.  This arrangement introduces isolated sites where guest molecules 
are accommodated.   
 
Figure 15 Crystal packing diagram of F1 viewed along [100]; water molecules are shown as 
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F2 – 4Rifaximin • 7.72ethylene glycol • 6.83H2O 
As indicated above, the crystal of F2 has a formula unit consisting of four independent 
rifaximin molecules as well as approximately eight ethylene glycol molecules and seven 
water molecules.  As such, its structural refinement presented a considerable challenge.  
A detailed account of the crystal structure follows.  
 
Host-host Intra- and Intermolecular Hydrogen Bond Interactions  
Figure 16 shows the zwitterionic structures as well as the host-host intra- and 
intermolecular hydrogen bond interactions in the asymmetric unit of F2.  Each host 
molecule adopts a similar motif of intra- and intermolecular hydrogen bond interactions.  
A unique interaction occurs in the molecule A in which the hydrogen bond O9A-
H9A···O8A is formed.  In each molecule, the hydrogen atom H2N simultaneously forms 
an intramolecular hydrogen bond with O4 and an intermolecular hydrogen bond with 
O11 of the neighbouring rifaximin molecule.  In other words, H2NA, H2NB, H2NC and 
H2ND all form bifurcated hydrogen bonds.  Hydrogen bonds N2A+-H2NA···O11C and 
N2C+-H2NC···O11A act as tethers, stabilising the formation of the dimeric unit A···C.  
The dimeric unit B···D is stabilised in an analogous fashion.  However, there is no         
O-H···O or N+-H···O intermolecular hydrogen bond between the host molecules A and B.  
 
Figure 16 The zwitterionic structures, and the host-host intra- and intermolecular hydrogen bond 
interactions for solvate F2.  The relevant hydrogen atoms are shown as spheres.  The other 
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Table 14 lists the geometrical details of the hydrogen bond interactions. For the 
intramolecular interactions, the average O···O distance is 2.62 Å with a mean angle of 
149o.  Furthermore, the mean N···O distance is 2.74 Å and the average angle is 146o.  For 
the O-H···O intermolecular interactions, the mean hydrogen bonding distance is 3.04 Å 
while the mean angle is 124o.        
 
Table 14 Intra- and intermolecular hydrogen bond interactions in the host molecules of solvate 
F2a 
Hydrogen bond O···O or N···O Distance (Å) Angle (o) 
Intramolecular 
O1A-H1A···O2A 2.403(12) 151.0 
O1B-H1B···O2B 2.453(13) 150.0 
O1C-H1C···O2C 2.455(11) 151.0 
O1D-H1D···O2D 2.483(14) 150.0 
N2A+-H2NA···O4A 2.756(11) 146.0 
N2B+-H2NB···O4B 2.780(13) 143.0 
N2C+-H2NC···O4C 2.722(12) 146.0 
N2D+-H2ND···O4D 2.715(13) 148.0 
O10A-H10A···O9A 2.775(14) 143.0 
O10B-H10B···O9B 2.743(15) 152.0 
O10C-H10C···O9C 2.732(14) 149.0 
O10D-H10D···O9D 2.705(4) 152.0 
O9A-H9A···O8A 2.819(14) 142.0 
Intermolecular 
N2A+-H2NA···O11C 3.040(13) 122.0 
N2C+-H2NC···O11A 3.043(14) 127.0 
N2B+-H2NB···O11D 2.925(14) 126.0 
N2D+-H2ND···O11B 3.147(15) 119.0 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
 
Numerous intramolecular C-H···O and C-H···N interactions (Table 15) are associated 
with the rifaximin conformations in F2.  For the intramolecular interactions, the average 
C···O distance is 2.87 Å while the average angle is 107o.  Also, the mean C···N distance is    
3.03 Å and mean angle 112o.  For the intermolecular interactions, the mean C···O distance 
is 3.36 Å while the average angle is 148o.   Notably, a C···O close contact C31B···O8A 
[3.24(2) Å] is found; this is the only significant observable interaction between the host 
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Table 15 Intra- and intermolecular C-H···O and C-H···N interactions in the host molecules of F2a 
Hydrogen bond C···O or C···N Distance (Å) Angle (o) Symmetry operatorb 
Intramolecular 
C14A-H14B···O3A 2.90(2) 105.0 x, y, z 
C14B-H14E···O2B 2.88(2) 106.0 x, y, z 
C14C-H14I···O2C 2.83(2) 108.0 x, y, z 
C14D-H14K···O3D 2.88(2) 106.0 x, y, z 
C18B-H18B···N1B 3.09(2) 118.0 x, y, z 
C18D-H18D···N1D 2.97(2) 106.0 x, y, z 
C25A-H25A···O8A 2.77(2) 104.0 x, y, z 
C25A-H25A···O9A 2.91(2) 108.0 x, y, z 
C25B-H25B···O8B 2.78(2) 102.0 x, y, z 
C25B-H25B···O9B 2.85(2) 108.0 x, y, z 
C25C-H25C···O8C 2.74(2) 106.0 x, y, z 
C25C-H25C···O9C 2.93(2) 107.0 x, y, z 
C25D-H25D···O8D 2.73(2) 103.0 x, y, z 
C25D-H25D···O9D 2.92(2) 107.0 x, y, z 
C27A-H27A···O7A 2.82(2) 104.0 x, y, z 
C27B-H27B···O7B 2.84(2) 108.0 x, y, z 
C27C-H27C···O7C 2.85(2) 104.0 x, y, z 
C27D-H27D···O7D 2.87(2) 111.0 x, y, z 
C28C-H28C···O3C 3.09(2) 115.0 x, y, z 
C30D-H30J···O11D 2.91(2) 102.0 x, y, z 
C32A-H32C···O9A 2.80(2) 101.0 x, y, z 
C33D-H33B···O7D 2.75(2) 100.0 x, y, z 
C33A-H33L···O7A 2.83(2) 101.0 x, y, z 
C33C-H33M···O7C 2.69(2) 100.0 x, y, z 
C36A-H38A···O11A 3.11(2) 123.0 x, y, z 
C38B-H38B···O11B 3.05(2) 112.0 x, y, z 
C38D-H38D···O11D 3.09(2) 113.0 x, y, z 
Intermolecular 
C13B-H13F···O1D 3.31(2) 142.0 x, y, z 
C13D-H13J···O1B 3.42(2) 152.0 x, y, z 
C13C-H13M···O1A 3.43(2) 162.0 x, y, z 
C41A-H41A···O11C 3.16(2) 120.0 x, y, z 
C31C-H31H···O2A 3.39(2) 153.0 1+x, y, z 
C36B-H36F···O8C 3.47(2) 158.0 1-x, 1/2+y, 1-z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Figure 17 shows the π-π interactions between the host molecules D and B as well as 
those between the molecules A and C in the asymmetric unit.  Table 16 lists the details of 
the π-π and C-H···π interactions.  The average distance for the π-π interactions is 3.70 Å 
(range 3.374 to 3.992 Å).  The mean distance for the C-H···π interactions is 3.39 Å with a 
mean angle of 124o. 




Figure 17 Aromatic rings involved in π-π interactions between rifaximin molecules B and D, and between 
A and C in the asymmetric unit.  The labelling of the centroids is analogous to that shown in the caption of 
Figure 8.  
 
Table 16 All possible π-π interactions with cg···cg < 4 Å and C-H···π interactions among the rifaximin 
molecules in F2a 




cg2···cg12  3.387(7)   -------- 
cg2···cg14  3.742(7)   -------- 
cg3···cg12  3.849(7) -------- 
cg3···cg13   3.508(8)   -------- 
cg4···cg14   3.855(7)   --------   
cg4···cg15  3.910(7)   -------- 
cg5···cg15  3.707(7)   -------- 
cg7···cg17   3.374(8)    -------- 
cg7···cg19  3.962(8)    -------- 
cg8···cg18  3.530(8)    -------- 
cg9···cg19  3.992(8)    -------- 
cg10···cg20  3.641(8)    -------- 
C-H···π interactions 
C28A-H28A···cg1(O3A-C6A-C5A-C11A-C12A) 3.08(2) 89.0 
C28B-H28B···cg6(O3B-C6B-C5B-C11B-C12B) 3.03(2) 91.0 
C28C-H28C···cg11(O3C-C6C-C5C-C11C-C12C) 2.94(2) 98.0 
C29D-H29D···cg16(O3D-C6D-C5D-C11D-C12D) 2.65(2) 66.0 
C33B-H33E···cg7(N2B-C4B-C3B-N3B-C42B) 3.67(2) 149.0 
C33C-H33H···cg12(N2C-C4C-C3C-N3C-C42C) 3.82(2) 145.0 
C33A-H33K···cg2(N2A-C4A-C3A-N3A-C42A) 3.69(2) 145.0 
C34A-H34A···cg5(C5A-C6A-C7A-C8A-C9A-C10A) 3.56(2) 144.0 
C34B-H34E···cg10(C5B-C6B-C7B-C8B-C9B-C10B) 3.55(2) 148.0 
C34D-H34K···cg19(C1D-C2D-C3D-C4D-C10D-C9D) 3.64(2) 125.0 
C34D-H34L···cg20(C5D-C6D-C7D-C8D-C9D-C10D) 3.44(2) 140.0 
C34C-H34M···cg15(C5C-C6C-C7C-C8C-C9C-C10C) 3.56(2) 149.0 
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Host-guest Interactions  
The host-guest hydrogen bond interactions are shown in Figure 18.  Atoms O2, O10, O11 
and N1 are involved in the hydrogen bond interactions in all four symmetry-independent 
host molecules.  A noteworthy observation is that no guest molecule serves as a bridge to 
associate the molecules B and A.  Furthermore, the overall hydrogen bond pattern is very 
complicated; therefore, the hydrogen bonds relating to molecules A and C, as well as 
those relating to molecules B and D, are discussed separately.  
 
Figure 18 Stereoview of the intermolecular O-H···O and N-H···O hydrogen bonds between the 
host and guest molecules in solvate F2.  The relevant oxygen atoms in the guest molecules are 
shown as spheres.  The hydrogen atoms are omitted for clarity.  
 
The O-H···O and N-H···O hydrogen bonds between the hosts (rifaximin molecules A and 
C) and the guests (ethylene glycol and water molecules) are shown in Figure 19.  No 
guest molecule is found to serve as a bridge to associate two rifaximin molecules A and 
C.  However, the ethylene glycol molecule (O3G-C3G-C4G-O4G) is found to associate 
molecule A and a symmetry-generated host molecule C by forming a hydrogen bond 















Figure 19 Stereoview of the O-H···O and N-H···O hydrogen bonds between the host (A and C) 
and guest molecules in F2.  The relevant oxygen and nitrogen atoms in the guest molecules are 
shown as spheres.  The other hydrogen atoms and guest molecules are omitted for clarity.   
 
 
Figure 20 The long hydrogen bonded chain O1A···O2A···O3G-C3G-C4G-O4G···O11C in F2.  
The relevant oxygen atoms are shown as spheres.  Atoms with gray labels have been symmetry-
generated from their asymmetric unit counterparts.   
 
The O-H···O and N-H···O hydrogen bonds between the host (rifaximin molecules B and 
D) and the guest (the ethylene glycol and water molecules) are shown in Figure 21.  
Molecules B and D are not bridged via any solvent molecules.  However, the ethylene 
glycol molecule (O7G-C7G-C8G-O8G) and the disordered water molecules O2WA and 
O2WB associate the molecule B and two symmetry-generated molecules D by forming 
two hydrogen bond chains O1B···O2B···O7G-C7G-C8G-O8G···O11D and 
































Figure 21 Stereoview of the O-H···O and N-H···O hydrogen bonds between the hosts (B and D) 
and guest molecules in F2.  The relevant oxygen atoms are shown as spheres.  The other 
hydrogen atoms and guest molecules are omitted for clarity.  Atoms with gray labels have been 
symmetry-generated from their asymmetric unit counterparts.   
 
Figure 22 The long hydrogen bonded chains O1B···O2B···O7G-C7G-C8G-O8G···O11D and 
O9B···O10B···O2WA/O2WB···O8D in F2.  The relevant oxygen atoms are shown as spheres.  
Atoms with gray labels have been symmetry-generated from their asymmetric unit counterparts.   
 
The details of these hydrogen bond interactions are listed in Table 17.  The average O···O 
distance for O-H···O interactions is 2.81 Å (range 2.699 to 3.022 Å).  The mean N···O 
distance for N-H···O interactions is 2.973 Å (range 2.93-3.03 Å) with a mean angle of 
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Table 17 Host-guest intermolecular hydrogen bond interactions in solvate F2a 
Hydrogen bond O···O and N···O Distances (Å) Angle (o) Symmetry operatorb 
O9D-H9D···O17G 2.73(4) 165 x, y, z 
O2WB···O8D 2.95(4) ----- -x, y-1/2, 2-z 
O2WA···O8D 2.90(3) ----- -x, y-1/2, 2-z 
O6W···O2D 2.79(5) ----- x, y, z 
O7W···O10D 2.77(2) ---- x, y, z 
O8G-H8G···O11D 3.02(3) 150 x-1, y, z 
O3W···O11B 2.82(2) ----- x, y, z 
O7G-H7G···O2B 2.70(3) 147 x, y, z 
O5G-H5G···O2B 2.74(4) 158 x, y, z 
O10B···O2WB 2.73(4) ----- x, y, z 
O10B···O2WA 2.82(3) ----- x, y, z 
O9B-H9B···O10G 2.70(2)   148 x, y, z 
O9G-H9G···O6B 2.91(2) 162 x, y, z 
O2G-H2G···O10A 2.85(2) 163 x, y, z 
O1G-H1G···O1A 2.79(2) 152 x, y, z 
O3G-H3G···O2A 2.87(1) 155 x, y, z 
O1W···O11A   2.77(2) ----- x, y, z 
O4G-H4G···O11C 2.83(2) 155 x-1, y, z 
O5W···O10C 2.74(1) ----- x, y, z 
O13G-H13G···O2C 2.72(3) 154 x, y, z 
O9C-H9C···O4WA 2.85(3) 139 x, y, z 
O15G-H15G···O10C 2.93(3) 171 x, y, z 
O11G-H11G···O10B 2.83(2) 156 x, y, z 
N1D-H1ND···O7W 3.03(2) 158 x, y, z 
N1B-H1NB···O11G 2.98(2) 161 x, y, z 
N1A-H1NA···O2G 2.96(1) 163 x, y, z 
N1C-H1NC···O5W 2.92(2) 161 x, y, z 
a Where no e.s.d. is reported for the angle, H atoms involved were added in idealised  positions in 
a riding model. 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
In addition, a host guest C-H···O hydrogen bond (C41D-H41D···O3W) is observed. 
[C···O 3.29(2) Å, C-H···O angle 155o] 
 
Guest-guest Interactions  
In the structure of F2, two different guest clusters are formed by the ethylene glycol and 
water molecules.  One of the clusters (namely cluster 1) is shown in Figure 23.  It is 
extended and a variety of disordered arrangements involving guest molecules occurs.  




Figure 23 The guest-guest intermolecular O-H···O interactions among the water and ethylene 
glycol molecules in F2.  (a) The labelling scheme of the cluster 1.  Atoms with gray labels have 
been symmetry-generated from their asymmetric unit counterparts. The disordered atoms are 
labelled with their site-occupancies.  (b) Stereoview of the cluster 1.   
 
 
Figure 24 presents the second guest cluster (cluster 2) which is intimately associated with 
two symmetry-independent host molecules A and D.  This cluster, which is relatively 









































Figure 24 The hydrogen bond interactions in the cluster 2.  The host molecule D with gray label 
has been symmetry-generated from its asymmetric unit counterparts.   
 
The water molecules O2WB, O4WA and O4WB as well as the ethylene glycol molecules 
O3G-C3G-C4G-O4G and O7G-C7G-C8G-O8G are not hydrogen bonded to any other 
guest molecules.  Specifically, the molecule O3G-C3G-C4G-O4G associates the 
rifaximin molecules A and C while the molecule O7G-C7G-C8G-O8G connects 
rifaximin molecules B and D. 
 
The details of the guest-guest intermolecular O-H···O interactions are listed in Table 18.  
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Table 18 The details of the guest-guest intermolecular hydrogen bond interactions in solvate F2a 
Hydrogen bond O···O Distance (Å) Angle (o) Symmetry operatorb 
O10G-H10G···O10W 3.152 175.2 x-1, y, z 
O6G-H6G···O9G 2.731 168.8 x, y, z 
O10W··O8WA 3.077 ----- x, y, z 
O8WA···O1W 3.049 ----- x, y, z 
O1W···O8WB 2.643 ----- x, y, z 
O8WA···O9WC 2.770 ----- 1-x, y-1/2, 1-z 
O1W···O7W 2.603 ----- 1-x, y-1/2, 1-z 
O7W···O9WA 2.643 ----- x, y, z 
O9WC···O9WA 2.690 ----- x, y, z 
O7W···O9WB 2.725 ----- x, y, z 
O18G···O9WC 2.599 ----- x, y, z 
O23G-H23G···O22G 2.726 161.4 x, y, z 
O22G-H22G···O20G 2.820 149.6 x, y, z 
O24G-H24G···O25G 2.844 159.4 x, y, z 
O21G-H21G···O3W 2.794 171.4 x, y, z 
O20G-H20G···O5W 2.739 159.1 1-x, 1/2+y, 2-z 
O5W···O3W 2.773 ----- 1-x, y-1/2, 2-z 
O21G···O19G 2.673 ----- x, y, z 
O19G···O12W 2.717 ----- 1-x, y-1/2, 2-z 
O25G···O16G 3.050 ----- 1-x, 1/2+y, 2-z 
O26G-H26G···O12W 2.537 157.6 -x, y-1/2, 2-z 
O27G-H27G···O16G 2.511 166.8 x, y, z 
O28G-H28G···O11W 2.708 150.7 1+x, y, z 
O11W···O13G 2.857 ----- x, y, z 
O15G···O11W 2.672 ----- 1+x, y, z 
O11W···O26G 2.933 ----- -x, y-1/2, 2-z 
O14G-H14G···O11G 2.851 167.2 -x, y-1/2, 2-z 
O12G-H12G···O2WA 2.758 156.6 x, y, z 
O18G-H18G···O28G 2.826 173.4 x-1, 1+y, z 
O1G···O6W 2.872 ----- -x, y-1/2, 1-z 
a Average e.s.d.s 0.008 Å for distance and 0.9o for angle 
b Symmetry operator applies to hydrogen bond acceptor atoms.  
 
Overall Intramolecular and Intermolecular Interactions in F2  
Figure 25 shows the overall hydrogen bond interactions in solvate F2.  The hydrogen 
bond network is fairly complicated; therefore, a schematic diagram illustrating the 
network for F2 is presented in Figure 26.     








Figure 26 Schematic diagram of the overall hydrogen bond interactions in F2.  The code letter for the 
symmetry operator of each rifaximin molecule is given as a suffix in the atom label.  (a = x, y, z; b = x, y, 
1+z; c = x-2, y, 1+z; d = -x, y-1/2, 2-z; e = -x-1, y-1/2, 2-z; f = -x, 1/2+y, 2-z; g = 1-x, 1/2+y, 2-z and h =   
x-1, y, 1+z.)  
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The host molecules A and C in F2 are related by a pseudo 2-fold rotation axis, as are 
molecules B and D (Figure 27).  In addition, the host molecules A and B are also related 
by pseudosymmetry.  
 
Figure 27 (a) A pseudo 2-fold rotation axis relating molecules A and C.   (b) A pseudo 2-fold 
rotation axis relating molecules B and D. 
 
The packing arrangement for F2 is shown in Figure 28.  Notably, no host-host 
intermolecular or host-guest intermolecular interactions are found involving the host 
molecules A and B.  The only interaction between them is the close contact C31B···O8A.  
Host-host interactions associate the host molecules parallel to the b-axis.  This 
arrangement introduces isolated sites which extend parallel to the a-axis and 











Figure 28 Crystal packing diagram for F2 viewed along [100]; solvent molecules are shown as 
green spheres for clarity.  Host molecules A, B, C and D in the asymmetric unit are shown in 
























The calculated and experimental PXRD traces for the tetrahydrate F1 and the ethylene 
glycol-water solvate F2 are shown in Figure 29.  In both cases, a slight shift in the 
computed trace to higher 2θ angles can be observed; this is due to the temperature 
difference at which the data were collected (experimental trace at 298 K, calculated trace 
at 173 K).  Furthermore, differences in intensities between corresponding PXRD peaks 
can be attributed to preferred orientation effects in samples of both F1 and F2.  However, 
the agreement between the experimental and calculated traces is generally convincing, 
indicating that each prepared sample was homogeneous.  
 
 














A hydrate F1 of rifaximin and an ethylene glycol-water solvate F2 were isolated by 
recrystallisation and characterised by X-ray diffraction methods.   
 
Conformation of the Rifaximin Host Molecules  
The similarity between the host molecule A of F1 and the hosts of F2 was demonstrated 
in the overlay diagram (Figure 2) and reflected in the parameters that described the 
relevant dihedral angles involving the three principal planes (Table 4) and relevant 
torsion angles along the ansa chain (Table 5).   
 
A considerable difference can be observed between the conformations of the rifaximin 
molecule B in F1 and those of the other host molecules (shown in Figure 2).  The main 
difference is reflected in the orientation of the bond C15=O11.  Specifically, this bond 
points away from the ansa chain in the host molecule B of F1 while pointing towards the 
ansa chain in the other host molecules.  This indicates the existence of two quite distinct 
conformations of the rifaximin molecule.  The ability of different included solvents to 
induce subtle variations in rifaximin molecular conformations is nicely illustrated in the 
solvate F2, with Z′ = 4 (Figure 2 and Table 4).   
 
Zwitterionic structure is a common feature associated with these distinct rifaximin 
conformations.  It results from proton transfer from a hydroxyl group on the chromophore 
to nitrogen atom N2 of the imidazole ring.   
 
The host molecules all adopt an open conformation.  Each of the distinct conformations 
of rifaximin observed in this study has geometrical parameters that fall within the range 
required for antibiotic activity.  
 
Hydrogen Bond Interactions 
Identical intramolecular hydrogen bond interactions O1-H1···O2 and N2-H2··O4 are 
found in all the rifaximin molecules in F1 and F2.  Furthermore, the average distance 
between O1 and O2 is 2.45 Å (range 2.40 – 2.48 Å) with an average angle of 150o.  The 
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mean N2···O4 distance is 2.76 Å (range 2.72 – 2.81 Å) with a mean angle of 144o (range 
140.0 – 148.0o).  The intramolecular hydrogen bond interaction O10-H10···O9 is found in 
the molecule A in F1 and in the molecules A, B, C and D in F2; however, host molecule 
B in F1 does not display this feature.  A unique intramolecular hydrogen bond O9B-
H9B···O10B exists in the molecule B in F1 while a unique hydrogen bond O9A-
H9A···O8A is present in the molecule A in F2.     
 
The motif of host-host intermolecular hydrogen bonds in F1 is completely different from 
that in F2.  In F1, the hydrogen bond O1B-H1NB···O11A stabilises the two symmetry-
independent rifaximin molecules in the asymmetric unit while another three host-host 
intermolecular  hydrogen bonds associate the host molecules along the b-axis (Table 8 
and Figure 15).  In F2, all the host-host interactions among the rifaximin molecules occur 
only within the asymmetric unit.  In more detail, similar hydrogen bonds                    
(N2+-H2N···O11) associate the molecules A and C, and a similar pattern is found for 
molecules B and D.  However, no such host-host hydrogen bond can be observed 
between host molecules A and B.  In fact, only a close contact O8A···C31B serves to 
associate these two symmetry-independent host molecules.  
 
Pseudosymmetry, in the form of pseudo 2-fold rotation axes, was found to exist in the 
packing arrangements of the crystals of F1 and F2.  Thus, host molecules A and B in F1 
are related a pseudo 2-fold axis, as are molecules A and C as well as molecules B and D 
in F2. (A more complex pseudosymmetry relates molecules A and B in solvate F2). 
Furthermore, the pseudo torsion angles C43A···C7A···C7B···C43B in F1, 
C43A···C7A···C7C···C43C in F2 and C43B···C7B···C7D···C43D in F2 are -78.3(2),          
-6.5(8) and -8.7(9)o, respectively (Figure 30).  Corresponding to these three torsional 
relationships, there are three, seven and five π-π interactions respectively, the smallest 
torsion angle coinciding with the largest extent of π-π interaction, as expected.  
 
 




Figure 30 Atoms defining the pseudo torsion angles (a) C43A···C7A···C7B···C43B in the 
molecules A and B in F1, (b) C43A···C7A···C7C···C43C in the molecules A and C in F2 and (c) 
C43B···C7B···C7D···C43D in the molecules B and D in F2. 
 
The host-guest intermolecular hydrogen bond interactions in F1 are compared with those 
in F2.  Whether the hydroxyl oxygen atoms and the nitrogen atoms in the host molecules 
are involved in the hydrogen bonds with the guest molecules are shown individually in 
Table 19.  In each molecule, both the O2 and O10 atoms are involved in the host-guest 
interactions.  Furthermore, the N and O atoms which are involved in the interactions are 
different between the crystallographically independent host molecule in the same hydrate 
or solvate.  
 
Table 19 Shows whether the nitrogen and oxygen atoms in the host molecules are involved in the 
host-guest H-bond interactions in F1 and F2. 
molecule O1 O2 O4 O6 O8 O9 O10 O11 N1 N2 
A Yes Yes Yes ----- Yes ----- Yes ----- Yes Yes F1 
B Yes Yes Yes ----- Yes ----- Yes ----- ----- Yes 
A Yes Yes ----- ----- ----- ----- Yes Yes Yes ----- 
B ----- Yes ----- Yes ----- Yes Yes Yes Yes ----- 
C ----- Yes ----- ----- ----- Yes Yes Yes Yes ----- 
F2 
D ----- Yes ----- ----- Yes Yes Yes ----- Yes ----- 
   
The packing diagrams of F1 are completely different from those of F2.  However, 
isolated sites for the included solvent molecules, located parallel to the a-axis, are found 
in both cases.  













Chapter 5: Rifaximin Solvates  
 
 322
Closing Remarks – Status of Rifaximin Species 
It is very relevant to note here that the author first isolated single crystals of solvate F1 in 
2007, subsequently solving and refining the crystal structure by the end of that year. In 
2008, the crystal structure of a solvate described as rifaximin tetrahydrate was reported 
by Bacchi et al.7  Exhaustive comparison of the crystal structure of F1 (TGA-derived 
formula rifaximin⋅3.7H2O) with the published structure of the tetrahydrate confirmed that 
they were indeed the same phase, the latter crystal evidently containing ~8% more water 
of crystallization. Bacchi et al. collected their X-ray data at 293 K.  Interestingly, the 
lower temperature of the author’s data-collection (173 K) did not yield significantly more 
accurate molecular and crystal packing parameters.  An overlay of the two crystal 
asymmetric units, presented in Figure 32, reveals only small host conformational 
differences and the subtle effects of temperature on solvent molecule locations.   
 
Figure 32 An overlay diagram of the tetrahydrate7 (black) and F1 (red).  Hydrogen atoms are 
omitted for clarity. 
 
The zwitterionic structure of rifaximin was established in both crystal structure 
determinations. One minor difference is that water molecule O1W (with s.o.f. 0.36) in F1 
adopts a unique position, not matched by a counterpart in the tetrahydrate.  
 
Despite the unforeseen duplication described above for F1 and the subsequently 
published tetrahydrate structure,7 the author pursued the search for other solid phases of 
rifaximin, successfully isolating solvate F2, which turned out to be a much more 
challenging structural problem. For this phase, a satisfactorily refined structural model 
O1W 
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was eventually obtained only after much effort to optimise the crystal quality and several 
X-ray data-collections to achieve the required resolution. 
 
To the author’s knowledge, the structures of the phases F1 and F2 are the only ones 
known for the drug rifaximin. Given the fact that they are not isostructural, a comparison 
of their similarities and differences was considered a worthy goal of this study. In 
particular, the high Z′ value for the solvate F2 (viz. 4) presented the opportunity for 
observing for the first time a potentially wider range of rifaximin conformations in the 
solid state than those afforded by solvate F1 (Z′ = 2), as well as novel crystal packing 
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In this chapter, we describe the thermal behaviours of the rifampicin and rifaximin 
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As explained in chapters 4 and 5, the derivation of molecular formulae for the solvates 
was achieved by combining data obtained from multiple Thermogravimetric Analysis 
(TGA) measurements with data from X-ray structural refinements.  In this chapter, the 
experimental mass loss (average data of multiple TGA measurements) for each solvate is 
compared with the respective calculated mass loss, implied by the derived solvate 
formula.   
 
Rifampicin Isostructural Series 1 (P1, P2, P3 and P4) 
P1:   rifampicin • 1.57methanol • 3H2O, 
P2:   rifampicin • 0.39methanol • 4.17H2O,  
P3:   rifampicin • 2ethanol •2H2O,  
P4:   rifampicin • 0.54ethanol • 3.92H2O 
 
Hot Stage Microscopy (HSM) 
The crystals of solvates P1 and P2 were placed on the same slide under silicone oil 
(Figure 1).  The colour of the crystal P2 was lighter than that of P1 at 30 oC.  This is 
probably due to the different compositions of P1 and P2.  The water and methanol 
molecules of P1 started to escape at ~70 oC resulting in bubbles forming on the surface of 
the crystal while no obvious appearance of bubbles was observed around the crystal P2.  
At 200 oC, both crystals began to decompose and turned dark brown in colour.  
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The crystals of P3 and P4 were treated in the same way and the corresponding HSM 
photographs are shown in Figure 2.  Similarly to the crystals of P1 and P2, the colour of 
crystal P3 was darker than that of P4 at 30 oC.  No appearance of bubbles was observed 
during the heating of P3 and P4.  However, both crystals were gradually surrounded by a 
yellow solution, resulting from re-dissolution of partially desolvated drug in ethanol 
liberated from the solvates.  
 
Figure 2 Thermal decay for the crystals of P3 and P4.   
 
All four crystals shown in Figures 1 and 2 started to show signs of decomposition at   
~200 oC and totally decomposed at ~220 oC.  This provides visual evidence that the 
crystals of P1, P2, P3 and P4 apparently changed into the same species after desolvation.  
It should be noted that for this solvate series as well as all the other series, variable 
temperature PXRD was employed in an attempt to characterise the desolvated material. 
(The likelihood of different amorphous forms of a given drug arising from different 
isostructural solvate series is mooted in the Discussion Section). 
 
TGA 
The TGA traces for P1 and P2 are shown in Figure 3.  The crystals of P1 lose mass 
immediately above 30 oC while those of P2 only start to lose mass at approximately       
42 oC.  This corresponds to the observation that crystals of P1 desolvate instantly when 
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derivative curves (DTG curves) of P1 and P2 (not shown), both solvates showed 
multiple-step mass loss indicating that they lost methanol and water molecules 
simultaneously during the heating process (given as B in Figure 3).  Point C indicates the 
decomposition of both samples with an onset temperature of ~180 oC.  The calculated 
mass loss is comparable to the experimental mass loss for P1 in the temperature range of 
30 oC to 134.2 oC; these losses are 12.5% and 12.4 ± 0.5% (n = 3), respectively.  The 
experimental mass loss for P2 is 9.7 ± 0.3% (n = 3) in the temperature range of 42.1 oC to 
133.2 oC; this is consistent with its calculated mass loss 9.6%.   
 
Figure 3 TGA traces for rifampicin solvates P1 (red) and P2 (blue)  
 
Similarly to P1 and P2, crystals of P3 (Figure 4, red) exhibited an instantaneous mass loss 
above 30 oC whilst those of P4 (Figure 4, blue) only lost mass at ~37 oC.  This result is 
consistent with the fact that P3 desolvates immediately after being removed from the 
crystallising solvent (indicated by point A in Figure 3).  Both curves exhibited multiple-
step mass loss, none of which corresponded convincingly to that of only ethanol or water 
molecules in the stated solvate formula.  This provides proof that both solvates lose the 
ethanol and water molecules concurrently during the heating process (represented by B in 
Figure 4).  The decomposition of the desolvated crystals occurred at ~180 oC, shown by 
C in the Figure.  The calculated mass loss is comparable to the experimental mass loss for 
P3 in the temperature range of 30 oC to 150.0 oC; these are 13.5% and 12.6 ± 0.9 % (n = 
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temperature range of 37.2 oC to 168.5 oC, and this is consistent with its calculated mass 
loss of 10.3%.    
 
Figure 4 TGA traces for rifampicin solvates P3 (red) and P4 (blue) 
 
For all four solvates P1, P2, P3 and P4, the experimental mass loss matches the respective 
calculated mass loss within the quoted experimental errors.  The consistency of the 
decomposition temperature (~180 oC) in these TGA traces strongly suggests that all the 
four solvates were converted into the same product after desolvation.  
 
Differential Scanning Calorimetry (DSC) 
The DSC traces of the four solvates are very similar (Figure 5).  They all exhibited one 
broad desolvation endotherm D, comprising two overlapping peaks.  This indicates the 
possibility of the presence of a solvent mixture (methanol/water, ethanol/water), which is 
consistent with the multiple-step mass loss B in the TGA traces for all four solvates in 




























(a) P1 and P2 
 
 
(b) P3 and P4 
Figure 5 DSC traces for P1 and P2 (a); P3 and P4 (b) 
 
For all four traces, a small endotherm E, interpreted as initial uptake of heat by the 
amorphous form of rifampicin, was observed and it is directly followed by an exotherm F 
indicating decomposition.  Furthermore, the onset temperatures of F in the four solvates 
are very similar (~187 oC).  This temperature is also consistent with the onset temperature 
of event C in the TGA traces for the four solvates in Figures 3 and 4.  The temperatures 
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of decomposition using DSC (~187 oC) and HSM (~220 oC) differ due to differences in 
crystal sizes and experimental conditions.    
 
Rifampicin Isostructural Series 2 (P5, P6 and P7) 
P5:  rifampicin • 2.5(1-propanol) • 4.3H2O  
P6:  rifampicin • 1.58(1-propanol) • 8.41H2O 
P7:  rifampicin • 0.6(iso-propanol) • 8.09H2O 
 
HSM 
Crystals of solvates P5 and P6 were immersed in silicone oil and placed side by side on a 
microscope slide (Figure 6).  For the crystal of solvate P5, the bubbling phenomenon 
appeared twice during the heating process.  The first appearance was observed between 
~91 oC and ~104 oC.  The second appearance was observed between ~121 oC and      
~163 oC.  Meanwhile, the crystal P6 experienced no obvious optical change until 
decomposition.  Both crystals decomposed at ~200 oC. 
 
Figure 6 HSM micrographs of solvates P5 and P6 recorded at various temperatures. 
 
Similarly to the crystal of P5, a crystal of solvate P7 (Figure 7) also experienced the 
bubbling phenomenon twice during the heating process.  The first bubbles formed at    
~83 oC, and continued until 114 oC.  The second bubbling phenomenon occurred in the 












Figure 7 HSM micrographs of solvate P7 recorded at various temperatures. 
 
The bubbling phenomenon indicates simultaneous loss of water and the included alcohol 
from the crystals.  Furthermore, the decomposition temperatures were almost identical in 
the cases of P5, P6 and P7.   
 
TGA 
The TGA traces for solvates P5, P6 and P7 are very similar (Figure 8).  They each 
displayed three thermal events A, B and C.  For P5 and P7, event A showed that the 
crystals lost mass instantly above 30 oC while the crystals of P6 only started to lose mass 
after ~37 oC.  These results are consistent with the fact that the crystals of P6 were 
obtained by leaving those of P5 on an open bench.  In each case, B indicates further 
simultaneous loss of water and alcohol while C indicates the onset of decomposition of 









Figure 8 TGA traces for rifampicin solvates P5 (top), P6 (middle) and P4 (bottom) 
 
The experimental mass loss for P5 is 22.1 ± 0.8% (n = 3) in the temperature range 30 oC 
to 170.0 oC while its calculated mass loss is 21.6%.  The experimental traces for P6 
showed a mass loss of 23.0 ± 0.4 % (n = 3) in the temperature range of 36.7 oC to       
166.7 oC while the calculated mass loss is 23.1%.  The experimental mass loss for P7 
is17.4 ± 0.8% (n = 3) in the temperature range of 30.0 oC to 160.0 oC while the calculated 
mass loss is 18.1%.  Hence, the total experimental mass loss for each solvate correlates 
well with the calculated mass loss.  The fact that the decomposition temperature in each 
TGA trace is very close (~189 oC) indicates that all the three solvates had transformed 
into the same species after desolvation. 
 
DSC 
The DSC trace for each of the solvates P5, P6 and P7 (Figure 9) showed three thermal 
events namely D, E and F.  Events D and E indicate the simultaneous desolvation 
followed by the decomposition of the material indicated by F.  Events D and E are 
attributed to desolvation since stepwise mass losses in TGA did not yield separate solvent 
contents in close accord with the stoichiometric formulae of the solvates.  Simultaneous 
loss of water and alcohol is presumably occurring.  However, the appearance of well-
separated peaks D, E possibly indicates some degree of solvent differentiation with 
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infinite guest cluster, respectively.  This possibly gives rise to the wider desolvation 
temperature range of D in P5 compared with that in P6.   
 
Figure 9 DSC traces for solvates P5 (top), P6 (middle) and P7 (bottom) 
 
In all three DSC traces, rifampicin decomposition commenced at ~186 oC.  The 
corresponding exotherm F correlates very well with the onset of decomposition shown in 
the TGA traces in Figure 8.  Again, it strongly suggested that all three solvates had been 
converted into the same species after desolvation. 
 
The following solvates (P8 - P11) do not belong to either of the previous isostructural 
series.  Each of them belongs to a unique solvate category.  
 
Solvate P8 
2rifampicin • 4.30iso-propanol • 14.7H2O 
 
HSM 
The crystal of P8 showed a colour change in the temperature range 30 oC to 190 oC, 
indicating the desolvation process (Figure 10).  The crystal showed signs of 
decomposition at ~190 oC.  
























Figure 10 HSM micrographs of solvate P8 recorded at various temperatures.  
 
TGA 
The TGA trace for P8 exhibited two thermal events, A and B (Figure 11).  The 
desolvation occurred over a wide temperature range (30 oC to 172.0 oC) and in what 
appear to be three steps, indicating the concurrent release of iso-propanol and water 
molecules from the solvate crystal.  Event B indicated the decomposition onset of P8 at 
187.9 oC.                                          
 
Figure 11 TGA trace for rifampicin solvate P8 
 
DSC 
The DSC trace for solvate P8 (Figure 12) showed a broad endotherm labelled C, 
indicating loss of included solvent between the temperatures of 37.6 oC and 133.3 oC.  A 
small endotherm D with onset temperature 175.3 oC represented initial uptake of heat by 
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Figure 12 DSC trace for rifampicin solvate P8  
 
For solvate P8, the onset temperatures of the thermal events that occurred in both TGA 
and DSC analysis correlated well with those shown in hot stage analysis.  
 
Solvate P9  
2rifampicin • 5.53(1-butanol) • 1.40H2O 
 
HSM 
The crystal of solvate P9 was clear at room temperature (Figure 13, 30 oC).  Micro-
fissures gradually appeared in the crystal during the heating process, indicating 
desolvation of the crystal.  Obvious bubbles started to appear at ~112 oC and stopped 
forming at ~146 oC, which again provides evidence of desolvation of the solvate crystal.  
The crystal then completely decomposed at ~188 oC, changing colour to dark brown. 
90 120 150 180 210 
T/oC 















Figure 13 HSM micrographs of solvate P9 recorded at various temperatures. 
 
TGA 
The TGA trace for solvate P9 showed a significant mass loss of 20.3 ± 0.7% (n = 3) in 
the temperature range 30.0 oC to 171.7 oC (represented by A in Figure 14).  This 
experimental mass loss is very close to the calculated mass loss (20.9%).  Event A shows 
essentially a two-step mass loss.  However, neither mass loss correlates well with that 
predicted from the derived stoichiometric formula.  This implies that there is 
simultaneous loss of water and 1-butanol.  Event B indicates the onset of decomposition 
of the desolvated compound at 191.5 oC. 
 
Figure 14 TGA trace for rifampicin solvate P9 
 



























The DSC trace for solvate P9 exhibited two endotherms D and E due to 1-butanol and 
water loss, followed by a decomposition exotherm F with the onset temperature of     
188.3 oC (Figure 15).  The onset of decomposition in DSC analysis corresponds well with 
that observed on TGA analysis. 
 
Figure 15 DSC trace for rifampicin solvate P9 
 
Solvate P10 
2rifampicin • 5.75ethylene glycol • 5.59H2O 
 
HSM 
Formation of micro-fissures in the crystal of solvate P10 was observed during the heating 
process (Figure 16).  These were attributed to the dehydration and loss of ethylene glycol 
from the crystal although no obvious bubbles appeared.  The crystal underwent a colour 
change (red to dark brown) at ~189 oC, suggesting the onset of decomposition.    
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Figure 16 HSM micrographs of solvate P10 recorded at various temperatures. 
 
TGA 
The TGA traces for solvate P10 showed a total mass loss of 21.0 ± 0.9% (n = 3) in the 
range from 30.0 oC to 164.2.0 oC (Figure 17).  The calculated mass loss is 21.8%.  Event 
A represents multiple-step mass loss which indicates simultaneous loss of water and 
ethylene glycol. The desolvated form then decomposed at ~191 oC, shown by B. 
 
Figure 17 TGA trace for rifampicin solvate P10 
 
DSC 
The DSC trace of solvate P10 (Figure 18) exhibited two broad endotherms D and E 
which are due to the loss of ethylene glycol and water molecules in the crystal, followed 




























Figure 18 DSC trace for rifampicin solvate P10 
 
Solvate P11  
2rifampicin • 6(1,4-dioxane) • 3H2O 
 
HSM 
The water and 1,4-dioxane molecules were released at ~53 oC, evidenced by the 
formation of bubbles from the crystal of solvate P11 (Figure 19).  The dehydration and 
desolvation continued until 154 oC during the heating process.  The crystal decomposed 
at ~201 oC evidenced by an obvious colour change to dark brown. 
 
Figure 19 HSM micrographs of solvate P11 recorded at various temperatures. 
   
TGA 
The TGA trace for P11 (Figure 20) showed multiple-step mass loss A, which is attributed 
to the simultaneous release of 1,4-dioxane and water molecules between the temperature 
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30.0 oC and 171.7 oC with the experimental mass loss of 25.3 ± 0.9% (n = 3).  This 
correlates well with the calculated mass loss 26.1%.  Event B corresponded to the 
decomposition of the desolvated form.  The onset of this event occurred at ~192 oC. 
 
Figure 20 TGA trace for rifampicin solvate P11 
 
DSC 
A broad endotherm C and a distinct exotherm D were evident in the DSC trace for 
solvate P11 (Figure 21).  The former was due to the simultaneous loss of water and      
1,4-dioxane while the latter was due to the decomposition of the desolvated compound 
with the onset temperature of 188.5 oC.   
 
Figure 21 DSC trace for rifampicin solvate P11 
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Rifaximin Hydrate F1 
F1:  2rifaximin • 7.4H2O 
 
HSM 
The crystal of hydrate F1 was clear and transparent at 30 oC (Figure 22).  The crystal 
colour gradually became more intense as a result of dehydration upon heating.  Further 
evidence of escaping water molecules was observed by the appearance of bubbles at    
~93 oC.  Crystal fragmentation also occurred during heating, indicating further 
dehydration and signs of decomposition (~226 oC).  The crystal completely decomposed 
at ~235 oC, shown by a colour change to dark brown. 
 
Figure 22 HSM micrographs of hydrate F1 recorded at various temperatures. 
 
TGA 
The TGA trace for hydrate F1 showed a two-step mass loss, labelled as A and B, 
respectively (Figure 23).  The first step, A, is attributed to the release of water molecules, 
occurring over a temperature range from 36.7 oC to 83.3 oC with a mass loss of             
7.0 ± 0.8% (n = 3).  The calculated mass loss is 7.8% and agrees well with the 
experimental mass loss.  The dehydrated compound then decomposed at ~231 oC.  
111oC 226oC 235oC 
93oC 85oC 30oC 




Figure 23 TGA trace for rifaximin hydrate F1 
 
DSC 
The DSC trace for hydrate F1 showed three independent thermal events C, D and E 
(Figure 24).  A broad endotherm C was attributed to the water release from 35.1 oC to 
134.6 oC.  This corresponds to the observation from HSM analysis.  A relatively sharp 
endotherm D represents the melting of the desolvated material followed by the 
decomposition and this stage can be observed clearly in HSM (colour change to red at 
226oC).  Exothermic peak E continues into the decomposition stage and appears at    
~230 oC.  Furthermore, the onset of decomposition determined by DSC corresponds with 
that obtained by TGA analysis.  
 
Figure 24 DSC trace for rifaximin hydrate F1 
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Solvate F2  
F2:  4rifampicin • 7.72ethylene glycol • 6.83H2O 
 
HSM 
The colour of the crystal of solvate F2 gradually became more intense with increasing 
temperature; this strongly suggests that the crystal experienced loss of ethylene glycol 
and water molecules during the heating process (Figure 25).  The crystal finally changed 
colour to brown and completely decomposed at ~234 oC.  
 
Figure 25 HSM micrographs of solvate F2 recorded at various temperatures. 
 
TGA 
Multiple-step mass loss A was evident from 30.0 oC to 206.0 oC (Figure 26).  This is 
attributed to the simultaneous release of ethylene glycol and water molecules from the 
solvate crystal.  The wide temperature range of the mass loss is due to the fact that a large 
amount of disordered ethylene glycol and water molecules formed a tight guest cluster in 
the structure of F2.  Furthermore, the X-ray analysis revealed that these guest clusters are 
isolated by intervening host molecules, which therefore impede their escape.  The 
experimental mass loss is 17.4 ± 1.2% (n = 5) while the calculated loss is 16.1%.  
Thermal event B indicates the onset of decomposition (230 oC) of the desolvated 
compound. 
234oC 218oC 
30oC 67oC 93oC 
132oC 




Figure 26 TGA trace for rifaximin solvate F2 
 
DSC 
The DSC trace in Figure 27 showed endothermic peaks labelled C and D, which are 
located in the temperature ranges of 35.1 – 92.0 oC and 94.5 – 138.8 oC respectively.  
Considering the fact that the dehydration of the hydrate F1 occurs within the temperature 
range 35.8 to 126.7 oC, one cannot simply assign peaks C and D as the dehydration and 
desolvation (ethylene glycol loss) peak, respectively.  In other words, both endotherm C 
and D represent the simultaneous loss of ethylene glycol and water molecules.  The 
exotherm E occurs at ~232 oC, demonstrating the decomposition of the desolvated form.  
Furthermore, this onset temperature determined from DSC analysis is in agreement with 


























Figure 27 DSC trace for rifaximin solvate F2 
 
Discussion 
Generally, the thermal behaviour of rifampicin solvates and rifaximin solvates can be 
divided into two parts: (a) simultaneous dehydration and loss of included organic solvent 
and (b) decomposition of the desolvated compound.  The temperature range of the event 
for each solvate determined based on TGA data (Table 1) correlates reasonably well with 
that obtained from DSC data (Table 2).     
 
Table 1 TGA results for the rifampicin solvates and rifaximin solvates 
Solvate  Mass loss 
range (oC) 
Experimental 





P1 30.0 – 134.2 12.4 ± 0.5% (n = 3) 12.5 184.3 
P2 42.1 – 133.2 9.7 ± 0.3% (n = 3) 9.6 182.7 
P3 30.0 – 150.0 12.6 ± 0.9%(n = 3) 13.5 182.3 
P4 37.2 – 168.5 10.3 ± 0.8% (n = 4) 10.3 182.4 
P5 30.0 – 170.0 22.1 ± 0.8% (n = 3) 21.6 189.0 
P6 36.7 – 166.7 23.0 ± 0.4% (n = 3) 23.1 189.0 
P7 30.0 – 160.0 17.4 ± 0.8% (n = 3) 18.1 189.0 
P8 30.0 – 172.0 24.0 ± 0.4% (n = 3) 24.1 187.9 
P9 30.0 – 171.7 20.3 ± 0.7% (n = 3) 20.9 191.5 
P10 30.0 – 164.2 21.0 ± 0.9% (n = 3) 21.8 191.0 
P11 30.0 – 171.7 25.3 ± 0.9% (n = 3) 26.1 191.5 
F1 36.7 – 83.3 7.0 ± 0.8% (n = 3) 7.8 230.9 




90 120 150 180 210 
T/oC 












Chapter 6: Thermal Analysis  
 
 347 
Table 2 DSC results for the rifampicin and rifaximin solvates  
Desolvation Solvate 
Range (oC) Onset (oC) Peak (oC) 
Decomposition 
onset (oC) 
P1 57.5 – 130.0 75.7 95.5 186.9 
P2 60.6 – 118.4 63.7 81.3 186.7 
P3 42.7 – 114.5 42.8 85.3 187.5 
P4 60.3 – 107.0 63.8 81.2 187.2 
39.3 – 105.0 53.3 74.0 P5 
129.6 – 157.4 130.6 142.5 
186.9 
47.2 – 90.3 55.6 74.8 P6 
98.3 – 154.5 125.5 138.5 
186.3 
P7 38.0 – 127.0 51.9 80.3 186.9 
P8 37.6 – 133.3 61.3 85.8 187.1 
P9 85.0 – 124.9 85.8 90.8 188.3 
32.9 – 94.1 61.3 67.3 P10 
94.5 – 195.4 112.6 142.7 
188.3 
P11 70.0 – 151.0 111.46 118.7 188.5 
F1 35.1 – 134.6 35.5 73.6 229.7 
35.5 – 92.0 39.1 63.8 F2 
94.5 – 138.8 107.0 112.1 
230.2 
 
For rifampicin solvates, the TGA mass loss range and DSC desolvation temperature 
range in isostructural series 1(P1 – P4) are narrower than those in series 2 (P5 – P7).  
This may due to the fact that the host molecule framework in the crystal structure of 
series 1 adopts a layered structure while that in series 2 adopts a clathrate-like structure.  
Therefore, solvent molecules in series 1 would tend to escape more easily than those in 
the series 2.  Furthermore, the difference between host molecule frameworks in the two 
series can also be related to the fact that the decomposition onset temperature of the 
desolvated material recorded in TGA of series 1 is lower (mean ~183 oC) than that of 
series 2 (mean ~189 oC).1  This trend is not, however, followed by the DSC data.  
 
As stated earlier, PXRD was employed in an attempt to characterise the desolvated 
materials of the six different solvatomorphic phases of rifampicin.  Notably, all the 
solvates were converted into an amorphous state after desolvation.  These amorphous 
phases possibly demonstrate polyamorphism2 (the ability of a substance to exist in 
several different amorphous modifications) based on their different TGA decomposition 
onset temperatures.  However, due to the time constraints on the author’s Ph.D study, a 
confirmation of this assumption is lacking.  In future work, more characterisation (e.g. 
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solubility testing) on these amorphous materials should be carried out to verify the 
existence of polyamorphism.  Furthermore, spectroscopic studies (e.g. NMR and IR) 
should be employed to confirm whether these amorphous phases have the chemical 
compositions corresponding to rifampicin.  
 
For rifaximin solvates, the decomposition temperatures of F1 and F2 are very close, 
indicating a possibility that F1 and F2 were converted into the same desolvated phases on 
heating.  However, more characterisation could be carried out to verify this assumption in 
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The initial intention was to attempt preparation of polymorphs, solvates, cyclodextrin 
complexes and cocrystals of the antitubercular drug isoxyl as well as to isolate and 
characterise a range of solvated forms of the antitubercular drugs rifampicin and 
rifaximin.  Achieving this goal would represent a contribution towards systematising the 
solid-state chemistry of these three drugs.    
 
Isoxyl 
The drug isoxyl has been employed as a useful antitubercular since the 1960s. Its 
polymorphism was investigated in 19711 when the unit cell dimensions of low precision 
and space group assignments for two polymorphic phases α and β were determined from 
X-ray diffraction photographs, and crude structural arrangements were postulated on the 
basis of these data.  However, no accurate molecular and crystal structures for these 
phases were subsequently published. Mechanistic aspects of the mode of action of isoxyl 
were elucidated in 2003 and 2007.2, 3  New derivatives of isoxyl were synthesised in 2006 
and 2008,4, 5 and a new dosage form of the drug was developed in 2010.6 These 
developments indicate an on-going commercial interest in isoxyl and motivated our 
revisiting the drug in this study. 
 
Polymorphism 
In this study, accurate molecular and crystal structures of two polymorphs (designated 1 
and 2) were determined for the first time by X-ray diffraction methods.  These two phases 
are conformational polymorphs. A combination of thermal, X-ray diffraction and 
solubility data allowed the construction of a schematic Energy-Temperature diagram for 
this dimorphic system. Forms 1 and 2 were established as being enantiotropically related, 
Form 2 being the metastable phase at room temperature.   
 
Solubility measurements at 25 oC revealed that Form 2 dissolved at a faster rate than 
Form 1 within the intial 12 h period. This is the expected behaviour since Form 2 is the 
metastable form at room temperature. However, a significant portion of Form 2 
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transformed into Form 1 during the solubility analysis.  This results in the solubility of 
Form 1 and Form 2 reaching the same level after 25 h.  If the same transition were to 
occur in vivo, then these results indicate that polymorphic control may not be crucial for 
oral dosage formulation (tablet/capsule) of isoxyl.  
 
Evidence for a third polymorph of isoxyl (designated Form 3) has been reported.7  
During the present study, much effort was invested into isolating this form in order to 
characterise it completely.  However, it has to date remained elusive.  It is possible that 
this particular form may have a significantly higher solubility relative to Forms 1 and 2 
since the difficulty experienced in isolating Form 3 strongly suggests that it is a 
metastable polymorph. Therefore, the appearance of this ‘missing’ form could eventually 
have significance in the pharmaceutical production of the drug isoxyl. 
 
Solvate of Isoxyl 
A solvate of isoxyl with 1,4-dioxane (S1) was isolated and characterised successfully by 
X-ray and thermal methods.  The solvate S1 desolvates to yield metastable polymorphic 
Form 2 of isoxyl, either following controlled heating or by spontaneous desolvation at 
ambient temperature during exposure to the atmosphere.  We assume that the 
transformation of S1 to polymorphic Form 2 (rather than Form 1) is facilitated by the 
presence of similar structural features in the crystals of S1 and Form 2 and the existence 
of a common ‘tape’ motif in their respective packing arrangements. 
 
Cyclodextrin (CD) Complexes  
The formation of a genuine β-CD-isoxyl inclusion complex was confirmed by finding 
that its experimental PXRD pattern matched a reference trace for a specific isostructural 
series of known β-CD inclusion complexes.  A genuine γ-CD-isoxyl inclusion complex 
was identified in the same manner.  Unequivocal identification yielded space group 
information for each complex and allowed deduction of approximate unit cell dimensions 
as well as the CD frameworks in the respective inclusion complexes.   
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For isoxyl, solubility enhancement measurements using β- and γ-CD solutions revealed 
that the aqueous solubility of the drug in these media increased by at least a factor of two 
in the former case, and three in the latter case, relative to its concentration in pure water. 
There is scope for enhancing the solubility of isoxyl more significantly by employing 
derivatised CDs (e.g. hydroxypropylated β-CD), though this was not a priority of this 
study. 
 
Cocrystal Formation  
A large number of experiments was performed in attempts to isolate cocrystals of isoxyl 
with over 10 different cocrystal formers.  However, little or no indication of cocrystal 
formation was observed under the conditions employed. Most often, the choice of solvent 
is crucial and failure to choose the correct solvent or solvent mixture may have been 
responsible for the lack of success. The negative results from this study could 
nevertheless serve as useful information for those engaged in screening for cocrystal 
formation of isoxyl.   
 
It is known that a new polymorph of either or both of the cocrystal partners can 
accidentally result during the attempted preparation of a cocrystal.8  In this study, 
serendipitous precipitations of new polymorphs of two important and widely-used co-
formers isonicotinamide and nicotinamide occurred during the attempt to prepare 
cocrystals of isoxyl.  From a practical viewpoint, an important result emerged: under the 
conditions employed in this study, the appearance of the new polymorph of 
isonicotinamide does not depend on the presence of isoxyl, while that of the new 
polymorph of nicotinamide does.  
    
For isonicotinamide, two polymorphs had been isolated earlier and their crystal structures 
were reported in 2003;9,10 however, their thermal relationship was hitherto unknown.  
These two forms, designated Forms 1 and 2 in this study, were evidently the only known 
polymorphs of isonicotinamide, despite its successful use as a cocrystal former in 56 
different single crystal structures reported for the period 1999 – 2010, based on a CSD11 
search.  The new form isolated in this study has been designated Form 3.  Its crystal 
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structure was determined and carefully compared with the known structures of Forms 1 
and 2. The precise differences at the conformational and crystal packing levels have been 
described in detail in this work.  An exhaustive exploration of the thermal behaviours of 
the three polymorphs of isonicotinamide, coupled with other experimental evidence, led 
to the conclusions that Form 1 is enantiotropically related to Forms 2 and 3, while 
Forms 2 and 3 are monotropically related.  
 
The single crystal structure of nicotinamide (Form 1) was determined in 195312 while the 
polymorphism of nicotinamide was first discussed in 2001.13  During the period 1950 – 
2010, although the structures of 18 cocrystals containing nicotinamide were determined 
successfully based on a CSD11 survey, the structure of only one nicotinamide polymorph 
was determined.  The new polymorph of nicotinamide characterised in this study has 
been designated Form 2.  The two forms may be described as conformational 
polymorphs. Furthermore, the two forms were established as being monotropically 
related, Form 1 being the more stable phase. 
 
Schematic Energy-Temperature diagrams for the trimorphic isonicotinamide system and 
the dimorphic nicotinamide system were constructed in this study.  Notably, in both 
cases, the density order of the polymorphs deduced from the E/T diagrams agrees with 
their calculated densities at 173 K.  
 
Rifamycins  
Rifampicin and rifaximin, two rifamycin derivatives, were investigated with respect to 
their solvatomorphism in this study.  The two compounds were found to crystallise as 
solvates with various organic solvents, water almost invariably being present in the 
crystal as well.  
 
The molecules of rifampicin and rifaximin tend to exist as zwitterions in the solid state. 
For rifampicin, this applies to all the host molecules in solvates P1 – P11 investigated in 
this study, except molecule A (one of two crystallographically independent host 
molecules A and B) in the structure of solvate P10.  For rifaximin, this applies to all the 
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host molecules in solvates F1 and F2.  Furthermore, the zwitterionic form is invariable, 
the common N+-H function being derived by proton transfer from the hydroxyl group on 
C8 to a nitrogen atom (piperazinyl atom N4 in the rifampicin molecule, and imidazole 
atom N2 in the rifaximin molecule). 
 
Rifampicin 
Administration of rifampicin, a semisynthetic derivative of rifamycin, is part of the 
standard therapy to treat tuberculosis.  It shows excellent oral bioavailability.  Although 
nine solvates of rifampicin have been reported since 1975, only one crystal structure was 
published, namely that of rifampicin pentahydrate.14  In the present study, the author 
successfully isolated and characterized a total of 11 solvated forms of rifampicin.  These 
solvates were classified into six isostructural series and the PXRD patterns computed 
from their accurately-determined crystal structures will in the future serve as useful 
references for the identification of new rifampicin solvates (just as the reference patterns 
for CD inclusion complexes used by the author were employed for the identification of 
newly prepared inclusion complexes).   
 
Isostructural series 1 comprises four different solvates: Rifampicin • 1.57methanol • 
3H2O (P1), Rifampicin • 0.39methanol • 4.17H2O (P2), Rifampicin • 2ethanol • 2H2O 
(P3) and Rifampicin • 0.54ethanol • 3.92H2O (P4).  Crystals of P2 and P4 may be 
obtained from the crystals of P1 and P3, respectively, when the latter are exposed to 
atmospheric humidity.  Isostructural series 2 comprises Rifampicin • 2.5(1-propanol) • 
4.3water (P5),   Rifampicin • 1.58(1-propanol) • 8.41water (P6) and Rifampicin • 0.6iso-
propanol • 8.09water (P7).  Crystals of P7 result from exposure of crystals of P6 to the 
atmosphere.  Thus, solvent guest exchange with water in the atmosphere, a feature of the 
solvate crystals P1 – P7, was demonstrated and shown to leave the Rifampicin host 
frameworks intact.  These results indicate that control of humidity is very necessary to 
ensure constancy and reproducibility in the preparation of particular solvates of 
Rifampicin.  
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The rifampicin molecules in solvates P1 – P4 (series 1), P8 and P10 display very similar 
structural features.  The hosts in solvate P9 possess different structural features from 
those in other solvates, reflected in the spatial arrangements of atoms O11 and C18.  This 
also applies to the rifampicin molecules in solvate P11.  All the host molecules in 
solvates P1 – P4 and P8 – P11 display an equatorial configuration of the piperazinyl ring.  
However, the rifampicin molecules in solvates P5 – P7 (series 2) show a larger variation 
in their structural features, including an axial configuration for the piperazinyl residue.     
 
A noteworthy observation is that crystals of P7 and crystals of P8 grew from the identical 
solvent mixture and crystallised at the same temperature, the only difference in their 
preparations being the lack of solution filtration in the former case and the need for 
filtration in the latter. This resulted in crystals with completely different morphology and 
properties.  Once again, this indicates that the need for strict control of preparative 
methods is essential to ensure constancy and reproducibility in the preparation of a given 
solvate.    
 
Rifaximin 
Rifaximin is a promising new oral drug in the treatment of tuberculosis.15 It is 
characterised by a wide spectrum of antibacterial action, however showing less than 1% 
gastrointestinal absorption.  In this study, rifaximin was found to be considerably less 
prone to solvatomorphism than rifampicin.  
 
The X-ray structure of rifaximin tetrahydrate was published by Bacchi et al.16 some 
months after the author had determined essentially the same structure.  There are two 
symmetry-independent host molecules A and B in the crystallographic asymmetric unit. 
Furthermore, the two molecules adopt significantly different conformations, reflected in 
two distinct orientations of the C15=O11 bond and consequent changes in proximal 
torsion angles. The author’s investigation of this phase extended to additional 
characterisation by thermal methods (TGA, DSC and HSM).  To the extent that it was 
possible, the thermal data were reconciled with crystal structural features (in particular 
the topology of guest solvent molecule inclusion).   
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A new solvate of rifaximin, F2, containing ethylene glycol and water, was isolated and 
characterised.  The structure of F2 contains four independent host molecules, all of which 
adopt very similar conformations to that of the host molecule A in the phase F1. 
However, the unit cell and host molecule framework of F2 are completely different from 
those of the rifaximin hydrate.  Thus, two distinct structural classes of rifaximin solvates 
have been established in this study.       
 
Regarding the use of ethylene glycol as a solvent in the preparation of solvated phases of 
the rifamycins, it is important to note here that this was initiated in a systematic study 
after it was discovered that large crystals of rifampicin, present in compound rifampicin 
suspensions, contained traces of toxic ethylene glycol, whose source was possibly as a 
contaminant of other industrial solvents employed in drug processing. This is the subject 
of a paper by principal author M. M. de Villiers,17 to which the author of this thesis 
contributed X-ray crystallographic evidence of the presence of ethylene glycol in solvate 
P10 as a representative rifampicin solvate.          
 
In summary, the isolation and unequivocal physicochemical characterisation of new solid 
forms of the antitubercular drugs reported in this thesis provide data that are relevant in 
the context of their processing, formulation and performance.  
 
Further Work 
Specific items that have been identified as meriting further investigation are mentioned 
here. It is desirable that further efforts to isolate and fully characterise the third 
polymorphic form of isoxyl (Form 3) be carried out.   
 
Another worthy goal is the full X-ray structural elucidation of the β- and γ-CD complexes 
of isoxyl if single crystals can be grown, and the accurate determination of the 
stoichiometry and stability constant of each complex in solution using NMR analysis.  
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 A more focused programme utilising commercial screening apparatus should be applied 
in the search for isoxyl cocrystals, since such cocrystals are likely to have significantly 
higher aqueous solubilities than that of the untreated drug.   
 
For the rifampicin and rifaximin solvates, the chemical compositions of their desolvated 
phases, which are produced by controlled heating, could be verified by spectroscopic 
studies (e.g. NMR and IR).  Furthermore, since the variable behaviour of residues 
resulting from desolvation of rifampicin solvates just prior to their decomposition 
suggests the possibility of polyamorphism, further characterisation of these phases (e.g. 
dissolution testing) could be employed to explore this possibility.  
 
Hydrogen bonding networks featured prominently in this work, having been observed 
and studied in both polymorphs and crystalline solvates.  The analyses undertaken were 
based on X-ray diffraction data, which often limit the location of H atoms, especially 
those associated with solvent molecules.  Future work could include neutron diffraction 
studies to determine such H atom positions accurately and hence obtain more 
comprehensive hydrogen bonding schemes.  A deeper understanding of the topologies of 
these networks could lead to their deliberate creation in crystals of new compounds.  
Other techniques that could be applied to gain more understanding of the hydrogen-
bonded networks include density functional theory (DFT) and Natural Bond Orbital 
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The folder Appendix on the disk attached to the inside back cover of this thesis contains: 
 
Appendix 1: A full list of the outcomes of recrystallisation of isoxyl from a range of 
solvents/solvent mixtures, as well as the results from other methods of polymorph 
preparation.   
 
Appendix 2: A full list of the outcomes of cocrystal formation experiments with isoxyl. 
  
Appendix 3: Supplementary crystallographic information for solved structures in this 
thesis is saved in a subfolder named according to the designation used in this thesis.  The 
files may be viewed with WORDPAD or NOTEPAD. 
 
Table Results of isoxyl polymorph preparation using various methods 
Method  Concentration (mg/ml) Crystallising form 
Crystallisation of raw material from 
single solvent systems* 
    
Acetonitrile 1 Form 1 
Methanol 2 Form 1 
Formamide 1 Form 1 
sec-butyl acetate 2 Form 1 
1,3-dioxolane 1 Form 1 
ethyl isobutyrate 2 Form1 
propyl chloride   2 Form 1 
n-propyl acetate 1 Form 1 
ethyl propionate 2 Form 1 
diacetamide 2 Form 1 
m-cresol 2 Form 1 
chloroform  2 Form 1 
bretylium aceticum 1 Form 1 
triethylamine 1 Form 1 
isoamyl Alcohol 2 Form 1 
isopropyl 2 Form 1 
3-nitro toluol 1 Form 1 
1-chloropentane 2 Form 1 
tetrahydropyran 2 Form 1 
dichloromethane 2 Form 1 
2-methylpropan-1-ol 2 Form 1 
2-propanol 2 Form 1 
1-propanol 2 Form 1 
1,2-dimethoxyethane 2 Form 1 
1-octanol 1 Form 1 
toluene  2 Form 1 
2-butanol  2 Form 1 
3-pentanol 2 Form 1 
triophere 1 Form 1 
4-ethylpridine 1 Form 1 
methyl isobutyrate 1 Form 1 
3-pentanone 1 Form 1 
diethylformamide 1 Form 1 
methoxyacetonitrile   2 Form 1 
pinacolone 1 Form 1 
tert-butylacetic acid 1 Form 1 
iso-butyronitrile 1 Form 1 
cyclohexanol 0.5 Form 1 
di-n-butyl ether 0.5 Form 1 
benzol 0.2 Form 1 
n-phenyl acetate 0.5 Form 1 
anylacetate 0.5 Form 1 
dimethyl sulfoxide 2 Form 1 
3-chlorophenol 2 Form 1 
diethyl ether  2 Form 2 
2-nitrotoluol 2 Form 2 
benzotrifluoride 1 Form 2 
formic acid 1 Form 2 
1-chloroheptane  0.5 Form 2 
dimethylformamide  0.2 Form 2 
chlorobenzene 0.5 Form 2 
acetone 2 Form 2 
n-methylformamide 1 Form 2 
1-chlorobutane 1 Form 2 
diatace 1 Form 2 
cyclohexane 0.1 Form 2 
carbon tetrachloride  0.1 Form 2 
3-methyl-1-butanol 2 Form 2 
3,3-dimethyl-2-butanone 1 Form 2 
Crystallisation from binary solvent 
systems* 
    
Water:Ethanol (1:9 v/v)  1 Form 1 
Water:Ethanol (2:8 v/v) 0.5 Form 2 
Vapor diffusion     
formamidea:2-propanolb  1 Form 1 
formamidea: Cyclohexanolb 1 Form 1 
formamidea: Ethanol 90%b 1 Form 1 
Solid-state grinding of either Form 1 or 
Form 2 
 No effect 
Sublimation  Form 1 + Form 2 
* Each solution was prepared at 10 oC lower than the boiling point of the solvent and filtered.  The solution 
was then allowed to cool to room temperature spontaneously for recystallisation to occur.  
a solvent, b precipitant 
 
Table Results of cocrystal formation experiments with Isoxyla  
Co-former Solvent Ratiob  Result 
1:1 Isonicotinamide Form 1 
2:1 Isonicotinamide Form 1 
Ethanol 90% 
1:2 Isonicotinamide Form 1 
1:1 Isonicotinamide Form 1 
2:1 Isonicotinamide Form 1 
Acetonitrile 
1:2 Isonicotinamide Form 1 
0.75:2 Isoxyl Form 2 
1:1 Isonicotinamide Form 1 
2:1 Isonicotinamide Form 1 
Ethanol 80% 
1:2 Isonicotinamide Form 1 
4:1 Isonicotinamide Forms 1 and 2 Chloroform 
6:1 Isonicotinamide Forms 1, 2, and 3 
4:1 Isonicotinamide Forms 1 and 2 Ethanol 99.4% 
6:1 Isonicotinamide Forms 1 and 2 
4:1 Isonicotinamide Forms 1 and 2 Ethyl acetate 
6:1 Isonicotinamide Forms 1 and 2 
3-methyl-2-butanol 5:1 Isonicotinamide Forms 1 and 2 
Ethyl isobutyrate 5:1 Isonicotinamide Forms 1 and 2 
1-butanol 2:1 Isonicotinamide Forms 1 
Isonicotinamide 
1-propanol 1:2 Isonicotinamide Forms 1 
1:1 Nicotinamide Form 1 
2:1 Nicotinamide Form 1 
Ethanol 90% 
1:2 Nicotinamide Form 1 
1:1 Nicotinamide Form 1 
2:1 Nicotinamide Form 1 
Acetonitrile 
1:2 Nicotinamide Form 1 
1:1 Nicotinamide Form 1 
2:1 Nicotinamide Form 1 
Ethanol 80% 
1:2 Nicotinamide Form 1 
Ethylene glycol 3:1 Nicotinamide Form 1 
Chloroform 6:1 Nicotinamide Form 1 
Ethanol 96.4% 6:1 Nicotinamide Form 1 
Ethyl acetate 7:1 Nicotinamide Form 2 
3-methyl-2-butanol 5:1 Nicotinamide Form 1 
Ethyl isobutyrate 5:1 Nicotinamide Form 1 
Toluene 6:1 Nicotinamide Form 1 
Nicotinamide 














Ethanol 99.6% 6:1 Saccharin 
Co-former Solvent Ratiob  Result 
Acetone  6:1 Saccharin 
Ethyl acetate 4:1 Saccharin 
3-methyl-2-butanol 5:1 Saccharin 
Ethyl isobutyrate 5:1 Saccharin 
chloroform 4:1 Saccharin 
1,4-dioxane 4:1 Saccharin 
methanol 4:1 Saccharin 






Acetonitrile  2:1 D-Tartaric acid 
4:1 D-Tartaric acid Ethyl acetate 
8:1 D-Tartaric acid 
Chloroform  8:1 D-Tartaric acid 
Ethyl isobutyrate 8:1 D-Tartaric acid 
Methanol  4:1 D-Tartaric acid 
Toluene  5:1 D-Tartaric acid 
1-butanol 2:1 D-Tartaric acid 
D-(+)-tartaric 
acid 
1-propanol 2:1 D-Tartaric acid 
2:1 L+Tartaric acid Acetonitrile  
6:1 L+Tartaric acid 
4:1 L+Tartaric acid Ethyl acetate 
8:1 L+Tartaric acid 
Chloroform  8:1 L+Tartaric acid 
Ethyl isobutyrate 8:1 L+Tartaric acid 
Methanol  4:1 L+Tartaric acid 
2:1 L+Tartaric acid 1-butanol 
5:1 L+Tartaric acid 
L-(+)-tartaric 
acid 
1-propanol 1:2 Isoxyl Form 1 
3:1 Succinic acid 1-butanol 
2:1 Succinic acid 
Ethanol 96.4% 4:1 Succinic acid 
Succinic acid 
1-propanol 1:2 Succinic acid 
Ethyl acetate  4:1 Citric acid 
Ethanol 96.4% 4:1 Citric acid 
1-butanol 2:1 Citric acid 
1-propanol 1:2 Citric acid 
Methanol 4:1 Citric acid monohydrate 
Citric acid 
Ethyl acetate 4:1 Citric acid monohydrate 
Ethyl acetate  4:1  Salicylic acid 
1-butanol 2:1 Salicylic acid 
Ethanol 96.4% 4:1 Salicylic acid 
Salicylic acid 
1-propanol 1:2 Salicylic acid 
Ethyl acetate 8:1 Maleic acid 
1-butanol 2:1 Maleic acid 
Maleic acid 
1-propanol 1:2 Maleic acid 
Oxalic acid Ethyl acetate 4:1 Oxalic acid 
Co-former Solvent Ratiob  Result 
Ethyl acetate  4:1 Oxalic acid 
1-butanol 2:1 Oxalic acid 
Ethanol 96.4 4:1 Oxalic acid 
Oxalic acid 
1-propanol 1:2 Oxalic acid 
a A physical mixture of 10 mg of isoxyl and the corresponding co-formers was dissolved in 2 ml 
solution at 10 oC lower than the boiling point of the solvent and filtered.  The solution was stirred 
for 10 minutes and filtered (0.45 µm nylon filter) while hot.  It was then placed in a Dewar flask 
containing water at the same dissolving temperature o allow for slow cooling to room 
temperature (spontaneously) for recystallisation to occur. 
 
b A molar ratio of cocrystal former: isoxyl is applied. 
 
 
 
 
